data_1z2q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z2q _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.54 -11.76 18.69 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.138 2.559 . . . . 0.0 112.846 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.7 155.38 50.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -60.4 122.79 15.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.115 0.483 . . . . 0.0 111.827 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.5 m120 -61.68 -26.68 68.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.928 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 -56.39 2.16 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.221 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.3 p -104.63 -3.6 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.73 69.96 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.725 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -71.74 143.51 49.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.416 0.608 . . . . 0.0 110.251 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.39 137.5 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.796 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.5 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 93.9 m-85 -83.29 134.43 34.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.162 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 p -126.38 172.58 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.268 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.2 p -50.54 -40.84 52.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.003 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.9 p -75.85 -26.34 57.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.254 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.56 113.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.376 0.608 . . . . 0.0 111.392 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -73.63 143.73 46.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.106 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 23.7 ttm105 -86.29 142.14 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.629 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -144.01 169.19 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 111.607 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.493 ' CE1' HG21 ' A' ' 46' ' ' VAL . 93.8 m-70 -128.83 146.82 50.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.537 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.3 t -90.44 137.99 31.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -72.76 -6.88 47.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.501 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 73.4 m-20 -100.69 -70.27 0.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.4 p -76.44 -23.78 53.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.91 21.98 79.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.39 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 21.2 m-85 -98.07 160.81 14.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 110.236 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.5 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 85.4 t -75.96 128.97 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.166 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 45' ' ' TYR . 3.2 mm? -133.43 138.58 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.45 176.32 8.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.727 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.08 -52.8 41.1 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.225 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -55.83 -35.84 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.32 -1.7 58.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.462 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -131.99 28.65 4.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.727 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 73.3 mtm180 -84.71 -16.39 41.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.227 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -81.31 164.7 22.0 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.5 136.18 32.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.527 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.96 154.34 25.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.793 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.9 154.0 20.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.548 HG22 ' CG ' ' A' ' 61' ' ' ARG . 2.3 mt -130.3 79.77 71.91 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 110.939 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.06 -8.96 19.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.179 2.586 . . . . 0.0 114.19 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.08 -37.83 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 109.193 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.548 ' CG ' HG22 ' A' ' 58' ' ' ILE . 14.2 mmm180 -83.03 1.04 42.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.454 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.13 6.94 61.3 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG23 ' CG ' ' A' ' 67' ' ' GLU . 75.6 mt -96.2 102.35 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.214 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -88.08 -18.54 28.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 56.0 mm-40 -103.06 142.53 24.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -56.43 124.0 15.21 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.674 1.583 . . . . 0.0 111.819 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' CG ' HG23 ' A' ' 63' ' ' ILE . 75.7 mm-40 -124.74 166.81 15.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -70.56 136.71 49.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.618 0.723 . . . . 0.0 111.639 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.501 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.3 m -145.24 -179.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.976 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.56 -168.35 1.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -76.26 -43.71 40.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.22 72.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 52.8 m -63.84 -40.57 96.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.743 0.306 . . . . 0.0 110.41 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.402 ' HB2' HG21 ' A' ' 69' ' ' VAL . 76.6 t80 -56.79 -39.6 74.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.1 mt -72.9 -52.49 14.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.02 -48.27 52.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.385 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.411 HD23 HG23 ' A' ' 58' ' ' ILE . 70.7 mt . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.47 -15.4 24.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.9 2.4 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.33 156.88 48.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.1 t -63.99 124.98 22.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.1 m-80 -60.28 -26.56 66.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.969 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.45 -55.92 2.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.444 -0.884 . . . . 0.0 114.341 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -105.23 -0.29 26.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 68.83 9.07 58.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.562 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 p -69.52 143.52 53.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.226 0.513 . . . . 0.0 110.211 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.99 138.98 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 92.2 m-85 -84.18 136.04 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.375 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -127.74 171.61 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.105 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -47.47 -41.1 19.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.808 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.1 p -73.54 -24.84 60.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.641 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -97.89 113.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.738 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.72 150.25 37.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.533 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 14.7 ttp180 -80.18 141.54 35.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 0.0 110.598 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -139.96 160.95 38.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.665 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.432 ' CE1' HG21 ' A' ' 46' ' ' VAL . 89.9 m-70 -128.49 146.05 50.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.523 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.9 t -91.33 136.2 33.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tpt180 -72.33 -4.63 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.531 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 77.1 m-20 -101.65 -71.54 0.71 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -76.51 -24.04 53.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.77 78.55 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.79 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.1 m-85 -99.01 160.91 13.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 77.5 t -78.36 128.75 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.543 ' N ' HD21 ' A' ' 47' ' ' LEU . 1.4 mm? -131.45 140.83 49.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.354 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.85 178.37 8.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.598 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -55.59 -52.15 50.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.43 -1.367 . . . . 0.0 112.047 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -54.67 -34.88 62.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.423 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -91.81 -2.23 57.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -132.3 28.93 4.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 12.9 mmt85 -84.68 -17.88 37.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.324 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -79.53 165.62 22.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.226 0.536 . . . . 0.0 111.475 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -141.37 134.71 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . . . -158.01 153.41 26.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.658 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -86.48 158.0 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.515 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.4 mt -134.15 78.37 58.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.919 0.39 . . . . 0.0 110.555 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.82 -12.14 32.74 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.265 2.644 . . . . 0.0 114.066 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.9 mmm -85.31 -38.29 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' CG ' HG22 ' A' ' 58' ' ' ILE . 13.9 mmm180 -83.86 1.76 41.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.673 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 9.22 60.39 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.686 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.495 ' CD1' ' HG2' ' A' ' 41' ' ' ARG . 61.8 mt -100.58 99.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.849 0.356 . . . . 0.0 110.356 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.4 p -85.04 -16.99 38.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.785 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 63' ' ' ILE . 22.6 mt-10 -102.81 145.06 29.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 14.7 Cg_endo -58.67 124.11 15.05 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.416 1.411 . . . . 0.0 111.657 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' CG ' HG21 ' A' ' 63' ' ' ILE . 76.4 mm-40 -124.85 167.78 14.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.747 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -72.06 137.2 46.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.652 0.739 . . . . 0.0 111.916 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.531 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 35.1 m -146.83 -178.06 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.126 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.477 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -96.4 -162.88 0.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -82.62 -42.67 17.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.67 75.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 111.691 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 37.0 m -63.19 -40.38 97.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.533 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 72.4 t80 -57.32 -38.97 74.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.66 -51.67 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.506 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.7 78.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.165 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 58' ' ' ILE . 88.6 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.503 0.668 . . . . 0.0 109.346 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.07 -12.29 27.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.07 2.514 . . . . 0.0 112.68 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.13 156.39 48.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.3 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' GLY . 18.4 t -64.54 125.29 24.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.174 0.511 . . . . 0.0 111.437 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 70.0 m-80 -59.5 -26.44 65.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.031 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.72 -55.46 2.15 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.165 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.8 p -102.92 -4.7 24.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 71.37 10.98 71.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.41 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.8 p -71.65 142.67 49.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.317 0.559 . . . . 0.0 110.278 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.78 137.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.534 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CZ ' HG13 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.86 134.53 34.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.276 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -127.26 169.61 13.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.954 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.6 m -46.84 -42.16 16.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.96 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.1 m -68.54 -36.09 78.34 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.316 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -90.65 113.67 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.338 0.59 . . . . 0.0 111.463 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.33 148.72 39.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.008 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' HG3' HG12 ' A' ' 46' ' ' VAL . 48.1 ttp85 -78.97 139.54 38.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.0 m-70 -141.94 162.74 34.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.453 ' CE1' HG23 ' A' ' 46' ' ' VAL . 89.5 m-70 -129.54 146.57 51.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.642 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 t -91.6 137.91 31.99 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -73.42 -5.47 40.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 76.0 m-20 -100.9 -72.06 0.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.613 0.244 . . . . 0.0 111.624 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 31.4 p -75.81 -24.89 55.93 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.24 21.63 78.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.746 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 26.1 m-85 -98.85 161.85 13.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.935 0.398 . . . . 0.0 110.459 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.511 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 85.2 t -78.44 128.93 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.076 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.513 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.2 mm? -131.41 139.07 49.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.44 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 p -75.64 177.09 7.06 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.704 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.48 -53.07 40.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.241 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 86.3 m-20 -55.53 -35.65 65.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.436 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -88.67 -2.03 58.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.317 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.1 p -132.55 27.62 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt180 -82.85 -17.85 42.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.139 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -79.47 165.06 23.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.281 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -140.82 136.0 31.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.424 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.417 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.39 154.48 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.468 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -92.25 150.8 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.533 HG23 ' CG ' ' A' ' 61' ' ' ARG . 3.0 mt -127.3 81.31 70.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 111.058 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.63 -9.98 22.77 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.206 2.604 . . . . 0.0 113.828 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -89.75 -36.89 14.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 109.263 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.533 ' CG ' HG23 ' A' ' 58' ' ' ILE . 5.3 mmm180 -86.79 15.57 5.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.677 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.02 10.34 85.1 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.854 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.428 HG21 ' CG ' ' A' ' 67' ' ' GLU . 74.8 mt -101.44 102.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -88.3 -19.11 27.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.588 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mt-10 -103.17 146.61 32.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.4 Cg_endo -59.14 123.47 13.52 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.62 1.546 . . . . 0.0 111.71 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.3 mm-40 -124.53 166.73 15.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -71.47 137.29 48.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.624 0.726 . . . . 0.0 112.0 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.511 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 30.0 m -145.5 -178.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.872 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.513 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -96.47 -166.45 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 55.6 t0 -78.89 -45.16 21.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.14 80.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.4 m -63.82 -41.25 97.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.388 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.7 t80 -56.38 -40.07 73.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.7 -52.3 18.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.11 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.15 -48.67 53.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.496 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 58' ' ' ILE . 58.9 mt . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.981 0.42 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.61 -14.94 30.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.942 2.428 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.93 156.95 47.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.459 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 47' ' ' LEU . 8.3 t -63.11 124.79 22.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.144 0.497 . . . . 0.0 111.439 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.437 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 66.1 m-80 -60.15 -26.21 66.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.289 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.82 2.25 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.343 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.4 p -104.42 -3.05 24.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.86 10.48 67.98 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.527 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.1 p -71.9 143.99 49.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.269 0.534 . . . . 0.0 110.168 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.93 138.77 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.469 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CZ ' HG13 ' A' ' 46' ' ' VAL . 96.7 m-85 -84.46 135.56 34.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -127.98 168.0 15.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.2 m -46.12 -43.78 15.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.312 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.13 -36.96 84.52 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.0 t -88.6 113.89 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -73.78 146.07 44.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.362 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.413 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 21.8 ttp-105 -80.33 140.11 36.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.441 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -142.11 164.64 29.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -130.79 147.44 52.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.568 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.7 t -90.23 137.0 32.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.403 ' HD3' ' HB3' ' A' ' 67' ' ' GLU . 53.2 mtp85 -71.43 -6.36 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.506 ' ND2' ' CD1' ' A' ' 58' ' ' ILE . 15.6 m-80 -102.88 -70.0 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.552 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.4 p -74.44 -24.81 59.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.783 0.325 . . . . 0.0 111.579 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.33 79.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.686 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.552 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 27.8 m-85 -97.0 164.37 12.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 110.682 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 62.2 t -80.83 128.4 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.059 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.51 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.5 mm? -132.12 137.62 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.5 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.1 p -77.32 173.33 12.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.743 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.11 -54.33 19.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.23 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 75.9 m-20 -54.92 -35.85 64.61 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.415 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -89.37 -1.82 58.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.22 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.1 p -131.16 25.22 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.743 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 57.9 mtm180 -80.36 -18.65 48.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.805 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -79.42 164.79 23.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.006 0.431 . . . . 0.0 111.157 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -143.1 138.15 29.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.5 155.56 22.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.912 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -82.45 159.48 22.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.623 HG21 ' HG2' ' A' ' 61' ' ' ARG . 1.3 mt -134.49 75.41 63.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -12.93 35.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.42 2.747 . . . . 0.0 114.34 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.8 mtt -87.05 -36.84 17.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.623 ' HG2' HG21 ' A' ' 58' ' ' ILE . 29.0 mmm180 -83.74 5.73 23.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.73 10.66 64.8 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.501 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.5 HG23 ' CG ' ' A' ' 67' ' ' GLU . 70.2 mt -102.21 102.54 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 0.0 110.363 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.9 p -87.83 -16.63 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.601 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 mt-10 -104.56 142.79 25.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 11.4 Cg_endo -55.13 122.57 11.94 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.879 1.719 . . . . 0.0 112.034 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' CG ' HG23 ' A' ' 63' ' ' ILE . 74.9 mm-40 -125.15 167.31 14.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.432 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -72.46 140.11 48.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.567 0.699 . . . . 0.0 111.898 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 m -147.3 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.085 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.51 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 2.9 p -93.48 -162.36 0.93 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.71 -41.74 17.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.97 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.586 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.14 -41.61 97.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 0.0 110.202 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -55.88 -40.61 73.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.51 -49.49 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.586 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.45 79.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD13 ' ND2' ' A' ' 42' ' ' ASN . 77.4 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.024 0.44 . . . . 0.0 110.816 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.908 0.385 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.07 -15.23 32.24 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.1 2.533 . . . . 0.0 112.651 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.68 46.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.401 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.2 t -62.3 122.48 15.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.761 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.5 m120 -61.12 -25.9 67.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.32 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.18 -55.76 2.3 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.51 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p -104.24 -2.65 25.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.13 7.97 64.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.253 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.0 p -69.6 143.0 53.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.099 0.449 . . . . 0.0 110.162 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.71 137.4 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.714 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.425 ' CZ ' HG13 ' A' ' 46' ' ' VAL . 92.5 m-85 -82.08 133.12 35.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.386 0.612 . . . . 0.0 109.886 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 p -124.7 173.03 8.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.174 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.1 p -50.4 -38.94 45.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.98 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 p -79.18 -22.91 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.651 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.03 113.12 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.629 . . . . 0.0 111.488 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -73.32 143.64 46.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.204 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' CG ' HG12 ' A' ' 46' ' ' VAL . 56.9 ttm-85 -84.71 141.14 30.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.428 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.3 m-70 -143.48 167.93 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.484 ' CD2' HG23 ' A' ' 46' ' ' VAL . 78.9 m80 -130.71 147.97 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.596 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.8 t -89.57 137.27 32.47 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -72.74 -6.34 43.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.518 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 78.2 m-20 -100.71 -70.26 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.571 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.99 -24.57 55.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.68 21.92 78.88 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.722 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.8 162.4 13.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.801 0.334 . . . . 0.0 110.512 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 39' ' ' HIS . 87.0 t -78.35 128.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.226 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 2.0 mm? -132.64 139.52 47.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -77.54 175.04 10.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.675 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.76 -52.87 35.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.673 -1.251 . . . . 0.0 112.358 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.67 -35.84 66.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 1.7 m -89.16 -2.34 58.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.24 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -131.78 27.3 4.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 74.9 mtt180 -82.19 -20.13 38.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.369 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -76.99 163.06 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 111.212 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -139.59 136.55 34.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.222 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB1' ' CD1' ' A' ' 74' ' ' TYR . . . -160.15 153.97 22.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -87.3 153.14 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.542 HG23 ' CG ' ' A' ' 61' ' ' ARG . 3.1 mt -129.25 77.6 77.33 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 110.808 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.8 -8.49 15.78 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 123.138 2.559 . . . . 0.0 113.894 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mmm -89.7 -37.87 14.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.0 109.36 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.542 ' CG ' HG23 ' A' ' 58' ' ' ILE . 2.8 mmm180 -84.31 2.71 38.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.441 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.25 7.68 61.98 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.535 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.48 HG23 ' CG ' ' A' ' 67' ' ' GLU . 72.7 mt -97.86 102.06 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.193 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.3 p -87.59 -17.43 31.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 mt-10 -103.11 142.01 23.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 32.2 Cg_exo -56.16 124.38 16.12 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.725 1.616 . . . . 0.0 112.061 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' HG23 ' A' ' 63' ' ' ILE . 74.4 mm-40 -126.41 166.85 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -69.25 136.44 51.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.473 0.654 . . . . 0.0 111.707 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 28.4 m -148.92 161.1 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.844 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.481 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -75.44 -168.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 55.3 p30 -81.15 -40.3 24.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.93 -44.41 73.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 111.37 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 64.3 m -63.91 -40.92 97.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.426 ' CD1' ' HB1' ' A' ' 56' ' ' ALA . 38.0 t80 -57.22 -41.09 78.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.9 mt -69.2 -49.05 60.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.748 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.91 83.15 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 58' ' ' ILE . 93.4 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.041 0.448 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.36 -15.69 25.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.913 2.409 . . . . 0.0 112.215 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.93 155.9 49.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.919 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.454 ' SG ' HD13 ' A' ' 47' ' ' LEU . 5.6 t -61.73 124.26 20.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 111.904 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 53.5 m-80 -61.41 -27.69 68.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.134 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 -56.05 2.5 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.619 -0.801 . . . . 0.0 114.716 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 p -105.56 -0.69 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.15 63.21 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.718 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.0 p -71.44 144.91 49.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.409 0.605 . . . . 0.0 109.837 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.96 140.33 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 81.2 m-85 -84.81 135.63 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.344 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.0 p -126.89 167.06 16.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -45.36 -41.67 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -70.5 -34.81 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.32 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.64 114.18 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.503 0.668 . . . . 0.0 111.554 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -78.72 150.19 32.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.669 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -90.34 142.53 27.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.137 0.494 . . . . 0.0 110.454 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.541 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.9 m-70 -139.7 168.14 20.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.129 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.72 143.93 49.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.757 0.313 . . . . 0.0 111.309 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.4 t -90.72 137.87 32.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -72.97 -5.22 37.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.557 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 78.6 m-20 -101.7 -72.21 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.785 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.0 p -77.09 -24.44 51.8 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.77 77.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.86 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.94 164.02 12.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' HIS . 60.9 t -80.8 128.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.55 ' N ' HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -130.7 137.64 49.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.348 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.27 174.29 8.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.729 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.08 -53.01 32.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.421 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.505 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 70.5 m-20 -56.26 -36.09 68.17 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -86.91 -3.33 59.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.135 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.2 p -131.66 26.03 4.71 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 70.8 mtp85 -82.21 -16.97 47.76 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.972 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -80.38 166.14 21.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -142.53 135.2 28.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.245 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.28 153.23 25.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.697 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.432 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.06 154.61 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.515 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.7 mt -131.35 81.11 66.24 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.997 0.427 . . . . 0.0 110.733 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.16 -8.12 19.29 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.981 2.454 . . . . 0.0 113.907 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.4 mtp -89.37 -37.12 15.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' CG ' HG22 ' A' ' 58' ' ' ILE . 13.7 mmm180 -84.83 4.0 35.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.19 4.42 66.64 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.533 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 HG21 ' CG ' ' A' ' 67' ' ' GLU . 74.2 mt -94.65 97.82 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.356 . . . . 0.0 110.157 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -84.66 -18.51 35.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.5 mt-10 -103.84 146.4 32.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.9 Cg_endo -57.89 123.84 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.029 1.819 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' CG ' HG21 ' A' ' 63' ' ' ILE . 80.5 mm-40 -126.42 167.52 15.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -71.76 137.49 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.732 0.777 . . . . 0.0 112.202 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.557 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.2 m -146.66 179.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.051 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.506 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -92.71 -162.25 0.91 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -83.51 -44.04 15.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.92 80.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.806 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.7 m -64.03 -40.99 97.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -55.8 -40.78 73.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.35 -53.99 12.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.34 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.9 -48.61 42.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.374 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 58' ' ' ILE . 72.3 mt . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.007 0.432 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.87 -10.09 21.27 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.137 2.558 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -135.99 158.01 45.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.366 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 47' ' ' LEU . 6.8 t -63.18 125.06 22.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 31.8 m120 -63.51 -25.49 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.364 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.28 -56.66 2.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.684 -0.77 . . . . 0.0 114.679 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 p -105.09 -1.85 25.07 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.05 65.77 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.423 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.4 p -67.09 143.89 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.257 0.528 . . . . 0.0 109.639 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.7 OUTLIER -84.25 143.44 11.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 94.5 m-85 -84.28 134.82 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.7 p -126.45 168.75 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.061 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.04 -44.7 31.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.356 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 m -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.562 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -87.96 113.04 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.364 0.602 . . . . 0.0 111.54 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -73.85 149.28 41.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.126 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.458 ' HG3' HG13 ' A' ' 46' ' ' VAL . 20.2 ttp180 -81.74 140.9 34.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.2 m-70 -142.23 165.89 26.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.144 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.458 ' CE1' HG21 ' A' ' 46' ' ' VAL . 96.7 m-70 -131.35 147.63 52.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 t -90.77 136.7 32.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.449 ' NE ' ' OE1' ' A' ' 67' ' ' GLU . 68.6 mtp85 -72.45 -5.45 36.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.501 ' ND2' ' CD1' ' A' ' 58' ' ' ILE . 14.7 m-80 -101.67 -70.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.9 p -75.0 -24.84 58.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.4 77.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.637 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.512 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.92 163.19 12.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 88.6 t -79.72 128.86 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.53 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 2.3 mm? -132.98 140.64 47.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.89 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 p -82.55 175.13 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.632 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -52.13 -52.65 34.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.127 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -53.85 -36.3 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.32 -1.26 57.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.703 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -132.47 25.91 4.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 110.089 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 19.6 mmt180 -79.23 -22.99 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -76.33 165.06 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.446 0.641 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -139.7 134.05 31.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.017 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.447 ' HB1' ' CE1' ' A' ' 74' ' ' TYR . . . -159.38 155.16 26.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.54 159.44 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.6 HG21 ' HG2' ' A' ' 61' ' ' ARG . 1.1 mt -133.12 74.96 72.33 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.092 0.473 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.95 -14.15 39.44 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.423 2.749 . . . . 0.0 114.491 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.3 mtm -86.54 -37.35 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG2' HG21 ' A' ' 58' ' ' ILE . 18.3 mmm180 -83.01 3.68 29.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.857 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.07 61.84 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.408 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CD1' HD13 ' A' ' 58' ' ' ILE . 63.7 mt -101.24 101.25 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.91 0.386 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -87.73 -16.01 35.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.434 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 63' ' ' ILE . 3.7 mp0 -103.19 145.2 30.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.0 Cg_endo -58.57 121.87 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.615 1.544 . . . . 0.0 112.005 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' NE ' ' A' ' 41' ' ' ARG . 94.7 mt-10 -125.49 168.74 13.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.702 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HB3' ' NH1' ' A' ' 68' ' ' ARG . 5.1 ptp180 -72.37 137.28 46.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.741 0.782 . . . . 0.0 112.333 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.41 -177.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.897 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.53 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -97.29 -162.14 0.93 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -82.81 -43.91 16.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.09 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 111.53 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -64.15 -40.53 96.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.289 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 79.8 t80 -57.25 -41.29 79.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.5 mt -70.64 -50.94 31.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.872 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.21 -48.33 54.34 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.422 HD11 HG23 ' A' ' 58' ' ' ILE . 44.8 mt . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.024 0.44 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.3 -12.3 25.24 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.056 2.504 . . . . 0.0 112.549 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.57 48.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.166 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.5 t -62.57 123.44 18.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.0 111.683 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.9 m120 -60.36 -26.79 66.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 -55.88 2.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.429 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.98 -3.15 25.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.41 8.96 67.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.437 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.4 p -70.01 142.69 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.208 0.504 . . . . 0.0 110.186 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.95 137.9 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.954 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.543 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 84.6 m-85 -83.73 134.64 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.5 p -127.48 171.2 11.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -46.9 -39.63 12.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 p -75.74 -25.45 56.55 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.828 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.9 t -96.74 112.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.36 0.6 . . . . 0.0 111.271 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -75.45 147.74 39.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.644 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.468 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.6 ttp85 -81.93 140.34 34.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.768 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -141.96 163.9 31.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.232 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -129.26 146.57 51.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.5 t -91.19 138.03 31.91 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -73.03 -5.43 38.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.499 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 76.2 m-20 -101.46 -71.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.505 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.1 p -76.94 -24.41 52.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 22.09 78.24 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.547 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.8 m-85 -98.17 161.2 13.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.896 0.379 . . . . 0.0 110.454 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.543 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 95.5 t -77.62 128.86 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.497 HD22 ' O ' ' A' ' 45' ' ' TYR . 1.7 mm? -132.2 139.15 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -78.88 175.94 10.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.731 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.51 -53.95 29.7 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.764 -1.207 . . . . 0.0 112.333 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -54.83 -35.53 64.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.429 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -90.33 -1.94 57.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.441 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 p -131.3 26.25 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 94.6 mtt-85 -80.96 -19.39 44.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.117 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -80.58 163.41 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.19 0.519 . . . . 0.0 111.438 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 mtm105 -139.36 136.99 35.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.274 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.49 154.62 27.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.95 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.97 151.77 20.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.537 HG21 ' CG ' ' A' ' 61' ' ' ARG . 3.3 mt -128.39 79.32 74.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.026 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.89 -9.97 20.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.217 2.611 . . . . 0.0 114.044 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.401 ' HE1' ' CD2' ' A' ' 77' ' ' LEU . 71.8 mtm -88.33 -37.87 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.537 ' CG ' HG21 ' A' ' 58' ' ' ILE . 30.8 mmm180 -83.17 1.01 42.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.441 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.42 60.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 58' ' ' ILE . 74.1 mt -96.64 101.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.398 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.3 p -88.25 -18.94 27.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.384 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 3.5 mm-40 -103.69 138.53 19.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.4 Cg_exo -52.99 124.3 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.692 1.595 . . . . 0.0 112.044 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 94.6 mt-10 -125.64 167.43 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -69.94 136.25 50.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 111.966 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.499 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 29.0 m -145.27 179.48 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.982 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.485 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.89 -166.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 56.3 p30 -79.36 -42.68 25.06 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -67.9 -45.95 72.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 111.7 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.2 m -63.63 -41.43 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.302 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 68.9 t80 -56.32 -40.36 74.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.55 -50.65 24.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.245 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.95 62.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.667 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD12 HG22 ' A' ' 58' ' ' ILE . 60.6 mt . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.973 0.416 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.67 -13.28 18.11 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.101 2.534 . . . . 0.0 112.644 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.64 155.82 49.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.438 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' A' ' 47' ' ' LEU . 4.7 t -59.62 123.93 18.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 111.552 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 29.5 m120 -60.83 -28.08 68.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.086 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.15 -54.77 2.36 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.329 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 p -103.68 -4.03 24.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.08 7.75 63.37 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.628 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p -69.88 144.16 52.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.264 0.532 . . . . 0.0 110.301 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.78 137.66 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.978 0.418 . . . . 0.0 112.066 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.471 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.41 134.59 34.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.213 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -128.04 170.78 12.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -49.3 -43.85 43.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.35 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.5 m -66.53 -35.82 81.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.65 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.6 t -89.59 112.66 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.288 0.566 . . . . 0.0 111.364 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -73.08 145.76 46.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.846 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' CG ' HG13 ' A' ' 46' ' ' VAL . 58.5 ttm-85 -83.81 141.34 31.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.656 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 99.8 m-70 -143.66 166.25 25.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -130.86 148.85 52.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.02 137.52 32.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' CG ' HD11 ' A' ' 63' ' ' ILE . 29.2 tpt180 -71.73 -7.18 46.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' OD1' HG23 ' A' ' 58' ' ' ILE . 68.6 m-20 -100.7 -69.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.514 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -76.98 -23.08 52.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.61 21.5 79.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.504 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.68 161.41 13.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.794 0.33 . . . . 0.0 110.252 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 85.2 t -79.21 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.24 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.4 mm? -132.41 141.01 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.743 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.2 p -79.45 177.81 8.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.687 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.88 -52.78 44.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.459 -1.353 . . . . 0.0 112.242 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -55.59 -35.58 65.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.15 -1.81 58.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.8 p -132.02 25.8 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 84.3 mtt-85 -79.88 -19.18 48.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.039 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -80.06 164.21 23.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.263 0.554 . . . . 0.0 111.771 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.76 135.91 31.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.284 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . . . -158.82 155.1 27.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.46 154.45 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.534 HG23 ' CG ' ' A' ' 61' ' ' ARG . 3.6 mt -129.97 80.37 71.29 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 0.0 110.58 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.99 -12.02 33.56 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.242 2.628 . . . . 0.0 114.189 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.3 mtp -86.4 -37.3 18.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.534 ' CG ' HG23 ' A' ' 58' ' ' ILE . 31.9 mmm180 -83.69 2.78 36.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.747 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.45 63.32 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.193 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 HG23 ' CG ' ' A' ' 67' ' ' GLU . 65.9 mt -97.87 100.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.79 -17.31 33.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.693 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mm-40 -103.26 143.92 27.59 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.0 Cg_endo -57.13 123.29 13.49 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.618 1.545 . . . . 0.0 111.698 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.483 ' CG ' HG23 ' A' ' 63' ' ' ILE . 75.6 mm-40 -123.72 167.76 13.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.837 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.38 135.79 47.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.695 0.759 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.51 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -146.0 -177.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.103 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.502 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 2.0 p -98.09 -162.7 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 53.9 p30 -82.97 -41.58 18.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.62 -46.23 69.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 111.541 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 65.3 m -64.01 -40.34 96.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.225 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 73.2 t80 -57.1 -40.42 76.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.1 mt -72.67 -52.92 13.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.46 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.64 -48.22 49.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 HD13 HG21 ' A' ' 58' ' ' ILE . 83.3 mt . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 121.048 0.451 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.64 -13.97 14.43 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.159 2.573 . . . . 0.0 113.181 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.58 48.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -59.65 125.82 25.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 112.051 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 36.2 m-80 -62.66 -27.76 69.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.37 -54.42 2.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.101 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.6 p -103.46 -3.77 24.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.83 11.64 66.51 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.611 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 5.3 p -72.55 143.86 48.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.492 0.646 . . . . 0.0 110.485 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.68 137.14 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 98.1 m-85 -82.56 135.06 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.863 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 169.44 12.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.28 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -47.19 -43.22 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 m -67.78 -37.91 82.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.4 t -87.2 113.06 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.353 0.597 . . . . 0.0 111.311 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -74.08 149.79 40.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.763 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG3' HG13 ' A' ' 46' ' ' VAL . 64.8 ttp85 -80.95 138.77 36.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.802 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 89.1 m-70 -142.76 165.12 28.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.129 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -128.18 146.58 50.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.725 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.0 t -90.3 137.47 32.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -72.57 -7.37 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 78.7 m-20 -101.21 -71.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.494 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.2 p -75.08 -24.04 58.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.695 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.66 20.86 79.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.734 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -99.07 163.24 12.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.953 0.406 . . . . 0.0 110.609 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 89.6 t -76.74 128.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.406 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 3.1 mm? -133.06 139.45 47.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.654 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.1 p -79.69 175.54 10.52 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.46 -53.59 34.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.307 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.37 -36.14 63.55 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 1.7 m -89.65 -1.89 58.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.1 p -132.39 26.78 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 90.6 mtt-85 -80.22 -19.24 47.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -79.59 164.61 23.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.153 0.501 . . . . 0.0 111.628 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.432 ' HB3' ' NH1' ' A' ' 55' ' ' ARG . 15.9 mtp-105 -140.85 137.93 33.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.84 154.3 23.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.863 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.75 147.82 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.514 ' CG2' ' HG3' ' A' ' 61' ' ' ARG . 2.8 mt -126.97 77.69 74.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.821 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.74 -8.18 12.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 123.393 2.729 . . . . 0.0 113.8 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.3 mtp -96.0 -34.99 11.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.766 0.793 . . . . 0.0 109.099 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.514 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 40.5 mtp85 -90.01 29.47 1.21 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.289 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.14 23.02 71.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.075 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.447 ' O ' ' C ' ' A' ' 58' ' ' ILE . 71.5 mt -119.44 101.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.748 0.309 . . . . 0.0 110.394 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.91 -22.86 24.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.817 0.341 . . . . 0.0 111.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.6 mm-40 -99.74 138.49 20.4 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 53.1 Cg_exo -52.72 123.04 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.4 1.4 . . . . 0.0 111.693 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 93.4 mt-10 -124.64 165.69 17.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.562 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -69.56 139.12 53.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.645 0.736 . . . . 0.0 112.186 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.524 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -145.14 -179.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.91 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.496 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -96.26 -164.98 1.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -80.19 -43.8 20.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.84 79.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.734 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 32.8 m -65.23 -40.1 93.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.377 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -57.17 -41.83 79.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.43 -50.56 37.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.272 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.18 61.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.399 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 58' ' ' ILE . 33.9 mt . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.134 0.492 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.21 -11.08 17.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.245 2.63 . . . . 0.0 112.952 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 156.41 48.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.461 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' HD12 ' A' ' 47' ' ' LEU . 1.8 t -59.58 123.76 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.147 0.499 . . . . 0.0 111.872 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 m-80 -61.81 -27.69 68.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.969 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.86 -54.73 2.41 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.104 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 p -104.09 -3.19 24.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 69.14 9.08 59.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.466 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 p -70.59 144.79 51.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.156 0.478 . . . . 0.0 110.164 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.95 136.62 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.144 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.532 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 99.0 m-85 -82.41 134.9 35.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.959 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 p -126.55 168.24 14.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.8 m -47.41 -43.58 23.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.9 m -66.51 -38.06 86.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.71 113.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 0.0 111.174 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.85 145.6 46.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.049 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.5 ttm105 -83.24 140.76 32.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.572 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -143.06 167.25 22.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.441 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -128.63 146.66 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.367 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.0 t -89.9 137.45 32.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 14.2 mmt180 -71.83 -7.67 49.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.495 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 75.0 m-20 -101.74 -70.33 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.533 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.7 p -75.83 -24.2 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.27 21.11 79.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.712 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 22.0 m-85 -98.72 161.49 13.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.732 0.301 . . . . 0.0 110.349 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 73.0 t -75.4 128.96 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 45' ' ' TYR . 3.7 mm? -132.54 139.42 47.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 p -80.04 174.33 11.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.729 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.66 -53.97 26.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.601 -1.285 . . . . 0.0 112.437 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -55.08 -35.32 64.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 1.7 m -89.62 -2.51 58.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.426 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -132.55 26.47 4.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt-85 -80.49 -20.39 43.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.168 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -78.55 163.69 25.32 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 111.289 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -138.26 135.89 35.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.957 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -156.39 153.94 29.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.973 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.427 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -93.65 149.29 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.544 ' CG2' ' HG3' ' A' ' 61' ' ' ARG . 2.1 mt -128.96 76.75 78.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.075 0.464 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.12 -8.43 12.12 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.329 2.686 . . . . 0.0 113.693 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.87 -35.66 11.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.708 0.766 . . . . 0.0 108.949 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.544 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 7.6 mtp-105 -90.28 29.06 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.002 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.45 72.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.11 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 58' ' ' ILE . 88.8 mt -123.52 97.93 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -86.84 -17.58 33.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.712 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.4 mt-10 -102.17 141.13 21.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 40.3 Cg_exo -55.39 122.52 11.88 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.492 1.461 . . . . 0.0 111.694 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 94.3 mt-10 -125.52 166.64 16.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -69.36 137.09 52.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.598 0.713 . . . . 0.0 111.984 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.495 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 26.9 m -145.89 -179.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.027 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.465 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.9 p -96.89 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -78.08 -42.31 32.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.76 -45.72 70.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 38.4 m -64.38 -41.54 96.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.443 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HB2' HG23 ' A' ' 69' ' ' VAL . 73.4 t80 -56.17 -39.59 72.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.0 mt -72.89 -54.56 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.454 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.54 -48.11 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.364 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 58' ' ' ILE . 82.6 mt . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 121.027 0.442 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.99 -11.85 21.5 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.039 2.493 . . . . 0.0 112.592 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.75 156.01 49.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.218 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.6 t -62.83 123.93 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.174 0.511 . . . . 0.0 111.488 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.7 m120 -59.15 -27.01 65.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.084 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.11 -55.51 2.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.327 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -103.84 -2.61 26.02 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 69.74 8.91 61.36 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.3 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 p -69.51 143.09 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.22 0.51 . . . . 0.0 110.009 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -80.08 137.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.905 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CZ ' HG13 ' A' ' 46' ' ' VAL . 87.0 m-85 -84.33 134.93 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.7 p -127.74 171.51 11.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.308 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.25 -41.16 26.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.0 p -72.35 -28.05 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.8 t -94.9 113.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.634 . . . . 0.0 111.435 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.81 148.17 40.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.369 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 17.9 ttp180 -82.33 140.61 33.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.611 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.0 m-70 -142.23 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -130.43 147.09 52.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.6 t -89.37 138.38 31.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.43 ' HG2' HD13 ' A' ' 63' ' ' ILE . 24.6 tpt180 -72.55 -7.05 48.1 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 71.2 m-20 -100.66 -70.04 0.75 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.3 p -77.51 -23.86 50.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 22.13 79.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.397 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.522 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.4 m-85 -98.48 163.14 12.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.828 0.347 . . . . 0.0 110.314 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.536 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 79.9 t -79.73 127.72 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.234 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.514 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.5 mm? -132.32 139.58 48.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.53 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.24 178.01 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.703 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.04 -53.8 35.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.481 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -55.28 -35.77 65.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.435 ' HB3' HD13 ' A' ' 47' ' ' LEU . 1.7 m -89.48 -2.34 58.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.361 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -131.8 26.15 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 93.3 mtt-85 -79.54 -21.4 45.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.305 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -80.16 165.07 22.8 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.279 0.561 . . . . 0.0 111.613 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -140.59 138.09 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.388 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.457 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.37 154.16 26.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.834 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.89 154.99 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.542 HG21 ' CG ' ' A' ' 61' ' ' ARG . 3.2 mt -130.21 79.53 72.52 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.09 -11.17 26.21 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.174 2.583 . . . . 0.0 113.91 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.7 mtp -86.91 -37.79 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.542 ' CG ' HG21 ' A' ' 58' ' ' ILE . 14.9 mmm180 -84.74 4.24 33.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.78 8.82 63.27 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.476 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.469 HG23 ' CG ' ' A' ' 67' ' ' GLU . 67.0 mt -99.09 100.83 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.241 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.0 p -87.09 -16.79 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.54 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 34.3 mt-10 -103.81 145.0 29.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 17.0 Cg_endo -58.18 123.34 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.688 1.592 . . . . 0.0 111.723 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' CG ' HG23 ' A' ' 63' ' ' ILE . 75.6 mm-40 -124.84 167.71 14.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -71.01 136.46 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 0.0 111.658 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.0 m -147.08 -178.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.159 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.514 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.34 -164.96 1.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.88 -43.97 21.29 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.58 74.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.429 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 54.0 m -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.338 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.457 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.7 t80 -56.34 -39.05 72.2 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.0 -54.93 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.672 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.05 -47.87 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.294 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.408 HD13 HG22 ' A' ' 58' ' ' ILE . 91.8 mt . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 121.142 0.496 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.64 -13.39 29.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.069 2.513 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.94 156.14 49.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.18 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' SG ' HD11 ' A' ' 47' ' ' LEU . 10.3 t -62.41 123.01 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.648 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 68.1 m-80 -60.45 -25.66 66.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.282 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.89 -55.87 2.06 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.189 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.5 p -103.09 -4.45 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 10.06 72.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.469 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 p -71.1 142.61 50.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.355 0.577 . . . . 0.0 110.353 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.21 138.84 18.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.784 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.4 m-85 -83.85 134.17 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.473 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.4 p -127.89 171.67 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.2 m -48.26 -40.98 26.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 p -73.01 -27.68 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.391 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.1 t -94.61 112.66 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.419 0.628 . . . . 0.0 111.345 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -73.85 145.67 44.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.397 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HG3' HG11 ' A' ' 46' ' ' VAL . 7.8 tpp180 -77.72 139.38 39.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 98.6 m-70 -142.72 161.9 36.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.221 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -129.96 147.19 51.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -89.9 137.85 31.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.3 -6.89 46.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.518 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 81.4 m-20 -101.54 -71.37 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.73 -24.07 56.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.97 22.14 79.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.371 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.2 m-85 -99.02 162.57 12.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 89.6 t -78.47 128.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 2.2 mm? -132.31 137.86 47.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.2 176.8 8.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.688 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.58 -54.36 30.71 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -54.85 -35.28 63.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.55 -2.35 58.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.38 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -132.33 26.18 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.0 mtt-85 -78.7 -21.39 48.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -78.39 162.07 26.7 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -138.1 138.22 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.01 153.55 24.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.5 147.97 22.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.537 ' CG2' ' HG3' ' A' ' 61' ' ' ARG . 2.3 mt -126.93 76.97 75.39 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 110.95 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.87 -6.97 10.26 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.253 2.636 . . . . 0.0 113.735 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.8 mtm -95.75 -36.11 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.723 0.773 . . . . 0.0 109.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.537 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 45.1 mtp85 -90.03 29.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 22.67 72.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.278 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 58' ' ' ILE . 76.3 mt -118.54 102.5 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 117.033 0.417 . . . . 0.0 110.544 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -87.52 -21.68 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.397 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 4.2 mt-10 -100.36 145.79 30.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.7 Cg_endo -59.49 123.25 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.738 1.625 . . . . 0.0 111.45 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' OE1' ' CD1' ' A' ' 63' ' ' ILE . 93.5 mt-10 -125.78 165.7 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.924 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.58 137.2 54.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 0.0 112.067 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 32.3 m -145.06 177.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.976 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.43 -168.78 1.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.25 -42.82 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.01 73.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 54.5 m -64.13 -41.06 97.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.397 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.402 ' HB2' HG21 ' A' ' 69' ' ' VAL . 74.5 t80 -56.5 -39.79 73.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt -70.28 -49.94 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.621 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.13 86.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.482 HD11 ' OD1' ' A' ' 42' ' ' ASN . 93.6 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.832 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.807 0.337 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.39 -11.82 33.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.146 2.564 . . . . 0.0 112.819 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 158.28 44.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.529 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.439 ' SG ' HD13 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -60.46 124.73 21.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 111.872 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -61.65 -25.92 67.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.79 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.38 -56.32 2.17 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 p -105.42 -2.3 23.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.47 9.58 68.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.191 -1.005 . . . . 0.0 113.737 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.7 p -71.25 143.78 50.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.412 0.606 . . . . 0.0 110.143 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.42 136.95 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.97 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.46 ' CD2' ' NH1' ' A' ' 37' ' ' ARG . 93.8 m-85 -83.03 134.93 35.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.095 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -125.75 168.08 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -47.08 -43.71 20.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.207 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.3 m -66.68 -36.92 83.68 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.025 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 48' ' ' CYS . 64.3 t -88.74 113.85 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.402 0.62 . . . . 0.0 111.468 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -76.75 150.93 36.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.548 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' NH1' ' CD2' ' A' ' 31' ' ' PHE . 68.7 mtt-85 -88.24 141.51 28.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.68 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.2 m-70 -140.01 166.21 25.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.52 144.47 49.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.834 0.35 . . . . 0.0 111.517 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.88 137.34 32.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -71.98 -6.22 40.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 76.7 m-20 -101.28 -71.82 0.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.688 0.28 . . . . 0.0 111.673 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.519 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -75.85 -25.67 56.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.357 . . . . 0.0 111.87 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 23.47 75.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.821 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.7 m-85 -100.45 163.24 12.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 0.0 110.63 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 38' ' ' HIS . 68.4 t -78.27 128.67 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.0 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.505 ' N ' HD21 ' A' ' 47' ' ' LEU . 1.8 mm? -131.63 138.3 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.294 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.433 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 12.2 p -76.92 174.25 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.708 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.8 -52.95 31.89 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.363 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 86.0 m-20 -55.47 -36.1 66.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -88.81 -2.49 58.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.337 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 p -131.97 26.53 4.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.1 mtt180 -80.76 -17.94 49.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.919 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -81.39 164.7 21.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 111.377 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -140.75 135.51 31.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.105 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.19 153.98 28.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.73 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.62 148.38 22.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.526 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.3 mt -124.9 82.47 60.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.28 -10.88 29.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.015 2.477 . . . . 0.0 114.048 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.95 -37.44 17.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.495 0.664 . . . . 0.0 109.267 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.526 ' CG ' HG22 ' A' ' 58' ' ' ILE . 34.4 mmm-85 -84.44 2.71 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.655 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 8.14 62.44 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.608 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 58' ' ' ILE . 81.6 mt -97.89 101.39 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.252 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.25 -19.25 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.59 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.0 mp0 -102.02 145.9 31.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 38.1 Cg_exo -58.45 123.04 12.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.413 1.409 . . . . 0.0 111.674 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' CG ' HG22 ' A' ' 63' ' ' ILE . 73.2 mm-40 -124.47 166.83 15.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.587 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -71.11 136.94 48.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.657 0.742 . . . . 0.0 111.978 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -145.81 179.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.035 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.479 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.1 p -94.61 -165.3 1.29 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -80.12 -44.06 20.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.3 76.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.752 0.31 . . . . 0.0 111.789 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.3 m -63.81 -41.54 97.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.086 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -56.31 -40.7 74.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.13 -51.41 21.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.352 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.13 -48.1 61.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.513 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 HD12 ' OD1' ' A' ' 42' ' ' ASN . 59.6 mt . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.987 0.423 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 -11.34 20.35 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.101 2.534 . . . . 0.0 112.849 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.29 156.97 48.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.44 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' SG ' HD12 ' A' ' 47' ' ' LEU . 11.2 t -63.08 123.95 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.121 0.486 . . . . 0.0 111.613 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -60.46 -26.43 66.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.269 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.06 -56.21 2.36 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.568 -0.825 . . . . 0.0 114.312 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.9 p -105.32 -1.72 24.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.78 11.08 68.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.647 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.6 p -72.27 143.45 48.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.261 0.53 . . . . 0.0 110.425 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.06 136.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.436 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.4 m-85 -82.6 133.79 35.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.08 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.7 p -126.23 169.88 12.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.075 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.3 m -48.12 -43.99 31.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -67.46 -36.25 80.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.079 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.4 t -87.49 113.27 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.407 0.622 . . . . 0.0 111.541 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -73.62 145.22 45.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.194 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HG3' HG11 ' A' ' 46' ' ' VAL . 63.3 ttm-85 -83.56 140.21 32.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.95 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -143.74 167.21 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.395 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -130.59 147.62 52.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.357 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.3 t -91.06 137.98 31.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 60.0 mtp180 -73.18 -5.1 37.04 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.519 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 77.1 m-20 -101.72 -72.31 0.69 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.624 0.25 . . . . 0.0 111.645 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.466 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . 30.8 p -74.59 -24.44 58.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.5 79.71 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.026 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 43' ' ' CYS . 36.0 m-85 -97.5 165.66 11.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.598 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 37' ' ' ARG . 92.9 t -81.27 128.28 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.52 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.3 mm? -131.67 138.17 48.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.1 p -76.82 177.03 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.15 -54.03 31.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.336 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -55.26 -34.99 64.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.43 ' HB3' HD13 ' A' ' 47' ' ' LEU . 1.7 m -89.2 -2.61 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 84.1 p -132.43 25.55 4.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 71.8 mtp180 -78.32 -21.94 48.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.976 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -77.62 162.91 26.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 111.723 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -138.67 137.09 36.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.06 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . . . -159.04 154.05 25.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.876 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.436 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.37 150.96 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.527 HG22 ' CG ' ' A' ' 61' ' ' ARG . 2.9 mt -127.64 82.31 68.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.22 -10.54 27.75 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.109 2.54 . . . . 0.0 113.99 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.16 -37.17 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.527 ' CG ' HG22 ' A' ' 58' ' ' ILE . 13.6 mmm180 -83.94 2.08 40.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.8 7.39 62.9 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.4 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 58' ' ' ILE . 77.2 mt -96.5 100.61 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.8 p -86.09 -19.03 30.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.431 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.2 mt-10 -102.84 146.43 32.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.9 Cg_endo -58.85 123.5 13.66 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.688 1.592 . . . . 0.0 111.954 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' CG ' HG23 ' A' ' 63' ' ' ILE . 75.6 mm-40 -125.32 166.84 15.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.697 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -70.15 137.01 50.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 112.095 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.519 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.8 m -146.43 179.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.904 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.52 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.67 -163.63 1.07 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.7 p-10 -82.6 -42.45 18.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.467 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.12 -45.18 74.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.748 0.308 . . . . 0.0 111.645 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 34.3 m -63.51 -41.38 98.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.256 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CE1' ' HB2' ' A' ' 56' ' ' ALA . 80.7 t80 -56.55 -39.71 73.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.72 -51.15 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.11 -47.52 65.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.391 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.41 HD12 HG23 ' A' ' 58' ' ' ILE . 71.6 mt . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -14.67 25.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.019 2.48 . . . . 0.0 112.648 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.02 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.1 t -60.59 125.23 22.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.315 0.579 . . . . 0.0 111.704 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.886 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.59 -56.17 2.05 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.234 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.5 p -103.08 -4.14 24.96 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.75 73.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.53 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 8.0 p -73.67 143.66 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.391 0.595 . . . . 0.0 110.324 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.78 137.39 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.794 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.517 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 86.4 m-85 -83.97 135.08 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.1 p -128.66 170.32 13.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.416 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.9 m -47.82 -44.46 28.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.535 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 m -65.44 -35.95 82.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 48' ' ' CYS . 99.0 t -90.03 113.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 111.625 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -75.38 148.89 38.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.402 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 24.2 ttp-105 -79.22 141.63 36.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 96.5 m-70 -141.22 160.75 39.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -126.8 145.83 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.375 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.8 t -91.34 137.18 32.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -72.1 -6.85 45.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.523 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 70.2 m-20 -100.66 -71.64 0.7 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 30.6 p -75.81 -24.28 55.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.05 79.6 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.449 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -98.54 162.12 13.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 110.515 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.517 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 90.2 t -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.39 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.522 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.9 mm? -132.12 140.06 48.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' HB2' HG12 ' A' ' 35' ' ' VAL . 4.5 p -78.17 -179.86 6.44 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.682 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.22 -53.65 41.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.206 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -55.2 -36.28 65.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.433 ' HB3' HD13 ' A' ' 47' ' ' LEU . 1.7 m -88.53 -2.01 58.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 p -131.9 26.48 4.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.682 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 81.9 mtt-85 -81.35 -16.86 51.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -85.24 167.18 15.89 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.145 0.498 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -144.03 140.88 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.15 154.43 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.606 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.39 149.98 22.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.533 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.6 mt -125.4 81.51 64.02 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.094 0.474 . . . . 0.0 110.596 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.64 -12.67 36.82 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.095 2.53 . . . . 0.0 114.318 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.2 mtm -85.72 -37.63 19.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.533 ' CG ' HG22 ' A' ' 58' ' ' ILE . 27.5 mmm180 -83.21 1.31 41.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.878 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.32 8.8 59.7 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.559 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 58' ' ' ILE . 69.4 mt -98.98 101.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.095 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.2 p -88.59 -17.56 29.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.5 mt-10 -103.03 142.31 24.29 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.42 122.39 11.63 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.533 1.489 . . . . 0.0 111.694 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.8 mm-40 -123.33 166.18 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.595 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 mtm105 -71.02 139.41 50.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.499 0.666 . . . . 0.0 111.328 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.523 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 28.3 m -147.35 -179.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.244 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.522 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -95.5 -164.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.25 -43.51 19.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -46.06 75.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 40.0 m -63.78 -40.16 96.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.211 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -56.92 -39.86 75.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 mt -72.47 -52.19 16.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.47 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.2 -49.63 52.02 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.559 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD11 ' OD1' ' A' ' 42' ' ' ASN . 58.8 mt . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 121.032 0.444 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.92 -11.43 18.09 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.958 2.439 . . . . 0.0 112.346 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.06 155.46 50.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.204 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -64.15 126.94 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.111 0.482 . . . . 0.0 111.437 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.8 m120 -60.9 -26.39 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.974 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.19 -55.85 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.229 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -102.88 -4.18 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.93 9.01 65.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.466 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.1 p -69.87 143.22 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.127 0.464 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.43 138.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.083 0.468 . . . . 0.0 112.036 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 96.3 m-85 -83.92 133.44 34.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.412 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 p -126.54 169.57 12.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -46.68 -39.87 12.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.349 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -73.71 -25.87 60.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.427 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -97.7 113.14 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.23 0.538 . . . . 0.0 111.253 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -76.51 149.1 36.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.896 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.44 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 18.6 ttp180 -79.29 140.77 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -140.39 158.83 43.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.76 145.33 50.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.353 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.0 t -91.14 137.79 32.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -72.95 -6.55 46.05 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.53 ' OD1' HG22 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.08 -72.53 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.696 0.284 . . . . 0.0 111.754 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.2 p -74.87 -25.02 58.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.815 0.34 . . . . 0.0 111.581 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.7 22.84 77.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.679 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.52 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.0 m-85 -99.1 162.76 12.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.626 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 78.5 t -79.28 128.06 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.969 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.536 ' N ' HD21 ' A' ' 47' ' ' LEU . 1.3 mm? -131.49 140.43 49.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.494 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.41 174.02 11.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.737 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.42 -54.19 21.44 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.545 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -54.66 -36.13 64.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.444 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.9 -2.39 58.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.141 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 p -131.91 25.79 4.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.796 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.6 mtt-85 -81.1 -18.05 47.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -80.03 163.43 24.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.571 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.78 136.68 34.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.231 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.511 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . . . -158.58 154.71 27.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.468 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.71 148.9 22.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.537 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.7 mt -126.69 79.64 71.48 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.915 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -10.02 21.64 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 123.111 2.54 . . . . 0.0 113.817 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.9 mmm -87.7 -37.53 16.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.537 ' CG ' HG22 ' A' ' 58' ' ' ILE . 16.2 mmm180 -84.14 3.44 34.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.507 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.95 6.61 65.09 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.243 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CG2' ' HG3' ' A' ' 67' ' ' GLU . 85.0 mt -95.54 100.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.777 0.322 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.5 p -87.45 -19.03 28.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mt-10 -103.33 138.6 19.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 51.2 Cg_exo -52.74 124.33 15.09 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.647 1.565 . . . . 0.0 112.17 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 93.8 mt-10 -125.28 166.67 16.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.551 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -70.24 138.61 51.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.675 0.75 . . . . 0.0 112.092 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.526 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 31.3 m -147.08 178.97 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.464 -1.243 . . . . 0.0 110.013 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.502 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -93.46 -165.2 1.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -81.24 -42.82 20.15 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.42 -44.9 77.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 27.0 m -63.52 -41.51 98.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.379 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 74.7 t80 -56.06 -39.94 72.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 mt -72.38 -51.8 18.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.1 -48.49 61.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.306 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 58' ' ' ILE . 60.0 mt . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.046 0 CA-C-O 121.046 0.45 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.81 -12.74 28.98 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.057 2.505 . . . . 0.0 112.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.8 156.68 48.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.356 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.3 t -62.03 125.14 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 111.523 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 68.7 m-80 -60.33 -26.72 66.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.86 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.43 -55.19 2.1 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.991 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 p -103.69 -4.94 23.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 70.97 11.58 70.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.791 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.1 p -72.03 143.41 49.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.374 0.587 . . . . 0.0 110.409 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.44 138.08 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 112.022 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.542 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.2 m-85 -84.99 135.72 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 p -127.6 169.52 13.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.815 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.6 m -46.63 -42.82 16.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.4 m -66.59 -37.22 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.251 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.35 113.38 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.318 0.58 . . . . 0.0 111.524 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -74.55 148.31 40.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.492 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HG3' HG11 ' A' ' 46' ' ' VAL . 13.7 ttp180 -78.63 141.4 38.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.409 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -142.18 163.01 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.05 147.52 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.906 0.384 . . . . 0.0 111.917 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.0 t -90.57 136.72 32.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 91.3 mtt-85 -70.17 -6.94 37.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.546 ' OD1' ' CD1' ' A' ' 58' ' ' ILE . 5.3 m-20 -102.9 -70.26 0.76 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.555 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.2 p -75.05 -25.83 58.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.054 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.82 20.31 79.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.391 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.555 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.5 m-85 -97.33 161.11 13.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.362 . . . . 0.0 110.668 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.542 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 99.4 t -78.43 128.89 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.089 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 70' ' ' CYS . 1.9 mm? -130.81 140.45 50.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -78.33 172.46 13.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.722 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.0 -52.51 30.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.248 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 89.3 m-20 -55.88 -34.96 65.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.77 -1.37 57.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 p -131.74 25.7 4.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.722 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 78.1 mtp180 -80.72 -19.35 45.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.076 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -78.35 164.77 24.55 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.198 0.523 . . . . 0.0 111.623 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -141.03 134.71 30.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.323 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.487 ' HB1' ' CD1' ' A' ' 74' ' ' TYR . . . -160.7 154.09 21.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.82 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.8 158.04 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.585 HG21 ' CG ' ' A' ' 61' ' ' ARG . 1.6 mt -132.96 76.64 69.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 110.326 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.8 -11.57 29.91 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.238 2.625 . . . . 0.0 114.337 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 85.7 mtp -86.36 -37.64 18.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.585 ' CG ' HG21 ' A' ' 58' ' ' ILE . 16.2 mmm180 -83.94 3.76 32.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.673 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 7.96 62.5 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.439 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 65' ' ' GLU . 65.8 mt -97.01 101.8 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.281 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 p -86.73 -18.34 31.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.671 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.461 ' O ' HG21 ' A' ' 63' ' ' ILE . 87.6 mt-10 -102.91 146.68 32.87 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 19.2 Cg_endo -59.05 122.35 11.44 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.553 1.502 . . . . 0.0 111.673 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 76.8 mm-40 -125.83 167.56 15.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.842 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -71.6 138.45 48.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.556 0.693 . . . . 0.0 112.092 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 74' ' ' TYR . 21.4 m -146.3 179.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.751 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.506 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 15.3 p -95.59 -172.53 2.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -73.39 -42.94 61.53 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.07 -45.03 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.297 . . . . 0.0 111.683 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.1 m -64.64 -40.64 95.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.339 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.487 ' CD1' ' HB1' ' A' ' 56' ' ' ALA . 18.9 t80 -56.33 -41.52 76.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.36 -48.26 67.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.51 86.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.489 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 HD11 ' ND2' ' A' ' 42' ' ' ASN . 89.1 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.353 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.99 0.424 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.31 -15.02 25.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.778 2.318 . . . . 0.0 112.612 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.38 155.59 50.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.336 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.427 ' SG ' HD11 ' A' ' 47' ' ' LEU . 5.7 t -61.51 125.17 22.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.111 0.482 . . . . 0.0 111.414 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.0 m120 -61.67 -26.13 67.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.224 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 -55.81 2.23 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.715 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.11 -1.58 27.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 7.71 61.91 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.278 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.0 p -69.92 143.92 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.237 0.519 . . . . 0.0 110.168 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.98 138.98 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.151 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.482 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.2 m-85 -82.42 133.91 35.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 110.27 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -126.88 169.06 13.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.74 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.3 m -44.73 -38.79 4.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.473 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -78.44 -26.76 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -96.14 112.87 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.177 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.417 ' NH1' ' CE1' ' A' ' 38' ' ' HIS . 18.1 mtp-105 -78.34 150.03 33.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.425 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -89.73 143.2 27.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.817 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.4 m-70 -138.84 164.44 29.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.389 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.86 143.34 48.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.8 t -90.53 136.57 32.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -70.44 -6.76 38.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 76.8 m-20 -101.82 -70.66 0.74 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.555 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.0 p -77.56 -25.32 49.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.13 72.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.916 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 20.7 m-85 -102.32 162.33 13.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.8 0.333 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 38' ' ' HIS . 60.5 t -77.35 129.19 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.246 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 47' ' ' LEU . 1.6 mm? -131.53 137.65 48.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.118 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.37 175.23 7.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.688 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.44 -53.01 37.48 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.497 -1.335 . . . . 0.0 112.044 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -54.76 -35.03 63.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.477 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.11 -3.63 58.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.444 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.4 p -131.41 27.93 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 88.4 mtt-85 -82.16 -19.21 40.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.197 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -78.59 163.52 25.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.273 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -140.0 135.16 32.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.263 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . . . -159.05 153.35 23.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.687 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.437 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.29 151.31 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.567 ' CG2' ' HG3' ' A' ' 61' ' ' ARG . 2.5 mt -127.37 74.97 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.14 0.495 . . . . 0.0 110.411 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.48 -9.02 14.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.127 2.551 . . . . 0.0 113.738 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.22 -36.72 12.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 32.5 mtp85 -89.43 26.34 1.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.358 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.63 23.36 76.72 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.276 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 73.5 mt -117.98 104.56 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.807 0.304 . . . . 0.0 110.326 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -91.31 -21.04 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 42.4 mt-10 -100.8 139.24 20.39 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.3 Cg_exo -52.71 123.02 11.99 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.591 1.527 . . . . 0.0 111.971 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 92.9 mt-10 -125.18 167.34 14.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.126 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -72.74 140.24 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 0.0 112.267 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.512 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 30.2 m -146.83 179.65 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.503 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.2 p -93.38 -163.62 1.07 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.112 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.86 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.5 m -63.57 -40.69 97.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.373 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 67.1 t80 -56.7 -39.72 74.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.02 -53.0 12.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.775 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.41 61.3 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.26 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD12 HG22 ' A' ' 58' ' ' ILE . 82.2 mt . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.36 -12.88 32.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.232 2.621 . . . . 0.0 113.053 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.08 159.65 41.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.6 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 5.2 t -62.93 128.84 37.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.266 0.555 . . . . 0.0 112.059 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 m-80 -69.19 -24.76 64.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.324 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.43 -57.88 2.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.855 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 p -105.78 -0.3 25.48 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.05 72.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.413 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.5 p -69.37 143.52 53.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.356 0.578 . . . . 0.0 109.795 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.16 144.45 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.571 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 89.7 m-85 -83.54 132.96 34.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.9 p -124.84 168.66 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 m -48.24 -44.5 33.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 m -66.96 -36.16 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.3 113.46 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 0.0 111.786 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -73.11 144.83 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.897 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' CG ' HG11 ' A' ' 46' ' ' VAL . 21.5 ttm105 -87.09 141.99 28.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.952 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -144.64 171.86 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -130.45 148.44 52.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.3 t -90.97 136.75 32.86 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -72.84 -5.68 39.84 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.545 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 77.9 m-20 -100.81 -71.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.62 0.247 . . . . 0.0 111.47 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.0 p -75.26 -24.72 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 111.614 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.46 20.45 79.86 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.507 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.6 m-85 -97.75 161.55 13.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.85 0.357 . . . . 0.0 110.538 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.571 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 95.0 t -76.6 128.44 37.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.089 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.6 mm? -131.78 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.493 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.0 p -79.38 -179.78 6.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.679 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.89 -53.72 42.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.674 -1.251 . . . . 0.0 112.225 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' NE ' ' A' ' 53' ' ' ARG . 92.7 m-20 -55.38 -35.81 65.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.466 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -88.92 -2.15 58.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.389 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -131.87 26.39 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.679 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.4 mtt180 -80.94 -18.3 47.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -80.08 162.9 24.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.106 0.479 . . . . 0.0 111.285 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp85 -139.8 135.62 33.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.93 153.39 26.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.814 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.441 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.97 149.46 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.532 HG21 ' CG ' ' A' ' 61' ' ' ARG . 3.4 mt -125.81 82.36 64.26 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.855 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -10.73 29.64 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.087 2.524 . . . . 0.0 114.028 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.85 -37.76 17.43 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.532 ' CG ' HG21 ' A' ' 58' ' ' ILE . 30.2 mmm180 -83.07 1.01 42.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.648 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 7.2 62.0 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.284 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.454 HG21 ' CG ' ' A' ' 67' ' ' GLU . 74.3 mt -96.85 100.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.66 -17.41 33.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.74 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.1 mt-10 -103.02 144.2 28.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 31.8 Cg_exo -57.11 123.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.642 1.561 . . . . 0.0 111.683 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.454 ' CG ' HG21 ' A' ' 63' ' ' ILE . 74.3 mm-40 -125.35 167.15 15.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -70.89 137.46 49.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.94 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.545 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -146.84 179.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.078 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.478 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -94.49 -160.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 20.9 t70 -85.02 -43.26 14.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.94 80.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 111.82 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 33.3 m -63.98 -40.85 97.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -57.94 -40.52 80.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.3 mt -69.76 -50.51 42.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.509 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.49 84.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.39 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD12 HG22 ' A' ' 58' ' ' ILE . 88.6 mt . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.524 0.202 . . . . 1.0700000000000001 111.313 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.22 -18.41 16.22 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.281 1.988 . . . . 0.60999999999999999 112.497 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.434 -0.348 . . . . 1.03 110.838 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -55.16 124.78 18.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.95999999999999996 111.7 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.48 -22.09 66.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 1.98 111.82 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.93 -68.11 1.4 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.649 -0.786 . . . . 0.17999999999999999 113.792 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 p -88.56 -27.8 21.16 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.984 0.365 . . . . 0.72999999999999998 111.984 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.28 26.6 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.455 -0.879 . . . . 0.17000000000000001 112.73 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 p -83.25 144.56 29.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.84999999999999998 110.635 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.48 143.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 1.54 111.09 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 88.7 m-85 -89.91 130.48 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.29999999999999999 111.099 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 p -120.46 175.32 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 1.05 110.728 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.8 m -54.91 -31.12 59.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.285 -0.416 . . . . 1.4299999999999999 111.363 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -44.91 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 1.8400000000000001 111.078 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.67 108.41 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.012 0.434 . . . . 1.05 110.895 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -74.87 163.45 27.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.788 -0.642 . . . . 3.4100000000000001 109.717 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.1 ttm105 -88.64 152.86 21.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.747 0.647 . . . . 4.2599999999999998 112.747 -178.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -157.52 139.61 14.35 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.342 -0.844 . . . . 0.28000000000000003 110.369 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -106.7 155.41 19.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.975 0.417 . . . . 2.1800000000000002 111.573 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.11 129.85 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.132 -0.692 . . . . 0.91000000000000003 109.132 179.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -62.27 -17.76 59.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.817 0.673 . . . . 2.7799999999999998 112.817 -177.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.42 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 66.1 m-80 -92.97 -69.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.665 0.269 . . . . 0.75 111.698 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.3 p -79.57 -41.36 27.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.519 -0.31 . . . . 0.81999999999999995 111.52 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.46 -13.02 66.07 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.416 -0.897 . . . . 0.10000000000000001 113.497 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -58.6 163.55 3.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.761 -0.459 . . . . 0.87 109.761 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 67.9 t -82.41 132.68 30.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.487 -0.485 . . . . 1.03 110.47 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 3.3 mm? -133.79 142.68 47.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 1.03 110.875 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.1 p -82.45 -173.01 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.907 -0.588 . . . . 0.90000000000000002 110.302 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.38 -57.95 16.96 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.604 -0.808 . . . . 0.17000000000000001 112.925 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -52.66 -51.36 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.915 0.388 . . . . 1.1499999999999999 111.606 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.413 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.6 m -66.98 -24.3 66.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.999 -0.546 . . . . 0.83999999999999997 111.996 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -115.06 45.48 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.541 . . . . 0.87 110.645 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -97.64 -25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 2.96 110.815 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -73.92 169.79 16.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.324 0.583 . . . . 1.02 112.299 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -145.76 138.92 26.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.225 -0.898 . . . . 3.3700000000000001 109.805 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.17 137.57 6.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 1.04 111.324 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.12 148.99 46.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 1.01 110.257 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 3.2 mt -126.59 76.57 74.11 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.595 -0.275 . . . . 1.0900000000000001 111.234 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.78 -26.53 79.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.403 2.069 . . . . 0.54000000000000004 112.543 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.6 mtp -71.87 -30.85 65.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.425 -0.352 . . . . 2.5600000000000001 110.759 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -101.3 21.69 13.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.346 -0.388 . . . . 1.8700000000000001 111.671 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.33 68.65 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.67 -0.776 . . . . 0.52000000000000002 113.268 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 33.1 mt -122.65 88.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.794 0.33 . . . . 1.03 110.671 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.56 -14.41 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.202 0.445 . . . . 1.04 112.202 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -101.49 147.96 34.54 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 121.22 -0.192 . . . . 2.02 110.908 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.32 120.59 8.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.13 1.887 . . . . 0.90000000000000002 112.085 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -125.78 164.07 21.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.047 0.451 . . . . 1.46 111.048 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.08 136.58 41.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.816 -0.629 . . . . 3.0499999999999998 112.531 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.42 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 33.4 m -144.31 -172.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.105 -0.952 . . . . 1.02 109.534 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.432 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 3.9 p -100.02 -157.18 0.59 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.186 -0.302 . . . . 0.75 110.186 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.43 -50.36 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.852 -0.339 . . . . 1.6299999999999999 111.025 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.52 -64.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.97999999999999998 110.959 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.5 m -50.55 -39.67 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.71999999999999997 111.813 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -59.76 -34.16 72.62 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.108 -0.701 . . . . 0.91000000000000003 109.108 177.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.69 -44.03 19.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.229 -0.896 . . . . 1.0700000000000001 109.473 178.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.93 -50.76 60.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.634 -0.712 . . . . 1.0800000000000001 110.727 179.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.7 mt . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 108.806 -0.813 . . . . 1.0800000000000001 108.806 178.324 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 148.41 85.61 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.771 2.314 . . . . 0.0 112.282 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 mt -60.61 -32.0 71.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.15 -156.14 24.95 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 m -59.39 -33.08 70.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 111.347 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.9 mtt -107.64 144.57 34.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 111.238 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.96 134.06 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.408 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.21 12.88 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.622 0.249 . . . . 0.0 111.529 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -73.07 -2.96 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.26 0.552 . . . . 0.0 109.583 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -66.18 142.07 57.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.057 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.1 p -118.63 152.01 36.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -125.15 144.89 50.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.059 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.96 82.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 44' ' ' GLY . 77.8 t80 -76.78 121.76 23.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.839 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 15' ' ' TRP . 47.2 p90 -92.24 118.15 30.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -81.95 127.11 32.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.306 0.574 . . . . 0.0 109.927 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.9 151.94 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.893 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.49 ' OD1' ' HD2' ' A' ' 37' ' ' ARG . 21.7 m-20 -54.44 -45.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.053 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.62 -41.59 88.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.182 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.81 -32.55 72.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.11 74.37 2.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.733 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.54 -11.76 18.69 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.138 2.559 . . . . 0.0 112.846 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.7 155.38 50.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -60.4 122.79 15.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.115 0.483 . . . . 0.0 111.827 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.5 m120 -61.68 -26.68 68.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.928 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 -56.39 2.16 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.221 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.3 p -104.63 -3.6 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.73 69.96 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.725 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -71.74 143.51 49.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.416 0.608 . . . . 0.0 110.251 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.39 137.5 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.796 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.5 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 93.9 m-85 -83.29 134.43 34.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.162 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.8 p -126.38 172.58 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.268 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.2 p -50.54 -40.84 52.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.003 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.9 p -75.85 -26.34 57.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.254 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.56 113.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.376 0.608 . . . . 0.0 111.392 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -73.63 143.73 46.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.106 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HD2' ' OD1' ' A' ' 18' ' ' ASP . 23.7 ttm105 -86.29 142.14 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.629 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -144.01 169.19 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 111.607 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.493 ' CE1' HG21 ' A' ' 46' ' ' VAL . 93.8 m-70 -128.83 146.82 50.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.537 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.3 t -90.44 137.99 31.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -72.76 -6.88 47.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.501 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 73.4 m-20 -100.69 -70.27 0.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.4 p -76.44 -23.78 53.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 72.91 21.98 79.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.39 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.498 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 21.2 m-85 -98.07 160.81 14.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 110.236 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.5 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 85.4 t -75.96 128.97 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.166 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 45' ' ' TYR . 3.2 mm? -133.43 138.58 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.45 176.32 8.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.727 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.08 -52.8 41.1 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.225 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -55.83 -35.84 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.32 -1.7 58.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.462 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -131.99 28.65 4.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.727 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 73.3 mtm180 -84.71 -16.39 41.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.227 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -81.31 164.7 22.0 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.5 136.18 32.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.527 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.96 154.34 25.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.793 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.9 154.0 20.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.548 HG22 ' CG ' ' A' ' 61' ' ' ARG . 2.3 mt -130.3 79.77 71.91 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 110.939 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.06 -8.96 19.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.179 2.586 . . . . 0.0 114.19 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.08 -37.83 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 109.193 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.548 ' CG ' HG22 ' A' ' 58' ' ' ILE . 14.2 mmm180 -83.03 1.04 42.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.454 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.13 6.94 61.3 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG23 ' CG ' ' A' ' 67' ' ' GLU . 75.6 mt -96.2 102.35 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.214 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -88.08 -18.54 28.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 56.0 mm-40 -103.06 142.53 24.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -56.43 124.0 15.21 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.674 1.583 . . . . 0.0 111.819 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' CG ' HG23 ' A' ' 63' ' ' ILE . 75.7 mm-40 -124.74 166.81 15.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -70.56 136.71 49.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.618 0.723 . . . . 0.0 111.639 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.501 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.3 m -145.24 -179.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.976 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.56 -168.35 1.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -76.26 -43.71 40.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.22 72.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 52.8 m -63.84 -40.57 96.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.743 0.306 . . . . 0.0 110.41 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.492 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 76.6 t80 -56.79 -39.6 74.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 18.1 mt -72.9 -52.49 14.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.536 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.02 -48.27 52.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.385 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.411 HD23 HG23 ' A' ' 58' ' ' ILE . 70.7 mt -65.27 -40.8 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 62.9 ttt180 -57.04 -19.7 20.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.627 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.7 p -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.996 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m -62.69 154.73 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -91.37 136.36 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.411 ' HB2' ' HE2' ' A' ' 82' ' ' MET . 72.5 mtm -81.57 129.87 34.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.975 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 145.18 56.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.507 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.27 149.78 21.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.869 2.379 . . . . 0.0 112.608 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.1 mt -88.34 138.35 31.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.79 -33.17 42.11 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.538 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.1 m -119.98 147.39 44.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.5 mtt -123.68 154.01 40.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.002 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.35 45.21 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.392 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.438 ' C ' ' H ' ' A' ' 10' ' ' GLN . 95.7 mt-10 -66.68 -11.09 52.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.617 0.246 . . . . 0.0 111.421 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -61.93 -6.91 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' H ' ' C ' ' A' ' 8' ' ' GLU . 59.7 tt0 -67.7 148.86 50.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.864 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.2 p -103.66 149.99 24.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -96.24 146.93 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.922 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.97 57.67 4.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.906 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 44' ' ' GLY . 81.7 t80 -76.38 122.74 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -91.91 118.67 30.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.419 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 62.8 tt0 -84.24 131.35 34.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.124 0.488 . . . . 0.0 109.685 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.27 154.18 28.47 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 37' ' ' ARG . 6.2 m-20 -55.3 -43.55 74.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.984 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.7 -42.49 86.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.373 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -70.25 -30.39 67.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 0.0 110.729 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.37 71.11 0.83 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.47 -15.4 24.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.9 2.4 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.33 156.88 48.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.1 t -63.99 124.98 22.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.1 m-80 -60.28 -26.56 66.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.969 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.45 -55.92 2.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.444 -0.884 . . . . 0.0 114.341 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -105.23 -0.29 26.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 68.83 9.07 58.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.562 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 p -69.52 143.52 53.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.226 0.513 . . . . 0.0 110.211 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.99 138.98 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 92.2 m-85 -84.18 136.04 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.375 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -127.74 171.61 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.105 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -47.47 -41.1 19.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.808 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.1 p -73.54 -24.84 60.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.641 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -97.89 113.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.738 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.72 150.25 37.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.533 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 18' ' ' ASP . 14.7 ttp180 -80.18 141.54 35.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 0.0 110.598 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -139.96 160.95 38.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.665 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.432 ' CE1' HG21 ' A' ' 46' ' ' VAL . 89.9 m-70 -128.49 146.05 50.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.523 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.9 t -91.33 136.2 33.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tpt180 -72.33 -4.63 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.531 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 77.1 m-20 -101.65 -71.54 0.71 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.536 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -76.51 -24.04 53.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.23 21.77 78.55 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.79 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.1 m-85 -99.01 160.91 13.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 77.5 t -78.36 128.75 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.543 ' N ' HD21 ' A' ' 47' ' ' LEU . 1.4 mm? -131.45 140.83 49.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.354 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.85 178.37 8.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.598 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -55.59 -52.15 50.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.43 -1.367 . . . . 0.0 112.047 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -54.67 -34.88 62.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.423 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -91.81 -2.23 57.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -132.3 28.93 4.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 12.9 mmt85 -84.68 -17.88 37.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.324 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -79.53 165.62 22.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.226 0.536 . . . . 0.0 111.475 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -141.37 134.71 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . . . -158.01 153.41 26.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.658 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.454 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -86.48 158.0 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.515 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.4 mt -134.15 78.37 58.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.919 0.39 . . . . 0.0 110.555 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.82 -12.14 32.74 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.265 2.644 . . . . 0.0 114.066 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.9 mmm -85.31 -38.29 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' CG ' HG22 ' A' ' 58' ' ' ILE . 13.9 mmm180 -83.86 1.76 41.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.673 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 9.22 60.39 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.686 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.495 ' CD1' ' HG2' ' A' ' 41' ' ' ARG . 61.8 mt -100.58 99.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.849 0.356 . . . . 0.0 110.356 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.4 p -85.04 -16.99 38.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.785 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' O ' HG23 ' A' ' 63' ' ' ILE . 22.6 mt-10 -102.81 145.06 29.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 14.7 Cg_endo -58.67 124.11 15.05 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.416 1.411 . . . . 0.0 111.657 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' CG ' HG21 ' A' ' 63' ' ' ILE . 76.4 mm-40 -124.85 167.78 14.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.747 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -72.06 137.2 46.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.652 0.739 . . . . 0.0 111.916 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.531 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 35.1 m -146.83 -178.06 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.126 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.477 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -96.4 -162.88 0.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -82.62 -42.67 17.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.67 75.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 111.691 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 37.0 m -63.19 -40.38 97.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.533 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 56' ' ' ALA . 72.4 t80 -57.32 -38.97 74.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.66 -51.67 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.506 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.7 78.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.165 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.411 HD11 HG23 ' A' ' 58' ' ' ILE . 88.6 mt -67.01 -41.04 87.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.503 0.668 . . . . 0.0 109.346 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -59.37 -17.93 34.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.811 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m -61.31 -38.77 88.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.925 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.9 m -68.96 155.62 40.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -99.4 129.0 45.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.358 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 65.9 mtm -83.46 134.51 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.5 148.75 40.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.433 -179.824 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.22 145.23 55.78 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.725 2.283 . . . . 0.0 112.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 mt -81.96 144.2 31.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.66 34.15 36.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.265 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.6 m -115.23 149.61 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 72.1 mtm -57.81 -33.74 68.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 135.21 45.84 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.437 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -88.96 7.37 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -72.53 -3.05 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.54 145.31 54.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.098 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.2 p -114.37 153.24 30.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.455 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 59.2 mttp -56.98 -38.81 73.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.81 169.66 28.59 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.384 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . 67.3 t80 -80.33 122.94 27.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.446 ' CZ3' ' HG2' ' A' ' 17' ' ' GLU . 45.9 p-90 -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -84.8 128.37 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.187 0.518 . . . . 0.0 109.846 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HG2' ' CZ3' ' A' ' 15' ' ' TRP . 96.4 mt-10 -59.72 152.91 21.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.231 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -56.68 -44.03 81.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.024 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.63 -42.33 91.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.053 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -72.11 -30.2 64.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.236 0.541 . . . . 0.0 110.289 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.39 68.18 1.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.699 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.07 -12.29 27.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.07 2.514 . . . . 0.0 112.68 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.13 156.39 48.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.3 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' GLY . 18.4 t -64.54 125.29 24.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.174 0.511 . . . . 0.0 111.437 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 70.0 m-80 -59.5 -26.44 65.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.031 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.72 -55.46 2.15 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.165 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.8 p -102.92 -4.7 24.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 71.37 10.98 71.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.41 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.8 p -71.65 142.67 49.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.317 0.559 . . . . 0.0 110.278 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.78 137.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.534 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' CZ ' HG13 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.86 134.53 34.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.276 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -127.26 169.61 13.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.954 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.6 m -46.84 -42.16 16.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.96 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.1 m -68.54 -36.09 78.34 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.316 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -90.65 113.67 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.338 0.59 . . . . 0.0 111.463 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.33 148.72 39.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.008 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' HG3' HG12 ' A' ' 46' ' ' VAL . 48.1 ttp85 -78.97 139.54 38.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.0 m-70 -141.94 162.74 34.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.453 ' CE1' HG23 ' A' ' 46' ' ' VAL . 89.5 m-70 -129.54 146.57 51.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.642 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 t -91.6 137.91 31.99 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -73.42 -5.47 40.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 76.0 m-20 -100.9 -72.06 0.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.613 0.244 . . . . 0.0 111.624 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 31.4 p -75.81 -24.89 55.93 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.24 21.63 78.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.746 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 26.1 m-85 -98.85 161.85 13.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.935 0.398 . . . . 0.0 110.459 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.511 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 85.2 t -78.44 128.93 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.076 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.513 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.2 mm? -131.41 139.07 49.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.44 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 p -75.64 177.09 7.06 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.704 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.48 -53.07 40.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.241 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 86.3 m-20 -55.53 -35.65 65.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.436 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -88.67 -2.03 58.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.317 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.1 p -132.55 27.62 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.704 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt180 -82.85 -17.85 42.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.139 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -79.47 165.06 23.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.281 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -140.82 136.0 31.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.424 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.417 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.39 154.48 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.468 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -92.25 150.8 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.533 HG23 ' CG ' ' A' ' 61' ' ' ARG . 3.0 mt -127.3 81.31 70.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 111.058 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.63 -9.98 22.77 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.206 2.604 . . . . 0.0 113.828 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -89.75 -36.89 14.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 109.263 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' CG ' HG23 ' A' ' 58' ' ' ILE . 5.3 mmm180 -86.79 15.57 5.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.677 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.02 10.34 85.1 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.854 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.428 HG21 ' CG ' ' A' ' 67' ' ' GLU . 74.8 mt -101.44 102.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -88.3 -19.11 27.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.588 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mt-10 -103.17 146.61 32.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.4 Cg_endo -59.14 123.47 13.52 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.62 1.546 . . . . 0.0 111.71 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.3 mm-40 -124.53 166.73 15.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -71.47 137.29 48.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.624 0.726 . . . . 0.0 112.0 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.511 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 30.0 m -145.5 -178.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.872 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.513 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -96.47 -166.45 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 55.6 t0 -78.89 -45.16 21.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.14 80.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.4 m -63.82 -41.25 97.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.388 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 75.7 t80 -56.38 -40.07 73.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 15.6 mt -71.7 -52.3 18.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.11 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.15 -48.67 53.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.496 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 58' ' ' ILE . 58.9 mt -65.88 -41.92 90.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 72.2 ttt-85 -56.06 -21.87 24.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.1 m -59.21 -36.4 75.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 110.778 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.6 m -59.1 -34.27 71.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -79.64 139.97 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.3 mtp -89.37 133.63 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.68 -49.86 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.963 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.458 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.89 145.84 71.08 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.745 2.296 . . . . 0.0 112.265 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 mt -83.9 141.63 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.27 -33.87 62.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.246 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -60.91 -27.98 68.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.951 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.4 mmm -95.28 138.52 32.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.18 2.91 68.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.598 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 8' ' ' GLU . 83.2 tt0 -87.85 12.71 12.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.615 0.245 . . . . 0.0 111.455 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -59.0 -17.96 29.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -61.01 144.3 53.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.049 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 76.6 p -144.78 161.43 39.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' GLY . 27.8 mttm -80.53 166.07 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.706 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' LYS . . . -29.97 108.75 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.113 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -80.63 121.64 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 111.072 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -89.87 119.9 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.574 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' OE1' ' CB ' ' A' ' 21' ' ' ALA . 50.4 tt0 -84.19 128.86 34.83 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.295 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -60.44 153.04 24.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.168 -0.923 . . . . 0.0 113.245 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . 41.2 t0 -54.94 -47.28 74.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.084 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -64.74 -41.51 95.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.168 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.53 -30.16 66.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.262 0.553 . . . . 0.0 110.225 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' CB ' ' OE1' ' A' ' 16' ' ' GLN . . . -111.47 70.58 0.82 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.842 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.61 -14.94 30.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.942 2.428 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.93 156.95 47.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.459 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 47' ' ' LEU . 8.3 t -63.11 124.79 22.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.144 0.497 . . . . 0.0 111.439 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.437 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 66.1 m-80 -60.15 -26.21 66.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.289 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.82 2.25 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.343 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.4 p -104.42 -3.05 24.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.86 10.48 67.98 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.527 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.1 p -71.9 143.99 49.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.269 0.534 . . . . 0.0 110.168 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.93 138.77 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.469 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' CZ ' HG13 ' A' ' 46' ' ' VAL . 96.7 m-85 -84.46 135.56 34.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -127.98 168.0 15.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.2 m -46.12 -43.78 15.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.312 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.13 -36.96 84.52 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.0 t -88.6 113.89 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -73.78 146.07 44.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.362 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 18' ' ' ASP . 21.8 ttp-105 -80.33 140.11 36.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.441 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -142.11 164.64 29.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -130.79 147.44 52.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.568 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.7 t -90.23 137.0 32.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.403 ' HD3' ' HB3' ' A' ' 67' ' ' GLU . 53.2 mtp85 -71.43 -6.36 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.506 ' ND2' ' CD1' ' A' ' 58' ' ' ILE . 15.6 m-80 -102.88 -70.0 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.552 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.4 p -74.44 -24.81 59.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.783 0.325 . . . . 0.0 111.579 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.33 79.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.686 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.552 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 27.8 m-85 -97.0 164.37 12.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 110.682 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 62.2 t -80.83 128.4 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.059 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.51 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.5 mm? -132.12 137.62 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.5 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.1 p -77.32 173.33 12.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.743 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.11 -54.33 19.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.23 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 75.9 m-20 -54.92 -35.85 64.61 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.415 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -89.37 -1.82 58.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.22 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.1 p -131.16 25.22 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.743 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 57.9 mtm180 -80.36 -18.65 48.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.805 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -79.42 164.79 23.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.006 0.431 . . . . 0.0 111.157 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -143.1 138.15 29.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.5 155.56 22.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.912 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -82.45 159.48 22.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.623 HG21 ' HG2' ' A' ' 61' ' ' ARG . 1.3 mt -134.49 75.41 63.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -12.93 35.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.42 2.747 . . . . 0.0 114.34 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.8 mtt -87.05 -36.84 17.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.623 ' HG2' HG21 ' A' ' 58' ' ' ILE . 29.0 mmm180 -83.74 5.73 23.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.73 10.66 64.8 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.501 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.5 HG23 ' CG ' ' A' ' 67' ' ' GLU . 70.2 mt -102.21 102.54 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 0.0 110.363 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.9 p -87.83 -16.63 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.601 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 mt-10 -104.56 142.79 25.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 11.4 Cg_endo -55.13 122.57 11.94 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.879 1.719 . . . . 0.0 112.034 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' CG ' HG23 ' A' ' 63' ' ' ILE . 74.9 mm-40 -125.15 167.31 14.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.432 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -72.46 140.11 48.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.567 0.699 . . . . 0.0 111.898 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 m -147.3 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.085 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.51 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 2.9 p -93.48 -162.36 0.93 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.71 -41.74 17.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.97 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.586 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.14 -41.61 97.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 0.0 110.202 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 87.6 t80 -55.88 -40.61 73.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.51 -49.49 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.586 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.45 79.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD13 ' ND2' ' A' ' 42' ' ' ASN . 77.4 mt -64.03 -38.17 90.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.024 0.44 . . . . 0.0 110.816 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 8.0 mtp-105 -64.37 -7.54 10.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.212 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.2 m -58.73 152.42 18.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.8 m -120.85 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.623 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -93.08 135.35 34.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 63.9 mtt -83.24 131.31 35.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.682 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.93 50.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.061 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.6 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.584 -0.206 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.2 147.31 93.97 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.079 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.5 mt -81.73 136.93 35.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.84 124.02 5.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.516 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.5 m -122.67 145.63 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 86.5 mtp -133.62 163.86 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.4 40.02 20.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.558 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -82.16 7.48 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.66 0.267 . . . . 0.0 111.262 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -58.73 -17.01 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -53.46 143.93 18.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.8 m -60.91 156.75 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 44.2 mtmt -56.33 -32.04 64.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.41 94.47 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.777 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 44' ' ' GLY . 67.5 t80 -78.8 123.13 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -91.99 117.8 30.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' OE1' ' CB ' ' A' ' 21' ' ' ALA . 47.7 tt0 -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.177 0.513 . . . . 0.0 109.866 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.29 154.47 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.483 ' CB ' ' NE ' ' A' ' 37' ' ' ARG . 39.0 p-10 -57.37 -43.94 83.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.541 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 97.3 mt-10 -65.73 -41.73 91.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.826 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -67.65 -32.68 73.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.125 0.488 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' CB ' ' OE1' ' A' ' 16' ' ' GLN . . . -111.41 72.12 0.91 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.787 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.07 -15.23 32.24 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.1 2.533 . . . . 0.0 112.651 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.68 46.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.401 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.2 t -62.3 122.48 15.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.761 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.5 m120 -61.12 -25.9 67.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.32 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.18 -55.76 2.3 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.51 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p -104.24 -2.65 25.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.13 7.97 64.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.253 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.0 p -69.6 143.0 53.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.099 0.449 . . . . 0.0 110.162 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.71 137.4 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.714 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.425 ' CZ ' HG13 ' A' ' 46' ' ' VAL . 92.5 m-85 -82.08 133.12 35.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.386 0.612 . . . . 0.0 109.886 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 p -124.7 173.03 8.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.174 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.1 p -50.4 -38.94 45.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.98 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 p -79.18 -22.91 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.651 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.8 t -96.03 113.12 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.629 . . . . 0.0 111.488 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -73.32 143.64 46.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.204 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NE ' ' CB ' ' A' ' 18' ' ' ASP . 56.9 ttm-85 -84.71 141.14 30.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.428 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.3 m-70 -143.48 167.93 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.484 ' CD2' HG23 ' A' ' 46' ' ' VAL . 78.9 m80 -130.71 147.97 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.596 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.8 t -89.57 137.27 32.47 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -72.74 -6.34 43.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.518 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 78.2 m-20 -100.71 -70.26 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.571 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.99 -24.57 55.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.68 21.92 78.88 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.722 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.8 162.4 13.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.801 0.334 . . . . 0.0 110.512 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 39' ' ' HIS . 87.0 t -78.35 128.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.226 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 2.0 mm? -132.64 139.52 47.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -77.54 175.04 10.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.675 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.76 -52.87 35.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.673 -1.251 . . . . 0.0 112.358 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -55.67 -35.84 66.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 1.7 m -89.16 -2.34 58.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.24 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -131.78 27.3 4.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.675 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 74.9 mtt180 -82.19 -20.13 38.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.369 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -76.99 163.06 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 111.212 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -139.59 136.55 34.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.222 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB1' ' CD1' ' A' ' 74' ' ' TYR . . . -160.15 153.97 22.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -87.3 153.14 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.542 HG23 ' CG ' ' A' ' 61' ' ' ARG . 3.1 mt -129.25 77.6 77.33 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 110.808 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.8 -8.49 15.78 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 123.138 2.559 . . . . 0.0 113.894 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mmm -89.7 -37.87 14.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.0 109.36 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.542 ' CG ' HG23 ' A' ' 58' ' ' ILE . 2.8 mmm180 -84.31 2.71 38.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.441 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.25 7.68 61.98 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.535 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.48 HG23 ' CG ' ' A' ' 67' ' ' GLU . 72.7 mt -97.86 102.06 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.193 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.3 p -87.59 -17.43 31.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 mt-10 -103.11 142.01 23.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 32.2 Cg_exo -56.16 124.38 16.12 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.725 1.616 . . . . 0.0 112.061 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' HG23 ' A' ' 63' ' ' ILE . 74.4 mm-40 -126.41 166.85 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -69.25 136.44 51.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.473 0.654 . . . . 0.0 111.707 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 28.4 m -148.92 161.1 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.844 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.481 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -75.44 -168.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 55.3 p30 -81.15 -40.3 24.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.93 -44.41 73.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 111.37 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 64.3 m -63.91 -40.92 97.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.662 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 38.0 t80 -57.22 -41.09 78.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.9 mt -69.2 -49.05 60.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.748 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.91 83.15 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 58' ' ' ILE . 93.4 mt -65.72 -36.67 84.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.55 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 68.4 mtp180 -67.17 -8.47 31.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.966 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.0 m -61.07 -32.01 71.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.259 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 t -43.84 134.44 4.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -90.11 133.32 34.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.1 mtm -78.26 134.18 37.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.041 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.45 146.75 52.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.465 -1.186 . . . . 0.0 112.497 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.91 145.18 89.9 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.573 2.182 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.0 mp -78.93 -4.97 52.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.38 -178.98 52.42 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.959 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.0 p -66.99 -20.38 65.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.693 0.282 . . . . 0.0 111.381 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 62.7 mtt -77.82 137.17 38.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.288 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -13.8 62.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.409 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.0 mp0 -98.05 15.86 22.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.642 0.258 . . . . 0.0 111.153 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -71.71 -4.82 29.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -62.51 140.55 58.62 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.467 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -135.87 160.1 39.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.095 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -102.27 145.84 28.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.69 83.14 0.13 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -77.94 121.1 23.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 111.298 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -94.97 120.06 34.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.417 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -85.19 128.0 34.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.352 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -55.38 154.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.865 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -56.68 -42.67 79.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.002 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -67.15 -42.6 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.044 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -66.92 -32.25 73.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.96 74.44 0.97 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.991 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.36 -15.69 25.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.913 2.409 . . . . 0.0 112.215 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.93 155.9 49.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.919 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.454 ' SG ' HD13 ' A' ' 47' ' ' LEU . 5.6 t -61.73 124.26 20.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 111.904 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 53.5 m-80 -61.41 -27.69 68.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.134 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 -56.05 2.5 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.619 -0.801 . . . . 0.0 114.716 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 p -105.56 -0.69 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.15 63.21 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.718 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.0 p -71.44 144.91 49.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.409 0.605 . . . . 0.0 109.837 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.96 140.33 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 81.2 m-85 -84.81 135.63 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.344 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.0 p -126.89 167.06 16.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -45.36 -41.67 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -70.5 -34.81 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.32 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.64 114.18 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.503 0.668 . . . . 0.0 111.554 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -78.72 150.19 32.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.669 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -90.34 142.53 27.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.137 0.494 . . . . 0.0 110.454 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.541 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.9 m-70 -139.7 168.14 20.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.129 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.72 143.93 49.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.757 0.313 . . . . 0.0 111.309 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.4 t -90.72 137.87 32.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -72.97 -5.22 37.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 78.6 m-20 -101.7 -72.21 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.785 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.0 p -77.09 -24.44 51.8 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.77 77.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.86 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.94 164.02 12.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 38' ' ' HIS . 60.9 t -80.8 128.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' N ' HD21 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -130.7 137.64 49.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.348 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.27 174.29 8.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.729 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.08 -53.01 32.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.421 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.505 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 70.5 m-20 -56.26 -36.09 68.17 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -86.91 -3.33 59.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.135 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.2 p -131.66 26.03 4.71 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 70.8 mtp85 -82.21 -16.97 47.76 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.972 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -80.38 166.14 21.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -142.53 135.2 28.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.245 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -158.28 153.23 25.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.697 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.432 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.06 154.61 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.515 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.7 mt -131.35 81.11 66.24 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.997 0.427 . . . . 0.0 110.733 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.16 -8.12 19.29 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.981 2.454 . . . . 0.0 113.907 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.4 mtp -89.37 -37.12 15.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' CG ' HG22 ' A' ' 58' ' ' ILE . 13.7 mmm180 -84.83 4.0 35.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.19 4.42 66.64 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.533 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 HG21 ' CG ' ' A' ' 67' ' ' GLU . 74.2 mt -94.65 97.82 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.356 . . . . 0.0 110.157 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -84.66 -18.51 35.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.5 mt-10 -103.84 146.4 32.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.9 Cg_endo -57.89 123.84 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.029 1.819 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' CG ' HG21 ' A' ' 63' ' ' ILE . 80.5 mm-40 -126.42 167.52 15.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -71.76 137.49 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.732 0.777 . . . . 0.0 112.202 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.557 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.2 m -146.66 179.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.051 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.506 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -92.71 -162.25 0.91 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -83.51 -44.04 15.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.92 80.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.806 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.7 m -64.03 -40.99 97.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 77.5 t80 -55.8 -40.78 73.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 13.3 mt -71.35 -53.99 12.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.34 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.9 -48.61 42.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.374 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 58' ' ' ILE . 72.3 mt -65.28 -42.33 93.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 52.8 ttt-85 -54.01 -20.84 6.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.393 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.9 p -59.22 -31.69 69.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.688 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.4 t -62.32 -34.39 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -94.35 121.21 35.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.255 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 70.9 mtm -87.57 133.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.683 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.39 57.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.714 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.853 -179.662 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.599 -0.201 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.53 149.63 85.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.824 2.349 . . . . 0.0 112.001 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.7 mt -81.69 140.29 34.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.94 -177.09 51.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.1 p -70.19 157.9 36.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.63 -37.66 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.34 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.35 175.23 40.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.543 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 8' ' ' GLU . 80.5 tt0 -91.23 16.6 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 110.885 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -71.43 -2.15 15.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.203 0.525 . . . . 0.0 109.62 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' O ' ' CB ' ' A' ' 11' ' ' SER . 40.7 tt0 -67.37 109.52 3.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.136 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 9.9 t 159.46 39.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.535 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.435 ' HG3' ' NH2' ' A' ' 61' ' ' ARG . 15.6 tttp -95.06 122.06 37.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.28 50.65 49.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.575 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -75.81 120.87 21.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.757 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -86.39 118.32 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -84.76 126.01 33.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.263 0.554 . . . . 0.0 109.655 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -58.92 153.68 16.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.056 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 35.1 p-10 -58.0 -43.28 86.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.245 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 98.9 mt-10 -66.01 -41.5 90.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.865 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -71.78 -30.09 65.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.263 0.554 . . . . 0.0 110.258 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.49 72.62 5.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.595 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.87 -10.09 21.27 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.137 2.558 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -135.99 158.01 45.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.366 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 47' ' ' LEU . 6.8 t -63.18 125.06 22.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 31.8 m120 -63.51 -25.49 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.364 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.28 -56.66 2.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.684 -0.77 . . . . 0.0 114.679 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 p -105.09 -1.85 25.07 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.05 65.77 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.423 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.4 p -67.09 143.89 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.257 0.528 . . . . 0.0 109.639 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.7 OUTLIER -84.25 143.44 11.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 94.5 m-85 -84.28 134.82 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.7 p -126.45 168.75 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.061 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.04 -44.7 31.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.356 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 m -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.562 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -87.96 113.04 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.364 0.602 . . . . 0.0 111.54 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -73.85 149.28 41.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.126 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.458 ' HG3' HG13 ' A' ' 46' ' ' VAL . 20.2 ttp180 -81.74 140.9 34.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.2 m-70 -142.23 165.89 26.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.144 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.458 ' CE1' HG21 ' A' ' 46' ' ' VAL . 96.7 m-70 -131.35 147.63 52.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 t -90.77 136.7 32.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.449 ' NE ' ' OE1' ' A' ' 67' ' ' GLU . 68.6 mtp85 -72.45 -5.45 36.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.501 ' ND2' ' CD1' ' A' ' 58' ' ' ILE . 14.7 m-80 -101.67 -70.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.9 p -75.0 -24.84 58.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.4 77.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.637 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.512 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.92 163.19 12.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 88.6 t -79.72 128.86 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.53 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 2.3 mm? -132.98 140.64 47.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.89 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 p -82.55 175.13 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.632 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -52.13 -52.65 34.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.127 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -53.85 -36.3 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 m -92.32 -1.26 57.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.703 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -132.47 25.91 4.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 110.089 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 19.6 mmt180 -79.23 -22.99 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -76.33 165.06 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.446 0.641 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -139.7 134.05 31.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.017 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.447 ' HB1' ' CE1' ' A' ' 74' ' ' TYR . . . -159.38 155.16 26.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.54 159.44 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.6 HG21 ' HG2' ' A' ' 61' ' ' ARG . 1.1 mt -133.12 74.96 72.33 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.092 0.473 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.95 -14.15 39.44 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.423 2.749 . . . . 0.0 114.491 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.3 mtm -86.54 -37.35 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG2' HG21 ' A' ' 58' ' ' ILE . 18.3 mmm180 -83.01 3.68 29.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.857 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.07 61.84 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.408 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CD1' HD13 ' A' ' 58' ' ' ILE . 63.7 mt -101.24 101.25 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.91 0.386 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -87.73 -16.01 35.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.434 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 63' ' ' ILE . 3.7 mp0 -103.19 145.2 30.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.0 Cg_endo -58.57 121.87 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.615 1.544 . . . . 0.0 112.005 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' OE1' ' NE ' ' A' ' 41' ' ' ARG . 94.7 mt-10 -125.49 168.74 13.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.702 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HB3' ' NH1' ' A' ' 68' ' ' ARG . 5.1 ptp180 -72.37 137.28 46.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.741 0.782 . . . . 0.0 112.333 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.41 -177.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.897 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.53 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -97.29 -162.14 0.93 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -82.81 -43.91 16.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.09 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 111.53 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -64.15 -40.53 96.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.289 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.447 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 79.8 t80 -57.25 -41.29 79.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.467 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 8.5 mt -70.64 -50.94 31.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.872 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.21 -48.33 54.34 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.422 HD11 HG23 ' A' ' 58' ' ' ILE . 44.8 mt -64.37 -42.3 96.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 61.0 ttt-85 -55.68 -19.42 10.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.593 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.8 p -59.6 -29.13 67.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -121.06 140.24 52.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -91.31 141.31 28.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.012 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.3 mtp -82.62 135.29 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.47 143.73 57.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.502 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.96 147.28 64.05 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.9 -35.16 74.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.794 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.28 176.12 27.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.438 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.8 p -61.66 -27.58 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 94.7 mmm -59.58 -36.03 75.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.038 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.66 31.07 55.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.201 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -82.26 7.59 13.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.555 0.217 . . . . 0.0 111.55 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -58.79 -18.15 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -57.54 142.26 45.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.001 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.2 p -120.89 151.57 39.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -103.72 134.98 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.29 152.61 40.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' GLY . 81.6 t80 -78.04 121.94 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -93.32 119.2 32.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -84.15 131.4 34.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.312 0.577 . . . . 0.0 110.347 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.7 153.73 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.044 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HB3' ' NE ' ' A' ' 37' ' ' ARG . 35.6 p-10 -57.59 -44.11 85.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.349 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 97.2 mt-10 -66.36 -42.06 88.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.122 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.96 -34.03 76.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.92 74.53 1.76 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.801 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.3 -12.3 25.24 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.056 2.504 . . . . 0.0 112.549 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.57 48.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.166 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.5 t -62.57 123.44 18.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.0 111.683 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.9 m120 -60.36 -26.79 66.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 -55.88 2.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.429 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.98 -3.15 25.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.41 8.96 67.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.437 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.4 p -70.01 142.69 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.208 0.504 . . . . 0.0 110.186 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.95 137.9 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.954 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.543 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 84.6 m-85 -83.73 134.64 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.5 p -127.48 171.2 11.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -46.9 -39.63 12.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 p -75.74 -25.45 56.55 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.828 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.9 t -96.74 112.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.36 0.6 . . . . 0.0 111.271 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -75.45 147.74 39.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.644 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.6 ttp85 -81.93 140.34 34.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.768 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.431 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -141.96 163.9 31.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.232 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -129.26 146.57 51.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.5 t -91.19 138.03 31.91 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -73.03 -5.43 38.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.499 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 76.2 m-20 -101.46 -71.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.505 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.1 p -76.94 -24.41 52.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.12 22.09 78.24 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.547 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.8 m-85 -98.17 161.2 13.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.896 0.379 . . . . 0.0 110.454 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.543 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 95.5 t -77.62 128.86 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.497 HD22 ' O ' ' A' ' 45' ' ' TYR . 1.7 mm? -132.2 139.15 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -78.88 175.94 10.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.731 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.51 -53.95 29.7 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.764 -1.207 . . . . 0.0 112.333 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -54.83 -35.53 64.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.429 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -90.33 -1.94 57.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.441 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 p -131.3 26.25 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 94.6 mtt-85 -80.96 -19.39 44.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.117 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -80.58 163.41 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.19 0.519 . . . . 0.0 111.438 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 mtm105 -139.36 136.99 35.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.274 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.49 154.62 27.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.95 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.97 151.77 20.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.537 HG21 ' CG ' ' A' ' 61' ' ' ARG . 3.3 mt -128.39 79.32 74.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.026 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.89 -9.97 20.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.217 2.611 . . . . 0.0 114.044 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.401 ' HE1' ' CD2' ' A' ' 77' ' ' LEU . 71.8 mtm -88.33 -37.87 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.537 ' CG ' HG21 ' A' ' 58' ' ' ILE . 30.8 mmm180 -83.17 1.01 42.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.441 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.42 60.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 58' ' ' ILE . 74.1 mt -96.64 101.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.398 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.3 p -88.25 -18.94 27.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.384 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 3.5 mm-40 -103.69 138.53 19.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.457 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.4 Cg_exo -52.99 124.3 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.692 1.595 . . . . 0.0 112.044 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 94.6 mt-10 -125.64 167.43 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -69.94 136.25 50.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 111.966 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.499 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 29.0 m -145.27 179.48 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.982 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.485 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.89 -166.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 56.3 p30 -79.36 -42.68 25.06 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -67.9 -45.95 72.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 111.7 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.2 m -63.63 -41.43 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.302 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.514 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 68.9 t80 -56.32 -40.36 74.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 78' ' ' ARG . 7.6 mt -72.55 -50.65 24.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.245 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.95 62.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.667 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD12 HG22 ' A' ' 58' ' ' ILE . 60.6 mt -65.68 -42.03 91.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 71.2 ttt180 -58.4 -20.42 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.771 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.2 m -51.5 -36.54 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.134 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.6 t -135.06 121.5 20.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.913 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -62.69 -37.44 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.822 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.9 mtm -90.64 134.69 34.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.069 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.32 145.92 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.592 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.78 -4.14 14.93 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.652 2.234 . . . . 0.0 112.177 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.32 -33.49 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.48 12.57 61.01 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.645 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -115.46 145.66 42.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 51.8 ttm -80.47 125.7 30.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.26 -170.87 45.18 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.738 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -81.58 7.29 12.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.519 0.199 . . . . 0.0 111.533 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -59.77 -13.78 11.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -46.25 -34.29 4.31 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.159 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -109.17 149.35 29.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -127.13 151.43 48.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.45 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.74 -4.76 57.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.996 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -80.09 122.27 26.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -91.91 119.47 31.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.886 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -82.42 127.81 33.64 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.31 0.576 . . . . 0.0 109.91 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.47 153.46 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.818 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 37' ' ' ARG . 6.3 m-20 -54.42 -46.49 73.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.295 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.9 -41.46 87.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.46 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -66.44 -33.14 75.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.159 0.504 . . . . 0.0 110.693 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.89 78.07 2.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.713 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.67 -13.28 18.11 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.101 2.534 . . . . 0.0 112.644 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.64 155.82 49.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.438 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' A' ' 47' ' ' LEU . 4.7 t -59.62 123.93 18.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 111.552 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 29.5 m120 -60.83 -28.08 68.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.086 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.15 -54.77 2.36 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.329 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 p -103.68 -4.03 24.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.08 7.75 63.37 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.628 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p -69.88 144.16 52.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.264 0.532 . . . . 0.0 110.301 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.78 137.66 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.978 0.418 . . . . 0.0 112.066 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.471 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.41 134.59 34.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.213 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -128.04 170.78 12.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -49.3 -43.85 43.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.35 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.5 m -66.53 -35.82 81.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.65 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.6 t -89.59 112.66 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.288 0.566 . . . . 0.0 111.364 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -73.08 145.76 46.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.846 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.473 ' HD2' ' OD1' ' A' ' 18' ' ' ASP . 58.5 ttm-85 -83.81 141.34 31.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.656 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 99.8 m-70 -143.66 166.25 25.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -130.86 148.85 52.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.02 137.52 32.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' CG ' HD11 ' A' ' 63' ' ' ILE . 29.2 tpt180 -71.73 -7.18 46.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' OD1' HG23 ' A' ' 58' ' ' ILE . 68.6 m-20 -100.7 -69.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.514 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -76.98 -23.08 52.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.61 21.5 79.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.504 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.68 161.41 13.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.794 0.33 . . . . 0.0 110.252 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 85.2 t -79.21 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.24 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.4 mm? -132.41 141.01 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.743 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.2 p -79.45 177.81 8.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.687 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.88 -52.78 44.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.459 -1.353 . . . . 0.0 112.242 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -55.59 -35.58 65.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.15 -1.81 58.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.8 p -132.02 25.8 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.687 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 84.3 mtt-85 -79.88 -19.18 48.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.039 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -80.06 164.21 23.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.263 0.554 . . . . 0.0 111.771 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.76 135.91 31.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.284 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . . . -158.82 155.1 27.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.46 154.45 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.534 HG23 ' CG ' ' A' ' 61' ' ' ARG . 3.6 mt -129.97 80.37 71.29 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 0.0 110.58 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.99 -12.02 33.56 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.242 2.628 . . . . 0.0 114.189 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.3 mtp -86.4 -37.3 18.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.534 ' CG ' HG23 ' A' ' 58' ' ' ILE . 31.9 mmm180 -83.69 2.78 36.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.747 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.45 63.32 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.193 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 HG23 ' CG ' ' A' ' 67' ' ' GLU . 65.9 mt -97.87 100.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.79 -17.31 33.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.693 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mm-40 -103.26 143.92 27.59 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.0 Cg_endo -57.13 123.29 13.49 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.618 1.545 . . . . 0.0 111.698 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.483 ' CG ' HG23 ' A' ' 63' ' ' ILE . 75.6 mm-40 -123.72 167.76 13.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.837 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.38 135.79 47.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.695 0.759 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.51 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -146.0 -177.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.103 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.502 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 2.0 p -98.09 -162.7 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 53.9 p30 -82.97 -41.58 18.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.62 -46.23 69.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 111.541 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 65.3 m -64.01 -40.34 96.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.225 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 73.2 t80 -57.1 -40.42 76.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 9.1 mt -72.67 -52.92 13.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.46 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.64 -48.22 49.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 HD13 HG21 ' A' ' 58' ' ' ILE . 83.3 mt -66.32 -41.64 89.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 53.0 ttt85 -56.08 -19.77 14.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.307 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.3 t -96.09 81.68 3.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.388 . . . . 0.0 110.605 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -123.1 147.61 46.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -56.73 -36.56 69.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 96.2 mmm -87.59 131.51 34.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.37 142.48 54.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.394 179.882 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.73 146.68 84.29 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.013 2.475 . . . . 0.0 112.315 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 mt -62.17 -35.2 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.39 10.52 62.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.7 t -66.59 155.67 37.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 111.013 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 92.6 mmm -56.63 -31.3 64.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.544 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.11 157.8 12.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.623 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 14' ' ' TYR . 94.5 mt-10 -94.88 16.29 16.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -58.17 -18.84 28.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.437 ' NE2' ' HB3' ' A' ' 12' ' ' LYS . 31.9 tt0 -61.97 127.47 31.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.819 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -64.81 -33.84 76.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HB3' ' NE2' ' A' ' 10' ' ' GLN . 19.9 tttt -60.66 -37.36 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.153 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.5 145.42 11.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.152 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 73.2 t80 -79.39 123.3 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.466 ' HB2' ' CE1' ' A' ' 39' ' ' HIS . 40.0 p90 -88.46 117.77 27.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.995 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -84.95 127.24 34.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.8 153.63 16.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -53.91 -46.11 71.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.7 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.8 -41.11 88.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.159 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.67 -34.15 75.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.199 0.523 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.39 77.54 1.68 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.619 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.64 -13.97 14.43 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.159 2.573 . . . . 0.0 113.181 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.58 48.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -59.65 125.82 25.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 112.051 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 36.2 m-80 -62.66 -27.76 69.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.37 -54.42 2.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.101 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.6 p -103.46 -3.77 24.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.83 11.64 66.51 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.611 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 5.3 p -72.55 143.86 48.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.492 0.646 . . . . 0.0 110.485 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.68 137.14 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 98.1 m-85 -82.56 135.06 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.863 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 169.44 12.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.28 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -47.19 -43.22 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 m -67.78 -37.91 82.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.4 t -87.2 113.06 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.353 0.597 . . . . 0.0 111.311 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -74.08 149.79 40.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.763 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HG3' HG13 ' A' ' 46' ' ' VAL . 64.8 ttp85 -80.95 138.77 36.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.802 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 89.1 m-70 -142.76 165.12 28.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.129 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.466 ' CE1' ' HB2' ' A' ' 15' ' ' TRP . 64.3 m170 -128.18 146.58 50.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.725 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.0 t -90.3 137.47 32.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -72.57 -7.37 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 78.7 m-20 -101.21 -71.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.494 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.2 p -75.08 -24.04 58.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.695 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.66 20.86 79.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.734 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -99.07 163.24 12.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.953 0.406 . . . . 0.0 110.609 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 89.6 t -76.74 128.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.406 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 3.1 mm? -133.06 139.45 47.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.654 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.1 p -79.69 175.54 10.52 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.46 -53.59 34.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.307 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.37 -36.14 63.55 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 1.7 m -89.65 -1.89 58.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.1 p -132.39 26.78 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 90.6 mtt-85 -80.22 -19.24 47.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -79.59 164.61 23.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.153 0.501 . . . . 0.0 111.628 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.432 ' HB3' ' NH1' ' A' ' 55' ' ' ARG . 15.9 mtp-105 -140.85 137.93 33.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.84 154.3 23.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.863 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.75 147.82 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.514 ' CG2' ' HG3' ' A' ' 61' ' ' ARG . 2.8 mt -126.97 77.69 74.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.821 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.74 -8.18 12.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 123.393 2.729 . . . . 0.0 113.8 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.3 mtp -96.0 -34.99 11.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.766 0.793 . . . . 0.0 109.099 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.514 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 40.5 mtp85 -90.01 29.47 1.21 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.289 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.14 23.02 71.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.075 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.447 ' O ' ' C ' ' A' ' 58' ' ' ILE . 71.5 mt -119.44 101.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.748 0.309 . . . . 0.0 110.394 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.91 -22.86 24.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.817 0.341 . . . . 0.0 111.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.6 mm-40 -99.74 138.49 20.4 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.515 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 53.1 Cg_exo -52.72 123.04 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.4 1.4 . . . . 0.0 111.693 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 93.4 mt-10 -124.64 165.69 17.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.562 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -69.56 139.12 53.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.645 0.736 . . . . 0.0 112.186 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.524 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -145.14 -179.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.91 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.496 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -96.26 -164.98 1.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -80.19 -43.8 20.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.84 79.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.734 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 32.8 m -65.23 -40.1 93.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.377 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 68.2 t80 -57.17 -41.83 79.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 78' ' ' ARG . 6.7 mt -70.43 -50.56 37.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.272 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.18 61.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.399 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD12 HG21 ' A' ' 58' ' ' ILE . 33.9 mt -65.4 -42.18 92.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.49 ' HB3' ' HA ' ' A' ' 75' ' ' LEU . 67.6 ttt180 -58.8 -20.5 50.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.725 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.8 t -105.2 148.47 26.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.078 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.5 t -117.1 144.71 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.725 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -89.63 130.46 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.77 -35.51 74.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.77 147.43 49.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.619 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.31 -4.94 16.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.594 2.196 . . . . 0.0 112.528 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 mt -85.27 144.43 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.54 144.66 40.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.603 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.5 p -63.56 -23.58 67.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 111.066 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 84.8 mtp -109.51 143.31 39.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.56 111.24 0.41 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.466 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 8' ' ' GLU . 80.3 tt0 -89.55 13.49 13.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.978 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -69.73 -4.18 18.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.281 0.563 . . . . 0.0 109.553 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -72.65 135.07 45.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.888 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -122.67 141.31 51.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.697 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -126.58 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.96 -171.86 48.29 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.231 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' GLY . 72.7 t80 -76.92 122.05 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -92.84 118.36 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.59 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -82.37 131.24 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 110.314 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -60.27 153.11 23.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.76 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.48 ' CB ' ' NE ' ' A' ' 37' ' ' ARG . 31.3 p-10 -56.66 -45.08 81.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.494 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -64.97 -42.2 94.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.012 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.01 -29.24 64.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.263 0.554 . . . . 0.0 110.588 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.49 72.76 5.36 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.498 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.21 -11.08 17.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.245 2.63 . . . . 0.0 112.952 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 156.41 48.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.461 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' HD12 ' A' ' 47' ' ' LEU . 1.8 t -59.58 123.76 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.147 0.499 . . . . 0.0 111.872 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 m-80 -61.81 -27.69 68.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.969 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.86 -54.73 2.41 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.104 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 p -104.09 -3.19 24.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 69.14 9.08 59.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.466 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 p -70.59 144.79 51.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.156 0.478 . . . . 0.0 110.164 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.95 136.62 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.144 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.532 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 99.0 m-85 -82.41 134.9 35.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.959 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 p -126.55 168.24 14.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.8 m -47.41 -43.58 23.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.9 m -66.51 -38.06 86.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.71 113.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 0.0 111.174 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.85 145.6 46.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.049 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.48 ' NE ' ' CB ' ' A' ' 18' ' ' ASP . 22.5 ttm105 -83.24 140.76 32.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.572 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -143.06 167.25 22.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.441 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -128.63 146.66 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.367 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.0 t -89.9 137.45 32.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 14.2 mmt180 -71.83 -7.67 49.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.495 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 75.0 m-20 -101.74 -70.33 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.533 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.7 p -75.83 -24.2 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.27 21.11 79.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.712 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 22.0 m-85 -98.72 161.49 13.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.732 0.301 . . . . 0.0 110.349 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 73.0 t -75.4 128.96 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.51 HD21 ' O ' ' A' ' 45' ' ' TYR . 3.7 mm? -132.54 139.42 47.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 p -80.04 174.33 11.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.729 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.66 -53.97 26.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.601 -1.285 . . . . 0.0 112.437 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -55.08 -35.32 64.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 70' ' ' CYS . 1.7 m -89.62 -2.51 58.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.426 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -132.55 26.47 4.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.729 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt-85 -80.49 -20.39 43.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.168 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -78.55 163.69 25.32 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 111.289 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -138.26 135.89 35.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.957 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -156.39 153.94 29.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.973 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.427 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -93.65 149.29 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.544 ' CG2' ' HG3' ' A' ' 61' ' ' ARG . 2.1 mt -128.96 76.75 78.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.075 0.464 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.12 -8.43 12.12 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.329 2.686 . . . . 0.0 113.693 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.87 -35.66 11.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.708 0.766 . . . . 0.0 108.949 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.544 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 7.6 mtp-105 -90.28 29.06 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.002 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.45 72.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.11 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.47 ' O ' ' C ' ' A' ' 58' ' ' ILE . 88.8 mt -123.52 97.93 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -86.84 -17.58 33.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.712 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.4 mt-10 -102.17 141.13 21.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 40.3 Cg_exo -55.39 122.52 11.88 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.492 1.461 . . . . 0.0 111.694 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 94.3 mt-10 -125.52 166.64 16.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -69.36 137.09 52.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.598 0.713 . . . . 0.0 111.984 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.495 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 26.9 m -145.89 -179.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.027 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.465 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.9 p -96.89 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -78.08 -42.31 32.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.76 -45.72 70.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 38.4 m -64.38 -41.54 96.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.443 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.544 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 73.4 t80 -56.17 -39.59 72.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 22.0 mt -72.89 -54.56 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.454 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.54 -48.11 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.364 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 58' ' ' ILE . 82.6 mt -66.31 -40.94 90.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 66.1 ttt180 -56.63 -19.42 16.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.247 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.7 t -58.22 -38.22 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 p -78.23 158.79 28.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -95.89 123.42 39.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 89.2 mtp -83.82 127.77 34.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.24 55.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.435 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.91 146.66 66.92 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.671 2.247 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.87 -37.06 78.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.708 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.19 -167.17 53.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 m -64.92 151.62 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.72 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.62 -35.27 75.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.197 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.63 -172.71 35.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.7 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -83.55 8.63 13.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -58.84 -17.66 25.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -52.08 -38.05 55.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.226 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.1 m -121.36 146.41 46.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.123 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 56.8 mttt -59.22 -37.11 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.626 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -138.25 142.02 12.7 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.241 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' A' ' 44' ' ' GLY . 85.5 t80 -79.25 122.01 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.307 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -89.08 118.79 29.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.839 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -85.14 127.05 34.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 109.747 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.31 153.35 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.969 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.447 ' HB3' ' NE ' ' A' ' 37' ' ' ARG . 28.9 p-10 -57.2 -43.63 82.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.868 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.37 -41.99 88.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.987 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -67.83 -33.85 75.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.197 0.522 . . . . 0.0 110.605 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.56 75.71 1.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.747 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.99 -11.85 21.5 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.039 2.493 . . . . 0.0 112.592 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.75 156.01 49.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.218 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.6 t -62.83 123.93 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.174 0.511 . . . . 0.0 111.488 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.7 m120 -59.15 -27.01 65.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.084 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.11 -55.51 2.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.327 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -103.84 -2.61 26.02 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 69.74 8.91 61.36 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.3 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 p -69.51 143.09 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.22 0.51 . . . . 0.0 110.009 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -80.08 137.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.905 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.536 ' CZ ' HG13 ' A' ' 46' ' ' VAL . 87.0 m-85 -84.33 134.93 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.7 p -127.74 171.51 11.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.308 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.25 -41.16 26.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.0 p -72.35 -28.05 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.8 t -94.9 113.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.634 . . . . 0.0 111.435 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.81 148.17 40.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.369 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.456 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 17.9 ttp180 -82.33 140.61 33.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.611 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.0 m-70 -142.23 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -130.43 147.09 52.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.6 t -89.37 138.38 31.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.43 ' HG2' HD13 ' A' ' 63' ' ' ILE . 24.6 tpt180 -72.55 -7.05 48.1 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 71.2 m-20 -100.66 -70.04 0.75 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.3 p -77.51 -23.86 50.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.28 22.13 79.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.397 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.522 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.4 m-85 -98.48 163.14 12.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.828 0.347 . . . . 0.0 110.314 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.536 HG13 ' CZ ' ' A' ' 31' ' ' PHE . 79.9 t -79.73 127.72 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.234 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.514 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.5 mm? -132.32 139.58 48.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.53 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.24 178.01 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.703 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.04 -53.8 35.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.481 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -55.28 -35.77 65.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.435 ' HB3' HD13 ' A' ' 47' ' ' LEU . 1.7 m -89.48 -2.34 58.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.361 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -131.8 26.15 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 93.3 mtt-85 -79.54 -21.4 45.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.305 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -80.16 165.07 22.8 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.279 0.561 . . . . 0.0 111.613 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -140.59 138.09 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.388 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.457 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.37 154.16 26.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.834 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.89 154.99 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.542 HG21 ' CG ' ' A' ' 61' ' ' ARG . 3.2 mt -130.21 79.53 72.52 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.09 -11.17 26.21 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.174 2.583 . . . . 0.0 113.91 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.7 mtp -86.91 -37.79 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.542 ' CG ' HG21 ' A' ' 58' ' ' ILE . 14.9 mmm180 -84.74 4.24 33.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.78 8.82 63.27 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.476 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG23 ' CG ' ' A' ' 67' ' ' GLU . 67.0 mt -99.09 100.83 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.241 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.0 p -87.09 -16.79 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.54 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 34.3 mt-10 -103.81 145.0 29.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 17.0 Cg_endo -58.18 123.34 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.688 1.592 . . . . 0.0 111.723 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' CG ' HG23 ' A' ' 63' ' ' ILE . 75.6 mm-40 -124.84 167.71 14.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -71.01 136.46 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 0.0 111.658 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.0 m -147.08 -178.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.159 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.514 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.34 -164.96 1.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.88 -43.97 21.29 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.58 74.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.429 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 54.0 m -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.338 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 75.7 t80 -56.34 -39.05 72.2 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 42.0 mt -73.0 -54.93 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.672 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.05 -47.87 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.294 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.408 HD13 HG22 ' A' ' 58' ' ' ILE . 91.8 mt -65.55 -41.43 93.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 17.1 ttp180 -57.24 -18.64 17.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.555 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.3 m -64.3 156.59 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.008 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.8 p -117.46 155.93 28.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -55.39 137.26 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.0 mtp -85.37 144.27 28.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.044 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.13 67.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.448 -1.196 . . . . 0.0 112.522 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.12 -3.19 12.81 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.879 2.386 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.87 141.93 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.17 117.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.425 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.5 p -134.89 157.16 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 86.2 mtp -120.03 148.44 43.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.66 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.3 -95.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.844 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 10' ' ' GLN . 96.0 mt-10 -65.19 -11.65 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -62.57 -5.81 2.93 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 8' ' ' GLU . 58.8 tt0 -66.26 139.78 58.1 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.048 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -64.23 153.57 37.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.572 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.12 134.39 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.62 55.59 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.668 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 76.7 t80 -79.06 121.96 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -92.49 118.99 31.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.69 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -83.93 130.67 34.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.243 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.03 154.31 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.935 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' OD1' ' HG2' ' A' ' 37' ' ' ARG . 31.6 m-20 -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.166 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.37 -42.16 83.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.98 -33.88 76.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.205 0.526 . . . . 0.0 110.644 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.43 72.61 1.29 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.538 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.64 -13.39 29.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.069 2.513 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.94 156.14 49.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.18 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' SG ' HD11 ' A' ' 47' ' ' LEU . 10.3 t -62.41 123.01 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.648 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 68.1 m-80 -60.45 -25.66 66.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.282 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.89 -55.87 2.06 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.189 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.5 p -103.09 -4.45 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 10.06 72.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.469 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 p -71.1 142.61 50.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.355 0.577 . . . . 0.0 110.353 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.21 138.84 18.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.784 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.4 m-85 -83.85 134.17 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.473 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.4 p -127.89 171.67 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.2 m -48.26 -40.98 26.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 p -73.01 -27.68 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.391 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.1 t -94.61 112.66 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.419 0.628 . . . . 0.0 111.345 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -73.85 145.67 44.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.397 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HG2' ' OD1' ' A' ' 18' ' ' ASP . 7.8 tpp180 -77.72 139.38 39.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 98.6 m-70 -142.72 161.9 36.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.221 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -129.96 147.19 51.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -89.9 137.85 31.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.3 -6.89 46.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.518 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 81.4 m-20 -101.54 -71.37 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.73 -24.07 56.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . 72.97 22.14 79.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.371 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.53 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.2 m-85 -99.02 162.57 12.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 89.6 t -78.47 128.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 2.2 mm? -132.31 137.86 47.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.2 176.8 8.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.688 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.58 -54.36 30.71 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -54.85 -35.28 63.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.55 -2.35 58.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.38 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -132.33 26.18 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.0 mtt-85 -78.7 -21.39 48.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -78.39 162.07 26.7 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -138.1 138.22 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.01 153.55 24.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.5 147.97 22.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.537 ' CG2' ' HG3' ' A' ' 61' ' ' ARG . 2.3 mt -126.93 76.97 75.39 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 110.95 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.87 -6.97 10.26 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.253 2.636 . . . . 0.0 113.735 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.8 mtm -95.75 -36.11 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.723 0.773 . . . . 0.0 109.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.537 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 45.1 mtp85 -90.03 29.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 22.67 72.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.278 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 58' ' ' ILE . 76.3 mt -118.54 102.5 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 117.033 0.417 . . . . 0.0 110.544 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -87.52 -21.68 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.397 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 4.2 mt-10 -100.36 145.79 30.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.7 Cg_endo -59.49 123.25 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.738 1.625 . . . . 0.0 111.45 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' OE1' ' CD1' ' A' ' 63' ' ' ILE . 93.5 mt-10 -125.78 165.7 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.924 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.58 137.2 54.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 0.0 112.067 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 32.3 m -145.06 177.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.976 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.489 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.43 -168.78 1.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.25 -42.82 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.01 73.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.416 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 54.5 m -64.13 -41.06 97.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.397 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' CE2' ' HD2' ' A' ' 78' ' ' ARG . 74.5 t80 -56.5 -39.79 73.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt -70.28 -49.94 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.621 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.13 86.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.482 HD11 ' OD1' ' A' ' 42' ' ' ASN . 93.6 mt -66.66 -36.57 82.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.832 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.537 ' HD2' ' CE2' ' A' ' 74' ' ' TYR . 12.9 mtt180 -68.45 -6.51 25.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.963 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 74.4 m -60.54 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 m -130.68 144.15 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.191 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.3 -34.0 73.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.509 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 95.6 mmm -88.14 137.85 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.63 145.68 48.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.068 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.473 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.35 138.9 87.2 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.832 2.355 . . . . 0.0 112.293 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.2 mt -90.8 138.51 31.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.506 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.38 -178.17 24.14 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.574 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.5 p -138.45 158.46 44.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.4 mmm -58.9 -36.05 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -174.92 51.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -91.41 8.73 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.44 -7.91 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.88 142.09 58.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.778 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -63.4 152.58 37.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -107.08 146.15 31.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.47 72.57 0.49 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.409 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 77.0 t80 -78.9 122.66 26.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.799 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -91.79 117.19 29.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.376 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -84.02 132.53 34.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.0 151.45 18.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.688 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -56.86 -42.72 80.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.83 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.9 -41.19 87.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.465 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.491 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 89.0 m-20 -62.53 -36.2 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . -114.54 77.66 4.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.505 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 17.1 Cg_exo -67.39 -11.82 33.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.146 2.564 . . . . 0.0 112.819 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 158.28 44.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.529 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.439 ' SG ' HD13 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -60.46 124.73 21.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 111.872 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -61.65 -25.92 67.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.79 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.38 -56.32 2.17 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 p -105.42 -2.3 23.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.47 9.58 68.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.191 -1.005 . . . . 0.0 113.737 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.7 p -71.25 143.78 50.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.412 0.606 . . . . 0.0 110.143 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.42 136.95 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.97 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.46 ' CD2' ' NH1' ' A' ' 37' ' ' ARG . 93.8 m-85 -83.03 134.93 35.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.095 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -125.75 168.08 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -47.08 -43.71 20.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.207 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.3 m -66.68 -36.92 83.68 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.025 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 48' ' ' CYS . 64.3 t -88.74 113.85 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.402 0.62 . . . . 0.0 111.468 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -76.75 150.93 36.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.548 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' NH1' ' CD2' ' A' ' 31' ' ' PHE . 68.7 mtt-85 -88.24 141.51 28.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.68 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.2 m-70 -140.01 166.21 25.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.52 144.47 49.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.834 0.35 . . . . 0.0 111.517 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.88 137.34 32.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -71.98 -6.22 40.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 76.7 m-20 -101.28 -71.82 0.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.688 0.28 . . . . 0.0 111.673 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.519 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -75.85 -25.67 56.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.357 . . . . 0.0 111.87 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . 74.13 23.47 75.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.821 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.7 m-85 -100.45 163.24 12.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 0.0 110.63 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 38' ' ' HIS . 68.4 t -78.27 128.67 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.0 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.505 ' N ' HD21 ' A' ' 47' ' ' LEU . 1.8 mm? -131.63 138.3 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.294 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.433 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 12.2 p -76.92 174.25 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.708 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.8 -52.95 31.89 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.363 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 86.0 m-20 -55.47 -36.1 66.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.479 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -88.81 -2.49 58.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.337 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 p -131.97 26.53 4.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.1 mtt180 -80.76 -17.94 49.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.919 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -81.39 164.7 21.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 111.377 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -140.75 135.51 31.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.105 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.19 153.98 28.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.73 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.62 148.38 22.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.526 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.3 mt -124.9 82.47 60.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.28 -10.88 29.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.015 2.477 . . . . 0.0 114.048 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.95 -37.44 17.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.495 0.664 . . . . 0.0 109.267 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.526 ' CG ' HG22 ' A' ' 58' ' ' ILE . 34.4 mmm-85 -84.44 2.71 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.655 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 8.14 62.44 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.608 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 58' ' ' ILE . 81.6 mt -97.89 101.39 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.252 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.25 -19.25 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.59 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.0 mp0 -102.02 145.9 31.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 38.1 Cg_exo -58.45 123.04 12.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.413 1.409 . . . . 0.0 111.674 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' CG ' HG22 ' A' ' 63' ' ' ILE . 73.2 mm-40 -124.47 166.83 15.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.587 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -71.11 136.94 48.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.657 0.742 . . . . 0.0 111.978 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -145.81 179.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.035 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.479 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.1 p -94.61 -165.3 1.29 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -80.12 -44.06 20.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.3 76.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.752 0.31 . . . . 0.0 111.789 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.3 m -63.81 -41.54 97.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.086 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 79.4 t80 -56.31 -40.7 74.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 11.7 mt -72.13 -51.41 21.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.352 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.13 -48.1 61.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.513 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 HD12 ' OD1' ' A' ' 42' ' ' ASN . 59.6 mt -66.67 -42.22 86.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 60.4 ttt180 -55.23 -21.39 13.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.389 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.1 p -101.58 141.62 34.17 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.61 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.5 p -89.46 -5.54 57.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.632 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -56.4 -33.44 65.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.019 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 92.4 mmm -59.74 -34.55 73.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.185 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.52 55.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.518 -179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.97 144.64 99.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.833 2.355 . . . . 0.0 112.311 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt -60.34 -34.29 73.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.421 . . . . 0.0 110.574 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -174.19 39.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.254 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.4 p -61.29 -28.34 69.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.895 0.379 . . . . 0.0 110.582 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 88.3 mtp -60.57 -35.37 75.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.9 99.89 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.52 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -91.94 13.03 19.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.597 0.237 . . . . 0.0 111.226 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -71.32 -0.95 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -80.7 124.86 29.37 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.985 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.2 p -136.65 142.61 43.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -121.22 20.06 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.111 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' NH2' ' A' ' 61' ' ' ARG . . . -59.46 93.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.172 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' GLY . 79.2 t80 -80.47 123.58 28.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.427 ' CD1' ' O ' ' A' ' 15' ' ' TRP . 44.2 p90 -91.85 118.74 31.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -81.89 132.7 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.142 0.496 . . . . 0.0 109.994 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.87 153.96 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 37' ' ' ARG . 14.1 t0 -53.93 -54.35 40.05 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.585 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.45 -40.41 94.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.815 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -69.86 -31.72 69.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB1' HG23 ' A' ' 46' ' ' VAL . . . -115.48 73.57 4.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.675 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 -11.34 20.35 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.101 2.534 . . . . 0.0 112.849 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.29 156.97 48.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.44 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' SG ' HD12 ' A' ' 47' ' ' LEU . 11.2 t -63.08 123.95 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.121 0.486 . . . . 0.0 111.613 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -60.46 -26.43 66.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.269 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.06 -56.21 2.36 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.568 -0.825 . . . . 0.0 114.312 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.9 p -105.32 -1.72 24.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.78 11.08 68.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.647 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.6 p -72.27 143.45 48.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.261 0.53 . . . . 0.0 110.425 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.06 136.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.436 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.4 m-85 -82.6 133.79 35.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.08 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.7 p -126.23 169.88 12.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.075 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.3 m -48.12 -43.99 31.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -67.46 -36.25 80.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.079 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.4 t -87.49 113.27 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.407 0.622 . . . . 0.0 111.541 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -73.62 145.22 45.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.194 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HG3' HG11 ' A' ' 46' ' ' VAL . 63.3 ttm-85 -83.56 140.21 32.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.95 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -143.74 167.21 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.395 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -130.59 147.62 52.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.357 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.3 t -91.06 137.98 31.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 60.0 mtp180 -73.18 -5.1 37.04 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.519 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 77.1 m-20 -101.72 -72.31 0.69 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.624 0.25 . . . . 0.0 111.645 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.466 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . 30.8 p -74.59 -24.44 58.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.64 19.5 79.71 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.026 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 43' ' ' CYS . 36.0 m-85 -97.5 165.66 11.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.598 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 37' ' ' ARG . 92.9 t -81.27 128.28 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.52 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.3 mm? -131.67 138.17 48.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.1 p -76.82 177.03 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.15 -54.03 31.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.336 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -55.26 -34.99 64.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.43 ' HB3' HD13 ' A' ' 47' ' ' LEU . 1.7 m -89.2 -2.61 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 84.1 p -132.43 25.55 4.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 71.8 mtp180 -78.32 -21.94 48.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.976 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -77.62 162.91 26.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 111.723 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -138.67 137.09 36.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.06 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . . . -159.04 154.05 25.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.876 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.436 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.37 150.96 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.527 HG22 ' CG ' ' A' ' 61' ' ' ARG . 2.9 mt -127.64 82.31 68.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.22 -10.54 27.75 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.109 2.54 . . . . 0.0 113.99 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.16 -37.17 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.527 ' CG ' HG22 ' A' ' 58' ' ' ILE . 13.6 mmm180 -83.94 2.08 40.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.8 7.39 62.9 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.4 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 58' ' ' ILE . 77.2 mt -96.5 100.61 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.8 p -86.09 -19.03 30.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.431 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.2 mt-10 -102.84 146.43 32.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.9 Cg_endo -58.85 123.5 13.66 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.688 1.592 . . . . 0.0 111.954 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' CG ' HG23 ' A' ' 63' ' ' ILE . 75.6 mm-40 -125.32 166.84 15.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.697 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -70.15 137.01 50.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 112.095 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.519 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.8 m -146.43 179.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.904 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.52 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.67 -163.63 1.07 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.7 p-10 -82.6 -42.45 18.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.12 -45.18 74.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.748 0.308 . . . . 0.0 111.645 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 34.3 m -63.51 -41.38 98.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.256 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 80.7 t80 -56.55 -39.71 73.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.2 mt -72.72 -51.15 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.324 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.11 -47.52 65.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.391 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.41 HD12 HG23 ' A' ' 58' ' ' ILE . 71.6 mt -65.19 -41.16 94.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 51.3 ttt85 -58.28 -17.68 21.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.6 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -58.28 -31.43 67.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.5 m -51.63 -32.96 31.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.923 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -84.57 117.73 23.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.565 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.3 mtm -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.8 56.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.045 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.521 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.429 ' HD2' ' HA3' ' A' ' 1' ' ' GLY . 17.5 Cg_endo -57.71 150.05 64.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.8 2.333 . . . . 0.0 112.375 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.46 141.53 30.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.68 -137.26 28.57 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 98.2 p -126.91 154.77 44.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 0.0 110.948 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 51.5 ttm -111.39 132.38 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.62 124.58 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.407 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 10' ' ' GLN . 92.7 mt-10 -71.55 -9.08 57.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.484 0.183 . . . . 0.0 111.318 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -59.38 -11.38 4.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 8' ' ' GLU . 58.2 tt0 -64.82 124.97 23.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.025 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.1 m -129.87 147.51 51.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -59.93 -32.86 71.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 110.104 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.7 145.08 8.51 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.951 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . 71.5 t80 -78.44 122.42 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.333 . . . . 0.0 111.126 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -95.1 119.92 34.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -85.27 131.0 34.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 154.01 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.826 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -55.78 -45.5 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.06 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.89 -42.37 90.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.516 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.05 -34.66 78.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 0.0 110.397 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.68 73.79 0.86 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.606 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -14.67 25.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.019 2.48 . . . . 0.0 112.648 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.02 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.1 t -60.59 125.23 22.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.315 0.579 . . . . 0.0 111.704 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.886 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.59 -56.17 2.05 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.234 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.5 p -103.08 -4.14 24.96 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.75 73.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.53 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 8.0 p -73.67 143.66 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.391 0.595 . . . . 0.0 110.324 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.78 137.39 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.794 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.517 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 86.4 m-85 -83.97 135.08 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.1 p -128.66 170.32 13.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.416 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.9 m -47.82 -44.46 28.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.535 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 m -65.44 -35.95 82.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 48' ' ' CYS . 99.0 t -90.03 113.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 111.625 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -75.38 148.89 38.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.402 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 24.2 ttp-105 -79.22 141.63 36.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 96.5 m-70 -141.22 160.75 39.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -126.8 145.83 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.375 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.8 t -91.34 137.18 32.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -72.1 -6.85 45.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.523 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 70.2 m-20 -100.66 -71.64 0.7 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 30.6 p -75.81 -24.28 55.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.02 21.05 79.6 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.449 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.527 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -98.54 162.12 13.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 110.515 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.517 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 90.2 t -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.39 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.522 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 1.9 mm? -132.12 140.06 48.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' HB2' HG12 ' A' ' 35' ' ' VAL . 4.5 p -78.17 -179.86 6.44 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.682 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.22 -53.65 41.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.206 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -55.2 -36.28 65.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.433 ' HB3' HD13 ' A' ' 47' ' ' LEU . 1.7 m -88.53 -2.01 58.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 p -131.9 26.48 4.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.682 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 81.9 mtt-85 -81.35 -16.86 51.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -85.24 167.18 15.89 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.145 0.498 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -144.03 140.88 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.15 154.43 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.606 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.39 149.98 22.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.533 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.6 mt -125.4 81.51 64.02 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.094 0.474 . . . . 0.0 110.596 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.64 -12.67 36.82 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.095 2.53 . . . . 0.0 114.318 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.2 mtm -85.72 -37.63 19.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' CG ' HG22 ' A' ' 58' ' ' ILE . 27.5 mmm180 -83.21 1.31 41.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.878 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.32 8.8 59.7 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.559 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 58' ' ' ILE . 69.4 mt -98.98 101.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.095 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.2 p -88.59 -17.56 29.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.5 mt-10 -103.03 142.31 24.29 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.42 122.39 11.63 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.533 1.489 . . . . 0.0 111.694 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.8 mm-40 -123.33 166.18 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.595 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 mtm105 -71.02 139.41 50.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.499 0.666 . . . . 0.0 111.328 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.523 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 28.3 m -147.35 -179.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.244 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.522 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -95.5 -164.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.25 -43.51 19.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -46.06 75.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 40.0 m -63.78 -40.16 96.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.211 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 83.8 t80 -56.92 -39.86 75.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 9.6 mt -72.47 -52.19 16.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.47 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.2 -49.63 52.02 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.559 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD11 ' OD1' ' A' ' 42' ' ' ASN . 58.8 mt -65.04 -41.56 95.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 52.3 ttt180 -57.26 -21.17 32.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.041 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -103.89 154.71 19.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 111.443 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 p -131.77 154.95 48.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -93.02 140.52 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.993 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 64.3 mtm -59.6 -34.17 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.48 68.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.237 -1.313 . . . . 0.0 112.406 179.857 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.31 145.54 98.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.872 2.382 . . . . 0.0 112.169 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.7 mt -85.43 140.97 30.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.07 144.53 34.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.658 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 p -75.15 -6.5 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 82.8 mtp -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.86 98.05 0.85 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.394 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -92.71 9.98 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.311 . . . . 0.0 111.489 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -58.74 -18.89 35.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.05 137.8 58.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.129 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.3 p -76.95 159.56 29.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.776 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -109.51 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.384 . . . . 0.0 110.981 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.77 169.57 27.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.763 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 44' ' ' GLY . 71.4 t80 -79.93 122.32 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -86.69 118.02 25.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -84.31 131.08 34.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.157 0.503 . . . . 0.0 109.807 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.01 153.94 35.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.501 ' OD1' ' HD3' ' A' ' 37' ' ' ARG . 11.5 m-20 -56.15 -43.93 78.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.769 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.53 -42.61 82.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.266 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -69.4 -32.4 71.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.25 0.548 . . . . 0.0 110.377 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.61 74.3 2.28 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.519 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.92 -11.43 18.09 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.958 2.439 . . . . 0.0 112.346 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.06 155.46 50.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.204 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -64.15 126.94 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.111 0.482 . . . . 0.0 111.437 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.8 m120 -60.9 -26.39 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.974 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.19 -55.85 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.229 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -102.88 -4.18 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.93 9.01 65.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.466 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.1 p -69.87 143.22 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.127 0.464 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.43 138.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.083 0.468 . . . . 0.0 112.036 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 96.3 m-85 -83.92 133.44 34.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.412 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 p -126.54 169.57 12.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -46.68 -39.87 12.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.349 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -73.71 -25.87 60.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.427 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -97.7 113.14 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.23 0.538 . . . . 0.0 111.253 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -76.51 149.1 36.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.896 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.501 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 18.6 ttp180 -79.29 140.77 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -140.39 158.83 43.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.76 145.33 50.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.353 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.0 t -91.14 137.79 32.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -72.95 -6.55 46.05 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.53 ' OD1' HG22 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.08 -72.53 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.696 0.284 . . . . 0.0 111.754 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.52 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.2 p -74.87 -25.02 58.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.815 0.34 . . . . 0.0 111.581 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.7 22.84 77.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.679 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.52 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.0 m-85 -99.1 162.76 12.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.626 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 78.5 t -79.28 128.06 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.969 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.536 ' N ' HD21 ' A' ' 47' ' ' LEU . 1.3 mm? -131.49 140.43 49.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.494 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.41 174.02 11.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.737 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.42 -54.19 21.44 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.545 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -54.66 -36.13 64.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.444 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.9 -2.39 58.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.141 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 p -131.91 25.79 4.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.796 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.6 mtt-85 -81.1 -18.05 47.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -80.03 163.43 24.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.571 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.78 136.68 34.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.231 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.511 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . . . -158.58 154.71 27.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.468 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.71 148.9 22.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.537 HG22 ' CG ' ' A' ' 61' ' ' ARG . 3.7 mt -126.69 79.64 71.48 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.915 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -10.02 21.64 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 123.111 2.54 . . . . 0.0 113.817 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.9 mmm -87.7 -37.53 16.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.537 ' CG ' HG22 ' A' ' 58' ' ' ILE . 16.2 mmm180 -84.14 3.44 34.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.507 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.95 6.61 65.09 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.243 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CG2' ' HG3' ' A' ' 67' ' ' GLU . 85.0 mt -95.54 100.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.777 0.322 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.5 p -87.45 -19.03 28.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mt-10 -103.33 138.6 19.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 51.2 Cg_exo -52.74 124.33 15.09 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.647 1.565 . . . . 0.0 112.17 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 93.8 mt-10 -125.28 166.67 16.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.551 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -70.24 138.61 51.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.675 0.75 . . . . 0.0 112.092 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.526 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 31.3 m -147.08 178.97 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.464 -1.243 . . . . 0.0 110.013 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.502 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -93.46 -165.2 1.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -81.24 -42.82 20.15 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.42 -44.9 77.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 27.0 m -63.52 -41.51 98.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.379 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 74.7 t80 -56.06 -39.94 72.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 8.8 mt -72.38 -51.8 18.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.1 -48.49 61.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.306 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 58' ' ' ILE . 60.0 mt -65.61 -42.05 92.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 64.7 ttt-85 -56.15 -18.94 11.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.182 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.8 m -58.83 151.16 22.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.6 m -120.88 148.9 43.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.53 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.56 -34.02 61.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 91.9 mtp -88.5 137.85 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.62 145.35 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.612 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.94 146.47 95.79 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.578 2.185 . . . . 0.0 112.08 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.0 mt -60.62 -27.7 67.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.12 6.73 48.54 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.15 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 m -59.24 -32.85 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.995 0.398 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 89.7 mtp -90.5 139.63 30.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.24 8.48 71.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.514 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 8' ' ' GLU . 86.5 tt0 -87.64 13.01 11.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.011 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -71.05 -4.9 27.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.246 0.546 . . . . 0.0 109.559 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -57.62 146.61 29.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 41' ' ' ARG . 31.2 t -113.36 144.78 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.069 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -66.27 133.42 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.729 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.57 153.21 5.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . 80.8 t80 -78.73 121.5 24.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.421 ' CD1' ' O ' ' A' ' 15' ' ' TRP . 48.6 p90 -89.78 119.25 30.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.68 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -84.8 129.23 34.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.562 . . . . 0.0 110.098 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.6 151.98 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.732 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -55.87 -44.66 78.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.68 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.85 -41.89 91.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -67.04 -34.58 78.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.576 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.84 74.24 1.29 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.767 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.81 -12.74 28.98 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.057 2.505 . . . . 0.0 112.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.8 156.68 48.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.356 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.3 t -62.03 125.14 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 111.523 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 68.7 m-80 -60.33 -26.72 66.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.86 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.43 -55.19 2.1 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.991 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 p -103.69 -4.94 23.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 70.97 11.58 70.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.791 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.1 p -72.03 143.41 49.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.374 0.587 . . . . 0.0 110.409 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.44 138.08 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 112.022 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.542 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.2 m-85 -84.99 135.72 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 p -127.6 169.52 13.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.815 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.6 m -46.63 -42.82 16.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.4 m -66.59 -37.22 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.251 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.35 113.38 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.318 0.58 . . . . 0.0 111.524 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -74.55 148.31 40.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.492 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HG3' HG11 ' A' ' 46' ' ' VAL . 13.7 ttp180 -78.63 141.4 38.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.409 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -142.18 163.01 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.05 147.52 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.906 0.384 . . . . 0.0 111.917 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.0 t -90.57 136.72 32.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 91.3 mtt-85 -70.17 -6.94 37.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.546 ' OD1' ' CD1' ' A' ' 58' ' ' ILE . 5.3 m-20 -102.9 -70.26 0.76 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.555 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.2 p -75.05 -25.83 58.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.054 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.82 20.31 79.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.391 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.555 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.5 m-85 -97.33 161.11 13.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.362 . . . . 0.0 110.668 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.542 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 99.4 t -78.43 128.89 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.089 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' A' ' 70' ' ' CYS . 1.9 mm? -130.81 140.45 50.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -78.33 172.46 13.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.722 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.0 -52.51 30.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.248 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 89.3 m-20 -55.88 -34.96 65.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.7 m -89.77 -1.37 57.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 p -131.74 25.7 4.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.722 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 78.1 mtp180 -80.72 -19.35 45.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.076 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -78.35 164.77 24.55 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.198 0.523 . . . . 0.0 111.623 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -141.03 134.71 30.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.323 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.487 ' HB1' ' CD1' ' A' ' 74' ' ' TYR . . . -160.7 154.09 21.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.82 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.8 158.04 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.585 HG21 ' CG ' ' A' ' 61' ' ' ARG . 1.6 mt -132.96 76.64 69.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 110.326 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.8 -11.57 29.91 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.238 2.625 . . . . 0.0 114.337 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 85.7 mtp -86.36 -37.64 18.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.585 ' CG ' HG21 ' A' ' 58' ' ' ILE . 16.2 mmm180 -83.94 3.76 32.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.673 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 7.96 62.5 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.439 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 65' ' ' GLU . 65.8 mt -97.01 101.8 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.281 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 p -86.73 -18.34 31.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.671 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.461 ' O ' HG21 ' A' ' 63' ' ' ILE . 87.6 mt-10 -102.91 146.68 32.87 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 19.2 Cg_endo -59.05 122.35 11.44 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.553 1.502 . . . . 0.0 111.673 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 76.8 mm-40 -125.83 167.56 15.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.842 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -71.6 138.45 48.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.556 0.693 . . . . 0.0 112.092 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 74' ' ' TYR . 21.4 m -146.3 179.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.751 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.506 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 15.3 p -95.59 -172.53 2.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -73.39 -42.94 61.53 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.07 -45.03 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.297 . . . . 0.0 111.683 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.1 m -64.64 -40.64 95.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.339 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.637 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 18.9 t80 -56.33 -41.52 76.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.36 -48.26 67.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.51 86.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.489 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD11 ' ND2' ' A' ' 42' ' ' ASN . 89.1 mt -66.1 -38.73 88.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.353 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 62.7 mtp180 -64.45 -10.38 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.029 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.8 p -58.81 -30.2 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.673 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.2 p -63.72 -29.42 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -94.88 122.69 37.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.1 mtm -84.52 133.76 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.74 145.49 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.547 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.0 150.64 37.45 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.869 2.38 . . . . 0.0 112.761 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.73 147.22 33.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.99 -152.45 8.47 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.565 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.2 p -60.09 -21.67 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 110.974 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 13.8 tpp -52.61 -39.97 62.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.059 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.87 126.32 7.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.257 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 8' ' ' GLU . 86.8 tt0 -76.47 -0.65 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.501 0.191 . . . . 0.0 111.321 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -64.03 -8.45 11.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 11' ' ' SER . 58.4 tt0 -63.41 142.37 58.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.709 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 10' ' ' GLN . 6.3 t 178.97 66.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.259 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -60.08 -36.22 76.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.045 0.45 . . . . 0.0 110.608 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.41 127.68 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.6 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -76.1 119.84 20.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 111.502 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -87.41 118.25 26.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -80.05 125.59 29.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.326 0.584 . . . . 0.0 110.163 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 148.63 29.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.647 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -57.71 -43.62 85.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.025 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.41 -42.9 82.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.178 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -66.03 -33.66 76.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.204 0.525 . . . . 0.0 110.63 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.91 76.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.952 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.31 -15.02 25.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.778 2.318 . . . . 0.0 112.612 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.38 155.59 50.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.336 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.427 ' SG ' HD11 ' A' ' 47' ' ' LEU . 5.7 t -61.51 125.17 22.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.111 0.482 . . . . 0.0 111.414 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.0 m120 -61.67 -26.13 67.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.224 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 -55.81 2.23 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.715 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.11 -1.58 27.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 7.71 61.91 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.278 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.0 p -69.92 143.92 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.237 0.519 . . . . 0.0 110.168 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.98 138.98 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.151 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.482 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.2 m-85 -82.42 133.91 35.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 110.27 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -126.88 169.06 13.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.74 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.3 m -44.73 -38.79 4.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.473 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -78.44 -26.76 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -96.14 112.87 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.177 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' NH1' ' CE1' ' A' ' 38' ' ' HIS . 18.1 mtp-105 -78.34 150.03 33.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.425 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -89.73 143.2 27.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.817 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.4 m-70 -138.84 164.44 29.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.389 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.86 143.34 48.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.8 t -90.53 136.57 32.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -70.44 -6.76 38.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 76.8 m-20 -101.82 -70.66 0.74 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.555 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.0 p -77.56 -25.32 49.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.13 72.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.916 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.555 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 20.7 m-85 -102.32 162.33 13.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.8 0.333 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 38' ' ' HIS . 60.5 t -77.35 129.19 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.246 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 47' ' ' LEU . 1.6 mm? -131.53 137.65 48.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.118 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.37 175.23 7.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.688 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.44 -53.01 37.48 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.497 -1.335 . . . . 0.0 112.044 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -54.76 -35.03 63.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.477 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.11 -3.63 58.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.444 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.4 p -131.41 27.93 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 88.4 mtt-85 -82.16 -19.21 40.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.197 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -78.59 163.52 25.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.273 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -140.0 135.16 32.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.263 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB3' ' CD1' ' A' ' 74' ' ' TYR . . . -159.05 153.35 23.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.687 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.437 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.29 151.31 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.567 ' CG2' ' HG3' ' A' ' 61' ' ' ARG . 2.5 mt -127.37 74.97 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.14 0.495 . . . . 0.0 110.411 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.48 -9.02 14.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.127 2.551 . . . . 0.0 113.738 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.22 -36.72 12.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 32.5 mtp85 -89.43 26.34 1.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.358 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.63 23.36 76.72 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.276 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 73.5 mt -117.98 104.56 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.807 0.304 . . . . 0.0 110.326 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -91.31 -21.04 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 42.4 mt-10 -100.8 139.24 20.39 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.3 Cg_exo -52.71 123.02 11.99 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.591 1.527 . . . . 0.0 111.971 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 65' ' ' GLU . 92.9 mt-10 -125.18 167.34 14.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.126 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -72.74 140.24 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 0.0 112.267 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.512 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 30.2 m -146.83 179.65 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.503 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.2 p -93.38 -163.62 1.07 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.112 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.86 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.5 m -63.57 -40.69 97.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.373 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 67.1 t80 -56.7 -39.72 74.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 8.8 mt -73.02 -53.0 12.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.41 61.3 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.26 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD12 HG22 ' A' ' 58' ' ' ILE . 82.2 mt -66.1 -41.94 89.92 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 59.7 ttt180 -56.5 -19.67 16.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.338 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -103.33 150.24 23.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.2 p -134.45 161.19 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.511 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.83 134.2 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.111 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 90.3 mtp -60.09 -35.07 74.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.88 54.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.282 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.38 -1.234 . . . . 0.0 112.511 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.096 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.425 ' HD2' ' HA3' ' A' ' 1' ' ' GLY . 19.6 Cg_endo -60.06 143.17 99.58 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.482 2.121 . . . . 0.0 112.088 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 76.0 mt -79.86 142.99 34.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 110.801 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.97 77.15 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.417 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.0 m -59.86 -36.01 75.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 68.3 mtm -127.77 151.83 48.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.441 . . . . 0.0 111.058 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.78 170.41 45.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.723 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.93 14.25 18.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.634 0.254 . . . . 0.0 111.213 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -70.9 -4.66 25.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.239 0.542 . . . . 0.0 109.65 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -65.03 143.56 57.86 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.134 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.4 m -120.86 149.4 42.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.579 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -113.34 144.95 41.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.38 153.33 17.61 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.453 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . 73.3 t80 -78.79 122.21 25.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 15' ' ' TRP . 20.0 p90 -94.08 119.01 32.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -83.18 131.89 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.511 . . . . 0.0 110.089 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.86 154.29 18.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.15 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 37' ' ' ARG . 14.9 m-20 -54.79 -46.31 74.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.317 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -40.76 88.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 92.8 m-20 -65.6 -32.78 74.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.949 0.404 . . . . 0.0 111.385 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.3 75.63 4.59 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.489 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 13.3 Cg_exo -70.36 -12.88 32.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.232 2.621 . . . . 0.0 113.053 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.08 159.65 41.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.6 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 5.2 t -62.93 128.84 37.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.266 0.555 . . . . 0.0 112.059 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 m-80 -69.19 -24.76 64.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.324 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.43 -57.88 2.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.855 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 p -105.78 -0.3 25.48 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.05 72.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.413 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.5 p -69.37 143.52 53.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.356 0.578 . . . . 0.0 109.795 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.16 144.45 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.571 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 89.7 m-85 -83.54 132.96 34.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.9 p -124.84 168.66 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 m -48.24 -44.5 33.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 m -66.96 -36.16 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.3 t -86.3 113.46 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 0.0 111.786 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -73.11 144.83 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.897 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 18' ' ' ASP . 21.5 ttm105 -87.09 141.99 28.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.952 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -144.64 171.86 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -130.45 148.44 52.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.3 t -90.97 136.75 32.86 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -72.84 -5.68 39.84 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.545 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 77.9 m-20 -100.81 -71.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.62 0.247 . . . . 0.0 111.47 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.0 p -75.26 -24.72 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 111.614 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.46 20.45 79.86 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.507 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.6 m-85 -97.75 161.55 13.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.85 0.357 . . . . 0.0 110.538 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.571 HG12 ' CZ ' ' A' ' 31' ' ' PHE . 95.0 t -76.6 128.44 37.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.089 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 47' ' ' LEU . 2.6 mm? -131.78 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.493 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.0 p -79.38 -179.78 6.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.679 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.89 -53.72 42.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.674 -1.251 . . . . 0.0 112.225 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' NE ' ' A' ' 53' ' ' ARG . 92.7 m-20 -55.38 -35.81 65.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.466 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.7 m -88.92 -2.15 58.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.389 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -131.87 26.39 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.679 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.4 mtt180 -80.94 -18.3 47.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -80.08 162.9 24.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.106 0.479 . . . . 0.0 111.285 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp85 -139.8 135.62 33.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.93 153.39 26.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.814 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.441 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.97 149.46 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.532 HG21 ' CG ' ' A' ' 61' ' ' ARG . 3.4 mt -125.81 82.36 64.26 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.855 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -10.73 29.64 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.087 2.524 . . . . 0.0 114.028 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.85 -37.76 17.43 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.532 ' CG ' HG21 ' A' ' 58' ' ' ILE . 30.2 mmm180 -83.07 1.01 42.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.648 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 7.2 62.0 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.284 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.454 HG21 ' CG ' ' A' ' 67' ' ' GLU . 74.3 mt -96.85 100.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.66 -17.41 33.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.74 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.1 mt-10 -103.02 144.2 28.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 31.8 Cg_exo -57.11 123.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.642 1.561 . . . . 0.0 111.683 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.454 ' CG ' HG21 ' A' ' 63' ' ' ILE . 74.3 mm-40 -125.35 167.15 15.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -70.89 137.46 49.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.94 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.545 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -146.84 179.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.078 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.478 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -94.49 -160.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 20.9 t70 -85.02 -43.26 14.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.94 80.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 111.82 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 33.3 m -63.98 -40.85 97.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.554 ' CE2' ' NE ' ' A' ' 78' ' ' ARG . 75.8 t80 -57.94 -40.52 80.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.3 mt -69.76 -50.51 42.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.509 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.49 84.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.39 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD12 HG22 ' A' ' 58' ' ' ILE . 88.6 mt -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' NE ' ' CE2' ' A' ' 74' ' ' TYR . 16.6 mtt180 -68.12 -5.2 16.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.034 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -58.06 -20.62 40.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.602 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 m -112.17 150.69 30.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -63.47 151.45 41.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.767 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 62.1 mtt -83.89 143.05 30.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.4 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.052 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.472 -1.182 . . . . 0.0 112.414 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 119.832 -0.427 . . . . 19.780000000000001 112.832 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.98 -48.19 7.06 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.025 1.816 . . . . 18.77 112.097 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mt -178.63 -53.94 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.792 -1.095 . . . . 18.059999999999999 108.475 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 41.32 -126.18 3.38 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.871 -1.059 . . . . 15.85 113.285 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.44 -34.5 54.52 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.652 -0.499 . . . . 15.41 109.652 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.419 ' HA ' ' CE ' ' A' ' 6' ' ' MET . 14.8 mmt -50.31 -26.64 5.05 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.045 -0.525 . . . . 15.4 110.943 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.91 -22.25 40.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.068 -0.587 . . . . 12.550000000000001 113.208 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -47.64 -18.91 0.17 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.251 0.834 . . . . 11.550000000000001 113.251 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -24.44 21.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.694 -1.224 . . . . 13.6 107.694 175.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -70.82 67.07 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.823 -1.08 . . . . 8.4900000000000002 108.182 175.552 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -19.07 107.62 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.474 0.71 . . . . 5.7599999999999998 112.579 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -38.32 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.781 0.801 . . . . 6.7300000000000004 110.412 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 11' ' ' SER . . . 94.13 86.26 1.64 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 107.661 -2.176 . . . . 1.8899999999999999 107.661 -174.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -44.02 124.09 3.66 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.97 0.414 . . . . 1.05 111.879 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.422 ' O ' ' CD1' ' A' ' 15' ' ' TRP . 3.4 p90 -78.21 124.33 27.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 4.4800000000000004 110.79 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -90.7 123.24 34.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.92000000000000004 109.813 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -50.97 160.84 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 1.45 112.198 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.87 -56.48 21.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 2.02 111.414 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -61.9 -42.74 99.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 1.45 111.391 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -61.23 -27.78 68.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.1799999999999999 111.236 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 76.65 41.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.558 -0.292 . . . . 1.0700000000000001 111.313 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.22 -18.41 16.22 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.281 1.988 . . . . 0.60999999999999999 112.497 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.434 -0.348 . . . . 1.03 110.838 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -55.16 124.78 18.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.95999999999999996 111.7 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.48 -22.09 66.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 1.98 111.82 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.93 -68.11 1.4 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.649 -0.786 . . . . 0.17999999999999999 113.792 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 p -88.56 -27.8 21.16 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.984 0.365 . . . . 0.72999999999999998 111.984 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.28 26.6 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.455 -0.879 . . . . 0.17000000000000001 112.73 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 p -83.25 144.56 29.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.84999999999999998 110.635 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.48 143.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 1.54 111.09 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 46' ' ' VAL . 88.7 m-85 -89.91 130.48 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.29999999999999999 111.099 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 p -120.46 175.32 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 1.05 110.728 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.8 m -54.91 -31.12 59.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.285 -0.416 . . . . 1.4299999999999999 111.363 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -44.91 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 1.8400000000000001 111.078 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.67 108.41 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.012 0.434 . . . . 1.05 110.895 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -74.87 163.45 27.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.788 -0.642 . . . . 3.4100000000000001 109.717 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.1 ttm105 -88.64 152.86 21.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.747 0.647 . . . . 4.2599999999999998 112.747 -178.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -157.52 139.61 14.35 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.342 -0.844 . . . . 0.28000000000000003 110.369 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.422 ' CD2' ' HB2' ' A' ' 15' ' ' TRP . 5.2 m-70 -106.7 155.41 19.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.975 0.417 . . . . 2.1800000000000002 111.573 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.11 129.85 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.132 -0.692 . . . . 0.91000000000000003 109.132 179.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -62.27 -17.76 59.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.817 0.673 . . . . 2.7799999999999998 112.817 -177.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.42 ' ND2' ' CG1' ' A' ' 69' ' ' VAL . 66.1 m-80 -92.97 -69.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.665 0.269 . . . . 0.75 111.698 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.3 p -79.57 -41.36 27.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.519 -0.31 . . . . 0.81999999999999995 111.52 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.418 ' HA3' ' C ' ' A' ' 13' ' ' GLY . . . 96.46 -13.02 66.07 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.416 -0.897 . . . . 0.10000000000000001 113.497 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -58.6 163.55 3.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.761 -0.459 . . . . 0.87 109.761 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 31' ' ' PHE . 67.9 t -82.41 132.68 30.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.487 -0.485 . . . . 1.03 110.47 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' CB ' ' A' ' 70' ' ' CYS . 3.3 mm? -133.79 142.68 47.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 1.03 110.875 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.1 p -82.45 -173.01 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.907 -0.588 . . . . 0.90000000000000002 110.302 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.38 -57.95 16.96 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.604 -0.808 . . . . 0.17000000000000001 112.925 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -52.66 -51.36 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.915 0.388 . . . . 1.1499999999999999 111.606 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.413 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.6 m -66.98 -24.3 66.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.999 -0.546 . . . . 0.83999999999999997 111.996 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -115.06 45.48 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.541 . . . . 0.87 110.645 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -97.64 -25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 2.96 110.815 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -73.92 169.79 16.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.324 0.583 . . . . 1.02 112.299 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -145.76 138.92 26.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.225 -0.898 . . . . 3.3700000000000001 109.805 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.17 137.57 6.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 1.04 111.324 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.12 148.99 46.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 1.01 110.257 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 63' ' ' ILE . 3.2 mt -126.59 76.57 74.11 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.595 -0.275 . . . . 1.0900000000000001 111.234 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.78 -26.53 79.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.403 2.069 . . . . 0.54000000000000004 112.543 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.6 mtp -71.87 -30.85 65.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.425 -0.352 . . . . 2.5600000000000001 110.759 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -101.3 21.69 13.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.346 -0.388 . . . . 1.8700000000000001 111.671 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.33 68.65 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.67 -0.776 . . . . 0.52000000000000002 113.268 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 33.1 mt -122.65 88.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.794 0.33 . . . . 1.03 110.671 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.56 -14.41 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.202 0.445 . . . . 1.04 112.202 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -101.49 147.96 34.54 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 121.22 -0.192 . . . . 2.02 110.908 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.32 120.59 8.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.13 1.887 . . . . 0.90000000000000002 112.085 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -125.78 164.07 21.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.047 0.451 . . . . 1.46 111.048 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.08 136.58 41.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.816 -0.629 . . . . 3.0499999999999998 112.531 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.42 ' CG1' ' ND2' ' A' ' 42' ' ' ASN . 33.4 m -144.31 -172.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.105 -0.952 . . . . 1.02 109.534 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.432 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 3.9 p -100.02 -157.18 0.59 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.186 -0.302 . . . . 0.75 110.186 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.43 -50.36 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.852 -0.339 . . . . 1.6299999999999999 111.025 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.52 -64.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.97999999999999998 110.959 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.5 m -50.55 -39.67 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.71999999999999997 111.813 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -59.76 -34.16 72.62 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.108 -0.701 . . . . 0.91000000000000003 109.108 177.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 79' ' ' SER . 8.3 mt -80.69 -44.03 19.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.229 -0.896 . . . . 1.0700000000000001 109.473 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' SER . . . -51.93 -50.76 60.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.634 -0.712 . . . . 1.0800000000000001 110.727 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.56 -37.5 87.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.806 -0.813 . . . . 1.0800000000000001 108.806 178.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -30.73 70.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.538 -0.912 . . . . 2.9199999999999999 108.538 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' ASN . 1.9 m -61.34 -15.96 41.19 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.305 -0.861 . . . . 1.9399999999999999 110.916 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 t -67.54 70.21 0.11 Allowed 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.729 -0.841 . . . . 3.2200000000000002 108.729 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' SER . 0.7 OUTLIER -33.9 143.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.642 0.978 . . . . 6.7599999999999998 113.642 -177.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 132.75 54.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.005 -0.998 . . . . 8.9700000000000006 110.905 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.13 26.85 3.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.176 -0.466 . . . . 9.8699999999999992 111.638 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.426 -1.208 . . . . 11.33 112.314 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.54 -11.76 18.69 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.138 2.559 . . . . 0.0 112.846 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.7 155.38 50.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -60.4 122.79 15.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.115 0.483 . . . . 0.0 111.827 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.5 m120 -61.68 -26.68 68.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.928 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 -56.39 2.16 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.221 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.3 p -104.63 -3.6 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.73 69.96 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.725 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -71.74 143.51 49.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.416 0.608 . . . . 0.0 110.251 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.39 137.5 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.796 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 93.9 m-85 -83.29 134.43 34.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.162 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.414 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 28.8 p -126.38 172.58 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.268 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.2 p -50.54 -40.84 52.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.003 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.9 p -75.85 -26.34 57.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.254 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 32' ' ' THR . 54.4 t -93.56 113.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.376 0.608 . . . . 0.0 111.392 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -73.63 143.73 46.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.106 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 23.7 ttm105 -86.29 142.14 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.629 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -144.01 169.19 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 111.607 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -128.83 146.82 50.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.537 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.3 t -90.44 137.99 31.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -72.76 -6.88 47.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.936 ' OD1' HD13 ' A' ' 58' ' ' ILE . 73.4 m-20 -100.69 -70.27 0.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.502 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.4 p -76.44 -23.78 53.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.91 21.98 79.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.39 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.502 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 21.2 m-85 -98.07 160.81 14.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 110.236 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.827 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.4 t -75.96 128.97 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.166 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.891 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.2 mm? -133.43 138.58 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.45 176.32 8.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.756 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.08 -52.8 41.1 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.225 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 95.0 m-20 -55.83 -35.84 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.891 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.32 -1.7 58.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.462 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -131.99 28.65 4.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 73.3 mtm180 -84.71 -16.39 41.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.227 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -81.31 164.7 22.0 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.5 136.18 32.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.527 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.96 154.34 25.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.793 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.9 154.0 20.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.936 HD13 ' OD1' ' A' ' 42' ' ' ASN . 2.3 mt -130.3 79.77 71.91 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 110.939 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.06 -8.96 19.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.179 2.586 . . . . 0.0 114.19 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.08 -37.83 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 109.193 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' A' ' 58' ' ' ILE . 14.2 mmm180 -83.03 1.04 42.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.454 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.13 6.94 61.3 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.924 HD12 HD12 ' A' ' 58' ' ' ILE . 75.6 mt -96.2 102.35 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.214 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -88.08 -18.54 28.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 56.0 mm-40 -103.06 142.53 24.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -56.43 124.0 15.21 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.674 1.583 . . . . 0.0 111.819 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.7 mm-40 -124.74 166.81 15.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -70.56 136.71 49.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.618 0.723 . . . . 0.0 111.639 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.607 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.3 m -145.24 -179.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.976 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.437 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.56 -168.35 1.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -76.26 -43.71 40.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.22 72.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 52.8 m -63.84 -40.57 96.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.743 0.306 . . . . 0.0 110.41 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 76.6 t80 -56.79 -39.6 74.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.1 mt -72.9 -52.49 14.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.02 -48.27 52.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.385 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.136 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.47 -15.4 24.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.9 2.4 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.33 156.88 48.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 29' ' ' CYS . 8.1 t -63.99 124.98 22.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -60.28 -26.56 66.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.969 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.45 -55.92 2.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.444 -0.884 . . . . 0.0 114.341 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -105.23 -0.29 26.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.83 9.07 58.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.562 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 24' ' ' CYS . 6.0 p -69.52 143.52 53.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.226 0.513 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.99 138.98 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 92.2 m-85 -84.18 136.04 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.375 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -127.74 171.61 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.105 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -47.47 -41.1 19.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.808 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.1 p -73.54 -24.84 60.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.641 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -97.89 113.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.738 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.72 150.25 37.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.533 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.472 ' HG3' HG13 ' A' ' 46' ' ' VAL . 14.7 ttp180 -80.18 141.54 35.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 0.0 110.598 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -139.96 160.95 38.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.665 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -128.49 146.05 50.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.523 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.9 t -91.33 136.2 33.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tpt180 -72.33 -4.63 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.91 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.1 m-20 -101.65 -71.54 0.71 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -76.51 -24.04 53.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.77 78.55 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.79 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.1 m-85 -99.01 160.91 13.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.868 ' C ' HD22 ' A' ' 47' ' ' LEU . 77.5 t -78.36 128.75 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.868 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.4 mm? -131.45 140.83 49.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.354 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.85 178.37 8.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.608 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -55.59 -52.15 50.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.43 -1.367 . . . . 0.0 112.047 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -54.67 -34.88 62.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.794 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -91.81 -2.23 57.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -132.3 28.93 4.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 12.9 mmt85 -84.68 -17.88 37.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.324 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -79.53 165.62 22.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.226 0.536 . . . . 0.0 111.475 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -141.37 134.71 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.01 153.41 26.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.658 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -86.48 158.0 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.91 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.4 mt -134.15 78.37 58.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.919 0.39 . . . . 0.0 110.555 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.82 -12.14 32.74 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.265 2.644 . . . . 0.0 114.066 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.9 mmm -85.31 -38.29 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.554 ' HG2' HG22 ' A' ' 58' ' ' ILE . 13.9 mmm180 -83.86 1.76 41.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.673 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 9.22 60.39 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.686 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.792 HD12 HD12 ' A' ' 58' ' ' ILE . 61.8 mt -100.58 99.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.849 0.356 . . . . 0.0 110.356 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.4 p -85.04 -16.99 38.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.785 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.6 mt-10 -102.81 145.06 29.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 14.7 Cg_endo -58.67 124.11 15.05 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.416 1.411 . . . . 0.0 111.657 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' CG ' HG21 ' A' ' 63' ' ' ILE . 76.4 mm-40 -124.85 167.78 14.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.747 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -72.06 137.2 46.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.652 0.739 . . . . 0.0 111.916 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.646 HG11 ' ND2' ' A' ' 42' ' ' ASN . 35.1 m -146.83 -178.06 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.126 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.475 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -96.4 -162.88 0.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -82.62 -42.67 17.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.67 75.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 111.691 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 37.0 m -63.19 -40.38 97.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.533 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 72.4 t80 -57.32 -38.97 74.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.66 -51.67 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.506 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.7 78.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.165 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.437 HD11 ' ND2' ' A' ' 42' ' ' ASN . 88.6 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.503 0.668 . . . . 0.0 109.346 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.07 -12.29 27.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.07 2.514 . . . . 0.0 112.68 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.13 156.39 48.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.3 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 18.4 t -64.54 125.29 24.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.174 0.511 . . . . 0.0 111.437 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -59.5 -26.44 65.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.031 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.72 -55.46 2.15 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.165 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.8 p -102.92 -4.7 24.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.37 10.98 71.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.41 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 12.8 p -71.65 142.67 49.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.317 0.559 . . . . 0.0 110.278 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.78 137.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.534 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.86 134.53 34.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.276 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -127.26 169.61 13.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.954 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.6 m -46.84 -42.16 16.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.96 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.1 m -68.54 -36.09 78.34 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.316 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -90.65 113.67 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.338 0.59 . . . . 0.0 111.463 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.33 148.72 39.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.008 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.1 ttp85 -78.97 139.54 38.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.0 m-70 -141.94 162.74 34.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 46' ' ' VAL . 89.5 m-70 -129.54 146.57 51.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.642 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 t -91.6 137.91 31.99 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -73.42 -5.47 40.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.943 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.0 m-20 -100.9 -72.06 0.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.613 0.244 . . . . 0.0 111.624 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.4 p -75.81 -24.89 55.93 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.24 21.63 78.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.746 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 26.1 m-85 -98.85 161.85 13.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.935 0.398 . . . . 0.0 110.459 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.85 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.2 t -78.44 128.93 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.076 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.85 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.2 mm? -131.41 139.07 49.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.44 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 p -75.64 177.09 7.06 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.73 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.48 -53.07 40.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.241 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 86.3 m-20 -55.53 -35.65 65.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.713 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.67 -2.03 58.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.317 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.1 p -132.55 27.62 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt180 -82.85 -17.85 42.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.139 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -79.47 165.06 23.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.281 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -140.82 136.0 31.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.424 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.39 154.48 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -92.25 150.8 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.943 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.0 mt -127.3 81.31 70.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 111.058 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.63 -9.98 22.77 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.206 2.604 . . . . 0.0 113.828 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -89.75 -36.89 14.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 109.263 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.525 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 5.3 mmm180 -86.79 15.57 5.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.677 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.02 10.34 85.1 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.854 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.928 HD12 HD12 ' A' ' 58' ' ' ILE . 74.8 mt -101.44 102.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -88.3 -19.11 27.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.588 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mt-10 -103.17 146.61 32.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.4 Cg_endo -59.14 123.47 13.52 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.62 1.546 . . . . 0.0 111.71 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.3 mm-40 -124.53 166.73 15.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -71.47 137.29 48.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.624 0.726 . . . . 0.0 112.0 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.621 HG11 ' ND2' ' A' ' 42' ' ' ASN . 30.0 m -145.5 -178.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.872 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.508 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -96.47 -166.45 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 55.6 t0 -78.89 -45.16 21.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.14 80.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.4 m -63.82 -41.25 97.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.388 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.7 t80 -56.38 -40.07 73.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.7 -52.3 18.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.11 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.15 -48.67 53.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.496 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.42 HD21 HG23 ' A' ' 58' ' ' ILE . 58.9 mt . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.415 ' HB3' HG21 ' A' ' 46' ' ' VAL . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.981 0.42 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.61 -14.94 30.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.942 2.428 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.93 156.95 47.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.459 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -63.11 124.79 22.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.144 0.497 . . . . 0.0 111.439 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -60.15 -26.21 66.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.289 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.82 2.25 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.343 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.4 p -104.42 -3.05 24.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.86 10.48 67.98 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.527 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.1 p -71.9 143.99 49.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.269 0.534 . . . . 0.0 110.168 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.93 138.77 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.469 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.559 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.7 m-85 -84.46 135.56 34.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -127.98 168.0 15.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.2 m -46.12 -43.78 15.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.312 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.13 -36.96 84.52 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.0 t -88.6 113.89 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -73.78 146.07 44.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.362 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 21.8 ttp-105 -80.33 140.11 36.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.441 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -142.11 164.64 29.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -130.79 147.44 52.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.568 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.7 t -90.23 137.0 32.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' A' ' 67' ' ' GLU . 53.2 mtp85 -71.43 -6.36 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.875 ' ND2' HD13 ' A' ' 58' ' ' ILE . 15.6 m-80 -102.88 -70.0 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.4 p -74.44 -24.81 59.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.783 0.325 . . . . 0.0 111.579 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.33 79.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.686 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 27.8 m-85 -97.0 164.37 12.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 110.682 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.86 ' C ' HD22 ' A' ' 47' ' ' LEU . 62.2 t -80.83 128.4 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.059 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.5 mm? -132.12 137.62 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.5 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.1 p -77.32 173.33 12.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.771 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.11 -54.33 19.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.23 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 75.9 m-20 -54.92 -35.85 64.61 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.788 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.37 -1.82 58.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.22 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.1 p -131.16 25.22 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.771 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 57.9 mtm180 -80.36 -18.65 48.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.805 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -79.42 164.79 23.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.006 0.431 . . . . 0.0 111.157 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -143.1 138.15 29.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -161.5 155.56 22.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.912 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.476 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -82.45 159.48 22.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.875 HD13 ' ND2' ' A' ' 42' ' ' ASN . 1.3 mt -134.49 75.41 63.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -12.93 35.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.42 2.747 . . . . 0.0 114.34 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.8 mtt -87.05 -36.84 17.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.682 ' HG2' HG22 ' A' ' 58' ' ' ILE . 29.0 mmm180 -83.74 5.73 23.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.73 10.66 64.8 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.501 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.784 HD12 HD12 ' A' ' 58' ' ' ILE . 70.2 mt -102.21 102.54 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 0.0 110.363 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.9 p -87.83 -16.63 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.601 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 mt-10 -104.56 142.79 25.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 11.4 Cg_endo -55.13 122.57 11.94 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.879 1.719 . . . . 0.0 112.034 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.9 mm-40 -125.15 167.31 14.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.432 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -72.46 140.11 48.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.567 0.699 . . . . 0.0 111.898 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 m -147.3 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.085 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.512 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.9 p -93.48 -162.36 0.93 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.71 -41.74 17.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.97 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.586 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.14 -41.61 97.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 0.0 110.202 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 87.6 t80 -55.88 -40.61 73.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.51 -49.49 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.586 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.45 79.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.855 HD11 HD21 ' A' ' 42' ' ' ASN . 77.4 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.024 0.44 . . . . 0.0 110.816 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.908 0.385 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.07 -15.23 32.24 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.1 2.533 . . . . 0.0 112.651 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.68 46.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.401 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 10.2 t -62.3 122.48 15.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.761 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.5 m120 -61.12 -25.9 67.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.32 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.18 -55.76 2.3 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.51 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p -104.24 -2.65 25.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.13 7.97 64.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.253 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -69.6 143.0 53.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.099 0.449 . . . . 0.0 110.162 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.71 137.4 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.714 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 92.5 m-85 -82.08 133.12 35.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.386 0.612 . . . . 0.0 109.886 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.416 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 17.2 p -124.7 173.03 8.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.174 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.1 p -50.4 -38.94 45.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.98 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 p -79.18 -22.91 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.651 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 32' ' ' THR . 41.8 t -96.03 113.12 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.629 . . . . 0.0 111.488 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -73.32 143.64 46.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.204 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.435 ' NH1' ' O ' ' A' ' 21' ' ' ALA . 56.9 ttm-85 -84.71 141.14 30.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.428 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.3 m-70 -143.48 167.93 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.444 ' NE2' HG22 ' A' ' 46' ' ' VAL . 78.9 m80 -130.71 147.97 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.596 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.8 t -89.57 137.27 32.47 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 67' ' ' GLU . 92.6 mtt-85 -72.74 -6.34 43.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.932 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.2 m-20 -100.71 -70.26 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.571 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.99 -24.57 55.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.68 21.92 78.88 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.722 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.8 162.4 13.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.801 0.334 . . . . 0.0 110.512 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.849 ' C ' HD22 ' A' ' 47' ' ' LEU . 87.0 t -78.35 128.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.226 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.849 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.0 mm? -132.64 139.52 47.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -77.54 175.04 10.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.703 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.76 -52.87 35.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.673 -1.251 . . . . 0.0 112.358 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 93.2 m-20 -55.67 -35.84 66.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.802 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.16 -2.34 58.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.24 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -131.78 27.3 4.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 74.9 mtt180 -82.19 -20.13 38.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.369 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -76.99 163.06 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 111.212 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -139.59 136.55 34.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.222 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -160.15 153.97 22.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -87.3 153.14 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 63' ' ' ILE . 3.1 mt -129.25 77.6 77.33 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 110.808 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.8 -8.49 15.78 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 123.138 2.559 . . . . 0.0 113.894 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mmm -89.7 -37.87 14.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.0 109.36 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 2.8 mmm180 -84.31 2.71 38.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.441 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.25 7.68 61.98 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.535 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 58' ' ' ILE . 72.7 mt -97.86 102.06 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.193 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.3 p -87.59 -17.43 31.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 mt-10 -103.11 142.01 23.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 32.2 Cg_exo -56.16 124.38 16.12 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.725 1.616 . . . . 0.0 112.061 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.4 mm-40 -126.41 166.85 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -69.25 136.44 51.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.473 0.654 . . . . 0.0 111.707 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.582 HG11 ' ND2' ' A' ' 42' ' ' ASN . 28.4 m -148.92 161.1 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.844 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.48 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -75.44 -168.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 55.3 p30 -81.15 -40.3 24.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.93 -44.41 73.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 111.37 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 64.3 m -63.91 -40.92 97.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 38.0 t80 -57.22 -41.09 78.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.9 mt -69.2 -49.05 60.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.748 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.91 83.15 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.439 HD11 ' ND2' ' A' ' 42' ' ' ASN . 93.4 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.041 0.448 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.36 -15.69 25.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.913 2.409 . . . . 0.0 112.215 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.93 155.9 49.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.919 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.6 t -61.73 124.26 20.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 111.904 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -61.41 -27.69 68.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.134 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 -56.05 2.5 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.619 -0.801 . . . . 0.0 114.716 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 p -105.56 -0.69 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.15 63.21 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.718 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 14.0 p -71.44 144.91 49.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.409 0.605 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.96 140.33 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 81.2 m-85 -84.81 135.63 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.344 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.0 p -126.89 167.06 16.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -45.36 -41.67 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -70.5 -34.81 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.32 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.64 114.18 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.503 0.668 . . . . 0.0 111.554 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -78.72 150.19 32.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.669 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -90.34 142.53 27.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.137 0.494 . . . . 0.0 110.454 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.9 m-70 -139.7 168.14 20.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.129 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.72 143.93 49.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.757 0.313 . . . . 0.0 111.309 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.4 t -90.72 137.87 32.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -72.97 -5.22 37.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.946 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.7 -72.21 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.785 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.0 p -77.09 -24.44 51.8 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.77 77.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.86 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.94 164.02 12.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.814 ' C ' HD22 ' A' ' 47' ' ' LEU . 60.9 t -80.8 128.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.814 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -130.7 137.64 49.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.348 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.27 174.29 8.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.756 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.08 -53.01 32.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.421 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 70.5 m-20 -56.26 -36.09 68.17 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.731 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -86.91 -3.33 59.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.135 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.2 p -131.66 26.03 4.71 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 70.8 mtp85 -82.21 -16.97 47.76 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.972 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -80.38 166.14 21.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -142.53 135.2 28.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.245 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.28 153.23 25.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.697 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.44 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.06 154.61 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.946 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.7 mt -131.35 81.11 66.24 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.997 0.427 . . . . 0.0 110.733 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.16 -8.12 19.29 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.981 2.454 . . . . 0.0 113.907 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.4 mtp -89.37 -37.12 15.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.531 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 13.7 mmm180 -84.83 4.0 35.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.19 4.42 66.64 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.533 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.863 HD12 HD12 ' A' ' 58' ' ' ILE . 74.2 mt -94.65 97.82 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.356 . . . . 0.0 110.157 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -84.66 -18.51 35.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 63' ' ' ILE . 2.5 mt-10 -103.84 146.4 32.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.9 Cg_endo -57.89 123.84 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.029 1.819 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 80.5 mm-40 -126.42 167.52 15.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -71.76 137.49 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.732 0.777 . . . . 0.0 112.202 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.684 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.2 m -146.66 179.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.051 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.498 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -92.71 -162.25 0.91 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -83.51 -44.04 15.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.92 80.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.806 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.7 m -64.03 -40.99 97.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 77.5 t80 -55.8 -40.78 73.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.35 -53.99 12.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.34 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.9 -48.61 42.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.374 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 58' ' ' ILE . 72.3 mt . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.007 0.432 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.87 -10.09 21.27 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.137 2.558 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -135.99 158.01 45.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.366 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 6.8 t -63.18 125.06 22.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 31.8 m120 -63.51 -25.49 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.364 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.28 -56.66 2.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.684 -0.77 . . . . 0.0 114.679 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 p -105.09 -1.85 25.07 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.05 65.77 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.423 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.4 p -67.09 143.89 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.257 0.528 . . . . 0.0 109.639 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.7 OUTLIER -84.25 143.44 11.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.649 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 94.5 m-85 -84.28 134.82 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.7 p -126.45 168.75 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.061 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.04 -44.7 31.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.356 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 m -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.562 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -87.96 113.04 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.364 0.602 . . . . 0.0 111.54 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -73.85 149.28 41.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.126 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.476 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 20.2 ttp180 -81.74 140.9 34.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.2 m-70 -142.23 165.89 26.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.144 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -131.35 147.63 52.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 t -90.77 136.7 32.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.449 ' NE ' ' OE1' ' A' ' 67' ' ' GLU . 68.6 mtp85 -72.45 -5.45 36.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.875 HD22 ' CG2' ' A' ' 58' ' ' ILE . 4.6 m120 -101.67 -70.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.9 p -75.0 -24.84 58.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.4 77.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.637 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.501 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.92 163.19 12.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.877 ' C ' HD22 ' A' ' 47' ' ' LEU . 88.6 t -79.72 128.86 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.877 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.3 mm? -132.98 140.64 47.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.89 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 p -82.55 175.13 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.643 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -52.13 -52.65 34.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.127 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -53.85 -36.3 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.866 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -92.32 -1.26 57.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.703 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -132.47 25.91 4.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 110.089 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 19.6 mmt180 -79.23 -22.99 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -76.33 165.06 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.446 0.641 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -139.7 134.05 31.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.017 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.38 155.16 26.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.54 159.44 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.875 ' CG2' HD22 ' A' ' 42' ' ' ASN . 1.1 mt -133.12 74.96 72.33 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.092 0.473 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.95 -14.15 39.44 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.423 2.749 . . . . 0.0 114.491 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.3 mtm -86.54 -37.35 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.674 ' HG2' HG22 ' A' ' 58' ' ' ILE . 18.3 mmm180 -83.01 3.68 29.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.857 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.07 61.84 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.408 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.699 HD12 HD12 ' A' ' 58' ' ' ILE . 63.7 mt -101.24 101.25 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.91 0.386 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -87.73 -16.01 35.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.434 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 63' ' ' ILE . 3.7 mp0 -103.19 145.2 30.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.0 Cg_endo -58.57 121.87 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.615 1.544 . . . . 0.0 112.005 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.637 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.7 mt-10 -125.49 168.74 13.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.702 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.489 ' NH1' ' HB3' ' A' ' 68' ' ' ARG . 5.1 ptp180 -72.37 137.28 46.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.741 0.782 . . . . 0.0 112.333 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.41 -177.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.897 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.53 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -97.29 -162.14 0.93 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -82.81 -43.91 16.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.09 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 111.53 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -64.15 -40.53 96.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.289 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.616 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 79.8 t80 -57.25 -41.29 79.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.5 mt -70.64 -50.94 31.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.872 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.21 -48.33 54.34 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.562 HD11 ' OD1' ' A' ' 42' ' ' ASN . 44.8 mt . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.024 0.44 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.3 -12.3 25.24 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.056 2.504 . . . . 0.0 112.549 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.57 48.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.166 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 15.5 t -62.57 123.44 18.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.0 111.683 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.9 m120 -60.36 -26.79 66.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 -55.88 2.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.429 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.98 -3.15 25.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.41 8.96 67.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.437 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 12.4 p -70.01 142.69 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.208 0.504 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.95 137.9 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.954 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 84.6 m-85 -83.73 134.64 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.5 p -127.48 171.2 11.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -46.9 -39.63 12.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 p -75.74 -25.45 56.55 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.828 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.9 t -96.74 112.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.36 0.6 . . . . 0.0 111.271 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -75.45 147.74 39.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.644 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.6 ttp85 -81.93 140.34 34.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.768 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -141.96 163.9 31.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.232 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -129.26 146.57 51.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.5 t -91.19 138.03 31.91 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -73.03 -5.43 38.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.94 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.2 m-20 -101.46 -71.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.1 p -76.94 -24.41 52.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 22.09 78.24 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.547 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.8 m-85 -98.17 161.2 13.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.896 0.379 . . . . 0.0 110.454 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.881 ' C ' HD22 ' A' ' 47' ' ' LEU . 95.5 t -77.62 128.86 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.881 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.7 mm? -132.2 139.15 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -78.88 175.94 10.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.754 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.51 -53.95 29.7 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.764 -1.207 . . . . 0.0 112.333 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -54.83 -35.53 64.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.761 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -90.33 -1.94 57.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.441 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 p -131.3 26.25 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.754 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 94.6 mtt-85 -80.96 -19.39 44.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.117 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -80.58 163.41 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.19 0.519 . . . . 0.0 111.438 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 mtm105 -139.36 136.99 35.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.274 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.49 154.62 27.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.95 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.97 151.77 20.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.94 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.3 mt -128.39 79.32 74.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.026 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.89 -9.97 20.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.217 2.611 . . . . 0.0 114.044 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 71.8 mtm -88.33 -37.87 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.5 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 30.8 mmm180 -83.17 1.01 42.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.441 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.42 60.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.904 HD12 HD12 ' A' ' 58' ' ' ILE . 74.1 mt -96.64 101.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.398 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.3 p -88.25 -18.94 27.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.384 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 3.5 mm-40 -103.69 138.53 19.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.4 Cg_exo -52.99 124.3 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.692 1.595 . . . . 0.0 112.044 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.618 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.6 mt-10 -125.64 167.43 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -69.94 136.25 50.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 111.966 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.594 HG11 ' ND2' ' A' ' 42' ' ' ASN . 29.0 m -145.27 179.48 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.982 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.482 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.89 -166.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 56.3 p30 -79.36 -42.68 25.06 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -67.9 -45.95 72.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 111.7 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.2 m -63.63 -41.43 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.302 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 68.9 t80 -56.32 -40.36 74.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.55 -50.65 24.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.245 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.95 62.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.667 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.036 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.973 0.416 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.67 -13.28 18.11 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.101 2.534 . . . . 0.0 112.644 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.64 155.82 49.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.438 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.7 t -59.62 123.93 18.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 111.552 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 29.5 m120 -60.83 -28.08 68.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.086 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.15 -54.77 2.36 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.329 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 p -103.68 -4.03 24.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.08 7.75 63.37 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.628 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p -69.88 144.16 52.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.264 0.532 . . . . 0.0 110.301 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.78 137.66 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.978 0.418 . . . . 0.0 112.066 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.652 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.41 134.59 34.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.213 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -128.04 170.78 12.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -49.3 -43.85 43.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.35 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.5 m -66.53 -35.82 81.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.65 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.6 t -89.59 112.66 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.288 0.566 . . . . 0.0 111.364 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -73.08 145.76 46.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.846 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.491 HH11 HG11 ' A' ' 46' ' ' VAL . 58.5 ttm-85 -83.81 141.34 31.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.656 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 99.8 m-70 -143.66 166.25 25.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.616 ' NE2' HG22 ' A' ' 46' ' ' VAL . 76.3 m80 -130.86 148.85 52.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.02 137.52 32.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 29.2 tpt180 -71.73 -7.18 46.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.861 ' OD1' HD13 ' A' ' 58' ' ' ILE . 68.6 m-20 -100.7 -69.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.3 p -76.98 -23.08 52.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.61 21.5 79.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.504 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.68 161.41 13.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.794 0.33 . . . . 0.0 110.252 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.84 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.2 t -79.21 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.24 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.878 HD12 ' HB3' ' A' ' 51' ' ' CYS . 2.4 mm? -132.41 141.01 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.743 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.2 p -79.45 177.81 8.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.88 -52.78 44.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.459 -1.353 . . . . 0.0 112.242 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -55.59 -35.58 65.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.878 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.15 -1.81 58.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.8 p -132.02 25.8 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 84.3 mtt-85 -79.88 -19.18 48.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.039 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -80.06 164.21 23.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.263 0.554 . . . . 0.0 111.771 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.76 135.91 31.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.284 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.82 155.1 27.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.46 154.45 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.861 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.6 mt -129.97 80.37 71.29 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 0.0 110.58 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.99 -12.02 33.56 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.242 2.628 . . . . 0.0 114.189 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.3 mtp -86.4 -37.3 18.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.533 ' HG2' HG22 ' A' ' 58' ' ' ILE . 31.9 mmm180 -83.69 2.78 36.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.747 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.45 63.32 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.193 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.857 HD12 HD12 ' A' ' 58' ' ' ILE . 65.9 mt -97.87 100.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.79 -17.31 33.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.693 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mm-40 -103.26 143.92 27.59 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.0 Cg_endo -57.13 123.29 13.49 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.618 1.545 . . . . 0.0 111.698 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -123.72 167.76 13.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.837 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.38 135.79 47.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.695 0.759 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.623 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -146.0 -177.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.103 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.504 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 2.0 p -98.09 -162.7 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 53.9 p30 -82.97 -41.58 18.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.62 -46.23 69.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 111.541 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 65.3 m -64.01 -40.34 96.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.225 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.6 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 73.2 t80 -57.1 -40.42 76.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.1 mt -72.67 -52.92 13.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.46 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.64 -48.22 49.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 ' ND2' ' A' ' 42' ' ' ASN . 83.3 mt . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HB3' HG21 ' A' ' 46' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 121.048 0.451 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.64 -13.97 14.43 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.159 2.573 . . . . 0.0 113.181 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.58 48.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -59.65 125.82 25.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 112.051 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 36.2 m-80 -62.66 -27.76 69.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.37 -54.42 2.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.101 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.6 p -103.46 -3.77 24.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.83 11.64 66.51 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.611 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 5.3 p -72.55 143.86 48.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.492 0.646 . . . . 0.0 110.485 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.68 137.14 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.613 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 98.1 m-85 -82.56 135.06 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.863 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 169.44 12.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.28 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -47.19 -43.22 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 m -67.78 -37.91 82.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 48' ' ' CYS . 62.4 t -87.2 113.06 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.353 0.597 . . . . 0.0 111.311 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -74.08 149.79 40.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.763 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG3' HG13 ' A' ' 46' ' ' VAL . 64.8 ttp85 -80.95 138.77 36.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.802 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 89.1 m-70 -142.76 165.12 28.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.129 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -128.18 146.58 50.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.725 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.0 t -90.3 137.47 32.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -72.57 -7.37 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.932 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.7 m-20 -101.21 -71.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.2 p -75.08 -24.04 58.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.695 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.66 20.86 79.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.734 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -99.07 163.24 12.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.953 0.406 . . . . 0.0 110.609 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.813 ' C ' HD22 ' A' ' 47' ' ' LEU . 89.6 t -76.74 128.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.406 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.878 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.1 mm? -133.06 139.45 47.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.654 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.406 ' HB2' HG11 ' A' ' 35' ' ' VAL . 14.1 p -79.69 175.54 10.52 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.73 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.46 -53.59 34.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.307 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.37 -36.14 63.55 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.878 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.65 -1.89 58.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.1 p -132.39 26.78 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 90.6 mtt-85 -80.22 -19.24 47.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -79.59 164.61 23.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.153 0.501 . . . . 0.0 111.628 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.45 ' NH1' ' HB3' ' A' ' 55' ' ' ARG . 15.9 mtp-105 -140.85 137.93 33.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.84 154.3 23.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.863 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.75 147.82 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.004 HD12 HD12 ' A' ' 63' ' ' ILE . 2.8 mt -126.97 77.69 74.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.821 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.74 -8.18 12.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 123.393 2.729 . . . . 0.0 113.8 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.3 mtp -96.0 -34.99 11.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.766 0.793 . . . . 0.0 109.099 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 40.5 mtp85 -90.01 29.47 1.21 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.289 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.14 23.02 71.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.075 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.004 HD12 HD12 ' A' ' 58' ' ' ILE . 71.5 mt -119.44 101.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.748 0.309 . . . . 0.0 110.394 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.91 -22.86 24.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.817 0.341 . . . . 0.0 111.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.6 mm-40 -99.74 138.49 20.4 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 53.1 Cg_exo -52.72 123.04 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.4 1.4 . . . . 0.0 111.693 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.667 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.4 mt-10 -124.64 165.69 17.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.562 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -69.56 139.12 53.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.645 0.736 . . . . 0.0 112.186 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.63 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -145.14 -179.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.91 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.496 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -96.26 -164.98 1.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -80.19 -43.8 20.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.84 79.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.734 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.8 m -65.23 -40.1 93.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.377 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -57.17 -41.83 79.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.43 -50.56 37.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.272 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.18 61.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.399 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.528 HD11 ' OD1' ' A' ' 42' ' ' ASN . 33.9 mt . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.134 0.492 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.21 -11.08 17.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.245 2.63 . . . . 0.0 112.952 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 156.41 48.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.461 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.8 t -59.58 123.76 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.147 0.499 . . . . 0.0 111.872 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -61.81 -27.69 68.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.969 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.86 -54.73 2.41 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.104 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 p -104.09 -3.19 24.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 69.14 9.08 59.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.466 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 p -70.59 144.79 51.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.156 0.478 . . . . 0.0 110.164 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -81.95 136.62 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.144 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.676 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 99.0 m-85 -82.41 134.9 35.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.959 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 p -126.55 168.24 14.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.8 m -47.41 -43.58 23.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.9 m -66.51 -38.06 86.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.71 113.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 0.0 111.174 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.85 145.6 46.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.049 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.5 ttm105 -83.24 140.76 32.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.572 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -143.06 167.25 22.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.441 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -128.63 146.66 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.367 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.0 t -89.9 137.45 32.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 14.2 mmt180 -71.83 -7.67 49.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.948 ' OD1' HD13 ' A' ' 58' ' ' ILE . 75.0 m-20 -101.74 -70.33 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.538 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.7 p -75.83 -24.2 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.27 21.11 79.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.712 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.538 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 22.0 m-85 -98.72 161.49 13.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.732 0.301 . . . . 0.0 110.349 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.787 ' C ' HD22 ' A' ' 47' ' ' LEU . 73.0 t -75.4 128.96 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.7 mm? -132.54 139.42 47.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 p -80.04 174.33 11.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.753 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.66 -53.97 26.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.601 -1.285 . . . . 0.0 112.437 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -55.08 -35.32 64.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.934 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.62 -2.51 58.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.426 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -132.55 26.47 4.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.753 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt-85 -80.49 -20.39 43.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.168 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -78.55 163.69 25.32 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 111.289 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -138.26 135.89 35.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.957 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -156.39 153.94 29.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.973 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.434 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -93.65 149.29 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.994 HD12 HD12 ' A' ' 63' ' ' ILE . 2.1 mt -128.96 76.75 78.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.075 0.464 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.12 -8.43 12.12 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.329 2.686 . . . . 0.0 113.693 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.87 -35.66 11.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.708 0.766 . . . . 0.0 108.949 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.535 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 7.6 mtp-105 -90.28 29.06 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.002 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.45 72.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.11 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.994 HD12 HD12 ' A' ' 58' ' ' ILE . 88.8 mt -123.52 97.93 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -86.84 -17.58 33.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.712 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.4 mt-10 -102.17 141.13 21.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 40.3 Cg_exo -55.39 122.52 11.88 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.492 1.461 . . . . 0.0 111.694 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.718 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.3 mt-10 -125.52 166.64 16.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -69.36 137.09 52.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.598 0.713 . . . . 0.0 111.984 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.594 HG11 ' ND2' ' A' ' 42' ' ' ASN . 26.9 m -145.89 -179.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.027 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 1.9 p -96.89 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -78.08 -42.31 32.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.76 -45.72 70.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 38.4 m -64.38 -41.54 96.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.443 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 73.4 t80 -56.17 -39.59 72.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.0 mt -72.89 -54.56 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.454 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.54 -48.11 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.364 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.416 HD11 ' OD1' ' A' ' 42' ' ' ASN . 82.6 mt . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 121.027 0.442 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.99 -11.85 21.5 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.039 2.493 . . . . 0.0 112.592 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.75 156.01 49.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.218 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 8.6 t -62.83 123.93 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.174 0.511 . . . . 0.0 111.488 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.7 m120 -59.15 -27.01 65.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.084 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.11 -55.51 2.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.327 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -103.84 -2.61 26.02 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.74 8.91 61.36 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.3 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.8 p -69.51 143.09 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.22 0.51 . . . . 0.0 110.009 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -80.08 137.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.905 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 87.0 m-85 -84.33 134.93 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.7 p -127.74 171.51 11.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.308 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.25 -41.16 26.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.0 p -72.35 -28.05 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.8 t -94.9 113.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.634 . . . . 0.0 111.435 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.81 148.17 40.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.369 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 17.9 ttp180 -82.33 140.61 33.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.611 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.0 m-70 -142.23 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -130.43 147.09 52.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.6 t -89.37 138.38 31.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 24.6 tpt180 -72.55 -7.05 48.1 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.934 ' OD1' HD13 ' A' ' 58' ' ' ILE . 71.2 m-20 -100.66 -70.04 0.75 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 29.3 p -77.51 -23.86 50.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 22.13 79.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.397 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.4 m-85 -98.48 163.14 12.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.828 0.347 . . . . 0.0 110.314 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.871 ' C ' HD22 ' A' ' 47' ' ' LEU . 79.9 t -79.73 127.72 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.234 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.871 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.5 mm? -132.32 139.58 48.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.53 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.24 178.01 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.731 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.04 -53.8 35.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.481 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 82.8 m-20 -55.28 -35.77 65.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.739 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.48 -2.34 58.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.361 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -131.8 26.15 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 93.3 mtt-85 -79.54 -21.4 45.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.305 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -80.16 165.07 22.8 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.279 0.561 . . . . 0.0 111.613 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -140.59 138.09 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.388 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.584 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.37 154.16 26.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.834 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.89 154.99 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.934 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.2 mt -130.21 79.53 72.52 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.09 -11.17 26.21 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.174 2.583 . . . . 0.0 113.91 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.7 mtp -86.91 -37.79 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG2' HG22 ' A' ' 58' ' ' ILE . 14.9 mmm180 -84.74 4.24 33.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.78 8.82 63.27 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.476 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.859 HD12 HD12 ' A' ' 58' ' ' ILE . 67.0 mt -99.09 100.83 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.241 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.0 p -87.09 -16.79 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.54 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 34.3 mt-10 -103.81 145.0 29.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 17.0 Cg_endo -58.18 123.34 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.688 1.592 . . . . 0.0 111.723 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -124.84 167.71 14.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -71.01 136.46 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 0.0 111.658 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.63 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.0 m -147.08 -178.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.159 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.512 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.34 -164.96 1.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.88 -43.97 21.29 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.58 74.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 54.0 m -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.338 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.7 t80 -56.34 -39.05 72.2 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.0 -54.93 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.672 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.05 -47.87 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.294 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.406 HD11 ' OD1' ' A' ' 42' ' ' ASN . 91.8 mt . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 46' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 121.142 0.496 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.64 -13.39 29.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.069 2.513 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.94 156.14 49.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.18 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 10.3 t -62.41 123.01 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.648 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -60.45 -25.66 66.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.282 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.89 -55.87 2.06 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.189 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.5 p -103.09 -4.45 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 10.06 72.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.469 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 8.5 p -71.1 142.61 50.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.355 0.577 . . . . 0.0 110.353 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.21 138.84 18.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.784 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.741 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.4 m-85 -83.85 134.17 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.473 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.4 p -127.89 171.67 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.2 m -48.26 -40.98 26.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 p -73.01 -27.68 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.391 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.1 t -94.61 112.66 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.419 0.628 . . . . 0.0 111.345 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -73.85 145.67 44.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.397 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.503 ' CD ' HG11 ' A' ' 46' ' ' VAL . 7.8 tpp180 -77.72 139.38 39.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 98.6 m-70 -142.72 161.9 36.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.221 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -129.96 147.19 51.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -89.9 137.85 31.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.3 -6.89 46.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.978 ' OD1' HD13 ' A' ' 58' ' ' ILE . 81.4 m-20 -101.54 -71.37 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.73 -24.07 56.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.97 22.14 79.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.371 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.522 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.2 m-85 -99.02 162.57 12.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.826 ' C ' HD22 ' A' ' 47' ' ' LEU . 89.6 t -78.47 128.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.826 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.2 mm? -132.31 137.86 47.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.2 176.8 8.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.58 -54.36 30.71 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -54.85 -35.28 63.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.783 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.55 -2.35 58.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.38 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -132.33 26.18 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.0 mtt-85 -78.7 -21.39 48.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -78.39 162.07 26.7 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -138.1 138.22 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.01 153.55 24.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.478 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.5 147.97 22.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.07 HD12 HD12 ' A' ' 63' ' ' ILE . 2.3 mt -126.93 76.97 75.39 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 110.95 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.87 -6.97 10.26 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.253 2.636 . . . . 0.0 113.735 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.8 mtm -95.75 -36.11 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.723 0.773 . . . . 0.0 109.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 45.1 mtp85 -90.03 29.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 22.67 72.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.278 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.07 HD12 HD12 ' A' ' 58' ' ' ILE . 76.3 mt -118.54 102.5 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 117.033 0.417 . . . . 0.0 110.544 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -87.52 -21.68 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.397 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 63' ' ' ILE . 4.2 mt-10 -100.36 145.79 30.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.7 Cg_endo -59.49 123.25 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.738 1.625 . . . . 0.0 111.45 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.749 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.5 mt-10 -125.78 165.7 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.924 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.58 137.2 54.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 0.0 112.067 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.575 HG11 HD21 ' A' ' 42' ' ' ASN . 32.3 m -145.06 177.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.976 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.488 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.43 -168.78 1.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.25 -42.82 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.01 73.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 54.5 m -64.13 -41.06 97.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.397 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 74.5 t80 -56.5 -39.79 73.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt -70.28 -49.94 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.621 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.13 86.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.492 HD11 ' OD1' ' A' ' 42' ' ' ASN . 93.6 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.832 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.807 0.337 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.39 -11.82 33.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.146 2.564 . . . . 0.0 112.819 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 158.28 44.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.529 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -60.46 124.73 21.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 111.872 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -61.65 -25.92 67.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.79 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.38 -56.32 2.17 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 p -105.42 -2.3 23.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.47 9.58 68.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.191 -1.005 . . . . 0.0 113.737 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.7 p -71.25 143.78 50.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.412 0.606 . . . . 0.0 110.143 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.42 136.95 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.97 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 93.8 m-85 -83.03 134.93 35.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.095 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -125.75 168.08 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -47.08 -43.71 20.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.207 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.3 m -66.68 -36.92 83.68 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.025 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 48' ' ' CYS . 64.3 t -88.74 113.85 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.402 0.62 . . . . 0.0 111.468 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -76.75 150.93 36.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.548 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' NH1' ' CD2' ' A' ' 31' ' ' PHE . 68.7 mtt-85 -88.24 141.51 28.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.68 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.2 m-70 -140.01 166.21 25.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.52 144.47 49.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.834 0.35 . . . . 0.0 111.517 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.88 137.34 32.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -71.98 -6.22 40.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.939 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.7 m-20 -101.28 -71.82 0.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.688 0.28 . . . . 0.0 111.673 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -75.85 -25.67 56.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.357 . . . . 0.0 111.87 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 23.47 75.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.821 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.7 m-85 -100.45 163.24 12.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 0.0 110.63 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.824 ' C ' HD22 ' A' ' 47' ' ' LEU . 68.4 t -78.27 128.67 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.0 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.824 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.8 mm? -131.63 138.3 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.294 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 12.2 p -76.92 174.25 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.74 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.8 -52.95 31.89 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.363 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 86.0 m-20 -55.47 -36.1 66.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.766 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.81 -2.49 58.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.337 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 p -131.97 26.53 4.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.1 mtt180 -80.76 -17.94 49.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.919 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -81.39 164.7 21.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 111.377 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -140.75 135.51 31.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.105 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -157.19 153.98 28.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.73 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.62 148.38 22.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.939 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.3 mt -124.9 82.47 60.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.28 -10.88 29.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.015 2.477 . . . . 0.0 114.048 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.95 -37.44 17.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.495 0.664 . . . . 0.0 109.267 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG2' HG22 ' A' ' 58' ' ' ILE . 34.4 mmm-85 -84.44 2.71 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.655 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 8.14 62.44 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.608 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.878 HD12 HD12 ' A' ' 58' ' ' ILE . 81.6 mt -97.89 101.39 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.252 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.25 -19.25 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.59 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.0 mp0 -102.02 145.9 31.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 38.1 Cg_exo -58.45 123.04 12.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.413 1.409 . . . . 0.0 111.674 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG2' ' CG2' ' A' ' 63' ' ' ILE . 73.2 mm-40 -124.47 166.83 15.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.587 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -71.11 136.94 48.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.657 0.742 . . . . 0.0 111.978 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.622 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -145.81 179.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.035 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.47 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.1 p -94.61 -165.3 1.29 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -80.12 -44.06 20.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.3 76.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.752 0.31 . . . . 0.0 111.789 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.3 m -63.81 -41.54 97.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.086 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 79.4 t80 -56.31 -40.7 74.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.13 -51.41 21.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.352 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.13 -48.1 61.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.513 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.469 HD11 ' OD1' ' A' ' 42' ' ' ASN . 59.6 mt . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.987 0.423 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 -11.34 20.35 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.101 2.534 . . . . 0.0 112.849 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.29 156.97 48.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.44 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 11.2 t -63.08 123.95 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.121 0.486 . . . . 0.0 111.613 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -60.46 -26.43 66.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.269 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.06 -56.21 2.36 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.568 -0.825 . . . . 0.0 114.312 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.9 p -105.32 -1.72 24.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.78 11.08 68.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.647 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.6 p -72.27 143.45 48.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.261 0.53 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.06 136.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.707 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.4 m-85 -82.6 133.79 35.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.08 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.7 p -126.23 169.88 12.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.075 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.3 m -48.12 -43.99 31.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -67.46 -36.25 80.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.079 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.4 t -87.49 113.27 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.407 0.622 . . . . 0.0 111.541 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -73.62 145.22 45.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.194 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.607 ' NH1' HG11 ' A' ' 46' ' ' VAL . 63.3 ttm-85 -83.56 140.21 32.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.95 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -143.74 167.21 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.395 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.439 ' NE2' HG22 ' A' ' 46' ' ' VAL . 50.6 m80 -130.59 147.62 52.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.357 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.3 t -91.06 137.98 31.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.43 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 60.0 mtp180 -73.18 -5.1 37.04 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.949 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.1 m-20 -101.72 -72.31 0.69 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.624 0.25 . . . . 0.0 111.645 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . 30.8 p -74.59 -24.44 58.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.5 79.71 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.026 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 43' ' ' CYS . 36.0 m-85 -97.5 165.66 11.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.598 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.865 ' C ' HD22 ' A' ' 47' ' ' LEU . 92.9 t -81.27 128.28 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.3 mm? -131.67 138.17 48.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.1 p -76.82 177.03 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.737 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.15 -54.03 31.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.336 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 84.0 m-20 -55.26 -34.99 64.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.748 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.2 -2.61 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 84.1 p -132.43 25.55 4.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 71.8 mtp180 -78.32 -21.94 48.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.976 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -77.62 162.91 26.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 111.723 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -138.67 137.09 36.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.06 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.599 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.04 154.05 25.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.876 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.37 150.96 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.949 HD13 ' OD1' ' A' ' 42' ' ' ASN . 2.9 mt -127.64 82.31 68.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.22 -10.54 27.75 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.109 2.54 . . . . 0.0 113.99 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.16 -37.17 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 13.6 mmm180 -83.94 2.08 40.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.8 7.39 62.9 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.4 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.871 HD12 HD12 ' A' ' 58' ' ' ILE . 77.2 mt -96.5 100.61 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.8 p -86.09 -19.03 30.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.448 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.2 mt-10 -102.84 146.43 32.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.9 Cg_endo -58.85 123.5 13.66 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.688 1.592 . . . . 0.0 111.954 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -125.32 166.84 15.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.697 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -70.15 137.01 50.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 112.095 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.6 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.8 m -146.43 179.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.904 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.516 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.67 -163.63 1.07 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.7 p-10 -82.6 -42.45 18.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.467 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.12 -45.18 74.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.748 0.308 . . . . 0.0 111.645 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.431 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 34.3 m -63.51 -41.38 98.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.256 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 80.7 t80 -56.55 -39.71 73.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.72 -51.15 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.11 -47.52 65.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.391 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD11 ' ND2' ' A' ' 42' ' ' ASN . 71.6 mt . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -14.67 25.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.019 2.48 . . . . 0.0 112.648 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.02 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.1 t -60.59 125.23 22.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.315 0.579 . . . . 0.0 111.704 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 64.8 m-80 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.886 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.59 -56.17 2.05 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.234 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.5 p -103.08 -4.14 24.96 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.75 73.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.53 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 8.0 p -73.67 143.66 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.391 0.595 . . . . 0.0 110.324 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.78 137.39 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.794 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 86.4 m-85 -83.97 135.08 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.1 p -128.66 170.32 13.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.416 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.9 m -47.82 -44.46 28.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.535 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 m -65.44 -35.95 82.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.03 113.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 111.625 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -75.38 148.89 38.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.402 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.473 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 24.2 ttp-105 -79.22 141.63 36.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 96.5 m-70 -141.22 160.75 39.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -126.8 145.83 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.375 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.8 t -91.34 137.18 32.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -72.1 -6.85 45.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.864 ' OD1' HD13 ' A' ' 58' ' ' ILE . 70.2 m-20 -100.66 -71.64 0.7 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 30.6 p -75.81 -24.28 55.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.05 79.6 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.449 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -98.54 162.12 13.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 110.515 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.863 ' C ' HD22 ' A' ' 47' ' ' LEU . 90.2 t -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.39 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.863 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.9 mm? -132.12 140.06 48.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.17 -179.86 6.44 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.708 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.22 -53.65 41.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.206 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 95.3 m-20 -55.2 -36.28 65.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.813 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.53 -2.01 58.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 p -131.9 26.48 4.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 81.9 mtt-85 -81.35 -16.86 51.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -85.24 167.18 15.89 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.145 0.498 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -144.03 140.88 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.15 154.43 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.606 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.39 149.98 22.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.877 HD12 HD12 ' A' ' 63' ' ' ILE . 3.6 mt -125.4 81.51 64.02 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.094 0.474 . . . . 0.0 110.596 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.64 -12.67 36.82 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.095 2.53 . . . . 0.0 114.318 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.2 mtm -85.72 -37.63 19.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.562 ' HG2' HG22 ' A' ' 58' ' ' ILE . 27.5 mmm180 -83.21 1.31 41.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.878 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.32 8.8 59.7 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.559 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.877 HD12 HD12 ' A' ' 58' ' ' ILE . 69.4 mt -98.98 101.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.095 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.2 p -88.59 -17.56 29.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.5 mt-10 -103.03 142.31 24.29 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.42 122.39 11.63 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.533 1.489 . . . . 0.0 111.694 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.8 mm-40 -123.33 166.18 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.595 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 mtm105 -71.02 139.41 50.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.499 0.666 . . . . 0.0 111.328 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.634 HG11 ' ND2' ' A' ' 42' ' ' ASN . 28.3 m -147.35 -179.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.244 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.522 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -95.5 -164.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.25 -43.51 19.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -46.06 75.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 40.0 m -63.78 -40.16 96.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.211 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 83.8 t80 -56.92 -39.86 75.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 mt -72.47 -52.19 16.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.47 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.2 -49.63 52.02 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.559 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.461 HD11 ' OD1' ' A' ' 42' ' ' ASN . 58.8 mt . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 121.032 0.444 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.92 -11.43 18.09 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.958 2.439 . . . . 0.0 112.346 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.06 155.46 50.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.204 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -64.15 126.94 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.111 0.482 . . . . 0.0 111.437 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.8 m120 -60.9 -26.39 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.974 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.19 -55.85 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.229 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -102.88 -4.18 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.93 9.01 65.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.466 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.1 p -69.87 143.22 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.127 0.464 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.43 138.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.083 0.468 . . . . 0.0 112.036 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.571 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.3 m-85 -83.92 133.44 34.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.412 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 p -126.54 169.57 12.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -46.68 -39.87 12.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.349 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -73.71 -25.87 60.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.427 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -97.7 113.14 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.23 0.538 . . . . 0.0 111.253 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -76.51 149.1 36.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.896 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' HG13 ' A' ' 46' ' ' VAL . 18.6 ttp180 -79.29 140.77 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -140.39 158.83 43.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.76 145.33 50.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.353 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.0 t -91.14 137.79 32.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -72.95 -6.55 46.05 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.925 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.08 -72.53 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.696 0.284 . . . . 0.0 111.754 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.2 p -74.87 -25.02 58.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.815 0.34 . . . . 0.0 111.581 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.7 22.84 77.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.679 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.0 m-85 -99.1 162.76 12.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.626 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.865 ' C ' HD22 ' A' ' 47' ' ' LEU . 78.5 t -79.28 128.06 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.969 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.3 mm? -131.49 140.43 49.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.494 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.41 174.02 11.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.761 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.42 -54.19 21.44 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.545 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -54.66 -36.13 64.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.762 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.9 -2.39 58.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.141 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 p -131.91 25.79 4.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.796 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.6 mtt-85 -81.1 -18.05 47.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -80.03 163.43 24.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.571 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.78 136.68 34.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.231 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.58 154.71 27.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.71 148.9 22.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.925 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.7 mt -126.69 79.64 71.48 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.915 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -10.02 21.64 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 123.111 2.54 . . . . 0.0 113.817 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.9 mmm -87.7 -37.53 16.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 16.2 mmm180 -84.14 3.44 34.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.507 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.95 6.61 65.09 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.243 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.893 HD12 HD12 ' A' ' 58' ' ' ILE . 85.0 mt -95.54 100.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.777 0.322 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.5 p -87.45 -19.03 28.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mt-10 -103.33 138.6 19.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 51.2 Cg_exo -52.74 124.33 15.09 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.647 1.565 . . . . 0.0 112.17 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.694 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.8 mt-10 -125.28 166.67 16.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.551 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -70.24 138.61 51.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.675 0.75 . . . . 0.0 112.092 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.648 HG11 ' ND2' ' A' ' 42' ' ' ASN . 31.3 m -147.08 178.97 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.464 -1.243 . . . . 0.0 110.013 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.499 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -93.46 -165.2 1.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -81.24 -42.82 20.15 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.42 -44.9 77.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 27.0 m -63.52 -41.51 98.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.379 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 74.7 t80 -56.06 -39.94 72.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 mt -72.38 -51.8 18.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.1 -48.49 61.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.306 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.477 HD11 ' ND2' ' A' ' 42' ' ' ASN . 60.0 mt . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.046 0 CA-C-O 121.046 0.45 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.81 -12.74 28.98 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.057 2.505 . . . . 0.0 112.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.8 156.68 48.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.356 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.3 t -62.03 125.14 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 111.523 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.33 -26.72 66.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.86 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.43 -55.19 2.1 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.991 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 p -103.69 -4.94 23.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 70.97 11.58 70.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.791 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.1 p -72.03 143.41 49.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.374 0.587 . . . . 0.0 110.409 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.44 138.08 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 112.022 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.2 m-85 -84.99 135.72 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 p -127.6 169.52 13.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.815 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.6 m -46.63 -42.82 16.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.4 m -66.59 -37.22 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.251 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.35 113.38 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.318 0.58 . . . . 0.0 111.524 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -74.55 148.31 40.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.492 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG3' HG13 ' A' ' 46' ' ' VAL . 13.7 ttp180 -78.63 141.4 38.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.409 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -142.18 163.01 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.05 147.52 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.906 0.384 . . . . 0.0 111.917 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.0 t -90.57 136.72 32.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.417 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 91.3 mtt-85 -70.17 -6.94 37.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 1.08 ' OD1' HD13 ' A' ' 58' ' ' ILE . 5.3 m-20 -102.9 -70.26 0.76 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.2 p -75.05 -25.83 58.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.054 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.82 20.31 79.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.391 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.5 m-85 -97.33 161.11 13.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.362 . . . . 0.0 110.668 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.83 ' C ' HD22 ' A' ' 47' ' ' LEU . 99.4 t -78.43 128.89 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.089 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 51' ' ' CYS . 1.9 mm? -130.81 140.45 50.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -78.33 172.46 13.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.0 -52.51 30.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.248 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 89.3 m-20 -55.88 -34.96 65.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.842 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.77 -1.37 57.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.278 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 p -131.74 25.7 4.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.748 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 78.1 mtp180 -80.72 -19.35 45.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.076 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -78.35 164.77 24.55 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.198 0.523 . . . . 0.0 111.623 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -141.03 134.71 30.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.323 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -160.7 154.09 21.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.82 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.8 158.04 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.08 HD13 ' OD1' ' A' ' 42' ' ' ASN . 1.6 mt -132.96 76.64 69.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 110.326 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.8 -11.57 29.91 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.238 2.625 . . . . 0.0 114.337 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 85.7 mtp -86.36 -37.64 18.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.621 ' HG2' HG22 ' A' ' 58' ' ' ILE . 16.2 mmm180 -83.94 3.76 32.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.673 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 7.96 62.5 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.439 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.897 HD12 HD12 ' A' ' 58' ' ' ILE . 65.8 mt -97.01 101.8 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.281 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 p -86.73 -18.34 31.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.671 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 63' ' ' ILE . 87.6 mt-10 -102.91 146.68 32.87 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.2 Cg_endo -59.05 122.35 11.44 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.553 1.502 . . . . 0.0 111.673 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 76.8 mm-40 -125.83 167.56 15.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.842 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -71.6 138.45 48.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.556 0.693 . . . . 0.0 112.092 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.3 179.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.751 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.531 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 15.3 p -95.59 -172.53 2.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -73.39 -42.94 61.53 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.07 -45.03 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.297 . . . . 0.0 111.683 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.1 m -64.64 -40.64 95.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.339 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 18.9 t80 -56.33 -41.52 76.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.36 -48.26 67.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.51 86.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.489 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.62 HD21 HG23 ' A' ' 58' ' ' ILE . 89.1 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.353 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.99 0.424 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.31 -15.02 25.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.778 2.318 . . . . 0.0 112.612 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.38 155.59 50.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.336 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.7 t -61.51 125.17 22.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.111 0.482 . . . . 0.0 111.414 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.0 m120 -61.67 -26.13 67.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.224 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 -55.81 2.23 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.715 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.11 -1.58 27.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 7.71 61.91 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.278 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -69.92 143.92 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.237 0.519 . . . . 0.0 110.168 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.98 138.98 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.151 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.2 m-85 -82.42 133.91 35.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 110.27 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -126.88 169.06 13.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.74 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.3 m -44.73 -38.79 4.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.473 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -78.44 -26.76 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -96.14 112.87 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.177 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -78.34 150.03 33.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.425 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -89.73 143.2 27.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.817 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 64.4 m80 -138.84 164.44 29.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.389 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.86 143.34 48.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.8 t -90.53 136.57 32.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -70.44 -6.76 38.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.907 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.8 m-20 -101.82 -70.66 0.74 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.0 p -77.56 -25.32 49.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.13 72.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.916 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 20.7 m-85 -102.32 162.33 13.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.8 0.333 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.825 ' C ' HD22 ' A' ' 47' ' ' LEU . 60.5 t -77.35 129.19 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.246 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.6 mm? -131.53 137.65 48.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.118 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.37 175.23 7.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.713 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.44 -53.01 37.48 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.497 -1.335 . . . . 0.0 112.044 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -54.76 -35.03 63.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.738 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.11 -3.63 58.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.444 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.4 p -131.41 27.93 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 88.4 mtt-85 -82.16 -19.21 40.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.197 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -78.59 163.52 25.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.273 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -140.0 135.16 32.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.263 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . . . -159.05 153.35 23.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.687 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.437 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.29 151.31 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.967 HD12 HD12 ' A' ' 63' ' ' ILE . 2.5 mt -127.37 74.97 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.14 0.495 . . . . 0.0 110.411 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.48 -9.02 14.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.127 2.551 . . . . 0.0 113.738 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.22 -36.72 12.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.556 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 32.5 mtp85 -89.43 26.34 1.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.358 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.63 23.36 76.72 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.276 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.967 HD12 HD12 ' A' ' 58' ' ' ILE . 73.5 mt -117.98 104.56 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.807 0.304 . . . . 0.0 110.326 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -91.31 -21.04 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 42.4 mt-10 -100.8 139.24 20.39 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.3 Cg_exo -52.71 123.02 11.99 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.591 1.527 . . . . 0.0 111.971 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.667 ' OE1' HD13 ' A' ' 63' ' ' ILE . 92.9 mt-10 -125.18 167.34 14.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.126 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -72.74 140.24 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 0.0 112.267 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.622 HG11 ' ND2' ' A' ' 42' ' ' ASN . 30.2 m -146.83 179.65 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.527 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.2 p -93.38 -163.62 1.07 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.112 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.86 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.5 m -63.57 -40.69 97.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.373 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 56' ' ' ALA . 67.1 t80 -56.7 -39.72 74.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.02 -53.0 12.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.775 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.41 61.3 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.26 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.518 HD11 ' OD1' ' A' ' 42' ' ' ASN . 82.2 mt . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.36 -12.88 32.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.232 2.621 . . . . 0.0 113.053 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.08 159.65 41.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.6 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.417 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.2 t -62.93 128.84 37.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.266 0.555 . . . . 0.0 112.059 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 m-80 -69.19 -24.76 64.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.324 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.43 -57.88 2.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.855 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 p -105.78 -0.3 25.48 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.05 72.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.413 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.5 p -69.37 143.52 53.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.356 0.578 . . . . 0.0 109.795 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.16 144.45 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.7 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 89.7 m-85 -83.54 132.96 34.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 28.9 p -124.84 168.66 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.925 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 m -48.24 -44.5 33.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 m -66.96 -36.16 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 32' ' ' THR . 77.3 t -86.3 113.46 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 0.0 111.786 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -73.11 144.83 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.897 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 21.5 ttm105 -87.09 141.99 28.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.952 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.2 m-70 -144.64 171.86 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' NE2' HG22 ' A' ' 46' ' ' VAL . 36.3 m80 -130.45 148.44 52.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.3 t -90.97 136.75 32.86 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -72.84 -5.68 39.84 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.931 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.9 m-20 -100.81 -71.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.62 0.247 . . . . 0.0 111.47 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.0 p -75.26 -24.72 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 111.614 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.46 20.45 79.86 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.6 m-85 -97.75 161.55 13.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.85 0.357 . . . . 0.0 110.538 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.808 ' C ' HD22 ' A' ' 47' ' ' LEU . 95.0 t -76.6 128.44 37.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.089 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.817 HD12 ' HB3' ' A' ' 51' ' ' CYS . 2.6 mm? -131.78 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.493 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.0 p -79.38 -179.78 6.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.89 -53.72 42.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.674 -1.251 . . . . 0.0 112.225 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' NE ' ' A' ' 53' ' ' ARG . 92.7 m-20 -55.38 -35.81 65.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.817 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.92 -2.15 58.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.389 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -131.87 26.39 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.4 mtt180 -80.94 -18.3 47.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -80.08 162.9 24.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.106 0.479 . . . . 0.0 111.285 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp85 -139.8 135.62 33.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -157.93 153.39 26.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.814 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.97 149.46 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.931 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.4 mt -125.81 82.36 64.26 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.855 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -10.73 29.64 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.087 2.524 . . . . 0.0 114.028 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.85 -37.76 17.43 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 58' ' ' ILE . 30.2 mmm180 -83.07 1.01 42.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.648 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 7.2 62.0 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.284 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.901 HD12 HD12 ' A' ' 58' ' ' ILE . 74.3 mt -96.85 100.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.66 -17.41 33.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.74 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.1 mt-10 -103.02 144.2 28.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 31.8 Cg_exo -57.11 123.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.642 1.561 . . . . 0.0 111.683 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.3 mm-40 -125.35 167.15 15.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -70.89 137.46 49.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.94 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.634 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -146.84 179.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.078 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 1.7 p -94.49 -160.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 20.9 t70 -85.02 -43.26 14.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.94 80.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 111.82 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 33.3 m -63.98 -40.85 97.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.8 t80 -57.94 -40.52 80.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.3 mt -69.76 -50.51 42.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.509 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.49 84.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.39 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD21 HG23 ' A' ' 58' ' ' ILE . 88.6 mt . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.524 0.202 . . . . 0.27 111.313 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.22 -18.41 16.22 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.281 1.988 . . . . 0.36 112.497 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.434 -0.348 . . . . 0.16 110.838 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -55.16 124.78 18.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.17 111.7 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.48 -22.09 66.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 1.19 111.82 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.93 -68.11 1.4 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.649 -0.786 . . . . 0.17 113.792 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 p -88.56 -27.8 21.16 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.984 0.365 . . . . 0.17 111.984 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.28 26.6 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.455 -0.879 . . . . 0.15 112.73 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 p -83.25 144.56 29.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.16 110.635 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.48 143.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.89 111.09 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 88.7 m-85 -89.91 130.48 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.23 111.099 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 p -120.46 175.32 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.19 110.728 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.8 m -54.91 -31.12 59.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.285 -0.416 . . . . 0.78 111.363 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -44.91 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 1.2 111.078 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.67 108.41 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.012 0.434 . . . . 0.2 110.895 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -74.87 163.45 27.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.788 -0.642 . . . . 2.74 109.717 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG2' HG13 ' A' ' 46' ' ' VAL . 15.1 ttm105 -88.64 152.86 21.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.747 0.647 . . . . 3.44 112.747 -178.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -157.52 139.61 14.35 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.342 -0.844 . . . . 0.22 110.369 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -106.7 155.41 19.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.975 0.417 . . . . 1.16 111.573 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.11 129.85 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.132 -0.692 . . . . 0.11 109.132 179.15 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -62.27 -17.76 59.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.817 0.673 . . . . 2.39 112.817 -177.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.549 ' ND2' HG11 ' A' ' 69' ' ' VAL . 66.1 m-80 -92.97 -69.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.665 0.269 . . . . 0.57 111.698 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.3 p -79.57 -41.36 27.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.519 -0.31 . . . . 0.11 111.52 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.46 -13.02 66.07 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.416 -0.897 . . . . 0.1 113.497 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -58.6 163.55 3.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.761 -0.459 . . . . 0.4 109.761 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 47' ' ' LEU . 67.9 t -82.41 132.68 30.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.487 -0.485 . . . . 0.17 110.47 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 46' ' ' VAL . 3.3 mm? -133.79 142.68 47.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.13 110.875 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.1 p -82.45 -173.01 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.907 -0.588 . . . . 0.15 110.302 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.38 -57.95 16.96 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.604 -0.808 . . . . 0.16 112.925 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -52.66 -51.36 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.915 0.388 . . . . 1.15 111.606 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.43 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.6 m -66.98 -24.3 66.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.999 -0.546 . . . . 0.14 111.996 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -115.06 45.48 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.541 . . . . 0.15 110.645 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -97.64 -25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 2.44 110.815 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -73.92 169.79 16.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.324 0.583 . . . . 0.62 112.299 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -145.76 138.92 26.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.225 -0.898 . . . . 2.76 109.805 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.17 137.57 6.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.09 111.324 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.12 148.99 46.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.19 110.257 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.558 HG23 HD21 ' A' ' 77' ' ' LEU . 3.2 mt -126.59 76.57 74.11 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.595 -0.275 . . . . 0.2 111.234 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.78 -26.53 79.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.403 2.069 . . . . 0.36 112.543 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.6 mtp -71.87 -30.85 65.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.425 -0.352 . . . . 1.96 110.759 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.421 ' HG2' HG22 ' A' ' 58' ' ' ILE . 15.5 mmm180 -101.3 21.69 13.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.346 -0.388 . . . . 1.43 111.671 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.33 68.65 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.67 -0.776 . . . . 0.52 113.268 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.497 ' CD1' HD12 ' A' ' 58' ' ' ILE . 33.1 mt -122.65 88.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.794 0.33 . . . . 0.17 110.671 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.56 -14.41 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.202 0.445 . . . . 0.27 112.202 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -101.49 147.96 34.54 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 121.22 -0.192 . . . . 2.02 110.908 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.32 120.59 8.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.13 1.887 . . . . 0.46 112.085 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' HG21 ' A' ' 63' ' ' ILE . 69.9 mm-40 -125.78 164.07 21.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.047 0.451 . . . . 1.46 111.048 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.08 136.58 41.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.816 -0.629 . . . . 2.42 112.531 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.549 HG11 ' ND2' ' A' ' 42' ' ' ASN . 33.4 m -144.31 -172.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.105 -0.952 . . . . 0.19 109.534 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 3.9 p -100.02 -157.18 0.59 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.186 -0.302 . . . . 0.16 110.186 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.43 -50.36 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.852 -0.339 . . . . 1.63 111.025 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.52 -64.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.12 110.959 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 62.5 m -50.55 -39.67 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.16 111.813 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -59.76 -34.16 72.62 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.108 -0.701 . . . . 0.27 109.108 177.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.69 -44.03 19.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.229 -0.896 . . . . 0.26 109.473 178.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 73' ' ' CYS . . . -51.93 -50.76 60.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.634 -0.712 . . . . 0.19 110.727 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 58' ' ' ILE . 60.7 mt . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 108.806 -0.813 . . . . 0.26 108.806 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 148.41 85.61 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.771 2.314 . . . . 0.0 112.282 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 mt -60.61 -32.0 71.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.15 -156.14 24.95 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 m -59.39 -33.08 70.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 111.347 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.9 mtt -107.64 144.57 34.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 111.238 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.96 134.06 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.408 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.21 12.88 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.622 0.249 . . . . 0.0 111.529 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -73.07 -2.96 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.26 0.552 . . . . 0.0 109.583 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -66.18 142.07 57.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.057 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.1 p -118.63 152.01 36.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -125.15 144.89 50.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.059 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.96 82.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 44' ' ' GLY . 77.8 t80 -76.78 121.76 23.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.839 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.468 ' O ' ' CD1' ' A' ' 15' ' ' TRP . 47.2 p90 -92.24 118.15 30.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.475 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 62.9 tt0 -81.95 127.11 32.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.306 0.574 . . . . 0.0 109.927 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.9 151.94 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.893 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' OD1' ' HD2' ' A' ' 37' ' ' ARG . 21.7 m-20 -54.44 -45.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.053 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.62 -41.59 88.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.182 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.81 -32.55 72.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -114.11 74.37 2.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.733 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.54 -11.76 18.69 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.138 2.559 . . . . 0.0 112.846 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.7 155.38 50.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -60.4 122.79 15.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.115 0.483 . . . . 0.0 111.827 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.5 m120 -61.68 -26.68 68.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.928 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 -56.39 2.16 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.221 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.3 p -104.63 -3.6 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.73 69.96 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.725 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -71.74 143.51 49.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.416 0.608 . . . . 0.0 110.251 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.39 137.5 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.796 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 93.9 m-85 -83.29 134.43 34.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.162 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.414 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 28.8 p -126.38 172.58 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.268 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.2 p -50.54 -40.84 52.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.003 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.9 p -75.85 -26.34 57.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.254 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 32' ' ' THR . 54.4 t -93.56 113.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.376 0.608 . . . . 0.0 111.392 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -73.63 143.73 46.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.106 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.518 ' HD2' ' OD1' ' A' ' 18' ' ' ASP . 23.7 ttm105 -86.29 142.14 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.629 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -144.01 169.19 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 111.607 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -128.83 146.82 50.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.537 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.3 t -90.44 137.99 31.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -72.76 -6.88 47.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.936 ' OD1' HD13 ' A' ' 58' ' ' ILE . 73.4 m-20 -100.69 -70.27 0.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.502 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.4 p -76.44 -23.78 53.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 72.91 21.98 79.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.39 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.502 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 21.2 m-85 -98.07 160.81 14.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 110.236 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.827 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.4 t -75.96 128.97 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.166 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.891 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.2 mm? -133.43 138.58 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.45 176.32 8.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.756 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.08 -52.8 41.1 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.225 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 95.0 m-20 -55.83 -35.84 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.891 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.32 -1.7 58.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.462 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -131.99 28.65 4.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 73.3 mtm180 -84.71 -16.39 41.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.227 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -81.31 164.7 22.0 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.5 136.18 32.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.527 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.96 154.34 25.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.793 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.9 154.0 20.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.936 HD13 ' OD1' ' A' ' 42' ' ' ASN . 2.3 mt -130.3 79.77 71.91 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 110.939 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.06 -8.96 19.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.179 2.586 . . . . 0.0 114.19 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.08 -37.83 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 109.193 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' A' ' 58' ' ' ILE . 14.2 mmm180 -83.03 1.04 42.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.454 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.13 6.94 61.3 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.924 HD12 HD12 ' A' ' 58' ' ' ILE . 75.6 mt -96.2 102.35 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.214 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -88.08 -18.54 28.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 56.0 mm-40 -103.06 142.53 24.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -56.43 124.0 15.21 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.674 1.583 . . . . 0.0 111.819 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.7 mm-40 -124.74 166.81 15.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -70.56 136.71 49.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.618 0.723 . . . . 0.0 111.639 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.607 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.3 m -145.24 -179.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.976 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.437 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.56 -168.35 1.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -76.26 -43.71 40.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.22 72.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 52.8 m -63.84 -40.57 96.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.743 0.306 . . . . 0.0 110.41 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.518 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 76.6 t80 -56.79 -39.6 74.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 18.1 mt -72.9 -52.49 14.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.536 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.02 -48.27 52.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.385 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.7 mt -65.27 -40.8 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 62.9 ttt180 -57.04 -19.7 20.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.627 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.7 p -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.996 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m -62.69 154.73 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -91.37 136.36 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 72.5 mtm -81.57 129.87 34.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.975 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 145.18 56.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.507 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.27 149.78 21.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.869 2.379 . . . . 0.0 112.608 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.1 mt -88.34 138.35 31.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.79 -33.17 42.11 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.538 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.1 m -119.98 147.39 44.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.5 mtt -123.68 154.01 40.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.002 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.35 45.21 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.392 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.68 -11.09 52.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.617 0.246 . . . . 0.0 111.421 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -61.93 -6.91 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -67.7 148.86 50.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.864 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.2 p -103.66 149.99 24.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -96.24 146.93 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.922 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.97 57.67 4.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.906 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 44' ' ' GLY . 81.7 t80 -76.38 122.74 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -91.91 118.67 30.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.419 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 62.8 tt0 -84.24 131.35 34.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.124 0.488 . . . . 0.0 109.685 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.27 154.18 28.47 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' A' ' 37' ' ' ARG . 6.2 m-20 -55.3 -43.55 74.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.984 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.7 -42.49 86.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.373 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -70.25 -30.39 67.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 0.0 110.729 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.37 71.11 0.83 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.47 -15.4 24.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.9 2.4 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.33 156.88 48.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 29' ' ' CYS . 8.1 t -63.99 124.98 22.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -60.28 -26.56 66.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.969 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.45 -55.92 2.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.444 -0.884 . . . . 0.0 114.341 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -105.23 -0.29 26.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.83 9.07 58.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.562 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 24' ' ' CYS . 6.0 p -69.52 143.52 53.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.226 0.513 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.99 138.98 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 92.2 m-85 -84.18 136.04 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.375 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -127.74 171.61 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.105 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -47.47 -41.1 19.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.808 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.1 p -73.54 -24.84 60.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.641 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -97.89 113.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.738 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.72 150.25 37.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.533 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' HD3' ' OD2' ' A' ' 18' ' ' ASP . 14.7 ttp180 -80.18 141.54 35.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 0.0 110.598 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -139.96 160.95 38.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.665 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -128.49 146.05 50.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.523 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.9 t -91.33 136.2 33.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tpt180 -72.33 -4.63 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.91 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.1 m-20 -101.65 -71.54 0.71 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -76.51 -24.04 53.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.23 21.77 78.55 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.79 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.1 m-85 -99.01 160.91 13.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.868 ' C ' HD22 ' A' ' 47' ' ' LEU . 77.5 t -78.36 128.75 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.868 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.4 mm? -131.45 140.83 49.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.354 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.85 178.37 8.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.608 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -55.59 -52.15 50.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.43 -1.367 . . . . 0.0 112.047 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -54.67 -34.88 62.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.794 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -91.81 -2.23 57.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -132.3 28.93 4.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 12.9 mmt85 -84.68 -17.88 37.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.324 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -79.53 165.62 22.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.226 0.536 . . . . 0.0 111.475 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -141.37 134.71 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.01 153.41 26.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.658 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -86.48 158.0 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.91 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.4 mt -134.15 78.37 58.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.919 0.39 . . . . 0.0 110.555 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.82 -12.14 32.74 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.265 2.644 . . . . 0.0 114.066 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.9 mmm -85.31 -38.29 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.554 ' HG2' HG22 ' A' ' 58' ' ' ILE . 13.9 mmm180 -83.86 1.76 41.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.673 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 9.22 60.39 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.686 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.792 HD12 HD12 ' A' ' 58' ' ' ILE . 61.8 mt -100.58 99.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.849 0.356 . . . . 0.0 110.356 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.4 p -85.04 -16.99 38.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.785 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.6 mt-10 -102.81 145.06 29.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 14.7 Cg_endo -58.67 124.11 15.05 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.416 1.411 . . . . 0.0 111.657 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' CG ' HG21 ' A' ' 63' ' ' ILE . 76.4 mm-40 -124.85 167.78 14.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.747 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -72.06 137.2 46.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.652 0.739 . . . . 0.0 111.916 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.646 HG11 ' ND2' ' A' ' 42' ' ' ASN . 35.1 m -146.83 -178.06 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.126 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.475 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -96.4 -162.88 0.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -82.62 -42.67 17.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.67 75.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 111.691 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 37.0 m -63.19 -40.38 97.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.533 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 72.4 t80 -57.32 -38.97 74.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.66 -51.67 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.506 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.7 78.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.165 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.437 HD11 ' ND2' ' A' ' 42' ' ' ASN . 88.6 mt -67.01 -41.04 87.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.503 0.668 . . . . 0.0 109.346 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -17.93 34.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.811 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m -61.31 -38.77 88.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.925 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.9 m -68.96 155.62 40.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -99.4 129.0 45.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.358 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 65.9 mtm -83.46 134.51 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.5 148.75 40.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.433 -179.824 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.22 145.23 55.78 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.725 2.283 . . . . 0.0 112.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 mt -81.96 144.2 31.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.66 34.15 36.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.265 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.6 m -115.23 149.61 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 72.1 mtm -57.81 -33.74 68.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 135.21 45.84 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.437 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -88.96 7.37 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -72.53 -3.05 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.54 145.31 54.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.098 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.2 p -114.37 153.24 30.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.455 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 59.2 mttp -56.98 -38.81 73.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.81 169.66 28.59 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.384 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . 67.3 t80 -80.33 122.94 27.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.463 ' CZ3' ' HG2' ' A' ' 17' ' ' GLU . 45.9 p-90 -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -84.8 128.37 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.187 0.518 . . . . 0.0 109.846 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HG2' ' CZ3' ' A' ' 15' ' ' TRP . 96.4 mt-10 -59.72 152.91 21.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.231 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -56.68 -44.03 81.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.024 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.63 -42.33 91.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.053 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -72.11 -30.2 64.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.236 0.541 . . . . 0.0 110.289 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.39 68.18 1.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.699 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.07 -12.29 27.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.07 2.514 . . . . 0.0 112.68 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.13 156.39 48.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.3 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 18.4 t -64.54 125.29 24.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.174 0.511 . . . . 0.0 111.437 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -59.5 -26.44 65.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.031 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.72 -55.46 2.15 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.165 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.8 p -102.92 -4.7 24.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.37 10.98 71.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.41 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 12.8 p -71.65 142.67 49.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.317 0.559 . . . . 0.0 110.278 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.78 137.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.534 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.86 134.53 34.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.276 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -127.26 169.61 13.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.954 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.6 m -46.84 -42.16 16.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.96 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.1 m -68.54 -36.09 78.34 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.316 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -90.65 113.67 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.338 0.59 . . . . 0.0 111.463 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.33 148.72 39.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.008 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.1 ttp85 -78.97 139.54 38.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.0 m-70 -141.94 162.74 34.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 46' ' ' VAL . 89.5 m-70 -129.54 146.57 51.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.642 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 t -91.6 137.91 31.99 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -73.42 -5.47 40.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.943 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.0 m-20 -100.9 -72.06 0.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.613 0.244 . . . . 0.0 111.624 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.4 p -75.81 -24.89 55.93 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.24 21.63 78.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.746 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 26.1 m-85 -98.85 161.85 13.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.935 0.398 . . . . 0.0 110.459 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.85 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.2 t -78.44 128.93 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.076 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.85 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.2 mm? -131.41 139.07 49.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.44 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 p -75.64 177.09 7.06 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.73 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.48 -53.07 40.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.241 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 86.3 m-20 -55.53 -35.65 65.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.713 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.67 -2.03 58.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.317 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.1 p -132.55 27.62 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt180 -82.85 -17.85 42.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.139 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -79.47 165.06 23.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.281 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -140.82 136.0 31.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.424 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.39 154.48 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -92.25 150.8 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.943 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.0 mt -127.3 81.31 70.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 111.058 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.63 -9.98 22.77 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.206 2.604 . . . . 0.0 113.828 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -89.75 -36.89 14.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 109.263 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.525 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 5.3 mmm180 -86.79 15.57 5.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.677 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.02 10.34 85.1 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.854 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.928 HD12 HD12 ' A' ' 58' ' ' ILE . 74.8 mt -101.44 102.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -88.3 -19.11 27.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.588 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mt-10 -103.17 146.61 32.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.4 Cg_endo -59.14 123.47 13.52 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.62 1.546 . . . . 0.0 111.71 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.3 mm-40 -124.53 166.73 15.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -71.47 137.29 48.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.624 0.726 . . . . 0.0 112.0 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.621 HG11 ' ND2' ' A' ' 42' ' ' ASN . 30.0 m -145.5 -178.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.872 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.508 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -96.47 -166.45 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 55.6 t0 -78.89 -45.16 21.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.14 80.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.4 m -63.82 -41.25 97.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.388 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.522 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 75.7 t80 -56.38 -40.07 73.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD23 ' HD3' ' A' ' 78' ' ' ARG . 15.6 mt -71.7 -52.3 18.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.11 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.15 -48.67 53.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.496 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD21 HG23 ' A' ' 58' ' ' ILE . 58.9 mt -65.88 -41.92 90.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 72.2 ttt-85 -56.06 -21.87 24.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.1 m -59.21 -36.4 75.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 110.778 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.6 m -59.1 -34.27 71.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -79.64 139.97 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.3 mtp -89.37 133.63 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.68 -49.86 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.963 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.458 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.89 145.84 71.08 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.745 2.296 . . . . 0.0 112.265 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 mt -83.9 141.63 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.27 -33.87 62.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.246 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -60.91 -27.98 68.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.951 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.4 mmm -95.28 138.52 32.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.18 2.91 68.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.598 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 83.2 tt0 -87.85 12.71 12.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.615 0.245 . . . . 0.0 111.455 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -59.0 -17.96 29.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -61.01 144.3 53.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.049 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 76.6 p -144.78 161.43 39.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' GLY . 27.8 mttm -80.53 166.07 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.706 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' LYS . . . -29.97 108.75 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.113 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -80.63 121.64 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 111.072 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -89.87 119.9 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.574 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.863 ' OE1' ' HB2' ' A' ' 21' ' ' ALA . 50.4 tt0 -84.19 128.86 34.83 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.295 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -60.44 153.04 24.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.168 -0.923 . . . . 0.0 113.245 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . 41.2 t0 -54.94 -47.28 74.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.084 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -64.74 -41.51 95.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.168 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.53 -30.16 66.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.262 0.553 . . . . 0.0 110.225 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . . . -111.47 70.58 0.82 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.842 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.61 -14.94 30.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.942 2.428 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.93 156.95 47.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.459 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -63.11 124.79 22.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.144 0.497 . . . . 0.0 111.439 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 66.1 m-80 -60.15 -26.21 66.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.289 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.82 2.25 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.343 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.4 p -104.42 -3.05 24.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.86 10.48 67.98 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.527 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.1 p -71.9 143.99 49.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.269 0.534 . . . . 0.0 110.168 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.93 138.77 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.469 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.559 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.7 m-85 -84.46 135.56 34.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -127.98 168.0 15.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.2 m -46.12 -43.78 15.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.312 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.13 -36.96 84.52 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.0 t -88.6 113.89 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -73.78 146.07 44.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.362 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 18' ' ' ASP . 21.8 ttp-105 -80.33 140.11 36.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.441 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -142.11 164.64 29.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -130.79 147.44 52.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.568 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.7 t -90.23 137.0 32.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' A' ' 67' ' ' GLU . 53.2 mtp85 -71.43 -6.36 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.875 ' ND2' HD13 ' A' ' 58' ' ' ILE . 15.6 m-80 -102.88 -70.0 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.4 p -74.44 -24.81 59.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.783 0.325 . . . . 0.0 111.579 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.33 79.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.686 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 27.8 m-85 -97.0 164.37 12.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 110.682 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.86 ' C ' HD22 ' A' ' 47' ' ' LEU . 62.2 t -80.83 128.4 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.059 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.5 mm? -132.12 137.62 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.5 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.1 p -77.32 173.33 12.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.771 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.11 -54.33 19.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.23 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 75.9 m-20 -54.92 -35.85 64.61 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.788 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.37 -1.82 58.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.22 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.1 p -131.16 25.22 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.771 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 57.9 mtm180 -80.36 -18.65 48.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.805 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -79.42 164.79 23.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.006 0.431 . . . . 0.0 111.157 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -143.1 138.15 29.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -161.5 155.56 22.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.912 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.476 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -82.45 159.48 22.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.875 HD13 ' ND2' ' A' ' 42' ' ' ASN . 1.3 mt -134.49 75.41 63.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -12.93 35.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.42 2.747 . . . . 0.0 114.34 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.8 mtt -87.05 -36.84 17.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.682 ' HG2' HG22 ' A' ' 58' ' ' ILE . 29.0 mmm180 -83.74 5.73 23.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.73 10.66 64.8 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.501 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.784 HD12 HD12 ' A' ' 58' ' ' ILE . 70.2 mt -102.21 102.54 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 0.0 110.363 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.9 p -87.83 -16.63 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.601 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 mt-10 -104.56 142.79 25.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 11.4 Cg_endo -55.13 122.57 11.94 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.879 1.719 . . . . 0.0 112.034 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.9 mm-40 -125.15 167.31 14.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.432 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -72.46 140.11 48.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.567 0.699 . . . . 0.0 111.898 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 m -147.3 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.085 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.512 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.9 p -93.48 -162.36 0.93 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.71 -41.74 17.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.97 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.586 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.14 -41.61 97.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 0.0 110.202 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.583 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 87.6 t80 -55.88 -40.61 73.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.51 -49.49 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.586 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.45 79.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.855 HD11 HD21 ' A' ' 42' ' ' ASN . 77.4 mt -64.03 -38.17 90.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.024 0.44 . . . . 0.0 110.816 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 8.0 mtp-105 -64.37 -7.54 10.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.212 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.2 m -58.73 152.42 18.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.8 m -120.85 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.623 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -93.08 135.35 34.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 63.9 mtt -83.24 131.31 35.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.682 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.93 50.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.061 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.6 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.584 -0.206 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.2 147.31 93.97 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.079 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.5 mt -81.73 136.93 35.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.84 124.02 5.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.516 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.5 m -122.67 145.63 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 86.5 mtp -133.62 163.86 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.4 40.02 20.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.558 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -82.16 7.48 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.66 0.267 . . . . 0.0 111.262 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -58.73 -17.01 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -53.46 143.93 18.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.8 m -60.91 156.75 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 44.2 mtmt -56.33 -32.04 64.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.41 94.47 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.777 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 44' ' ' GLY . 67.5 t80 -78.8 123.13 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -91.99 117.8 30.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.942 ' OE1' ' HB2' ' A' ' 21' ' ' ALA . 47.7 tt0 -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.177 0.513 . . . . 0.0 109.866 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.29 154.47 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.483 ' CB ' ' NE ' ' A' ' 37' ' ' ARG . 39.0 p-10 -57.37 -43.94 83.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.541 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 97.3 mt-10 -65.73 -41.73 91.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.826 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -67.65 -32.68 73.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.125 0.488 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.942 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . . . -111.41 72.12 0.91 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.787 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.07 -15.23 32.24 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.1 2.533 . . . . 0.0 112.651 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.68 46.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.401 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 10.2 t -62.3 122.48 15.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.761 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.5 m120 -61.12 -25.9 67.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.32 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.18 -55.76 2.3 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.51 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p -104.24 -2.65 25.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.13 7.97 64.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.253 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -69.6 143.0 53.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.099 0.449 . . . . 0.0 110.162 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.71 137.4 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.714 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 92.5 m-85 -82.08 133.12 35.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.386 0.612 . . . . 0.0 109.886 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.416 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 17.2 p -124.7 173.03 8.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.174 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.1 p -50.4 -38.94 45.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.98 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 p -79.18 -22.91 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.651 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 32' ' ' THR . 41.8 t -96.03 113.12 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.629 . . . . 0.0 111.488 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -73.32 143.64 46.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.204 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NE ' ' CB ' ' A' ' 18' ' ' ASP . 56.9 ttm-85 -84.71 141.14 30.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.428 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.3 m-70 -143.48 167.93 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.444 ' NE2' HG22 ' A' ' 46' ' ' VAL . 78.9 m80 -130.71 147.97 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.596 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.8 t -89.57 137.27 32.47 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 67' ' ' GLU . 92.6 mtt-85 -72.74 -6.34 43.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.932 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.2 m-20 -100.71 -70.26 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.571 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.99 -24.57 55.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.68 21.92 78.88 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.722 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.8 162.4 13.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.801 0.334 . . . . 0.0 110.512 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.849 ' C ' HD22 ' A' ' 47' ' ' LEU . 87.0 t -78.35 128.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.226 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.849 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.0 mm? -132.64 139.52 47.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -77.54 175.04 10.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.703 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.76 -52.87 35.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.673 -1.251 . . . . 0.0 112.358 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 93.2 m-20 -55.67 -35.84 66.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.802 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.16 -2.34 58.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.24 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -131.78 27.3 4.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 74.9 mtt180 -82.19 -20.13 38.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.369 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -76.99 163.06 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 111.212 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -139.59 136.55 34.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.222 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -160.15 153.97 22.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -87.3 153.14 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 63' ' ' ILE . 3.1 mt -129.25 77.6 77.33 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 110.808 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.8 -8.49 15.78 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 123.138 2.559 . . . . 0.0 113.894 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mmm -89.7 -37.87 14.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.0 109.36 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 2.8 mmm180 -84.31 2.71 38.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.441 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.25 7.68 61.98 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.535 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 58' ' ' ILE . 72.7 mt -97.86 102.06 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.193 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.3 p -87.59 -17.43 31.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 mt-10 -103.11 142.01 23.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 32.2 Cg_exo -56.16 124.38 16.12 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.725 1.616 . . . . 0.0 112.061 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.4 mm-40 -126.41 166.85 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -69.25 136.44 51.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.473 0.654 . . . . 0.0 111.707 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.582 HG11 ' ND2' ' A' ' 42' ' ' ASN . 28.4 m -148.92 161.1 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.844 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.48 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -75.44 -168.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 55.3 p30 -81.15 -40.3 24.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.93 -44.41 73.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 111.37 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 64.3 m -63.91 -40.92 97.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.656 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 38.0 t80 -57.22 -41.09 78.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.9 mt -69.2 -49.05 60.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.748 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.91 83.15 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.439 HD11 ' ND2' ' A' ' 42' ' ' ASN . 93.4 mt -65.72 -36.67 84.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.55 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.656 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 68.4 mtp180 -67.17 -8.47 31.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.966 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.0 m -61.07 -32.01 71.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.259 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 t -43.84 134.44 4.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -90.11 133.32 34.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.1 mtm -78.26 134.18 37.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.041 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.45 146.75 52.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.465 -1.186 . . . . 0.0 112.497 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.91 145.18 89.9 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.573 2.182 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 3' ' ' LEU . 6.0 mp -78.93 -4.97 52.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.38 -178.98 52.42 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.959 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.0 p -66.99 -20.38 65.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.693 0.282 . . . . 0.0 111.381 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 62.7 mtt -77.82 137.17 38.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.288 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -13.8 62.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.409 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.0 mp0 -98.05 15.86 22.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.642 0.258 . . . . 0.0 111.153 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -71.71 -4.82 29.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -62.51 140.55 58.62 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.467 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -135.87 160.1 39.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.095 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -102.27 145.84 28.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.69 83.14 0.13 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -77.94 121.1 23.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 111.298 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -94.97 120.06 34.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.417 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -85.19 128.0 34.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.352 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -55.38 154.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.865 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -56.68 -42.67 79.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.002 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -67.15 -42.6 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.044 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -66.92 -32.25 73.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.96 74.44 0.97 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.991 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.36 -15.69 25.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.913 2.409 . . . . 0.0 112.215 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.93 155.9 49.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.919 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.6 t -61.73 124.26 20.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 111.904 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -61.41 -27.69 68.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.134 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 -56.05 2.5 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.619 -0.801 . . . . 0.0 114.716 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 p -105.56 -0.69 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.15 63.21 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.718 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 14.0 p -71.44 144.91 49.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.409 0.605 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.96 140.33 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 81.2 m-85 -84.81 135.63 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.344 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.0 p -126.89 167.06 16.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -45.36 -41.67 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -70.5 -34.81 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.32 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.64 114.18 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.503 0.668 . . . . 0.0 111.554 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -78.72 150.19 32.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.669 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -90.34 142.53 27.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.137 0.494 . . . . 0.0 110.454 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.9 m-70 -139.7 168.14 20.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.129 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.72 143.93 49.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.757 0.313 . . . . 0.0 111.309 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.4 t -90.72 137.87 32.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -72.97 -5.22 37.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.946 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.7 -72.21 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.785 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.0 p -77.09 -24.44 51.8 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.77 77.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.86 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.94 164.02 12.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.814 ' C ' HD22 ' A' ' 47' ' ' LEU . 60.9 t -80.8 128.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.814 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -130.7 137.64 49.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.348 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.27 174.29 8.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.756 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.08 -53.01 32.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.421 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 70.5 m-20 -56.26 -36.09 68.17 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.731 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -86.91 -3.33 59.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.135 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.2 p -131.66 26.03 4.71 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 70.8 mtp85 -82.21 -16.97 47.76 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.972 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -80.38 166.14 21.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -142.53 135.2 28.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.245 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.28 153.23 25.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.697 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.44 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.06 154.61 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.946 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.7 mt -131.35 81.11 66.24 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.997 0.427 . . . . 0.0 110.733 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.16 -8.12 19.29 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.981 2.454 . . . . 0.0 113.907 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.4 mtp -89.37 -37.12 15.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.531 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 13.7 mmm180 -84.83 4.0 35.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.19 4.42 66.64 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.533 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.863 HD12 HD12 ' A' ' 58' ' ' ILE . 74.2 mt -94.65 97.82 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.356 . . . . 0.0 110.157 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -84.66 -18.51 35.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 63' ' ' ILE . 2.5 mt-10 -103.84 146.4 32.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.9 Cg_endo -57.89 123.84 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.029 1.819 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 80.5 mm-40 -126.42 167.52 15.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -71.76 137.49 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.732 0.777 . . . . 0.0 112.202 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.684 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.2 m -146.66 179.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.051 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.498 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -92.71 -162.25 0.91 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -83.51 -44.04 15.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.92 80.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.806 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.7 m -64.03 -40.99 97.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 77.5 t80 -55.8 -40.78 73.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.512 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 13.3 mt -71.35 -53.99 12.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.34 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.9 -48.61 42.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.374 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 58' ' ' ILE . 72.3 mt -65.28 -42.33 93.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 52.8 ttt-85 -54.01 -20.84 6.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.393 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.9 p -59.22 -31.69 69.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.688 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.4 t -62.32 -34.39 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -94.35 121.21 35.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.255 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 70.9 mtm -87.57 133.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.683 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.39 57.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.714 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.853 -179.662 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.599 -0.201 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.53 149.63 85.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.824 2.349 . . . . 0.0 112.001 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.7 mt -81.69 140.29 34.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.94 -177.09 51.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.1 p -70.19 157.9 36.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.63 -37.66 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.34 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.35 175.23 40.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.543 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 80.5 tt0 -91.23 16.6 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 110.885 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -71.43 -2.15 15.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.203 0.525 . . . . 0.0 109.62 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' O ' ' CB ' ' A' ' 11' ' ' SER . 40.7 tt0 -67.37 109.52 3.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.136 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 9.9 t 159.46 39.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.535 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HG3' ' NH2' ' A' ' 61' ' ' ARG . 15.6 tttp -95.06 122.06 37.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.28 50.65 49.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.575 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -75.81 120.87 21.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.757 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -86.39 118.32 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -84.76 126.01 33.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.263 0.554 . . . . 0.0 109.655 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -58.92 153.68 16.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.056 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 35.1 p-10 -58.0 -43.28 86.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.245 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 98.9 mt-10 -66.01 -41.5 90.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.865 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -71.78 -30.09 65.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.263 0.554 . . . . 0.0 110.258 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.49 72.62 5.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.595 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.87 -10.09 21.27 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.137 2.558 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -135.99 158.01 45.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.366 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 6.8 t -63.18 125.06 22.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 31.8 m120 -63.51 -25.49 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.364 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.28 -56.66 2.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.684 -0.77 . . . . 0.0 114.679 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 p -105.09 -1.85 25.07 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.05 65.77 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.423 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.4 p -67.09 143.89 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.257 0.528 . . . . 0.0 109.639 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.7 OUTLIER -84.25 143.44 11.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.649 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 94.5 m-85 -84.28 134.82 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.7 p -126.45 168.75 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.061 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.04 -44.7 31.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.356 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 m -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.562 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -87.96 113.04 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.364 0.602 . . . . 0.0 111.54 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -73.85 149.28 41.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.126 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 20.2 ttp180 -81.74 140.9 34.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.2 m-70 -142.23 165.89 26.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.144 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -131.35 147.63 52.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 t -90.77 136.7 32.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.449 ' NE ' ' OE1' ' A' ' 67' ' ' GLU . 68.6 mtp85 -72.45 -5.45 36.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.875 HD22 ' CG2' ' A' ' 58' ' ' ILE . 4.6 m120 -101.67 -70.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.9 p -75.0 -24.84 58.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.4 77.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.637 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.501 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.92 163.19 12.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.877 ' C ' HD22 ' A' ' 47' ' ' LEU . 88.6 t -79.72 128.86 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.877 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.3 mm? -132.98 140.64 47.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.89 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 p -82.55 175.13 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.643 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -52.13 -52.65 34.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.127 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -53.85 -36.3 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.866 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -92.32 -1.26 57.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.703 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -132.47 25.91 4.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 110.089 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 19.6 mmt180 -79.23 -22.99 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -76.33 165.06 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.446 0.641 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -139.7 134.05 31.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.017 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.38 155.16 26.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.54 159.44 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.875 ' CG2' HD22 ' A' ' 42' ' ' ASN . 1.1 mt -133.12 74.96 72.33 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.092 0.473 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.95 -14.15 39.44 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.423 2.749 . . . . 0.0 114.491 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.3 mtm -86.54 -37.35 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.674 ' HG2' HG22 ' A' ' 58' ' ' ILE . 18.3 mmm180 -83.01 3.68 29.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.857 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.07 61.84 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.408 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.699 HD12 HD12 ' A' ' 58' ' ' ILE . 63.7 mt -101.24 101.25 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.91 0.386 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -87.73 -16.01 35.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.434 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 63' ' ' ILE . 3.7 mp0 -103.19 145.2 30.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.0 Cg_endo -58.57 121.87 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.615 1.544 . . . . 0.0 112.005 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.637 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.7 mt-10 -125.49 168.74 13.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.702 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.489 ' NH1' ' HB3' ' A' ' 68' ' ' ARG . 5.1 ptp180 -72.37 137.28 46.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.741 0.782 . . . . 0.0 112.333 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.41 -177.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.897 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.53 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -97.29 -162.14 0.93 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -82.81 -43.91 16.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.09 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 111.53 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -64.15 -40.53 96.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.289 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.616 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 79.8 t80 -57.25 -41.29 79.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 8.5 mt -70.64 -50.94 31.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.872 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.21 -48.33 54.34 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.562 HD11 ' OD1' ' A' ' 42' ' ' ASN . 44.8 mt -64.37 -42.3 96.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 61.0 ttt-85 -55.68 -19.42 10.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.593 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.8 p -59.6 -29.13 67.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -121.06 140.24 52.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -91.31 141.31 28.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.012 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.3 mtp -82.62 135.29 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.47 143.73 57.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.502 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.96 147.28 64.05 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.9 -35.16 74.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.794 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.28 176.12 27.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.438 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.8 p -61.66 -27.58 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 94.7 mmm -59.58 -36.03 75.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.038 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.66 31.07 55.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.201 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -82.26 7.59 13.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.555 0.217 . . . . 0.0 111.55 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -58.79 -18.15 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -57.54 142.26 45.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.001 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.2 p -120.89 151.57 39.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -103.72 134.98 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.29 152.61 40.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' GLY . 81.6 t80 -78.04 121.94 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -93.32 119.2 32.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -84.15 131.4 34.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.312 0.577 . . . . 0.0 110.347 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.7 153.73 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.044 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.463 ' HB3' ' NE ' ' A' ' 37' ' ' ARG . 35.6 p-10 -57.59 -44.11 85.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.349 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 97.2 mt-10 -66.36 -42.06 88.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.122 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.96 -34.03 76.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.92 74.53 1.76 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.801 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.3 -12.3 25.24 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.056 2.504 . . . . 0.0 112.549 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.57 48.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.166 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 15.5 t -62.57 123.44 18.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.0 111.683 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.9 m120 -60.36 -26.79 66.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 -55.88 2.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.429 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.98 -3.15 25.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.41 8.96 67.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.437 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 12.4 p -70.01 142.69 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.208 0.504 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.95 137.9 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.954 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 84.6 m-85 -83.73 134.64 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.5 p -127.48 171.2 11.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -46.9 -39.63 12.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 p -75.74 -25.45 56.55 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.828 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.9 t -96.74 112.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.36 0.6 . . . . 0.0 111.271 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -75.45 147.74 39.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.644 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.6 ttp85 -81.93 140.34 34.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.768 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -141.96 163.9 31.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.232 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -129.26 146.57 51.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.5 t -91.19 138.03 31.91 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -73.03 -5.43 38.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.94 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.2 m-20 -101.46 -71.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.1 p -76.94 -24.41 52.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.12 22.09 78.24 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.547 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.8 m-85 -98.17 161.2 13.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.896 0.379 . . . . 0.0 110.454 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.881 ' C ' HD22 ' A' ' 47' ' ' LEU . 95.5 t -77.62 128.86 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.881 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.7 mm? -132.2 139.15 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -78.88 175.94 10.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.754 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.51 -53.95 29.7 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.764 -1.207 . . . . 0.0 112.333 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -54.83 -35.53 64.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.761 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -90.33 -1.94 57.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.441 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 p -131.3 26.25 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.754 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 94.6 mtt-85 -80.96 -19.39 44.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.117 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -80.58 163.41 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.19 0.519 . . . . 0.0 111.438 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 mtm105 -139.36 136.99 35.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.274 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.49 154.62 27.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.95 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.97 151.77 20.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.94 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.3 mt -128.39 79.32 74.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.026 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.89 -9.97 20.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.217 2.611 . . . . 0.0 114.044 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 71.8 mtm -88.33 -37.87 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.5 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 30.8 mmm180 -83.17 1.01 42.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.441 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.42 60.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.904 HD12 HD12 ' A' ' 58' ' ' ILE . 74.1 mt -96.64 101.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.398 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.3 p -88.25 -18.94 27.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.384 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 3.5 mm-40 -103.69 138.53 19.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.4 Cg_exo -52.99 124.3 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.692 1.595 . . . . 0.0 112.044 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.618 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.6 mt-10 -125.64 167.43 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -69.94 136.25 50.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 111.966 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.594 HG11 ' ND2' ' A' ' 42' ' ' ASN . 29.0 m -145.27 179.48 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.982 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.482 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.89 -166.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 56.3 p30 -79.36 -42.68 25.06 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -67.9 -45.95 72.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 111.7 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.2 m -63.63 -41.43 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.302 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.538 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 68.9 t80 -56.32 -40.36 74.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 78' ' ' ARG . 7.6 mt -72.55 -50.65 24.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.245 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.95 62.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.667 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 mt -65.68 -42.03 91.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.548 ' HD3' HD23 ' A' ' 75' ' ' LEU . 71.2 ttt180 -58.4 -20.42 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.771 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.2 m -51.5 -36.54 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.134 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.6 t -135.06 121.5 20.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.913 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -62.69 -37.44 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.822 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.9 mtm -90.64 134.69 34.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.069 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.32 145.92 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.592 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.78 -4.14 14.93 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.652 2.234 . . . . 0.0 112.177 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.32 -33.49 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.48 12.57 61.01 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.645 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -115.46 145.66 42.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 51.8 ttm -80.47 125.7 30.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.26 -170.87 45.18 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.738 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -81.58 7.29 12.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.519 0.199 . . . . 0.0 111.533 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -59.77 -13.78 11.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -46.25 -34.29 4.31 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.159 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -109.17 149.35 29.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -127.13 151.43 48.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.45 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.74 -4.76 57.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.996 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -80.09 122.27 26.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 48.0 p90 -91.91 119.47 31.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.886 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.599 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 63.7 tt0 -82.42 127.81 33.64 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.31 0.576 . . . . 0.0 109.91 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.47 153.46 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.818 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' OD1' ' HD2' ' A' ' 37' ' ' ARG . 6.3 m-20 -54.42 -46.49 73.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.295 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.9 -41.46 87.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.46 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -66.44 -33.14 75.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.159 0.504 . . . . 0.0 110.693 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.599 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -112.89 78.07 2.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.713 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.67 -13.28 18.11 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.101 2.534 . . . . 0.0 112.644 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.64 155.82 49.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.438 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.7 t -59.62 123.93 18.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 111.552 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 29.5 m120 -60.83 -28.08 68.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.086 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.15 -54.77 2.36 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.329 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 p -103.68 -4.03 24.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.08 7.75 63.37 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.628 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p -69.88 144.16 52.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.264 0.532 . . . . 0.0 110.301 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.78 137.66 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.978 0.418 . . . . 0.0 112.066 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.652 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.41 134.59 34.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.213 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -128.04 170.78 12.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -49.3 -43.85 43.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.35 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.5 m -66.53 -35.82 81.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.65 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.6 t -89.59 112.66 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.288 0.566 . . . . 0.0 111.364 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -73.08 145.76 46.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.846 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' HD2' ' OD1' ' A' ' 18' ' ' ASP . 58.5 ttm-85 -83.81 141.34 31.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.656 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 99.8 m-70 -143.66 166.25 25.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.616 ' NE2' HG22 ' A' ' 46' ' ' VAL . 76.3 m80 -130.86 148.85 52.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.02 137.52 32.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 29.2 tpt180 -71.73 -7.18 46.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.861 ' OD1' HD13 ' A' ' 58' ' ' ILE . 68.6 m-20 -100.7 -69.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.3 p -76.98 -23.08 52.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 15' ' ' TRP . . . 73.61 21.5 79.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.504 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.68 161.41 13.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.794 0.33 . . . . 0.0 110.252 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.84 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.2 t -79.21 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.24 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.878 HD12 ' HB3' ' A' ' 51' ' ' CYS . 2.4 mm? -132.41 141.01 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.743 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.2 p -79.45 177.81 8.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.88 -52.78 44.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.459 -1.353 . . . . 0.0 112.242 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -55.59 -35.58 65.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.878 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.15 -1.81 58.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.8 p -132.02 25.8 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 84.3 mtt-85 -79.88 -19.18 48.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.039 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -80.06 164.21 23.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.263 0.554 . . . . 0.0 111.771 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.76 135.91 31.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.284 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.82 155.1 27.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.46 154.45 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.861 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.6 mt -129.97 80.37 71.29 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 0.0 110.58 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.99 -12.02 33.56 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.242 2.628 . . . . 0.0 114.189 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.3 mtp -86.4 -37.3 18.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' HG2' HG22 ' A' ' 58' ' ' ILE . 31.9 mmm180 -83.69 2.78 36.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.747 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.45 63.32 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.193 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.857 HD12 HD12 ' A' ' 58' ' ' ILE . 65.9 mt -97.87 100.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.79 -17.31 33.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.693 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mm-40 -103.26 143.92 27.59 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.0 Cg_endo -57.13 123.29 13.49 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.618 1.545 . . . . 0.0 111.698 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -123.72 167.76 13.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.837 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.38 135.79 47.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.695 0.759 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.623 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -146.0 -177.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.103 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.504 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 2.0 p -98.09 -162.7 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 53.9 p30 -82.97 -41.58 18.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.62 -46.23 69.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 111.541 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 65.3 m -64.01 -40.34 96.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.225 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.6 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 73.2 t80 -57.1 -40.42 76.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.573 HD23 ' HD3' ' A' ' 78' ' ' ARG . 9.1 mt -72.67 -52.92 13.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.46 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.64 -48.22 49.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 ' ND2' ' A' ' 42' ' ' ASN . 83.3 mt -66.32 -41.64 89.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.573 ' HD3' HD23 ' A' ' 75' ' ' LEU . 53.0 ttt85 -56.08 -19.77 14.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.307 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.3 t -96.09 81.68 3.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.388 . . . . 0.0 110.605 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -123.1 147.61 46.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -56.73 -36.56 69.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 96.2 mmm -87.59 131.51 34.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.37 142.48 54.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.394 179.882 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.73 146.68 84.29 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.013 2.475 . . . . 0.0 112.315 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 mt -62.17 -35.2 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.39 10.52 62.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.7 t -66.59 155.67 37.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 111.013 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 92.6 mmm -56.63 -31.3 64.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.544 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.11 157.8 12.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.623 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 14' ' ' TYR . 94.5 mt-10 -94.88 16.29 16.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -58.17 -18.84 28.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -61.97 127.47 31.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.819 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -64.81 -33.84 76.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -60.66 -37.36 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.5 145.42 11.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.152 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 73.2 t80 -79.39 123.3 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.481 ' HB2' ' CE1' ' A' ' 39' ' ' HIS . 40.0 p90 -88.46 117.77 27.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.995 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.455 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 63.9 tt0 -84.95 127.24 34.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.8 153.63 16.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -53.91 -46.11 71.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.7 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.8 -41.11 88.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.159 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.67 -34.15 75.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.199 0.523 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -111.39 77.54 1.68 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.619 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.64 -13.97 14.43 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.159 2.573 . . . . 0.0 113.181 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.58 48.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -59.65 125.82 25.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 112.051 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 36.2 m-80 -62.66 -27.76 69.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.37 -54.42 2.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.101 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.6 p -103.46 -3.77 24.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.83 11.64 66.51 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.611 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 5.3 p -72.55 143.86 48.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.492 0.646 . . . . 0.0 110.485 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.68 137.14 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.613 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 98.1 m-85 -82.56 135.06 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.863 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 169.44 12.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.28 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -47.19 -43.22 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 m -67.78 -37.91 82.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 48' ' ' CYS . 62.4 t -87.2 113.06 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.353 0.597 . . . . 0.0 111.311 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -74.08 149.79 40.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.763 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG3' HG13 ' A' ' 46' ' ' VAL . 64.8 ttp85 -80.95 138.77 36.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.802 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 89.1 m-70 -142.76 165.12 28.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.129 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 15' ' ' TRP . 64.3 m170 -128.18 146.58 50.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.725 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.0 t -90.3 137.47 32.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -72.57 -7.37 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.932 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.7 m-20 -101.21 -71.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.2 p -75.08 -24.04 58.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.695 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.66 20.86 79.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.734 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -99.07 163.24 12.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.953 0.406 . . . . 0.0 110.609 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.813 ' C ' HD22 ' A' ' 47' ' ' LEU . 89.6 t -76.74 128.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.406 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.878 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.1 mm? -133.06 139.45 47.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.654 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.406 ' HB2' HG11 ' A' ' 35' ' ' VAL . 14.1 p -79.69 175.54 10.52 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.73 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.46 -53.59 34.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.307 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.37 -36.14 63.55 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.878 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.65 -1.89 58.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.1 p -132.39 26.78 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 90.6 mtt-85 -80.22 -19.24 47.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -79.59 164.61 23.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.153 0.501 . . . . 0.0 111.628 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.45 ' NH1' ' HB3' ' A' ' 55' ' ' ARG . 15.9 mtp-105 -140.85 137.93 33.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.84 154.3 23.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.863 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.75 147.82 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.004 HD12 HD12 ' A' ' 63' ' ' ILE . 2.8 mt -126.97 77.69 74.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.821 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.74 -8.18 12.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 123.393 2.729 . . . . 0.0 113.8 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.3 mtp -96.0 -34.99 11.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.766 0.793 . . . . 0.0 109.099 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 40.5 mtp85 -90.01 29.47 1.21 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.289 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.14 23.02 71.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.075 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.004 HD12 HD12 ' A' ' 58' ' ' ILE . 71.5 mt -119.44 101.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.748 0.309 . . . . 0.0 110.394 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.91 -22.86 24.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.817 0.341 . . . . 0.0 111.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.6 mm-40 -99.74 138.49 20.4 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 53.1 Cg_exo -52.72 123.04 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.4 1.4 . . . . 0.0 111.693 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.667 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.4 mt-10 -124.64 165.69 17.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.562 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -69.56 139.12 53.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.645 0.736 . . . . 0.0 112.186 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.63 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -145.14 -179.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.91 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.496 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -96.26 -164.98 1.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -80.19 -43.8 20.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.84 79.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.734 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.8 m -65.23 -40.1 93.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.377 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 68.2 t80 -57.17 -41.83 79.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 78' ' ' ARG . 6.7 mt -70.43 -50.56 37.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.272 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.18 61.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.399 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.528 HD11 ' OD1' ' A' ' 42' ' ' ASN . 33.9 mt -65.4 -42.18 92.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HB3' ' HA ' ' A' ' 75' ' ' LEU . 67.6 ttt180 -58.8 -20.5 50.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.725 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.8 t -105.2 148.47 26.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.078 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.5 t -117.1 144.71 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.725 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -89.63 130.46 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.77 -35.51 74.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.77 147.43 49.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.619 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.31 -4.94 16.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.594 2.196 . . . . 0.0 112.528 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 mt -85.27 144.43 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.54 144.66 40.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.603 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.5 p -63.56 -23.58 67.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 111.066 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 84.8 mtp -109.51 143.31 39.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.56 111.24 0.41 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.466 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 80.3 tt0 -89.55 13.49 13.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.978 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -69.73 -4.18 18.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.281 0.563 . . . . 0.0 109.553 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -72.65 135.07 45.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.888 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -122.67 141.31 51.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.697 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -126.58 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.96 -171.86 48.29 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.231 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' GLY . 72.7 t80 -76.92 122.05 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 47.4 p-90 -92.84 118.36 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.59 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 63.5 tt0 -82.37 131.24 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 110.314 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -60.27 153.11 23.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.76 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . 31.3 p-10 -56.66 -45.08 81.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.494 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -64.97 -42.2 94.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.012 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.01 -29.24 64.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.263 0.554 . . . . 0.0 110.588 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -116.49 72.76 5.36 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.498 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.21 -11.08 17.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.245 2.63 . . . . 0.0 112.952 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 156.41 48.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.461 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.8 t -59.58 123.76 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.147 0.499 . . . . 0.0 111.872 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -61.81 -27.69 68.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.969 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.86 -54.73 2.41 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.104 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 p -104.09 -3.19 24.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 69.14 9.08 59.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.466 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 p -70.59 144.79 51.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.156 0.478 . . . . 0.0 110.164 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -81.95 136.62 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.144 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.676 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 99.0 m-85 -82.41 134.9 35.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.959 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 p -126.55 168.24 14.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.8 m -47.41 -43.58 23.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.9 m -66.51 -38.06 86.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.71 113.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 0.0 111.174 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.85 145.6 46.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.049 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 18' ' ' ASP . 22.5 ttm105 -83.24 140.76 32.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.572 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -143.06 167.25 22.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.441 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -128.63 146.66 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.367 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.0 t -89.9 137.45 32.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 14.2 mmt180 -71.83 -7.67 49.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.948 ' OD1' HD13 ' A' ' 58' ' ' ILE . 75.0 m-20 -101.74 -70.33 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.538 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.7 p -75.83 -24.2 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.27 21.11 79.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.712 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.538 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 22.0 m-85 -98.72 161.49 13.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.732 0.301 . . . . 0.0 110.349 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.787 ' C ' HD22 ' A' ' 47' ' ' LEU . 73.0 t -75.4 128.96 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.7 mm? -132.54 139.42 47.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 p -80.04 174.33 11.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.753 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.66 -53.97 26.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.601 -1.285 . . . . 0.0 112.437 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -55.08 -35.32 64.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.934 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.62 -2.51 58.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.426 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -132.55 26.47 4.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.753 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt-85 -80.49 -20.39 43.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.168 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -78.55 163.69 25.32 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 111.289 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -138.26 135.89 35.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.957 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -156.39 153.94 29.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.973 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.434 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -93.65 149.29 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.994 HD12 HD12 ' A' ' 63' ' ' ILE . 2.1 mt -128.96 76.75 78.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.075 0.464 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.12 -8.43 12.12 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.329 2.686 . . . . 0.0 113.693 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.87 -35.66 11.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.708 0.766 . . . . 0.0 108.949 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.535 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 7.6 mtp-105 -90.28 29.06 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.002 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.45 72.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.11 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.994 HD12 HD12 ' A' ' 58' ' ' ILE . 88.8 mt -123.52 97.93 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -86.84 -17.58 33.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.712 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.4 mt-10 -102.17 141.13 21.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 40.3 Cg_exo -55.39 122.52 11.88 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.492 1.461 . . . . 0.0 111.694 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.718 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.3 mt-10 -125.52 166.64 16.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -69.36 137.09 52.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.598 0.713 . . . . 0.0 111.984 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.594 HG11 ' ND2' ' A' ' 42' ' ' ASN . 26.9 m -145.89 -179.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.027 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 1.9 p -96.89 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -78.08 -42.31 32.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.76 -45.72 70.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 38.4 m -64.38 -41.54 96.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.443 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 73.4 t80 -56.17 -39.59 72.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 22.0 mt -72.89 -54.56 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.454 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.54 -48.11 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.364 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.416 HD11 ' OD1' ' A' ' 42' ' ' ASN . 82.6 mt -66.31 -40.94 90.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 66.1 ttt180 -56.63 -19.42 16.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.247 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.7 t -58.22 -38.22 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 p -78.23 158.79 28.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -95.89 123.42 39.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 89.2 mtp -83.82 127.77 34.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.24 55.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.435 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.91 146.66 66.92 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.671 2.247 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.87 -37.06 78.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.708 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.19 -167.17 53.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 m -64.92 151.62 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.72 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.62 -35.27 75.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.197 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.63 -172.71 35.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.7 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -83.55 8.63 13.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -58.84 -17.66 25.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -52.08 -38.05 55.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.226 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.1 m -121.36 146.41 46.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.123 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 56.8 mttt -59.22 -37.11 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.626 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -138.25 142.02 12.7 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.241 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' A' ' 44' ' ' GLY . 85.5 t80 -79.25 122.01 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.307 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -89.08 118.79 29.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.839 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 63.4 tt0 -85.14 127.05 34.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 109.747 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.31 153.35 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.969 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HB3' ' NE ' ' A' ' 37' ' ' ARG . 28.9 p-10 -57.2 -43.63 82.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.868 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.37 -41.99 88.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.987 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -67.83 -33.85 75.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.197 0.522 . . . . 0.0 110.605 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -112.56 75.71 1.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.747 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.99 -11.85 21.5 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.039 2.493 . . . . 0.0 112.592 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.75 156.01 49.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.218 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 8.6 t -62.83 123.93 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.174 0.511 . . . . 0.0 111.488 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.7 m120 -59.15 -27.01 65.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.084 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.11 -55.51 2.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.327 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -103.84 -2.61 26.02 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.74 8.91 61.36 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.3 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.8 p -69.51 143.09 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.22 0.51 . . . . 0.0 110.009 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -80.08 137.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.905 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 87.0 m-85 -84.33 134.93 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.7 p -127.74 171.51 11.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.308 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.25 -41.16 26.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.0 p -72.35 -28.05 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.8 t -94.9 113.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.634 . . . . 0.0 111.435 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.81 148.17 40.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.369 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 17.9 ttp180 -82.33 140.61 33.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.611 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.0 m-70 -142.23 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -130.43 147.09 52.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.6 t -89.37 138.38 31.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 24.6 tpt180 -72.55 -7.05 48.1 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.934 ' OD1' HD13 ' A' ' 58' ' ' ILE . 71.2 m-20 -100.66 -70.04 0.75 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 29.3 p -77.51 -23.86 50.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.28 22.13 79.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.397 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.4 m-85 -98.48 163.14 12.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.828 0.347 . . . . 0.0 110.314 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.871 ' C ' HD22 ' A' ' 47' ' ' LEU . 79.9 t -79.73 127.72 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.234 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.871 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.5 mm? -132.32 139.58 48.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.53 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.24 178.01 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.731 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.04 -53.8 35.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.481 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 82.8 m-20 -55.28 -35.77 65.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.739 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.48 -2.34 58.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.361 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -131.8 26.15 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 93.3 mtt-85 -79.54 -21.4 45.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.305 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.8 m80 -80.16 165.07 22.8 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.279 0.561 . . . . 0.0 111.613 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -140.59 138.09 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.388 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.584 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.37 154.16 26.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.834 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.89 154.99 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.934 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.2 mt -130.21 79.53 72.52 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.09 -11.17 26.21 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.174 2.583 . . . . 0.0 113.91 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.7 mtp -86.91 -37.79 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG2' HG22 ' A' ' 58' ' ' ILE . 14.9 mmm180 -84.74 4.24 33.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.78 8.82 63.27 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.476 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.859 HD12 HD12 ' A' ' 58' ' ' ILE . 67.0 mt -99.09 100.83 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.241 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.0 p -87.09 -16.79 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.54 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 34.3 mt-10 -103.81 145.0 29.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 17.0 Cg_endo -58.18 123.34 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.688 1.592 . . . . 0.0 111.723 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -124.84 167.71 14.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -71.01 136.46 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 0.0 111.658 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.63 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.0 m -147.08 -178.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.159 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.512 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.34 -164.96 1.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.88 -43.97 21.29 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.58 74.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 54.0 m -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.338 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.7 t80 -56.34 -39.05 72.2 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 42.0 mt -73.0 -54.93 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.672 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.05 -47.87 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.294 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.406 HD11 ' OD1' ' A' ' 42' ' ' ASN . 91.8 mt -65.55 -41.43 93.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 17.1 ttp180 -57.24 -18.64 17.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.555 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.3 m -64.3 156.59 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.008 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.8 p -117.46 155.93 28.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -55.39 137.26 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.0 mtp -85.37 144.27 28.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.044 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.13 67.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.448 -1.196 . . . . 0.0 112.522 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.12 -3.19 12.81 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.879 2.386 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.87 141.93 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.17 117.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.425 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.5 p -134.89 157.16 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 86.2 mtp -120.03 148.44 43.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.66 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.3 -95.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.844 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 10' ' ' GLN . 96.0 mt-10 -65.19 -11.65 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -62.57 -5.81 2.93 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 8' ' ' GLU . 58.8 tt0 -66.26 139.78 58.1 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.048 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -64.23 153.57 37.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.572 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.12 134.39 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.62 55.59 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.668 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.409 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 76.7 t80 -79.06 121.96 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -92.49 118.99 31.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.69 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 64.1 tt0 -83.93 130.67 34.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.243 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.03 154.31 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.935 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' OD1' ' HG2' ' A' ' 37' ' ' ARG . 31.6 m-20 -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.166 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.37 -42.16 83.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.98 -33.88 76.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.205 0.526 . . . . 0.0 110.644 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 46' ' ' VAL . . . -112.43 72.61 1.29 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.538 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.64 -13.39 29.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.069 2.513 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.94 156.14 49.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.18 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 10.3 t -62.41 123.01 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.648 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -60.45 -25.66 66.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.282 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.89 -55.87 2.06 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.189 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.5 p -103.09 -4.45 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 10.06 72.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.469 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 8.5 p -71.1 142.61 50.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.355 0.577 . . . . 0.0 110.353 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.21 138.84 18.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.784 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.741 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.4 m-85 -83.85 134.17 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.473 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.4 p -127.89 171.67 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.2 m -48.26 -40.98 26.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 p -73.01 -27.68 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.391 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.1 t -94.61 112.66 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.419 0.628 . . . . 0.0 111.345 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -73.85 145.67 44.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.397 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.503 ' CD ' HG11 ' A' ' 46' ' ' VAL . 7.8 tpp180 -77.72 139.38 39.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 98.6 m-70 -142.72 161.9 36.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.221 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -129.96 147.19 51.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -89.9 137.85 31.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.3 -6.89 46.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.978 ' OD1' HD13 ' A' ' 58' ' ' ILE . 81.4 m-20 -101.54 -71.37 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.73 -24.07 56.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . 72.97 22.14 79.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.371 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.522 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.2 m-85 -99.02 162.57 12.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.826 ' C ' HD22 ' A' ' 47' ' ' LEU . 89.6 t -78.47 128.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.826 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.2 mm? -132.31 137.86 47.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.2 176.8 8.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.58 -54.36 30.71 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -54.85 -35.28 63.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.783 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.55 -2.35 58.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.38 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -132.33 26.18 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.0 mtt-85 -78.7 -21.39 48.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -78.39 162.07 26.7 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -138.1 138.22 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.01 153.55 24.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.5 147.97 22.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.07 HD12 HD12 ' A' ' 63' ' ' ILE . 2.3 mt -126.93 76.97 75.39 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 110.95 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.87 -6.97 10.26 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.253 2.636 . . . . 0.0 113.735 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.8 mtm -95.75 -36.11 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.723 0.773 . . . . 0.0 109.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 45.1 mtp85 -90.03 29.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 22.67 72.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.278 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.07 HD12 HD12 ' A' ' 58' ' ' ILE . 76.3 mt -118.54 102.5 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 117.033 0.417 . . . . 0.0 110.544 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -87.52 -21.68 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.397 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 63' ' ' ILE . 4.2 mt-10 -100.36 145.79 30.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.7 Cg_endo -59.49 123.25 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.738 1.625 . . . . 0.0 111.45 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.749 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.5 mt-10 -125.78 165.7 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.924 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.58 137.2 54.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 0.0 112.067 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.575 HG11 HD21 ' A' ' 42' ' ' ASN . 32.3 m -145.06 177.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.976 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.488 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.43 -168.78 1.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.25 -42.82 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.01 73.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 54.5 m -64.13 -41.06 97.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.397 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.536 ' CE2' ' HD2' ' A' ' 78' ' ' ARG . 74.5 t80 -56.5 -39.79 73.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt -70.28 -49.94 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.621 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.13 86.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.492 HD11 ' OD1' ' A' ' 42' ' ' ASN . 93.6 mt -66.66 -36.57 82.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.832 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.536 ' HD2' ' CE2' ' A' ' 74' ' ' TYR . 12.9 mtt180 -68.45 -6.51 25.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.963 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 74.4 m -60.54 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 m -130.68 144.15 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.191 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.3 -34.0 73.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.509 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 95.6 mmm -88.14 137.85 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.63 145.68 48.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.068 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.473 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.35 138.9 87.2 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.832 2.355 . . . . 0.0 112.293 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.2 mt -90.8 138.51 31.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.506 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.38 -178.17 24.14 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.574 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.5 p -138.45 158.46 44.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.4 mmm -58.9 -36.05 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -174.92 51.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -91.41 8.73 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.44 -7.91 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.88 142.09 58.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.778 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -63.4 152.58 37.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -107.08 146.15 31.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.47 72.57 0.49 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.414 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 77.0 t80 -78.9 122.66 26.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.799 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -91.79 117.19 29.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.376 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 62.7 tt0 -84.02 132.53 34.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.0 151.45 18.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.688 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -56.86 -42.72 80.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.83 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.9 -41.19 87.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.465 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 89.0 m-20 -62.53 -36.2 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . -114.54 77.66 4.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.505 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 17.1 Cg_exo -67.39 -11.82 33.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.146 2.564 . . . . 0.0 112.819 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 158.28 44.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.529 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -60.46 124.73 21.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 111.872 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -61.65 -25.92 67.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.79 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.38 -56.32 2.17 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 p -105.42 -2.3 23.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.47 9.58 68.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.191 -1.005 . . . . 0.0 113.737 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.7 p -71.25 143.78 50.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.412 0.606 . . . . 0.0 110.143 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.42 136.95 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.97 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 93.8 m-85 -83.03 134.93 35.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.095 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -125.75 168.08 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -47.08 -43.71 20.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.207 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.3 m -66.68 -36.92 83.68 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.025 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 48' ' ' CYS . 64.3 t -88.74 113.85 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.402 0.62 . . . . 0.0 111.468 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -76.75 150.93 36.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.548 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' NH1' ' CD2' ' A' ' 31' ' ' PHE . 68.7 mtt-85 -88.24 141.51 28.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.68 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.2 m-70 -140.01 166.21 25.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.52 144.47 49.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.834 0.35 . . . . 0.0 111.517 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.88 137.34 32.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -71.98 -6.22 40.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.939 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.7 m-20 -101.28 -71.82 0.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.688 0.28 . . . . 0.0 111.673 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -75.85 -25.67 56.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.357 . . . . 0.0 111.87 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . 74.13 23.47 75.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.821 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.7 m-85 -100.45 163.24 12.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 0.0 110.63 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.824 ' C ' HD22 ' A' ' 47' ' ' LEU . 68.4 t -78.27 128.67 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.0 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.824 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.8 mm? -131.63 138.3 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.294 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 12.2 p -76.92 174.25 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.74 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.8 -52.95 31.89 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.363 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 86.0 m-20 -55.47 -36.1 66.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.766 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.81 -2.49 58.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.337 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 p -131.97 26.53 4.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.1 mtt180 -80.76 -17.94 49.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.919 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -81.39 164.7 21.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 111.377 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -140.75 135.51 31.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.105 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -157.19 153.98 28.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.73 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.62 148.38 22.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.939 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.3 mt -124.9 82.47 60.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.28 -10.88 29.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.015 2.477 . . . . 0.0 114.048 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.95 -37.44 17.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.495 0.664 . . . . 0.0 109.267 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG2' HG22 ' A' ' 58' ' ' ILE . 34.4 mmm-85 -84.44 2.71 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.655 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 8.14 62.44 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.608 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.878 HD12 HD12 ' A' ' 58' ' ' ILE . 81.6 mt -97.89 101.39 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.252 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.25 -19.25 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.59 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.0 mp0 -102.02 145.9 31.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 38.1 Cg_exo -58.45 123.04 12.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.413 1.409 . . . . 0.0 111.674 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG2' ' CG2' ' A' ' 63' ' ' ILE . 73.2 mm-40 -124.47 166.83 15.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.587 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -71.11 136.94 48.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.657 0.742 . . . . 0.0 111.978 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.622 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -145.81 179.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.035 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.47 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.1 p -94.61 -165.3 1.29 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -80.12 -44.06 20.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.3 76.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.752 0.31 . . . . 0.0 111.789 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.3 m -63.81 -41.54 97.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.086 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 79.4 t80 -56.31 -40.7 74.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.68 HD23 ' HD3' ' A' ' 78' ' ' ARG . 11.7 mt -72.13 -51.41 21.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.352 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.13 -48.1 61.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.513 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.469 HD11 ' OD1' ' A' ' 42' ' ' ASN . 59.6 mt -66.67 -42.22 86.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.68 ' HD3' HD23 ' A' ' 75' ' ' LEU . 60.4 ttt180 -55.23 -21.39 13.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.389 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.1 p -101.58 141.62 34.17 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.61 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.5 p -89.46 -5.54 57.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.632 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -56.4 -33.44 65.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.019 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 92.4 mmm -59.74 -34.55 73.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.185 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.52 55.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.518 -179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.97 144.64 99.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.833 2.355 . . . . 0.0 112.311 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt -60.34 -34.29 73.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.421 . . . . 0.0 110.574 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -174.19 39.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.254 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.4 p -61.29 -28.34 69.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.895 0.379 . . . . 0.0 110.582 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 88.3 mtp -60.57 -35.37 75.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.9 99.89 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.52 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 6' ' ' MET . 95.3 mt-10 -91.94 13.03 19.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.597 0.237 . . . . 0.0 111.226 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -71.32 -0.95 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -80.7 124.86 29.37 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.985 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.2 p -136.65 142.61 43.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -121.22 20.06 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.111 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' NH2' ' A' ' 61' ' ' ARG . . . -59.46 93.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.172 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' GLY . 79.2 t80 -80.47 123.58 28.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.427 ' O ' ' CD1' ' A' ' 15' ' ' TRP . 44.2 p90 -91.85 118.74 31.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 61.5 tt0 -81.89 132.7 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.142 0.496 . . . . 0.0 109.994 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.87 153.96 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' OD1' ' NH2' ' A' ' 37' ' ' ARG . 14.1 t0 -53.93 -54.35 40.05 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.585 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.45 -40.41 94.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.815 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -69.86 -31.72 69.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -115.48 73.57 4.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.675 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 -11.34 20.35 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.101 2.534 . . . . 0.0 112.849 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.29 156.97 48.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.44 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 11.2 t -63.08 123.95 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.121 0.486 . . . . 0.0 111.613 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -60.46 -26.43 66.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.269 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.06 -56.21 2.36 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.568 -0.825 . . . . 0.0 114.312 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.9 p -105.32 -1.72 24.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.78 11.08 68.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.647 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.6 p -72.27 143.45 48.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.261 0.53 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.06 136.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.707 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.4 m-85 -82.6 133.79 35.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.08 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.7 p -126.23 169.88 12.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.075 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.3 m -48.12 -43.99 31.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -67.46 -36.25 80.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.079 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.4 t -87.49 113.27 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.407 0.622 . . . . 0.0 111.541 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -73.62 145.22 45.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.194 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.607 ' NH1' HG11 ' A' ' 46' ' ' VAL . 63.3 ttm-85 -83.56 140.21 32.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.95 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -143.74 167.21 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.395 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.439 ' NE2' HG22 ' A' ' 46' ' ' VAL . 50.6 m80 -130.59 147.62 52.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.357 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.3 t -91.06 137.98 31.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.43 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 60.0 mtp180 -73.18 -5.1 37.04 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.949 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.1 m-20 -101.72 -72.31 0.69 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.624 0.25 . . . . 0.0 111.645 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . 30.8 p -74.59 -24.44 58.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.64 19.5 79.71 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.026 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 43' ' ' CYS . 36.0 m-85 -97.5 165.66 11.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.598 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.865 ' C ' HD22 ' A' ' 47' ' ' LEU . 92.9 t -81.27 128.28 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.3 mm? -131.67 138.17 48.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.1 p -76.82 177.03 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.737 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.15 -54.03 31.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.336 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 84.0 m-20 -55.26 -34.99 64.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.748 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.2 -2.61 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 84.1 p -132.43 25.55 4.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 71.8 mtp180 -78.32 -21.94 48.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.976 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -77.62 162.91 26.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 111.723 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -138.67 137.09 36.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.06 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.599 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.04 154.05 25.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.876 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.37 150.96 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.949 HD13 ' OD1' ' A' ' 42' ' ' ASN . 2.9 mt -127.64 82.31 68.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.22 -10.54 27.75 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.109 2.54 . . . . 0.0 113.99 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.16 -37.17 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 13.6 mmm180 -83.94 2.08 40.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.8 7.39 62.9 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.4 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.871 HD12 HD12 ' A' ' 58' ' ' ILE . 77.2 mt -96.5 100.61 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.8 p -86.09 -19.03 30.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.448 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.2 mt-10 -102.84 146.43 32.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.9 Cg_endo -58.85 123.5 13.66 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.688 1.592 . . . . 0.0 111.954 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -125.32 166.84 15.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.697 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -70.15 137.01 50.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 112.095 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.6 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.8 m -146.43 179.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.904 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.516 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.67 -163.63 1.07 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.7 p-10 -82.6 -42.45 18.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.12 -45.18 74.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.748 0.308 . . . . 0.0 111.645 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.431 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 34.3 m -63.51 -41.38 98.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.256 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 80.7 t80 -56.55 -39.71 73.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.2 mt -72.72 -51.15 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.324 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.11 -47.52 65.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.391 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD11 ' ND2' ' A' ' 42' ' ' ASN . 71.6 mt -65.19 -41.16 94.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 51.3 ttt85 -58.28 -17.68 21.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.6 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -58.28 -31.43 67.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.5 m -51.63 -32.96 31.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.923 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -84.57 117.73 23.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.565 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.3 mtm -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.8 56.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.045 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.521 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.443 ' HA3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' HD2' ' HA3' ' A' ' 1' ' ' GLY . 17.5 Cg_endo -57.71 150.05 64.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.8 2.333 . . . . 0.0 112.375 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.46 141.53 30.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.68 -137.26 28.57 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 98.2 p -126.91 154.77 44.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 0.0 110.948 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 51.5 ttm -111.39 132.38 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.62 124.58 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.407 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -71.55 -9.08 57.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.484 0.183 . . . . 0.0 111.318 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -59.38 -11.38 4.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.82 124.97 23.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.025 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.1 m -129.87 147.51 51.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -59.93 -32.86 71.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 110.104 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.7 145.08 8.51 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.951 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . 71.5 t80 -78.44 122.42 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.333 . . . . 0.0 111.126 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -95.1 119.92 34.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -85.27 131.0 34.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 154.01 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.826 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -55.78 -45.5 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.06 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.89 -42.37 90.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.516 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.05 -34.66 78.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 0.0 110.397 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.68 73.79 0.86 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.606 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -14.67 25.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.019 2.48 . . . . 0.0 112.648 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.02 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.1 t -60.59 125.23 22.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.315 0.579 . . . . 0.0 111.704 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 64.8 m-80 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.886 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.59 -56.17 2.05 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.234 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.5 p -103.08 -4.14 24.96 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.75 73.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.53 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 8.0 p -73.67 143.66 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.391 0.595 . . . . 0.0 110.324 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.78 137.39 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.794 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 86.4 m-85 -83.97 135.08 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.1 p -128.66 170.32 13.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.416 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.9 m -47.82 -44.46 28.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.535 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 m -65.44 -35.95 82.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.03 113.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 111.625 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -75.38 148.89 38.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.402 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.473 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 24.2 ttp-105 -79.22 141.63 36.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 96.5 m-70 -141.22 160.75 39.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -126.8 145.83 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.375 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.8 t -91.34 137.18 32.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -72.1 -6.85 45.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.864 ' OD1' HD13 ' A' ' 58' ' ' ILE . 70.2 m-20 -100.66 -71.64 0.7 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 30.6 p -75.81 -24.28 55.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.02 21.05 79.6 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.449 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -98.54 162.12 13.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 110.515 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.863 ' C ' HD22 ' A' ' 47' ' ' LEU . 90.2 t -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.39 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.863 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.9 mm? -132.12 140.06 48.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.17 -179.86 6.44 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.708 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.22 -53.65 41.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.206 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 95.3 m-20 -55.2 -36.28 65.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.813 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.53 -2.01 58.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 p -131.9 26.48 4.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 81.9 mtt-85 -81.35 -16.86 51.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -85.24 167.18 15.89 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.145 0.498 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -144.03 140.88 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.15 154.43 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.606 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.39 149.98 22.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.877 HD12 HD12 ' A' ' 63' ' ' ILE . 3.6 mt -125.4 81.51 64.02 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.094 0.474 . . . . 0.0 110.596 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.64 -12.67 36.82 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.095 2.53 . . . . 0.0 114.318 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.2 mtm -85.72 -37.63 19.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.562 ' HG2' HG22 ' A' ' 58' ' ' ILE . 27.5 mmm180 -83.21 1.31 41.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.878 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.32 8.8 59.7 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.559 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.877 HD12 HD12 ' A' ' 58' ' ' ILE . 69.4 mt -98.98 101.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.095 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.2 p -88.59 -17.56 29.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.5 mt-10 -103.03 142.31 24.29 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.42 122.39 11.63 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.533 1.489 . . . . 0.0 111.694 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.8 mm-40 -123.33 166.18 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.595 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 mtm105 -71.02 139.41 50.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.499 0.666 . . . . 0.0 111.328 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.634 HG11 ' ND2' ' A' ' 42' ' ' ASN . 28.3 m -147.35 -179.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.244 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.522 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -95.5 -164.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.25 -43.51 19.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -46.06 75.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 40.0 m -63.78 -40.16 96.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.211 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 83.8 t80 -56.92 -39.86 75.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.713 HD23 ' HD3' ' A' ' 78' ' ' ARG . 9.6 mt -72.47 -52.19 16.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.47 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.2 -49.63 52.02 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.559 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.461 HD11 ' OD1' ' A' ' 42' ' ' ASN . 58.8 mt -65.04 -41.56 95.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.713 ' HD3' HD23 ' A' ' 75' ' ' LEU . 52.3 ttt180 -57.26 -21.17 32.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.041 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -103.89 154.71 19.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 111.443 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 p -131.77 154.95 48.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -93.02 140.52 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.993 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 64.3 mtm -59.6 -34.17 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.48 68.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.237 -1.313 . . . . 0.0 112.406 179.857 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.31 145.54 98.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.872 2.382 . . . . 0.0 112.169 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.7 mt -85.43 140.97 30.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.07 144.53 34.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.658 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 p -75.15 -6.5 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 82.8 mtp -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.86 98.05 0.85 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.394 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -92.71 9.98 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.311 . . . . 0.0 111.489 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -58.74 -18.89 35.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.05 137.8 58.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.129 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.3 p -76.95 159.56 29.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.776 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -109.51 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.384 . . . . 0.0 110.981 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.77 169.57 27.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.763 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 44' ' ' GLY . 71.4 t80 -79.93 122.32 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -86.69 118.02 25.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.609 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 62.1 tt0 -84.31 131.08 34.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.157 0.503 . . . . 0.0 109.807 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HA ' ' NH1' ' A' ' 37' ' ' ARG . 95.8 mt-10 -64.01 153.94 35.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' OD1' ' HD3' ' A' ' 37' ' ' ARG . 11.5 m-20 -56.15 -43.93 78.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.769 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.53 -42.61 82.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.266 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -69.4 -32.4 71.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.25 0.548 . . . . 0.0 110.377 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.609 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -113.61 74.3 2.28 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.519 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.92 -11.43 18.09 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.958 2.439 . . . . 0.0 112.346 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.06 155.46 50.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.204 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -64.15 126.94 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.111 0.482 . . . . 0.0 111.437 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.8 m120 -60.9 -26.39 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.974 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.19 -55.85 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.229 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -102.88 -4.18 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.93 9.01 65.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.466 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.1 p -69.87 143.22 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.127 0.464 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.43 138.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.083 0.468 . . . . 0.0 112.036 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.571 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.3 m-85 -83.92 133.44 34.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.412 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 p -126.54 169.57 12.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -46.68 -39.87 12.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.349 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -73.71 -25.87 60.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.427 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -97.7 113.14 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.23 0.538 . . . . 0.0 111.253 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -76.51 149.1 36.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.896 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 18.6 ttp180 -79.29 140.77 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -140.39 158.83 43.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -125.76 145.33 50.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.353 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.0 t -91.14 137.79 32.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -72.95 -6.55 46.05 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.925 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.08 -72.53 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.696 0.284 . . . . 0.0 111.754 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.2 p -74.87 -25.02 58.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.815 0.34 . . . . 0.0 111.581 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.7 22.84 77.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.679 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.0 m-85 -99.1 162.76 12.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.626 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.865 ' C ' HD22 ' A' ' 47' ' ' LEU . 78.5 t -79.28 128.06 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.969 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.3 mm? -131.49 140.43 49.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.494 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.41 174.02 11.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.761 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.42 -54.19 21.44 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.545 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -54.66 -36.13 64.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.762 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.9 -2.39 58.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.141 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 p -131.91 25.79 4.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.796 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.6 mtt-85 -81.1 -18.05 47.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -80.03 163.43 24.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.571 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.78 136.68 34.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.231 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.58 154.71 27.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.71 148.9 22.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.925 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.7 mt -126.69 79.64 71.48 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.915 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -10.02 21.64 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 123.111 2.54 . . . . 0.0 113.817 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.9 mmm -87.7 -37.53 16.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 16.2 mmm180 -84.14 3.44 34.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.507 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.95 6.61 65.09 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.243 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.893 HD12 HD12 ' A' ' 58' ' ' ILE . 85.0 mt -95.54 100.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.777 0.322 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.5 p -87.45 -19.03 28.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mt-10 -103.33 138.6 19.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 51.2 Cg_exo -52.74 124.33 15.09 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.647 1.565 . . . . 0.0 112.17 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.694 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.8 mt-10 -125.28 166.67 16.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.551 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -70.24 138.61 51.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.675 0.75 . . . . 0.0 112.092 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.648 HG11 ' ND2' ' A' ' 42' ' ' ASN . 31.3 m -147.08 178.97 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.464 -1.243 . . . . 0.0 110.013 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.499 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -93.46 -165.2 1.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -81.24 -42.82 20.15 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.42 -44.9 77.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 27.0 m -63.52 -41.51 98.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.379 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 74.7 t80 -56.06 -39.94 72.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.57 HD23 ' HD3' ' A' ' 78' ' ' ARG . 8.8 mt -72.38 -51.8 18.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.1 -48.49 61.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.306 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.477 HD11 ' ND2' ' A' ' 42' ' ' ASN . 60.0 mt -65.61 -42.05 92.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.57 ' HD3' HD23 ' A' ' 75' ' ' LEU . 64.7 ttt-85 -56.15 -18.94 11.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.182 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.8 m -58.83 151.16 22.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.6 m -120.88 148.9 43.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.53 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.56 -34.02 61.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 91.9 mtp -88.5 137.85 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.62 145.35 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.612 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 1' ' ' GLY . 18.0 Cg_endo -59.94 146.47 95.79 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.578 2.185 . . . . 0.0 112.08 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.0 mt -60.62 -27.7 67.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.12 6.73 48.54 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.15 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 m -59.24 -32.85 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.995 0.398 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 89.7 mtp -90.5 139.63 30.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.24 8.48 71.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.514 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 86.5 tt0 -87.64 13.01 11.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.011 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -71.05 -4.9 27.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.246 0.546 . . . . 0.0 109.559 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -57.62 146.61 29.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 41' ' ' ARG . 31.2 t -113.36 144.78 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.069 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -66.27 133.42 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.729 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.57 153.21 5.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . 80.8 t80 -78.73 121.5 24.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' A' ' 15' ' ' TRP . 48.6 p90 -89.78 119.25 30.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.68 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 64.1 tt0 -84.8 129.23 34.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.562 . . . . 0.0 110.098 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.6 151.98 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.732 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' CB ' ' HD3' ' A' ' 37' ' ' ARG . 37.6 t0 -55.87 -44.66 78.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.68 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.85 -41.89 91.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -67.04 -34.58 78.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.576 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -111.84 74.24 1.29 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.767 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.81 -12.74 28.98 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.057 2.505 . . . . 0.0 112.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.8 156.68 48.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.356 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.3 t -62.03 125.14 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 111.523 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.33 -26.72 66.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.86 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.43 -55.19 2.1 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.991 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 p -103.69 -4.94 23.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 70.97 11.58 70.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.791 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.1 p -72.03 143.41 49.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.374 0.587 . . . . 0.0 110.409 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.44 138.08 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 112.022 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.2 m-85 -84.99 135.72 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 p -127.6 169.52 13.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.815 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.6 m -46.63 -42.82 16.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.4 m -66.59 -37.22 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.251 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.35 113.38 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.318 0.58 . . . . 0.0 111.524 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -74.55 148.31 40.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.492 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG3' HG13 ' A' ' 46' ' ' VAL . 13.7 ttp180 -78.63 141.4 38.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.409 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -142.18 163.01 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.05 147.52 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.906 0.384 . . . . 0.0 111.917 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.0 t -90.57 136.72 32.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 91.3 mtt-85 -70.17 -6.94 37.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 1.08 ' OD1' HD13 ' A' ' 58' ' ' ILE . 5.3 m-20 -102.9 -70.26 0.76 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.2 p -75.05 -25.83 58.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.054 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.82 20.31 79.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.391 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.5 m-85 -97.33 161.11 13.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.362 . . . . 0.0 110.668 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.83 ' C ' HD22 ' A' ' 47' ' ' LEU . 99.4 t -78.43 128.89 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.089 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 51' ' ' CYS . 1.9 mm? -130.81 140.45 50.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -78.33 172.46 13.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.0 -52.51 30.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.248 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 89.3 m-20 -55.88 -34.96 65.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.842 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.77 -1.37 57.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.278 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 p -131.74 25.7 4.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.748 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 78.1 mtp180 -80.72 -19.35 45.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.076 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -78.35 164.77 24.55 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.198 0.523 . . . . 0.0 111.623 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -141.03 134.71 30.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.323 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -160.7 154.09 21.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.82 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.8 158.04 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.08 HD13 ' OD1' ' A' ' 42' ' ' ASN . 1.6 mt -132.96 76.64 69.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 110.326 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.8 -11.57 29.91 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.238 2.625 . . . . 0.0 114.337 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 85.7 mtp -86.36 -37.64 18.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.621 ' HG2' HG22 ' A' ' 58' ' ' ILE . 16.2 mmm180 -83.94 3.76 32.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.673 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 7.96 62.5 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.439 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.897 HD12 HD12 ' A' ' 58' ' ' ILE . 65.8 mt -97.01 101.8 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.281 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 p -86.73 -18.34 31.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.671 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 63' ' ' ILE . 87.6 mt-10 -102.91 146.68 32.87 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.2 Cg_endo -59.05 122.35 11.44 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.553 1.502 . . . . 0.0 111.673 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 76.8 mm-40 -125.83 167.56 15.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.842 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -71.6 138.45 48.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.556 0.693 . . . . 0.0 112.092 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.3 179.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.751 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.531 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 15.3 p -95.59 -172.53 2.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -73.39 -42.94 61.53 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.07 -45.03 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.297 . . . . 0.0 111.683 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.1 m -64.64 -40.64 95.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.339 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.627 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 18.9 t80 -56.33 -41.52 76.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.36 -48.26 67.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.51 86.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.489 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.62 HD21 HG23 ' A' ' 58' ' ' ILE . 89.1 mt -66.1 -38.73 88.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.353 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 62.7 mtp180 -64.45 -10.38 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.029 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.8 p -58.81 -30.2 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.673 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.2 p -63.72 -29.42 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -94.88 122.69 37.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.1 mtm -84.52 133.76 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.74 145.49 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.547 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.0 150.64 37.45 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.869 2.38 . . . . 0.0 112.761 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.73 147.22 33.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.99 -152.45 8.47 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.565 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.2 p -60.09 -21.67 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 110.974 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 13.8 tpp -52.61 -39.97 62.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.059 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.87 126.32 7.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.257 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 86.8 tt0 -76.47 -0.65 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.501 0.191 . . . . 0.0 111.321 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -64.03 -8.45 11.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 11' ' ' SER . 58.4 tt0 -63.41 142.37 58.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.709 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 10' ' ' GLN . 6.3 t 178.97 66.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.259 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -60.08 -36.22 76.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.045 0.45 . . . . 0.0 110.608 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.41 127.68 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.6 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 81.3 t80 -76.1 119.84 20.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 111.502 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -87.41 118.25 26.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -80.05 125.59 29.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.326 0.584 . . . . 0.0 110.163 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 148.63 29.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.647 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -57.71 -43.62 85.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.025 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.41 -42.9 82.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.178 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -66.03 -33.66 76.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.204 0.525 . . . . 0.0 110.63 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.91 76.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.952 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.31 -15.02 25.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.778 2.318 . . . . 0.0 112.612 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.38 155.59 50.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.336 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.7 t -61.51 125.17 22.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.111 0.482 . . . . 0.0 111.414 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.0 m120 -61.67 -26.13 67.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.224 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 -55.81 2.23 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.715 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.11 -1.58 27.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 7.71 61.91 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.278 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -69.92 143.92 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.237 0.519 . . . . 0.0 110.168 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.98 138.98 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.151 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.2 m-85 -82.42 133.91 35.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 110.27 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -126.88 169.06 13.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.74 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.3 m -44.73 -38.79 4.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.473 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -78.44 -26.76 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -96.14 112.87 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.177 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -78.34 150.03 33.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.425 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -89.73 143.2 27.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.817 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 64.4 m80 -138.84 164.44 29.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.389 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.86 143.34 48.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.8 t -90.53 136.57 32.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -70.44 -6.76 38.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.907 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.8 m-20 -101.82 -70.66 0.74 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.0 p -77.56 -25.32 49.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . 75.11 24.13 72.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.916 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 20.7 m-85 -102.32 162.33 13.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.8 0.333 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.825 ' C ' HD22 ' A' ' 47' ' ' LEU . 60.5 t -77.35 129.19 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.246 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.6 mm? -131.53 137.65 48.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.118 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.37 175.23 7.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.713 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.44 -53.01 37.48 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.497 -1.335 . . . . 0.0 112.044 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -54.76 -35.03 63.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.738 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.11 -3.63 58.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.444 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.4 p -131.41 27.93 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 88.4 mtt-85 -82.16 -19.21 40.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.197 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -78.59 163.52 25.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.273 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -140.0 135.16 32.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.263 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . . . -159.05 153.35 23.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.687 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.437 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.29 151.31 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.967 HD12 HD12 ' A' ' 63' ' ' ILE . 2.5 mt -127.37 74.97 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.14 0.495 . . . . 0.0 110.411 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.48 -9.02 14.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.127 2.551 . . . . 0.0 113.738 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.22 -36.72 12.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.556 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 32.5 mtp85 -89.43 26.34 1.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.358 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.63 23.36 76.72 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.276 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.967 HD12 HD12 ' A' ' 58' ' ' ILE . 73.5 mt -117.98 104.56 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.807 0.304 . . . . 0.0 110.326 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -91.31 -21.04 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 42.4 mt-10 -100.8 139.24 20.39 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.3 Cg_exo -52.71 123.02 11.99 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.591 1.527 . . . . 0.0 111.971 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.667 ' OE1' HD13 ' A' ' 63' ' ' ILE . 92.9 mt-10 -125.18 167.34 14.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.126 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -72.74 140.24 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 0.0 112.267 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.622 HG11 ' ND2' ' A' ' 42' ' ' ASN . 30.2 m -146.83 179.65 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.527 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.2 p -93.38 -163.62 1.07 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.112 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.86 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.5 m -63.57 -40.69 97.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.373 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 67.1 t80 -56.7 -39.72 74.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.572 HD23 ' HD3' ' A' ' 78' ' ' ARG . 8.8 mt -73.02 -53.0 12.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.41 61.3 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.26 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.518 HD11 ' OD1' ' A' ' 42' ' ' ASN . 82.2 mt -66.1 -41.94 89.92 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.572 ' HD3' HD23 ' A' ' 75' ' ' LEU . 59.7 ttt180 -56.5 -19.67 16.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.338 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -103.33 150.24 23.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.2 p -134.45 161.19 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.511 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.83 134.2 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.111 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 90.3 mtp -60.09 -35.07 74.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.88 54.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.282 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.38 -1.234 . . . . 0.0 112.511 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.096 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.442 ' HD2' ' HA3' ' A' ' 1' ' ' GLY . 19.6 Cg_endo -60.06 143.17 99.58 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.482 2.121 . . . . 0.0 112.088 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 76.0 mt -79.86 142.99 34.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 110.801 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.97 77.15 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.417 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.0 m -59.86 -36.01 75.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 68.3 mtm -127.77 151.83 48.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.441 . . . . 0.0 111.058 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.78 170.41 45.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.723 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.93 14.25 18.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.634 0.254 . . . . 0.0 111.213 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -70.9 -4.66 25.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.239 0.542 . . . . 0.0 109.65 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -65.03 143.56 57.86 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.134 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.4 m -120.86 149.4 42.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.579 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -113.34 144.95 41.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.38 153.33 17.61 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.453 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . 73.3 t80 -78.79 122.21 25.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 15' ' ' TRP . 20.0 p90 -94.08 119.01 32.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -83.18 131.89 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.511 . . . . 0.0 110.089 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.86 154.29 18.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.15 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' OD1' ' HD2' ' A' ' 37' ' ' ARG . 14.9 m-20 -54.79 -46.31 74.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.317 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -40.76 88.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.52 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 92.8 m-20 -65.6 -32.78 74.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.949 0.404 . . . . 0.0 111.385 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.3 75.63 4.59 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.489 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 13.3 Cg_exo -70.36 -12.88 32.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.232 2.621 . . . . 0.0 113.053 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.08 159.65 41.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.6 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.417 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.2 t -62.93 128.84 37.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.266 0.555 . . . . 0.0 112.059 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 m-80 -69.19 -24.76 64.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.324 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.43 -57.88 2.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.855 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 p -105.78 -0.3 25.48 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.05 72.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.413 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.5 p -69.37 143.52 53.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.356 0.578 . . . . 0.0 109.795 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.16 144.45 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.7 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 89.7 m-85 -83.54 132.96 34.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 28.9 p -124.84 168.66 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.925 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 m -48.24 -44.5 33.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 m -66.96 -36.16 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 32' ' ' THR . 77.3 t -86.3 113.46 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 0.0 111.786 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -73.11 144.83 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.897 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 21.5 ttm105 -87.09 141.99 28.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.952 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.2 m-70 -144.64 171.86 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' NE2' HG22 ' A' ' 46' ' ' VAL . 36.3 m80 -130.45 148.44 52.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.3 t -90.97 136.75 32.86 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -72.84 -5.68 39.84 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.931 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.9 m-20 -100.81 -71.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.62 0.247 . . . . 0.0 111.47 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.0 p -75.26 -24.72 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 111.614 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.46 20.45 79.86 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.6 m-85 -97.75 161.55 13.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.85 0.357 . . . . 0.0 110.538 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.808 ' C ' HD22 ' A' ' 47' ' ' LEU . 95.0 t -76.6 128.44 37.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.089 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.817 HD12 ' HB3' ' A' ' 51' ' ' CYS . 2.6 mm? -131.78 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.493 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.0 p -79.38 -179.78 6.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.89 -53.72 42.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.674 -1.251 . . . . 0.0 112.225 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' NE ' ' A' ' 53' ' ' ARG . 92.7 m-20 -55.38 -35.81 65.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.817 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.92 -2.15 58.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.389 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -131.87 26.39 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.4 mtt180 -80.94 -18.3 47.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -80.08 162.9 24.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.106 0.479 . . . . 0.0 111.285 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp85 -139.8 135.62 33.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -157.93 153.39 26.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.814 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.97 149.46 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.931 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.4 mt -125.81 82.36 64.26 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.855 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -10.73 29.64 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.087 2.524 . . . . 0.0 114.028 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.85 -37.76 17.43 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 58' ' ' ILE . 30.2 mmm180 -83.07 1.01 42.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.648 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 7.2 62.0 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.284 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.901 HD12 HD12 ' A' ' 58' ' ' ILE . 74.3 mt -96.85 100.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.66 -17.41 33.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.74 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.1 mt-10 -103.02 144.2 28.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 31.8 Cg_exo -57.11 123.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.642 1.561 . . . . 0.0 111.683 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.3 mm-40 -125.35 167.15 15.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -70.89 137.46 49.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.94 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.634 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -146.84 179.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.078 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 1.7 p -94.49 -160.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 20.9 t70 -85.02 -43.26 14.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.94 80.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 111.82 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 33.3 m -63.98 -40.85 97.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.554 ' CE2' ' NE ' ' A' ' 78' ' ' ARG . 75.8 t80 -57.94 -40.52 80.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.3 mt -69.76 -50.51 42.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.509 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.49 84.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.39 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD21 HG23 ' A' ' 58' ' ' ILE . 88.6 mt -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' NE ' ' CE2' ' A' ' 74' ' ' TYR . 16.6 mtt180 -68.12 -5.2 16.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.034 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -58.06 -20.62 40.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.602 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 m -112.17 150.69 30.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -63.47 151.45 41.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.767 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 62.1 mtt -83.89 143.05 30.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.4 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.052 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.472 -1.182 . . . . 0.0 112.414 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 119.832 -0.427 . . . . 19.56 112.832 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.98 -48.19 7.06 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.025 1.816 . . . . 18.34 112.097 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mt -178.63 -53.94 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.792 -1.095 . . . . 17.73 108.475 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 41.32 -126.18 3.38 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.871 -1.059 . . . . 15.69 113.285 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.44 -34.5 54.52 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.652 -0.499 . . . . 15.14 109.652 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 6' ' ' MET . 14.8 mmt -50.31 -26.64 5.05 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.045 -0.525 . . . . 15.2 110.943 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.91 -22.25 40.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.068 -0.587 . . . . 12.41 113.208 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -47.64 -18.91 0.17 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.251 0.834 . . . . 11.0 113.251 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -24.44 21.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.694 -1.224 . . . . 13.3 107.694 175.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -70.82 67.07 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.823 -1.08 . . . . 8.3 108.182 175.552 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -19.07 107.62 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.474 0.71 . . . . 5.58 112.579 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -38.32 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.781 0.801 . . . . 6.35 110.412 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' C ' ' HA3' ' A' ' 44' ' ' GLY . . . 94.13 86.26 1.64 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 107.661 -2.176 . . . . 1.23 107.661 -174.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -44.02 124.09 3.66 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.97 0.414 . . . . 0.49 111.879 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.422 ' O ' ' CD1' ' A' ' 15' ' ' TRP . 3.4 p90 -78.21 124.33 27.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 3.44 110.79 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.444 ' HB3' HG23 ' A' ' 46' ' ' VAL . 44.8 tt0 -90.7 123.24 34.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.81 109.813 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -50.97 160.84 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 1.45 112.198 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.87 -56.48 21.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 2.02 111.414 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -61.9 -42.74 99.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 1.45 111.391 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -61.23 -27.78 68.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.18 111.236 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 76.65 41.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.558 -0.292 . . . . 0.27 111.313 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.22 -18.41 16.22 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.281 1.988 . . . . 0.36 112.497 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.434 -0.348 . . . . 0.16 110.838 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -55.16 124.78 18.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.17 111.7 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.48 -22.09 66.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 1.19 111.82 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.93 -68.11 1.4 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.649 -0.786 . . . . 0.17 113.792 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 p -88.56 -27.8 21.16 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.984 0.365 . . . . 0.17 111.984 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.28 26.6 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.455 -0.879 . . . . 0.15 112.73 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 p -83.25 144.56 29.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.16 110.635 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.48 143.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.89 111.09 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 88.7 m-85 -89.91 130.48 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.23 111.099 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 p -120.46 175.32 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.19 110.728 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.8 m -54.91 -31.12 59.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.285 -0.416 . . . . 0.78 111.363 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -44.91 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 1.2 111.078 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.67 108.41 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.012 0.434 . . . . 0.2 110.895 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -74.87 163.45 27.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.788 -0.642 . . . . 2.74 109.717 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG2' HG13 ' A' ' 46' ' ' VAL . 15.1 ttm105 -88.64 152.86 21.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.747 0.647 . . . . 3.44 112.747 -178.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -157.52 139.61 14.35 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.342 -0.844 . . . . 0.22 110.369 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -106.7 155.41 19.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.975 0.417 . . . . 1.16 111.573 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.11 129.85 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.132 -0.692 . . . . 0.11 109.132 179.15 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -62.27 -17.76 59.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.817 0.673 . . . . 2.39 112.817 -177.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.549 ' ND2' HG11 ' A' ' 69' ' ' VAL . 66.1 m-80 -92.97 -69.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.665 0.269 . . . . 0.57 111.698 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.3 p -79.57 -41.36 27.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.519 -0.31 . . . . 0.11 111.52 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.448 ' HA3' ' C ' ' A' ' 13' ' ' GLY . . . 96.46 -13.02 66.07 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.416 -0.897 . . . . 0.1 113.497 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -58.6 163.55 3.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.761 -0.459 . . . . 0.4 109.761 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 47' ' ' LEU . 67.9 t -82.41 132.68 30.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.487 -0.485 . . . . 0.17 110.47 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 46' ' ' VAL . 3.3 mm? -133.79 142.68 47.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.13 110.875 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.1 p -82.45 -173.01 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.907 -0.588 . . . . 0.15 110.302 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.38 -57.95 16.96 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.604 -0.808 . . . . 0.16 112.925 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -52.66 -51.36 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.915 0.388 . . . . 1.15 111.606 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.43 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.6 m -66.98 -24.3 66.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.999 -0.546 . . . . 0.14 111.996 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -115.06 45.48 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.541 . . . . 0.15 110.645 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -97.64 -25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 2.44 110.815 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -73.92 169.79 16.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.324 0.583 . . . . 0.62 112.299 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -145.76 138.92 26.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.225 -0.898 . . . . 2.76 109.805 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.17 137.57 6.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.09 111.324 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.12 148.99 46.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.19 110.257 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.558 HG23 HD21 ' A' ' 77' ' ' LEU . 3.2 mt -126.59 76.57 74.11 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.595 -0.275 . . . . 0.2 111.234 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.78 -26.53 79.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.403 2.069 . . . . 0.36 112.543 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.6 mtp -71.87 -30.85 65.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.425 -0.352 . . . . 1.96 110.759 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' HG2' HG22 ' A' ' 58' ' ' ILE . 15.5 mmm180 -101.3 21.69 13.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.346 -0.388 . . . . 1.43 111.671 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.33 68.65 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.67 -0.776 . . . . 0.52 113.268 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.497 ' CD1' HD12 ' A' ' 58' ' ' ILE . 33.1 mt -122.65 88.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.794 0.33 . . . . 0.17 110.671 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.56 -14.41 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.202 0.445 . . . . 0.27 112.202 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -101.49 147.96 34.54 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 121.22 -0.192 . . . . 2.02 110.908 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.32 120.59 8.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.13 1.887 . . . . 0.46 112.085 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' HG21 ' A' ' 63' ' ' ILE . 69.9 mm-40 -125.78 164.07 21.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.047 0.451 . . . . 1.46 111.048 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.08 136.58 41.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.816 -0.629 . . . . 2.42 112.531 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.549 HG11 ' ND2' ' A' ' 42' ' ' ASN . 33.4 m -144.31 -172.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.105 -0.952 . . . . 0.19 109.534 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 3.9 p -100.02 -157.18 0.59 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.186 -0.302 . . . . 0.16 110.186 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.43 -50.36 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.852 -0.339 . . . . 1.63 111.025 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.52 -64.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.12 110.959 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 62.5 m -50.55 -39.67 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.16 111.813 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -59.76 -34.16 72.62 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.108 -0.701 . . . . 0.27 109.108 177.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 79' ' ' SER . 8.3 mt -80.69 -44.03 19.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.229 -0.896 . . . . 0.26 109.473 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 73' ' ' CYS . . . -51.93 -50.76 60.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.634 -0.712 . . . . 0.19 110.727 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 58' ' ' ILE . 60.7 mt -64.56 -37.5 87.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.806 -0.813 . . . . 0.26 108.806 178.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -30.73 70.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.538 -0.912 . . . . 2.3 108.538 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 81' ' ' ASN . 1.9 m -61.34 -15.96 41.19 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.305 -0.861 . . . . 1.46 110.916 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 t -67.54 70.21 0.11 Allowed 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.729 -0.841 . . . . 3.14 108.729 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 79' ' ' SER . 0.7 OUTLIER -33.9 143.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.642 0.978 . . . . 6.23 113.642 -177.76 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 132.75 54.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.005 -0.998 . . . . 8.68 110.905 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.13 26.85 3.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.176 -0.466 . . . . 9.26 111.638 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.426 -1.208 . . . . 11.33 112.314 -179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.995 0.426 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.54 -11.76 18.69 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.138 2.559 . . . . 0.0 112.846 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.7 155.38 50.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -60.4 122.79 15.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.115 0.483 . . . . 0.0 111.827 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.5 m120 -61.68 -26.68 68.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.928 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 -56.39 2.16 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.221 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.3 p -104.63 -3.6 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.73 69.96 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.725 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -71.74 143.51 49.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.416 0.608 . . . . 0.0 110.251 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.39 137.5 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.796 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 93.9 m-85 -83.29 134.43 34.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.162 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.414 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 28.8 p -126.38 172.58 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.268 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.2 p -50.54 -40.84 52.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.003 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.9 p -75.85 -26.34 57.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.254 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 32' ' ' THR . 54.4 t -93.56 113.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.376 0.608 . . . . 0.0 111.392 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -73.63 143.73 46.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.106 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.515 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 23.7 ttm105 -86.29 142.14 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.629 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -144.01 169.19 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 111.607 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.551 ' CE1' HG22 ' A' ' 46' ' ' VAL . 93.8 m-70 -128.83 146.82 50.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.537 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.3 t -90.44 137.99 31.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -72.76 -6.88 47.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.936 ' OD1' HD13 ' A' ' 58' ' ' ILE . 73.4 m-20 -100.69 -70.27 0.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.502 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.4 p -76.44 -23.78 53.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.91 21.98 79.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.39 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.502 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 21.2 m-85 -98.07 160.81 14.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 110.236 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.827 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.4 t -75.96 128.97 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.166 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.891 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.2 mm? -133.43 138.58 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.45 176.32 8.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.756 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.08 -52.8 41.1 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.225 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 95.0 m-20 -55.83 -35.84 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.891 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.32 -1.7 58.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.462 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -131.99 28.65 4.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 73.3 mtm180 -84.71 -16.39 41.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.227 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -81.31 164.7 22.0 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.5 136.18 32.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.527 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.96 154.34 25.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.793 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.9 154.0 20.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.936 HD13 ' OD1' ' A' ' 42' ' ' ASN . 2.3 mt -130.3 79.77 71.91 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 110.939 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.06 -8.96 19.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.179 2.586 . . . . 0.0 114.19 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.08 -37.83 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 109.193 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' A' ' 58' ' ' ILE . 14.2 mmm180 -83.03 1.04 42.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.454 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.13 6.94 61.3 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.924 HD12 HD12 ' A' ' 58' ' ' ILE . 75.6 mt -96.2 102.35 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.214 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -88.08 -18.54 28.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 56.0 mm-40 -103.06 142.53 24.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -56.43 124.0 15.21 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.674 1.583 . . . . 0.0 111.819 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.7 mm-40 -124.74 166.81 15.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -70.56 136.71 49.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.618 0.723 . . . . 0.0 111.639 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.607 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.3 m -145.24 -179.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.976 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.437 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.56 -168.35 1.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -76.26 -43.71 40.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.22 72.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 52.8 m -63.84 -40.57 96.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.743 0.306 . . . . 0.0 110.41 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 76.6 t80 -56.79 -39.6 74.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.1 mt -72.9 -52.49 14.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.536 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.02 -48.27 52.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.385 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.136 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.47 -15.4 24.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.9 2.4 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.33 156.88 48.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 29' ' ' CYS . 8.1 t -63.99 124.98 22.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.1 m-80 -60.28 -26.56 66.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.969 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.45 -55.92 2.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.444 -0.884 . . . . 0.0 114.341 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -105.23 -0.29 26.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.83 9.07 58.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.562 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 24' ' ' CYS . 6.0 p -69.52 143.52 53.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.226 0.513 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.99 138.98 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 92.2 m-85 -84.18 136.04 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.375 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -127.74 171.61 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.105 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -47.47 -41.1 19.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.808 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.1 p -73.54 -24.84 60.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.641 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -97.89 113.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.738 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.72 150.25 37.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.533 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.472 ' HG3' HG13 ' A' ' 46' ' ' VAL . 14.7 ttp180 -80.18 141.54 35.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 0.0 110.598 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -139.96 160.95 38.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.665 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' CE1' HG22 ' A' ' 46' ' ' VAL . 89.9 m-70 -128.49 146.05 50.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.523 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.9 t -91.33 136.2 33.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.527 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tpt180 -72.33 -4.63 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.91 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.1 m-20 -101.65 -71.54 0.71 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -76.51 -24.04 53.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.77 78.55 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.79 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.1 m-85 -99.01 160.91 13.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.868 ' C ' HD22 ' A' ' 47' ' ' LEU . 77.5 t -78.36 128.75 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.868 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.4 mm? -131.45 140.83 49.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.354 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.85 178.37 8.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.608 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -55.59 -52.15 50.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.43 -1.367 . . . . 0.0 112.047 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -54.67 -34.88 62.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.794 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -91.81 -2.23 57.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -132.3 28.93 4.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 12.9 mmt85 -84.68 -17.88 37.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.324 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -79.53 165.62 22.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.226 0.536 . . . . 0.0 111.475 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -141.37 134.71 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.01 153.41 26.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.658 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -86.48 158.0 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.91 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.4 mt -134.15 78.37 58.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.919 0.39 . . . . 0.0 110.555 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.82 -12.14 32.74 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.265 2.644 . . . . 0.0 114.066 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.9 mmm -85.31 -38.29 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.554 ' HG2' HG22 ' A' ' 58' ' ' ILE . 13.9 mmm180 -83.86 1.76 41.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.673 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 9.22 60.39 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.686 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.792 HD12 HD12 ' A' ' 58' ' ' ILE . 61.8 mt -100.58 99.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.849 0.356 . . . . 0.0 110.356 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.4 p -85.04 -16.99 38.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.785 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.6 mt-10 -102.81 145.06 29.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 14.7 Cg_endo -58.67 124.11 15.05 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.416 1.411 . . . . 0.0 111.657 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' CG ' HG21 ' A' ' 63' ' ' ILE . 76.4 mm-40 -124.85 167.78 14.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.747 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -72.06 137.2 46.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.652 0.739 . . . . 0.0 111.916 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.646 HG11 ' ND2' ' A' ' 42' ' ' ASN . 35.1 m -146.83 -178.06 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.126 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.475 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -96.4 -162.88 0.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -82.62 -42.67 17.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.67 75.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 111.691 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 37.0 m -63.19 -40.38 97.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.533 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 72.4 t80 -57.32 -38.97 74.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.66 -51.67 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.506 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.7 78.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.165 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.437 HD11 ' ND2' ' A' ' 42' ' ' ASN . 88.6 mt . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 121.503 0.668 . . . . 0.0 109.346 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.07 -12.29 27.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.07 2.514 . . . . 0.0 112.68 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.13 156.39 48.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.3 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 18.4 t -64.54 125.29 24.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.174 0.511 . . . . 0.0 111.437 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.475 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 70.0 m-80 -59.5 -26.44 65.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.031 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.72 -55.46 2.15 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.165 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.8 p -102.92 -4.7 24.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.37 10.98 71.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.41 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 12.8 p -71.65 142.67 49.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.317 0.559 . . . . 0.0 110.278 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.78 137.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.534 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.86 134.53 34.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.276 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -127.26 169.61 13.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.954 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.6 m -46.84 -42.16 16.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.96 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.1 m -68.54 -36.09 78.34 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.316 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -90.65 113.67 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.338 0.59 . . . . 0.0 111.463 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.33 148.72 39.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.008 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.1 ttp85 -78.97 139.54 38.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.0 m-70 -141.94 162.74 34.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 46' ' ' VAL . 89.5 m-70 -129.54 146.57 51.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.642 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 t -91.6 137.91 31.99 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -73.42 -5.47 40.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.943 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.0 m-20 -100.9 -72.06 0.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.613 0.244 . . . . 0.0 111.624 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.4 p -75.81 -24.89 55.93 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.24 21.63 78.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.746 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 26.1 m-85 -98.85 161.85 13.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.935 0.398 . . . . 0.0 110.459 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.85 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.2 t -78.44 128.93 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.076 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.85 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.2 mm? -131.41 139.07 49.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.44 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 p -75.64 177.09 7.06 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.73 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.48 -53.07 40.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.241 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 86.3 m-20 -55.53 -35.65 65.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.713 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.67 -2.03 58.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.317 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.1 p -132.55 27.62 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt180 -82.85 -17.85 42.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.139 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -79.47 165.06 23.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.281 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -140.82 136.0 31.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.424 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.39 154.48 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -92.25 150.8 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.943 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.0 mt -127.3 81.31 70.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 111.058 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.63 -9.98 22.77 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.206 2.604 . . . . 0.0 113.828 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -89.75 -36.89 14.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 109.263 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.525 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 5.3 mmm180 -86.79 15.57 5.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.677 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.02 10.34 85.1 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.854 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.928 HD12 HD12 ' A' ' 58' ' ' ILE . 74.8 mt -101.44 102.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -88.3 -19.11 27.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.588 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mt-10 -103.17 146.61 32.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.4 Cg_endo -59.14 123.47 13.52 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.62 1.546 . . . . 0.0 111.71 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.3 mm-40 -124.53 166.73 15.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -71.47 137.29 48.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.624 0.726 . . . . 0.0 112.0 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.621 HG11 ' ND2' ' A' ' 42' ' ' ASN . 30.0 m -145.5 -178.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.872 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.508 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -96.47 -166.45 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 55.6 t0 -78.89 -45.16 21.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.14 80.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.4 m -63.82 -41.25 97.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.388 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.7 t80 -56.38 -40.07 73.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.6 mt -71.7 -52.3 18.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.11 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.15 -48.67 53.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.496 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.42 HD21 HG23 ' A' ' 58' ' ' ILE . 58.9 mt . . . . . 0 C--N 1.325 -0.465 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.415 ' HB3' HG21 ' A' ' 46' ' ' VAL . . . . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.981 0.42 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.61 -14.94 30.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.942 2.428 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.93 156.95 47.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.459 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -63.11 124.79 22.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.144 0.497 . . . . 0.0 111.439 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 66.1 m-80 -60.15 -26.21 66.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.289 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.82 2.25 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.343 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.4 p -104.42 -3.05 24.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.86 10.48 67.98 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.527 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.1 p -71.9 143.99 49.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.269 0.534 . . . . 0.0 110.168 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.93 138.77 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.469 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.559 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.7 m-85 -84.46 135.56 34.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -127.98 168.0 15.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.2 m -46.12 -43.78 15.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.312 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.13 -36.96 84.52 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.0 t -88.6 113.89 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -73.78 146.07 44.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.362 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.433 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 21.8 ttp-105 -80.33 140.11 36.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.441 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -142.11 164.64 29.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.6 ' CE1' HG22 ' A' ' 46' ' ' VAL . 93.2 m-70 -130.79 147.44 52.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.568 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.7 t -90.23 137.0 32.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' A' ' 67' ' ' GLU . 53.2 mtp85 -71.43 -6.36 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.875 ' ND2' HD13 ' A' ' 58' ' ' ILE . 15.6 m-80 -102.88 -70.0 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.4 p -74.44 -24.81 59.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.783 0.325 . . . . 0.0 111.579 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.33 79.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.686 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.545 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 27.8 m-85 -97.0 164.37 12.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 110.682 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.86 ' C ' HD22 ' A' ' 47' ' ' LEU . 62.2 t -80.83 128.4 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.059 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.5 mm? -132.12 137.62 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.5 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.1 p -77.32 173.33 12.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.771 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.11 -54.33 19.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.23 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 75.9 m-20 -54.92 -35.85 64.61 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.788 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.37 -1.82 58.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.22 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.1 p -131.16 25.22 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.771 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 57.9 mtm180 -80.36 -18.65 48.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.805 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -79.42 164.79 23.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.006 0.431 . . . . 0.0 111.157 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -143.1 138.15 29.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -161.5 155.56 22.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.912 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.476 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -82.45 159.48 22.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.875 HD13 ' ND2' ' A' ' 42' ' ' ASN . 1.3 mt -134.49 75.41 63.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -12.93 35.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.42 2.747 . . . . 0.0 114.34 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.8 mtt -87.05 -36.84 17.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.682 ' HG2' HG22 ' A' ' 58' ' ' ILE . 29.0 mmm180 -83.74 5.73 23.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.73 10.66 64.8 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.501 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.784 HD12 HD12 ' A' ' 58' ' ' ILE . 70.2 mt -102.21 102.54 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 0.0 110.363 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.9 p -87.83 -16.63 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.601 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 mt-10 -104.56 142.79 25.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 11.4 Cg_endo -55.13 122.57 11.94 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.879 1.719 . . . . 0.0 112.034 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.9 mm-40 -125.15 167.31 14.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.432 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -72.46 140.11 48.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.567 0.699 . . . . 0.0 111.898 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 m -147.3 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.085 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.512 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.9 p -93.48 -162.36 0.93 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.71 -41.74 17.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.97 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.586 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.14 -41.61 97.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 0.0 110.202 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.521 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 87.6 t80 -55.88 -40.61 73.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.51 -49.49 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.586 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.45 79.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.855 HD11 HD21 ' A' ' 42' ' ' ASN . 77.4 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.024 0.44 . . . . 0.0 110.816 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.908 0.385 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.07 -15.23 32.24 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.1 2.533 . . . . 0.0 112.651 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.68 46.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.401 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 10.2 t -62.3 122.48 15.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.761 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.5 m120 -61.12 -25.9 67.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.32 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.18 -55.76 2.3 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.51 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p -104.24 -2.65 25.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.13 7.97 64.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.253 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -69.6 143.0 53.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.099 0.449 . . . . 0.0 110.162 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.71 137.4 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.714 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 92.5 m-85 -82.08 133.12 35.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.386 0.612 . . . . 0.0 109.886 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.416 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 17.2 p -124.7 173.03 8.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.174 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.1 p -50.4 -38.94 45.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.98 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 p -79.18 -22.91 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.651 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 32' ' ' THR . 41.8 t -96.03 113.12 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.629 . . . . 0.0 111.488 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -73.32 143.64 46.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.204 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.435 ' NH1' ' O ' ' A' ' 21' ' ' ALA . 56.9 ttm-85 -84.71 141.14 30.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.428 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.3 m-70 -143.48 167.93 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.444 ' NE2' HG22 ' A' ' 46' ' ' VAL . 78.9 m80 -130.71 147.97 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.596 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.8 t -89.57 137.27 32.47 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 67' ' ' GLU . 92.6 mtt-85 -72.74 -6.34 43.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.932 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.2 m-20 -100.71 -70.26 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.571 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.99 -24.57 55.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.68 21.92 78.88 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.722 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.8 162.4 13.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.801 0.334 . . . . 0.0 110.512 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.849 ' C ' HD22 ' A' ' 47' ' ' LEU . 87.0 t -78.35 128.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.226 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.849 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.0 mm? -132.64 139.52 47.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -77.54 175.04 10.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.703 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.76 -52.87 35.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.673 -1.251 . . . . 0.0 112.358 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 93.2 m-20 -55.67 -35.84 66.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.802 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.16 -2.34 58.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.24 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -131.78 27.3 4.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 74.9 mtt180 -82.19 -20.13 38.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.369 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -76.99 163.06 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 111.212 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -139.59 136.55 34.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.222 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -160.15 153.97 22.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -87.3 153.14 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 63' ' ' ILE . 3.1 mt -129.25 77.6 77.33 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 110.808 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.8 -8.49 15.78 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 123.138 2.559 . . . . 0.0 113.894 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mmm -89.7 -37.87 14.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.0 109.36 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 2.8 mmm180 -84.31 2.71 38.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.441 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.25 7.68 61.98 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.535 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 58' ' ' ILE . 72.7 mt -97.86 102.06 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.193 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.3 p -87.59 -17.43 31.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 mt-10 -103.11 142.01 23.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 32.2 Cg_exo -56.16 124.38 16.12 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.725 1.616 . . . . 0.0 112.061 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.4 mm-40 -126.41 166.85 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -69.25 136.44 51.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.473 0.654 . . . . 0.0 111.707 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.582 HG11 ' ND2' ' A' ' 42' ' ' ASN . 28.4 m -148.92 161.1 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.844 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.48 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -75.44 -168.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 55.3 p30 -81.15 -40.3 24.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.93 -44.41 73.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 111.37 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 64.3 m -63.91 -40.92 97.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 38.0 t80 -57.22 -41.09 78.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.9 mt -69.2 -49.05 60.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.748 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.91 83.15 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.439 HD11 ' ND2' ' A' ' 42' ' ' ASN . 93.4 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.55 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.041 0.448 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.36 -15.69 25.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.913 2.409 . . . . 0.0 112.215 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.93 155.9 49.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.919 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.6 t -61.73 124.26 20.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 111.904 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 53.5 m-80 -61.41 -27.69 68.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.134 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 -56.05 2.5 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.619 -0.801 . . . . 0.0 114.716 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 p -105.56 -0.69 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.15 63.21 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.718 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 14.0 p -71.44 144.91 49.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.409 0.605 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.96 140.33 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 81.2 m-85 -84.81 135.63 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.344 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.0 p -126.89 167.06 16.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -45.36 -41.67 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -70.5 -34.81 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.32 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.64 114.18 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.503 0.668 . . . . 0.0 111.554 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -78.72 150.19 32.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.669 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -90.34 142.53 27.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.137 0.494 . . . . 0.0 110.454 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.9 m-70 -139.7 168.14 20.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.129 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.72 143.93 49.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.757 0.313 . . . . 0.0 111.309 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.4 t -90.72 137.87 32.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -72.97 -5.22 37.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.946 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.7 -72.21 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.785 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.0 p -77.09 -24.44 51.8 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.77 77.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.86 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.94 164.02 12.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.814 ' C ' HD22 ' A' ' 47' ' ' LEU . 60.9 t -80.8 128.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.814 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -130.7 137.64 49.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.348 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.27 174.29 8.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.756 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.08 -53.01 32.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.421 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 70.5 m-20 -56.26 -36.09 68.17 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.731 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -86.91 -3.33 59.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.135 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.2 p -131.66 26.03 4.71 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 70.8 mtp85 -82.21 -16.97 47.76 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.972 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -80.38 166.14 21.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -142.53 135.2 28.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.245 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.28 153.23 25.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.697 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.44 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.06 154.61 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.946 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.7 mt -131.35 81.11 66.24 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.997 0.427 . . . . 0.0 110.733 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.16 -8.12 19.29 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.981 2.454 . . . . 0.0 113.907 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.4 mtp -89.37 -37.12 15.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.531 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 13.7 mmm180 -84.83 4.0 35.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.19 4.42 66.64 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.533 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.863 HD12 HD12 ' A' ' 58' ' ' ILE . 74.2 mt -94.65 97.82 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.356 . . . . 0.0 110.157 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -84.66 -18.51 35.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 63' ' ' ILE . 2.5 mt-10 -103.84 146.4 32.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.9 Cg_endo -57.89 123.84 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.029 1.819 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 80.5 mm-40 -126.42 167.52 15.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -71.76 137.49 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.732 0.777 . . . . 0.0 112.202 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.684 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.2 m -146.66 179.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.051 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.498 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -92.71 -162.25 0.91 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -83.51 -44.04 15.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.92 80.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.806 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.7 m -64.03 -40.99 97.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 77.5 t80 -55.8 -40.78 73.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.3 mt -71.35 -53.99 12.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.34 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.9 -48.61 42.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.374 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 58' ' ' ILE . 72.3 mt . . . . . 0 C--N 1.325 -0.5 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.007 0.432 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.87 -10.09 21.27 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.137 2.558 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -135.99 158.01 45.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.366 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 6.8 t -63.18 125.06 22.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 31.8 m120 -63.51 -25.49 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.364 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.28 -56.66 2.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.684 -0.77 . . . . 0.0 114.679 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 p -105.09 -1.85 25.07 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.05 65.77 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.423 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.4 p -67.09 143.89 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.257 0.528 . . . . 0.0 109.639 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.7 OUTLIER -84.25 143.44 11.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.649 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 94.5 m-85 -84.28 134.82 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.7 p -126.45 168.75 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.061 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.04 -44.7 31.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.356 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 m -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.562 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -87.96 113.04 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.364 0.602 . . . . 0.0 111.54 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -73.85 149.28 41.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.126 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.476 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 20.2 ttp180 -81.74 140.9 34.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.2 m-70 -142.23 165.89 26.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.144 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.558 ' CE1' HG22 ' A' ' 46' ' ' VAL . 96.7 m-70 -131.35 147.63 52.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 t -90.77 136.7 32.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.449 ' NE ' ' OE1' ' A' ' 67' ' ' GLU . 68.6 mtp85 -72.45 -5.45 36.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.91 ' ND2' HD13 ' A' ' 58' ' ' ILE . 14.7 m-80 -101.67 -70.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.9 p -75.0 -24.84 58.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.4 77.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.637 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.501 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.92 163.19 12.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.877 ' C ' HD22 ' A' ' 47' ' ' LEU . 88.6 t -79.72 128.86 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.877 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.3 mm? -132.98 140.64 47.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.89 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 p -82.55 175.13 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.643 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -52.13 -52.65 34.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.127 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -53.85 -36.3 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.866 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -92.32 -1.26 57.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.703 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -132.47 25.91 4.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 110.089 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 19.6 mmt180 -79.23 -22.99 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -76.33 165.06 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.446 0.641 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -139.7 134.05 31.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.017 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.38 155.16 26.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.54 159.44 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.91 HD13 ' ND2' ' A' ' 42' ' ' ASN . 1.1 mt -133.12 74.96 72.33 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.092 0.473 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.95 -14.15 39.44 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.423 2.749 . . . . 0.0 114.491 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.3 mtm -86.54 -37.35 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.674 ' HG2' HG22 ' A' ' 58' ' ' ILE . 18.3 mmm180 -83.01 3.68 29.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.857 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.07 61.84 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.408 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.699 HD12 HD12 ' A' ' 58' ' ' ILE . 63.7 mt -101.24 101.25 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.91 0.386 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -87.73 -16.01 35.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.434 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 63' ' ' ILE . 3.7 mp0 -103.19 145.2 30.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.0 Cg_endo -58.57 121.87 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.615 1.544 . . . . 0.0 112.005 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.637 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.7 mt-10 -125.49 168.74 13.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.702 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.489 ' NH1' ' HB3' ' A' ' 68' ' ' ARG . 5.1 ptp180 -72.37 137.28 46.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.741 0.782 . . . . 0.0 112.333 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.403 ' CG1' HD22 ' A' ' 42' ' ' ASN . 21.5 m -145.41 -177.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.897 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.53 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -97.29 -162.14 0.93 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -82.81 -43.91 16.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.09 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 111.53 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -64.15 -40.53 96.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.289 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.616 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 79.8 t80 -57.25 -41.29 79.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.5 mt -70.64 -50.94 31.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.872 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.21 -48.33 54.34 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.824 HD11 HD21 ' A' ' 42' ' ' ASN . 44.8 mt . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.024 0.44 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.3 -12.3 25.24 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.056 2.504 . . . . 0.0 112.549 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.57 48.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.166 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 15.5 t -62.57 123.44 18.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.0 111.683 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.9 m120 -60.36 -26.79 66.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 -55.88 2.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.429 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.98 -3.15 25.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.41 8.96 67.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.437 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 12.4 p -70.01 142.69 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.208 0.504 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.95 137.9 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.954 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 84.6 m-85 -83.73 134.64 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.5 p -127.48 171.2 11.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -46.9 -39.63 12.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 p -75.74 -25.45 56.55 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.828 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.9 t -96.74 112.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.36 0.6 . . . . 0.0 111.271 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -75.45 147.74 39.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.644 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.6 ttp85 -81.93 140.34 34.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.768 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -141.96 163.9 31.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.232 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -129.26 146.57 51.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.5 t -91.19 138.03 31.91 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -73.03 -5.43 38.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.94 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.2 m-20 -101.46 -71.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.1 p -76.94 -24.41 52.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.12 22.09 78.24 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.547 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.8 m-85 -98.17 161.2 13.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.896 0.379 . . . . 0.0 110.454 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.881 ' C ' HD22 ' A' ' 47' ' ' LEU . 95.5 t -77.62 128.86 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.881 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.7 mm? -132.2 139.15 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -78.88 175.94 10.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.754 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.51 -53.95 29.7 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.764 -1.207 . . . . 0.0 112.333 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -54.83 -35.53 64.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.761 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -90.33 -1.94 57.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.441 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 p -131.3 26.25 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.754 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 94.6 mtt-85 -80.96 -19.39 44.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.117 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -80.58 163.41 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.19 0.519 . . . . 0.0 111.438 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 mtm105 -139.36 136.99 35.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.274 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.49 154.62 27.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.95 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.97 151.77 20.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.94 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.3 mt -128.39 79.32 74.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.026 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.89 -9.97 20.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.217 2.611 . . . . 0.0 114.044 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 71.8 mtm -88.33 -37.87 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.5 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 30.8 mmm180 -83.17 1.01 42.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.441 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.42 60.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.904 HD12 HD12 ' A' ' 58' ' ' ILE . 74.1 mt -96.64 101.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.398 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.3 p -88.25 -18.94 27.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.384 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 3.5 mm-40 -103.69 138.53 19.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.4 Cg_exo -52.99 124.3 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.692 1.595 . . . . 0.0 112.044 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.618 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.6 mt-10 -125.64 167.43 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -69.94 136.25 50.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 111.966 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.594 HG11 ' ND2' ' A' ' 42' ' ' ASN . 29.0 m -145.27 179.48 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.982 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.482 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.89 -166.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 56.3 p30 -79.36 -42.68 25.06 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -67.9 -45.95 72.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 111.7 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.2 m -63.63 -41.43 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.302 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 68.9 t80 -56.32 -40.36 74.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 mt -72.55 -50.65 24.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.245 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.95 62.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.667 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--N 1.324 -0.514 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.036 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.973 0.416 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.67 -13.28 18.11 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.101 2.534 . . . . 0.0 112.644 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.64 155.82 49.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.438 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.7 t -59.62 123.93 18.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 111.552 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 29.5 m120 -60.83 -28.08 68.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.086 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.15 -54.77 2.36 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.329 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 p -103.68 -4.03 24.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.08 7.75 63.37 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.628 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p -69.88 144.16 52.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.264 0.532 . . . . 0.0 110.301 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.78 137.66 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.978 0.418 . . . . 0.0 112.066 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.652 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.41 134.59 34.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.213 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -128.04 170.78 12.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -49.3 -43.85 43.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.35 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.5 m -66.53 -35.82 81.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.65 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.6 t -89.59 112.66 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.288 0.566 . . . . 0.0 111.364 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -73.08 145.76 46.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.846 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.491 HH11 HG11 ' A' ' 46' ' ' VAL . 58.5 ttm-85 -83.81 141.34 31.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.656 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 99.8 m-70 -143.66 166.25 25.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.616 ' NE2' HG22 ' A' ' 46' ' ' VAL . 76.3 m80 -130.86 148.85 52.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.02 137.52 32.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 29.2 tpt180 -71.73 -7.18 46.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.861 ' OD1' HD13 ' A' ' 58' ' ' ILE . 68.6 m-20 -100.7 -69.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.3 p -76.98 -23.08 52.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.61 21.5 79.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.504 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.68 161.41 13.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.794 0.33 . . . . 0.0 110.252 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.84 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.2 t -79.21 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.24 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.878 HD12 ' HB3' ' A' ' 51' ' ' CYS . 2.4 mm? -132.41 141.01 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.743 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.2 p -79.45 177.81 8.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.88 -52.78 44.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.459 -1.353 . . . . 0.0 112.242 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -55.59 -35.58 65.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.878 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.15 -1.81 58.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.8 p -132.02 25.8 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 84.3 mtt-85 -79.88 -19.18 48.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.039 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -80.06 164.21 23.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.263 0.554 . . . . 0.0 111.771 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.76 135.91 31.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.284 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.82 155.1 27.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.473 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.46 154.45 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.861 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.6 mt -129.97 80.37 71.29 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 0.0 110.58 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.99 -12.02 33.56 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.242 2.628 . . . . 0.0 114.189 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.3 mtp -86.4 -37.3 18.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.533 ' HG2' HG22 ' A' ' 58' ' ' ILE . 31.9 mmm180 -83.69 2.78 36.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.747 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.45 63.32 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.193 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.857 HD12 HD12 ' A' ' 58' ' ' ILE . 65.9 mt -97.87 100.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.79 -17.31 33.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.693 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mm-40 -103.26 143.92 27.59 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.0 Cg_endo -57.13 123.29 13.49 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.618 1.545 . . . . 0.0 111.698 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -123.72 167.76 13.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.837 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.38 135.79 47.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.695 0.759 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.623 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -146.0 -177.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.103 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.504 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 2.0 p -98.09 -162.7 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 53.9 p30 -82.97 -41.58 18.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.62 -46.23 69.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 111.541 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 65.3 m -64.01 -40.34 96.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.225 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.6 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 73.2 t80 -57.1 -40.42 76.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.1 mt -72.67 -52.92 13.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.46 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.64 -48.22 49.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 ' ND2' ' A' ' 42' ' ' ASN . 83.3 mt . . . . . 0 C--N 1.325 -0.483 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HB3' HG21 ' A' ' 46' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 121.048 0.451 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.64 -13.97 14.43 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.159 2.573 . . . . 0.0 113.181 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.58 48.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -59.65 125.82 25.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 112.051 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 36.2 m-80 -62.66 -27.76 69.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.37 -54.42 2.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.101 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.6 p -103.46 -3.77 24.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.83 11.64 66.51 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.611 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 5.3 p -72.55 143.86 48.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.492 0.646 . . . . 0.0 110.485 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.68 137.14 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.613 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 98.1 m-85 -82.56 135.06 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.863 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 169.44 12.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.28 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -47.19 -43.22 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 m -67.78 -37.91 82.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 48' ' ' CYS . 62.4 t -87.2 113.06 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.353 0.597 . . . . 0.0 111.311 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -74.08 149.79 40.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.763 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG3' HG13 ' A' ' 46' ' ' VAL . 64.8 ttp85 -80.95 138.77 36.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.802 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 89.1 m-70 -142.76 165.12 28.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.129 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -128.18 146.58 50.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.725 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.0 t -90.3 137.47 32.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -72.57 -7.37 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.932 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.7 m-20 -101.21 -71.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.2 p -75.08 -24.04 58.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.695 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.66 20.86 79.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.734 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -99.07 163.24 12.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.953 0.406 . . . . 0.0 110.609 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.813 ' C ' HD22 ' A' ' 47' ' ' LEU . 89.6 t -76.74 128.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.406 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.878 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.1 mm? -133.06 139.45 47.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.654 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.406 ' HB2' HG11 ' A' ' 35' ' ' VAL . 14.1 p -79.69 175.54 10.52 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.73 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.46 -53.59 34.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.307 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.37 -36.14 63.55 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.878 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.65 -1.89 58.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.1 p -132.39 26.78 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 90.6 mtt-85 -80.22 -19.24 47.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -79.59 164.61 23.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.153 0.501 . . . . 0.0 111.628 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.45 ' NH1' ' HB3' ' A' ' 55' ' ' ARG . 15.9 mtp-105 -140.85 137.93 33.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.84 154.3 23.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.863 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.75 147.82 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.004 HD12 HD12 ' A' ' 63' ' ' ILE . 2.8 mt -126.97 77.69 74.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.821 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.74 -8.18 12.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 123.393 2.729 . . . . 0.0 113.8 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.3 mtp -96.0 -34.99 11.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.766 0.793 . . . . 0.0 109.099 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 40.5 mtp85 -90.01 29.47 1.21 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.289 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.14 23.02 71.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.075 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.004 HD12 HD12 ' A' ' 58' ' ' ILE . 71.5 mt -119.44 101.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.748 0.309 . . . . 0.0 110.394 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.91 -22.86 24.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.817 0.341 . . . . 0.0 111.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.6 mm-40 -99.74 138.49 20.4 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 53.1 Cg_exo -52.72 123.04 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.4 1.4 . . . . 0.0 111.693 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.667 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.4 mt-10 -124.64 165.69 17.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.562 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -69.56 139.12 53.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.645 0.736 . . . . 0.0 112.186 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.63 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -145.14 -179.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.91 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.496 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -96.26 -164.98 1.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -80.19 -43.8 20.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.84 79.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.734 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.8 m -65.23 -40.1 93.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.377 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -57.17 -41.83 79.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.43 -50.56 37.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.272 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.18 61.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.399 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.528 HD11 ' OD1' ' A' ' 42' ' ' ASN . 33.9 mt . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.134 0.492 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.21 -11.08 17.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.245 2.63 . . . . 0.0 112.952 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 156.41 48.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.461 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.8 t -59.58 123.76 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.147 0.499 . . . . 0.0 111.872 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.54 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 m-80 -61.81 -27.69 68.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.969 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.86 -54.73 2.41 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.104 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 p -104.09 -3.19 24.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 69.14 9.08 59.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.466 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 p -70.59 144.79 51.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.156 0.478 . . . . 0.0 110.164 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -81.95 136.62 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.144 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.676 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 99.0 m-85 -82.41 134.9 35.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.959 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 p -126.55 168.24 14.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.8 m -47.41 -43.58 23.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.9 m -66.51 -38.06 86.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.71 113.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 0.0 111.174 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.85 145.6 46.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.049 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.474 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.5 ttm105 -83.24 140.76 32.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.572 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -143.06 167.25 22.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.441 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.452 ' CE1' HG22 ' A' ' 46' ' ' VAL . 96.7 m-70 -128.63 146.66 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.367 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.0 t -89.9 137.45 32.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.509 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 14.2 mmt180 -71.83 -7.67 49.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.948 ' OD1' HD13 ' A' ' 58' ' ' ILE . 75.0 m-20 -101.74 -70.33 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.538 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.7 p -75.83 -24.2 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.27 21.11 79.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.712 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.54 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 22.0 m-85 -98.72 161.49 13.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.732 0.301 . . . . 0.0 110.349 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.787 ' C ' HD22 ' A' ' 47' ' ' LEU . 73.0 t -75.4 128.96 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.7 mm? -132.54 139.42 47.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 p -80.04 174.33 11.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.753 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.66 -53.97 26.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.601 -1.285 . . . . 0.0 112.437 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -55.08 -35.32 64.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.934 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.62 -2.51 58.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.426 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -132.55 26.47 4.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.753 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt-85 -80.49 -20.39 43.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.168 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -78.55 163.69 25.32 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 111.289 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -138.26 135.89 35.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.957 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -156.39 153.94 29.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.973 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.434 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -93.65 149.29 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.994 HD12 HD12 ' A' ' 63' ' ' ILE . 2.1 mt -128.96 76.75 78.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.075 0.464 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.12 -8.43 12.12 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.329 2.686 . . . . 0.0 113.693 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.87 -35.66 11.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.708 0.766 . . . . 0.0 108.949 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.535 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 7.6 mtp-105 -90.28 29.06 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.002 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.45 72.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.11 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.994 HD12 HD12 ' A' ' 58' ' ' ILE . 88.8 mt -123.52 97.93 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -86.84 -17.58 33.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.712 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.4 mt-10 -102.17 141.13 21.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 40.3 Cg_exo -55.39 122.52 11.88 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.492 1.461 . . . . 0.0 111.694 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.718 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.3 mt-10 -125.52 166.64 16.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -69.36 137.09 52.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.598 0.713 . . . . 0.0 111.984 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.594 HG11 ' ND2' ' A' ' 42' ' ' ASN . 26.9 m -145.89 -179.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.027 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 1.9 p -96.89 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -78.08 -42.31 32.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.76 -45.72 70.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 38.4 m -64.38 -41.54 96.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.443 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.557 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 73.4 t80 -56.17 -39.59 72.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.0 mt -72.89 -54.56 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.454 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.54 -48.11 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.364 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.416 HD11 ' OD1' ' A' ' 42' ' ' ASN . 82.6 mt . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 121.027 0.442 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.99 -11.85 21.5 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.039 2.493 . . . . 0.0 112.592 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.75 156.01 49.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.218 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 8.6 t -62.83 123.93 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.174 0.511 . . . . 0.0 111.488 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.7 m120 -59.15 -27.01 65.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.084 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.11 -55.51 2.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.327 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -103.84 -2.61 26.02 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.74 8.91 61.36 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.3 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.8 p -69.51 143.09 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.22 0.51 . . . . 0.0 110.009 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -80.08 137.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.905 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 87.0 m-85 -84.33 134.93 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.7 p -127.74 171.51 11.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.308 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.25 -41.16 26.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.0 p -72.35 -28.05 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.8 t -94.9 113.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.634 . . . . 0.0 111.435 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.81 148.17 40.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.369 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 17.9 ttp180 -82.33 140.61 33.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.611 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.0 m-70 -142.23 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -130.43 147.09 52.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.6 t -89.37 138.38 31.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 24.6 tpt180 -72.55 -7.05 48.1 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.934 ' OD1' HD13 ' A' ' 58' ' ' ILE . 71.2 m-20 -100.66 -70.04 0.75 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 29.3 p -77.51 -23.86 50.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.28 22.13 79.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.397 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.4 m-85 -98.48 163.14 12.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.828 0.347 . . . . 0.0 110.314 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.871 ' C ' HD22 ' A' ' 47' ' ' LEU . 79.9 t -79.73 127.72 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.234 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.871 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.5 mm? -132.32 139.58 48.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.53 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.24 178.01 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.731 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.04 -53.8 35.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.481 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 82.8 m-20 -55.28 -35.77 65.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.739 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.48 -2.34 58.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.361 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -131.8 26.15 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 93.3 mtt-85 -79.54 -21.4 45.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.305 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -80.16 165.07 22.8 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.279 0.561 . . . . 0.0 111.613 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -140.59 138.09 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.388 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.584 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.37 154.16 26.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.834 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.89 154.99 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.934 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.2 mt -130.21 79.53 72.52 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.09 -11.17 26.21 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.174 2.583 . . . . 0.0 113.91 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.7 mtp -86.91 -37.79 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG2' HG22 ' A' ' 58' ' ' ILE . 14.9 mmm180 -84.74 4.24 33.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.78 8.82 63.27 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.476 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.859 HD12 HD12 ' A' ' 58' ' ' ILE . 67.0 mt -99.09 100.83 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.241 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.0 p -87.09 -16.79 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.54 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 34.3 mt-10 -103.81 145.0 29.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 17.0 Cg_endo -58.18 123.34 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.688 1.592 . . . . 0.0 111.723 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -124.84 167.71 14.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -71.01 136.46 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 0.0 111.658 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.63 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.0 m -147.08 -178.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.159 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.512 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.34 -164.96 1.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.88 -43.97 21.29 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.58 74.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 54.0 m -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.338 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.7 t80 -56.34 -39.05 72.2 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.0 -54.93 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.672 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.05 -47.87 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.294 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.406 HD11 ' OD1' ' A' ' 42' ' ' ASN . 91.8 mt . . . . . 0 C--N 1.325 -0.497 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 46' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 121.142 0.496 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.64 -13.39 29.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.069 2.513 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.94 156.14 49.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.18 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 10.3 t -62.41 123.01 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.648 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 68.1 m-80 -60.45 -25.66 66.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.282 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.89 -55.87 2.06 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.189 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.5 p -103.09 -4.45 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 10.06 72.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.469 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 8.5 p -71.1 142.61 50.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.355 0.577 . . . . 0.0 110.353 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.21 138.84 18.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.784 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.741 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.4 m-85 -83.85 134.17 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.473 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.4 p -127.89 171.67 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.2 m -48.26 -40.98 26.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 p -73.01 -27.68 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.391 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.1 t -94.61 112.66 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.419 0.628 . . . . 0.0 111.345 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -73.85 145.67 44.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.397 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.503 ' CD ' HG11 ' A' ' 46' ' ' VAL . 7.8 tpp180 -77.72 139.38 39.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 98.6 m-70 -142.72 161.9 36.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.221 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -129.96 147.19 51.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -89.9 137.85 31.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.3 -6.89 46.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.978 ' OD1' HD13 ' A' ' 58' ' ' ILE . 81.4 m-20 -101.54 -71.37 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.73 -24.07 56.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.97 22.14 79.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.371 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.522 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.2 m-85 -99.02 162.57 12.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.826 ' C ' HD22 ' A' ' 47' ' ' LEU . 89.6 t -78.47 128.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.826 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.2 mm? -132.31 137.86 47.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.2 176.8 8.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.58 -54.36 30.71 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -54.85 -35.28 63.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.783 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.55 -2.35 58.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.38 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -132.33 26.18 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.0 mtt-85 -78.7 -21.39 48.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -78.39 162.07 26.7 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -138.1 138.22 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.01 153.55 24.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.478 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.5 147.97 22.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.07 HD12 HD12 ' A' ' 63' ' ' ILE . 2.3 mt -126.93 76.97 75.39 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 110.95 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.87 -6.97 10.26 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.253 2.636 . . . . 0.0 113.735 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.8 mtm -95.75 -36.11 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.723 0.773 . . . . 0.0 109.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 45.1 mtp85 -90.03 29.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 22.67 72.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.278 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.07 HD12 HD12 ' A' ' 58' ' ' ILE . 76.3 mt -118.54 102.5 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 117.033 0.417 . . . . 0.0 110.544 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -87.52 -21.68 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.397 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 63' ' ' ILE . 4.2 mt-10 -100.36 145.79 30.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.7 Cg_endo -59.49 123.25 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.738 1.625 . . . . 0.0 111.45 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.749 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.5 mt-10 -125.78 165.7 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.924 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.58 137.2 54.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 0.0 112.067 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.575 HG11 HD21 ' A' ' 42' ' ' ASN . 32.3 m -145.06 177.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.976 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.488 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.43 -168.78 1.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.25 -42.82 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.01 73.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 54.5 m -64.13 -41.06 97.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.397 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 74.5 t80 -56.5 -39.79 73.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt -70.28 -49.94 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.621 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.13 86.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.492 HD11 ' OD1' ' A' ' 42' ' ' ASN . 93.6 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.832 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.807 0.337 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.39 -11.82 33.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.146 2.564 . . . . 0.0 112.819 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 158.28 44.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.529 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -60.46 124.73 21.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 111.872 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -61.65 -25.92 67.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.79 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.38 -56.32 2.17 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 p -105.42 -2.3 23.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.47 9.58 68.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.191 -1.005 . . . . 0.0 113.737 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.7 p -71.25 143.78 50.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.412 0.606 . . . . 0.0 110.143 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.42 136.95 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.97 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 93.8 m-85 -83.03 134.93 35.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.095 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -125.75 168.08 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -47.08 -43.71 20.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.207 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.3 m -66.68 -36.92 83.68 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.025 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 48' ' ' CYS . 64.3 t -88.74 113.85 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.402 0.62 . . . . 0.0 111.468 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -76.75 150.93 36.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.548 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' NH1' ' CD2' ' A' ' 31' ' ' PHE . 68.7 mtt-85 -88.24 141.51 28.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.68 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.2 m-70 -140.01 166.21 25.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.52 144.47 49.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.834 0.35 . . . . 0.0 111.517 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.88 137.34 32.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -71.98 -6.22 40.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.939 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.7 m-20 -101.28 -71.82 0.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.688 0.28 . . . . 0.0 111.673 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -75.85 -25.67 56.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.357 . . . . 0.0 111.87 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.13 23.47 75.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.821 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.7 m-85 -100.45 163.24 12.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 0.0 110.63 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.824 ' C ' HD22 ' A' ' 47' ' ' LEU . 68.4 t -78.27 128.67 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.0 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.824 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.8 mm? -131.63 138.3 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.294 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 12.2 p -76.92 174.25 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.74 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.8 -52.95 31.89 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.363 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 86.0 m-20 -55.47 -36.1 66.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.766 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.81 -2.49 58.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.337 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 p -131.97 26.53 4.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.1 mtt180 -80.76 -17.94 49.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.919 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -81.39 164.7 21.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 111.377 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -140.75 135.51 31.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.105 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -157.19 153.98 28.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.73 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.62 148.38 22.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.939 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.3 mt -124.9 82.47 60.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.28 -10.88 29.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.015 2.477 . . . . 0.0 114.048 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.95 -37.44 17.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.495 0.664 . . . . 0.0 109.267 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG2' HG22 ' A' ' 58' ' ' ILE . 34.4 mmm-85 -84.44 2.71 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.655 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 8.14 62.44 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.608 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.878 HD12 HD12 ' A' ' 58' ' ' ILE . 81.6 mt -97.89 101.39 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.252 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.25 -19.25 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.59 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.0 mp0 -102.02 145.9 31.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 38.1 Cg_exo -58.45 123.04 12.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.413 1.409 . . . . 0.0 111.674 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG2' ' CG2' ' A' ' 63' ' ' ILE . 73.2 mm-40 -124.47 166.83 15.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.587 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -71.11 136.94 48.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.657 0.742 . . . . 0.0 111.978 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.622 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -145.81 179.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.035 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.47 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.1 p -94.61 -165.3 1.29 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -80.12 -44.06 20.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.3 76.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.752 0.31 . . . . 0.0 111.789 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.3 m -63.81 -41.54 97.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.086 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 79.4 t80 -56.31 -40.7 74.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.13 -51.41 21.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.352 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.13 -48.1 61.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.513 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.469 HD11 ' OD1' ' A' ' 42' ' ' ASN . 59.6 mt . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.987 0.423 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 -11.34 20.35 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.101 2.534 . . . . 0.0 112.849 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.29 156.97 48.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.44 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 11.2 t -63.08 123.95 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.121 0.486 . . . . 0.0 111.613 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -60.46 -26.43 66.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.269 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.06 -56.21 2.36 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.568 -0.825 . . . . 0.0 114.312 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.9 p -105.32 -1.72 24.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.78 11.08 68.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.647 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.6 p -72.27 143.45 48.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.261 0.53 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.06 136.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.707 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.4 m-85 -82.6 133.79 35.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.08 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.7 p -126.23 169.88 12.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.075 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.3 m -48.12 -43.99 31.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -67.46 -36.25 80.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.079 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.4 t -87.49 113.27 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.407 0.622 . . . . 0.0 111.541 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -73.62 145.22 45.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.194 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.607 ' NH1' HG11 ' A' ' 46' ' ' VAL . 63.3 ttm-85 -83.56 140.21 32.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.95 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -143.74 167.21 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.395 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.635 ' CE1' HG22 ' A' ' 46' ' ' VAL . 96.7 m-70 -130.59 147.62 52.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.357 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.3 t -91.06 137.98 31.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.43 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 60.0 mtp180 -73.18 -5.1 37.04 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.949 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.1 m-20 -101.72 -72.31 0.69 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.624 0.25 . . . . 0.0 111.645 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . 30.8 p -74.59 -24.44 58.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 19.5 79.71 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.026 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 43' ' ' CYS . 36.0 m-85 -97.5 165.66 11.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.598 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.865 ' C ' HD22 ' A' ' 47' ' ' LEU . 92.9 t -81.27 128.28 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.3 mm? -131.67 138.17 48.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.1 p -76.82 177.03 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.737 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.15 -54.03 31.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.336 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 84.0 m-20 -55.26 -34.99 64.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.748 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.2 -2.61 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 84.1 p -132.43 25.55 4.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 71.8 mtp180 -78.32 -21.94 48.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.976 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -77.62 162.91 26.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 111.723 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -138.67 137.09 36.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.06 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.599 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.04 154.05 25.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.876 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.37 150.96 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.949 HD13 ' OD1' ' A' ' 42' ' ' ASN . 2.9 mt -127.64 82.31 68.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.22 -10.54 27.75 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.109 2.54 . . . . 0.0 113.99 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.16 -37.17 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 13.6 mmm180 -83.94 2.08 40.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.8 7.39 62.9 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.4 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.871 HD12 HD12 ' A' ' 58' ' ' ILE . 77.2 mt -96.5 100.61 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.8 p -86.09 -19.03 30.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.448 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.2 mt-10 -102.84 146.43 32.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.9 Cg_endo -58.85 123.5 13.66 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.688 1.592 . . . . 0.0 111.954 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -125.32 166.84 15.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.697 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -70.15 137.01 50.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 112.095 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.6 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.8 m -146.43 179.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.904 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.516 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.67 -163.63 1.07 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.7 p-10 -82.6 -42.45 18.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.467 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.12 -45.18 74.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.748 0.308 . . . . 0.0 111.645 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.431 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 34.3 m -63.51 -41.38 98.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.256 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 80.7 t80 -56.55 -39.71 73.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 mt -72.72 -51.15 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.324 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.11 -47.52 65.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.391 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD11 ' ND2' ' A' ' 42' ' ' ASN . 71.6 mt . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -14.67 25.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.019 2.48 . . . . 0.0 112.648 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.02 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.1 t -60.59 125.23 22.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.315 0.579 . . . . 0.0 111.704 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 64.8 m-80 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.886 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.59 -56.17 2.05 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.234 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.5 p -103.08 -4.14 24.96 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.75 73.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.53 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 8.0 p -73.67 143.66 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.391 0.595 . . . . 0.0 110.324 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.78 137.39 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.794 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 86.4 m-85 -83.97 135.08 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.1 p -128.66 170.32 13.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.416 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.9 m -47.82 -44.46 28.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.535 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 m -65.44 -35.95 82.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.03 113.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 111.625 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -75.38 148.89 38.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.402 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.473 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 24.2 ttp-105 -79.22 141.63 36.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 96.5 m-70 -141.22 160.75 39.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -126.8 145.83 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.375 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.8 t -91.34 137.18 32.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -72.1 -6.85 45.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.864 ' OD1' HD13 ' A' ' 58' ' ' ILE . 70.2 m-20 -100.66 -71.64 0.7 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 30.6 p -75.81 -24.28 55.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 21.05 79.6 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.449 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -98.54 162.12 13.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 110.515 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.863 ' C ' HD22 ' A' ' 47' ' ' LEU . 90.2 t -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.39 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.863 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.9 mm? -132.12 140.06 48.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.17 -179.86 6.44 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.708 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.22 -53.65 41.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.206 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 95.3 m-20 -55.2 -36.28 65.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.813 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.53 -2.01 58.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 p -131.9 26.48 4.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 81.9 mtt-85 -81.35 -16.86 51.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -85.24 167.18 15.89 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.145 0.498 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -144.03 140.88 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.15 154.43 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.606 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.39 149.98 22.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.877 HD12 HD12 ' A' ' 63' ' ' ILE . 3.6 mt -125.4 81.51 64.02 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.094 0.474 . . . . 0.0 110.596 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.64 -12.67 36.82 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.095 2.53 . . . . 0.0 114.318 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.2 mtm -85.72 -37.63 19.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.562 ' HG2' HG22 ' A' ' 58' ' ' ILE . 27.5 mmm180 -83.21 1.31 41.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.878 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.32 8.8 59.7 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.559 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.877 HD12 HD12 ' A' ' 58' ' ' ILE . 69.4 mt -98.98 101.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.095 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.2 p -88.59 -17.56 29.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.5 mt-10 -103.03 142.31 24.29 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.42 122.39 11.63 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.533 1.489 . . . . 0.0 111.694 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.8 mm-40 -123.33 166.18 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.595 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 mtm105 -71.02 139.41 50.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.499 0.666 . . . . 0.0 111.328 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.634 HG11 ' ND2' ' A' ' 42' ' ' ASN . 28.3 m -147.35 -179.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.244 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.522 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -95.5 -164.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.25 -43.51 19.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -46.06 75.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 40.0 m -63.78 -40.16 96.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.211 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 83.8 t80 -56.92 -39.86 75.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 mt -72.47 -52.19 16.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.47 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.2 -49.63 52.02 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.559 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.461 HD11 ' OD1' ' A' ' 42' ' ' ASN . 58.8 mt . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 121.032 0.444 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.92 -11.43 18.09 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.958 2.439 . . . . 0.0 112.346 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.06 155.46 50.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.204 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -64.15 126.94 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.111 0.482 . . . . 0.0 111.437 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.8 m120 -60.9 -26.39 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.974 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.19 -55.85 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.229 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -102.88 -4.18 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.93 9.01 65.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.466 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.1 p -69.87 143.22 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.127 0.464 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.43 138.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.083 0.468 . . . . 0.0 112.036 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.571 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.3 m-85 -83.92 133.44 34.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.412 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 p -126.54 169.57 12.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -46.68 -39.87 12.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.349 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -73.71 -25.87 60.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.427 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -97.7 113.14 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.23 0.538 . . . . 0.0 111.253 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -76.51 149.1 36.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.896 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' HG13 ' A' ' 46' ' ' VAL . 18.6 ttp180 -79.29 140.77 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -140.39 158.83 43.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.76 145.33 50.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.353 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.0 t -91.14 137.79 32.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -72.95 -6.55 46.05 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.925 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.08 -72.53 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.696 0.284 . . . . 0.0 111.754 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.2 p -74.87 -25.02 58.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.815 0.34 . . . . 0.0 111.581 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.7 22.84 77.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.679 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.0 m-85 -99.1 162.76 12.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.626 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.865 ' C ' HD22 ' A' ' 47' ' ' LEU . 78.5 t -79.28 128.06 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.969 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.3 mm? -131.49 140.43 49.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.494 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.41 174.02 11.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.761 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.42 -54.19 21.44 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.545 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -54.66 -36.13 64.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.762 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.9 -2.39 58.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.141 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 p -131.91 25.79 4.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.796 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.6 mtt-85 -81.1 -18.05 47.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -80.03 163.43 24.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.571 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.78 136.68 34.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.231 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.58 154.71 27.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.71 148.9 22.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.925 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.7 mt -126.69 79.64 71.48 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.915 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -10.02 21.64 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 123.111 2.54 . . . . 0.0 113.817 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.9 mmm -87.7 -37.53 16.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 16.2 mmm180 -84.14 3.44 34.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.507 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.95 6.61 65.09 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.243 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.893 HD12 HD12 ' A' ' 58' ' ' ILE . 85.0 mt -95.54 100.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.777 0.322 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.5 p -87.45 -19.03 28.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mt-10 -103.33 138.6 19.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 51.2 Cg_exo -52.74 124.33 15.09 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.647 1.565 . . . . 0.0 112.17 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.694 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.8 mt-10 -125.28 166.67 16.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.551 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -70.24 138.61 51.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.675 0.75 . . . . 0.0 112.092 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.648 HG11 ' ND2' ' A' ' 42' ' ' ASN . 31.3 m -147.08 178.97 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.464 -1.243 . . . . 0.0 110.013 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.499 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -93.46 -165.2 1.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -81.24 -42.82 20.15 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.42 -44.9 77.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 27.0 m -63.52 -41.51 98.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.379 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 74.7 t80 -56.06 -39.94 72.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 mt -72.38 -51.8 18.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.1 -48.49 61.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.306 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.477 HD11 ' ND2' ' A' ' 42' ' ' ASN . 60.0 mt . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.046 0 CA-C-O 121.046 0.45 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.81 -12.74 28.98 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.057 2.505 . . . . 0.0 112.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.8 156.68 48.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.356 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.3 t -62.03 125.14 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 111.523 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.481 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 68.7 m-80 -60.33 -26.72 66.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.86 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.43 -55.19 2.1 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.991 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 p -103.69 -4.94 23.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 70.97 11.58 70.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.791 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.1 p -72.03 143.41 49.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.374 0.587 . . . . 0.0 110.409 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.44 138.08 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 112.022 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.2 m-85 -84.99 135.72 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 p -127.6 169.52 13.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.815 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.6 m -46.63 -42.82 16.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.4 m -66.59 -37.22 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.251 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.35 113.38 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.318 0.58 . . . . 0.0 111.524 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -74.55 148.31 40.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.492 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG3' HG13 ' A' ' 46' ' ' VAL . 13.7 ttp180 -78.63 141.4 38.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.409 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -142.18 163.01 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.05 147.52 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.906 0.384 . . . . 0.0 111.917 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.0 t -90.57 136.72 32.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.417 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 91.3 mtt-85 -70.17 -6.94 37.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 1.08 ' OD1' HD13 ' A' ' 58' ' ' ILE . 5.3 m-20 -102.9 -70.26 0.76 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.2 p -75.05 -25.83 58.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.054 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.82 20.31 79.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.391 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.5 m-85 -97.33 161.11 13.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.362 . . . . 0.0 110.668 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.83 ' C ' HD22 ' A' ' 47' ' ' LEU . 99.4 t -78.43 128.89 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.089 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 51' ' ' CYS . 1.9 mm? -130.81 140.45 50.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -78.33 172.46 13.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.0 -52.51 30.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.248 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 89.3 m-20 -55.88 -34.96 65.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.842 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.77 -1.37 57.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.278 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 p -131.74 25.7 4.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.748 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 78.1 mtp180 -80.72 -19.35 45.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.076 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -78.35 164.77 24.55 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.198 0.523 . . . . 0.0 111.623 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -141.03 134.71 30.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.323 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -160.7 154.09 21.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.82 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.8 158.04 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.08 HD13 ' OD1' ' A' ' 42' ' ' ASN . 1.6 mt -132.96 76.64 69.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 110.326 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.8 -11.57 29.91 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.238 2.625 . . . . 0.0 114.337 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 85.7 mtp -86.36 -37.64 18.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.621 ' HG2' HG22 ' A' ' 58' ' ' ILE . 16.2 mmm180 -83.94 3.76 32.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.673 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 7.96 62.5 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.439 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.897 HD12 HD12 ' A' ' 58' ' ' ILE . 65.8 mt -97.01 101.8 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.281 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 p -86.73 -18.34 31.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.671 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 63' ' ' ILE . 87.6 mt-10 -102.91 146.68 32.87 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.2 Cg_endo -59.05 122.35 11.44 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.553 1.502 . . . . 0.0 111.673 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 76.8 mm-40 -125.83 167.56 15.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.842 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -71.6 138.45 48.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.556 0.693 . . . . 0.0 112.092 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.3 179.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.751 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.531 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 15.3 p -95.59 -172.53 2.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -73.39 -42.94 61.53 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.07 -45.03 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.297 . . . . 0.0 111.683 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.1 m -64.64 -40.64 95.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.339 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 18.9 t80 -56.33 -41.52 76.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.36 -48.26 67.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.51 86.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.489 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.62 HD21 HG23 ' A' ' 58' ' ' ILE . 89.1 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.353 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.99 0.424 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.31 -15.02 25.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.778 2.318 . . . . 0.0 112.612 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.38 155.59 50.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.336 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.7 t -61.51 125.17 22.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.111 0.482 . . . . 0.0 111.414 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.0 m120 -61.67 -26.13 67.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.224 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 -55.81 2.23 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.715 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.11 -1.58 27.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 7.71 61.91 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.278 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -69.92 143.92 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.237 0.519 . . . . 0.0 110.168 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.98 138.98 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.151 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.2 m-85 -82.42 133.91 35.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 110.27 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -126.88 169.06 13.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.74 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.3 m -44.73 -38.79 4.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.473 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -78.44 -26.76 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -96.14 112.87 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.177 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.417 ' NH1' ' CE1' ' A' ' 38' ' ' HIS . 18.1 mtp-105 -78.34 150.03 33.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.425 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -89.73 143.2 27.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.817 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.4 m-70 -138.84 164.44 29.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.389 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.86 143.34 48.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.8 t -90.53 136.57 32.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -70.44 -6.76 38.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.907 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.8 m-20 -101.82 -70.66 0.74 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.0 p -77.56 -25.32 49.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.11 24.13 72.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.916 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 20.7 m-85 -102.32 162.33 13.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.8 0.333 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.825 ' C ' HD22 ' A' ' 47' ' ' LEU . 60.5 t -77.35 129.19 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.246 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.6 mm? -131.53 137.65 48.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.118 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.37 175.23 7.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.713 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.44 -53.01 37.48 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.497 -1.335 . . . . 0.0 112.044 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -54.76 -35.03 63.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.738 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.11 -3.63 58.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.444 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.4 p -131.41 27.93 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 88.4 mtt-85 -82.16 -19.21 40.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.197 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -78.59 163.52 25.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.273 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -140.0 135.16 32.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.263 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . . . -159.05 153.35 23.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.687 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.437 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.29 151.31 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.967 HD12 HD12 ' A' ' 63' ' ' ILE . 2.5 mt -127.37 74.97 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.14 0.495 . . . . 0.0 110.411 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.48 -9.02 14.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.127 2.551 . . . . 0.0 113.738 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.22 -36.72 12.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.556 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 32.5 mtp85 -89.43 26.34 1.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.358 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.63 23.36 76.72 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.276 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.967 HD12 HD12 ' A' ' 58' ' ' ILE . 73.5 mt -117.98 104.56 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.807 0.304 . . . . 0.0 110.326 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -91.31 -21.04 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 42.4 mt-10 -100.8 139.24 20.39 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.3 Cg_exo -52.71 123.02 11.99 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.591 1.527 . . . . 0.0 111.971 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.667 ' OE1' HD13 ' A' ' 63' ' ' ILE . 92.9 mt-10 -125.18 167.34 14.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.126 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -72.74 140.24 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 0.0 112.267 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.622 HG11 ' ND2' ' A' ' 42' ' ' ASN . 30.2 m -146.83 179.65 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.527 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.2 p -93.38 -163.62 1.07 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.112 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.86 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.5 m -63.57 -40.69 97.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.373 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 56' ' ' ALA . 67.1 t80 -56.7 -39.72 74.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.02 -53.0 12.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.775 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.41 61.3 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.26 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.518 HD11 ' OD1' ' A' ' 42' ' ' ASN . 82.2 mt . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.36 -12.88 32.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.232 2.621 . . . . 0.0 113.053 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.08 159.65 41.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.6 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.417 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.2 t -62.93 128.84 37.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.266 0.555 . . . . 0.0 112.059 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 m-80 -69.19 -24.76 64.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.324 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.43 -57.88 2.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.855 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 p -105.78 -0.3 25.48 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.05 72.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.413 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.5 p -69.37 143.52 53.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.356 0.578 . . . . 0.0 109.795 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.16 144.45 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.7 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 89.7 m-85 -83.54 132.96 34.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 28.9 p -124.84 168.66 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.925 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 m -48.24 -44.5 33.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 m -66.96 -36.16 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 32' ' ' THR . 77.3 t -86.3 113.46 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 0.0 111.786 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -73.11 144.83 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.897 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 21.5 ttm105 -87.09 141.99 28.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.952 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.2 m-70 -144.64 171.86 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.617 ' CE1' HG22 ' A' ' 46' ' ' VAL . 90.5 m-70 -130.45 148.44 52.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.3 t -90.97 136.75 32.86 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -72.84 -5.68 39.84 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.931 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.9 m-20 -100.81 -71.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.62 0.247 . . . . 0.0 111.47 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.0 p -75.26 -24.72 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 111.614 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.46 20.45 79.86 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.6 m-85 -97.75 161.55 13.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.85 0.357 . . . . 0.0 110.538 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.808 ' C ' HD22 ' A' ' 47' ' ' LEU . 95.0 t -76.6 128.44 37.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.089 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.817 HD12 ' HB3' ' A' ' 51' ' ' CYS . 2.6 mm? -131.78 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.493 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.0 p -79.38 -179.78 6.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.89 -53.72 42.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.674 -1.251 . . . . 0.0 112.225 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' NE ' ' A' ' 53' ' ' ARG . 92.7 m-20 -55.38 -35.81 65.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.817 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.92 -2.15 58.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.389 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -131.87 26.39 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.4 mtt180 -80.94 -18.3 47.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -80.08 162.9 24.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.106 0.479 . . . . 0.0 111.285 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp85 -139.8 135.62 33.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -157.93 153.39 26.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.814 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.97 149.46 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.931 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.4 mt -125.81 82.36 64.26 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.855 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -10.73 29.64 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.087 2.524 . . . . 0.0 114.028 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.85 -37.76 17.43 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 58' ' ' ILE . 30.2 mmm180 -83.07 1.01 42.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.648 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 7.2 62.0 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.284 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.901 HD12 HD12 ' A' ' 58' ' ' ILE . 74.3 mt -96.85 100.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.66 -17.41 33.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.74 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.1 mt-10 -103.02 144.2 28.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 31.8 Cg_exo -57.11 123.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.642 1.561 . . . . 0.0 111.683 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.3 mm-40 -125.35 167.15 15.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -70.89 137.46 49.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.94 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.634 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -146.84 179.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.078 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 1.7 p -94.49 -160.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 20.9 t70 -85.02 -43.26 14.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.94 80.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 111.82 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 33.3 m -63.98 -40.85 97.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.8 t80 -57.94 -40.52 80.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.3 mt -69.76 -50.51 42.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.509 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.49 84.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.39 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD21 HG23 ' A' ' 58' ' ' ILE . 88.6 mt . . . . . 0 C--N 1.326 -0.442 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.524 0.202 . . . . 0.27 111.313 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.22 -18.41 16.22 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.281 1.988 . . . . 0.36 112.497 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.434 -0.348 . . . . 0.16 110.838 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -55.16 124.78 18.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.17 111.7 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.48 -22.09 66.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 1.19 111.82 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.93 -68.11 1.4 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.649 -0.786 . . . . 0.17 113.792 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 p -88.56 -27.8 21.16 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.984 0.365 . . . . 0.17 111.984 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.28 26.6 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.455 -0.879 . . . . 0.15 112.73 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 p -83.25 144.56 29.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.16 110.635 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.48 143.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.89 111.09 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 88.7 m-85 -89.91 130.48 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.23 111.099 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 p -120.46 175.32 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.19 110.728 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.8 m -54.91 -31.12 59.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.285 -0.416 . . . . 0.78 111.363 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -44.91 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 1.2 111.078 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.67 108.41 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.012 0.434 . . . . 0.2 110.895 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -74.87 163.45 27.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.788 -0.642 . . . . 2.74 109.717 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG2' HG13 ' A' ' 46' ' ' VAL . 15.1 ttm105 -88.64 152.86 21.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.747 0.647 . . . . 3.44 112.747 -178.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -157.52 139.61 14.35 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.342 -0.844 . . . . 0.22 110.369 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -106.7 155.41 19.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.975 0.417 . . . . 1.16 111.573 -179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.11 129.85 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.132 -0.692 . . . . 0.11 109.132 179.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -62.27 -17.76 59.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.817 0.673 . . . . 2.39 112.817 -177.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.549 ' ND2' HG11 ' A' ' 69' ' ' VAL . 66.1 m-80 -92.97 -69.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.665 0.269 . . . . 0.57 111.698 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.3 p -79.57 -41.36 27.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.519 -0.31 . . . . 0.11 111.52 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.46 -13.02 66.07 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.416 -0.897 . . . . 0.1 113.497 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -58.6 163.55 3.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.761 -0.459 . . . . 0.4 109.761 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 47' ' ' LEU . 67.9 t -82.41 132.68 30.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.487 -0.485 . . . . 0.17 110.47 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 46' ' ' VAL . 3.3 mm? -133.79 142.68 47.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.13 110.875 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.1 p -82.45 -173.01 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.907 -0.588 . . . . 0.15 110.302 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.38 -57.95 16.96 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.604 -0.808 . . . . 0.16 112.925 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -52.66 -51.36 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.915 0.388 . . . . 1.15 111.606 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.43 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.6 m -66.98 -24.3 66.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.999 -0.546 . . . . 0.14 111.996 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -115.06 45.48 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.541 . . . . 0.15 110.645 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -97.64 -25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 2.44 110.815 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -73.92 169.79 16.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.324 0.583 . . . . 0.62 112.299 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -145.76 138.92 26.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.225 -0.898 . . . . 2.76 109.805 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.17 137.57 6.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.09 111.324 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.12 148.99 46.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.19 110.257 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.558 HG23 HD21 ' A' ' 77' ' ' LEU . 3.2 mt -126.59 76.57 74.11 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.595 -0.275 . . . . 0.2 111.234 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.78 -26.53 79.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.403 2.069 . . . . 0.36 112.543 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.6 mtp -71.87 -30.85 65.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.425 -0.352 . . . . 1.96 110.759 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.421 ' HG2' HG22 ' A' ' 58' ' ' ILE . 15.5 mmm180 -101.3 21.69 13.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.346 -0.388 . . . . 1.43 111.671 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.33 68.65 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.67 -0.776 . . . . 0.52 113.268 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.497 ' CD1' HD12 ' A' ' 58' ' ' ILE . 33.1 mt -122.65 88.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.794 0.33 . . . . 0.17 110.671 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.56 -14.41 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.202 0.445 . . . . 0.27 112.202 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -101.49 147.96 34.54 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 121.22 -0.192 . . . . 2.02 110.908 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.32 120.59 8.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.13 1.887 . . . . 0.46 112.085 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' HG21 ' A' ' 63' ' ' ILE . 69.9 mm-40 -125.78 164.07 21.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.047 0.451 . . . . 1.46 111.048 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.08 136.58 41.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.816 -0.629 . . . . 2.42 112.531 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.549 HG11 ' ND2' ' A' ' 42' ' ' ASN . 33.4 m -144.31 -172.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.105 -0.952 . . . . 0.19 109.534 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 3.9 p -100.02 -157.18 0.59 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.186 -0.302 . . . . 0.16 110.186 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.43 -50.36 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.852 -0.339 . . . . 1.63 111.025 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.52 -64.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.12 110.959 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 62.5 m -50.55 -39.67 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.16 111.813 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -59.76 -34.16 72.62 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.108 -0.701 . . . . 0.27 109.108 177.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.69 -44.03 19.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.229 -0.896 . . . . 0.26 109.473 178.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 73' ' ' CYS . . . -51.93 -50.76 60.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.634 -0.712 . . . . 0.19 110.727 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 58' ' ' ILE . 60.7 mt . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 108.806 -0.813 . . . . 0.26 108.806 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.07 148.41 85.61 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.771 2.314 . . . . 0.0 112.282 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 mt -60.61 -32.0 71.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.15 -156.14 24.95 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.597 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 m -59.39 -33.08 70.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.688 0.28 . . . . 0.0 111.347 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 63.9 mtt -107.64 144.57 34.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 111.238 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -154.96 134.06 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.408 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -89.21 12.88 14.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.622 0.249 . . . . 0.0 111.529 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.3 mmtm -73.07 -2.96 23.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.26 0.552 . . . . 0.0 109.583 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -66.18 142.07 57.85 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.057 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 99.1 p -118.63 152.01 36.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -125.15 144.89 50.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.059 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.96 82.15 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.57 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 44' ' ' GLY . 77.8 t80 -76.78 121.76 23.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.839 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.468 ' O ' ' CD1' ' A' ' 15' ' ' TRP . 47.2 p90 -92.24 118.15 30.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.579 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.475 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 62.9 tt0 -81.95 127.11 32.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.306 0.574 . . . . 0.0 109.927 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.9 151.94 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.906 . . . . 0.0 112.893 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' OD1' ' HD2' ' A' ' 37' ' ' ARG . 21.7 m-20 -54.44 -45.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.053 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.62 -41.59 88.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.182 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.81 -32.55 72.34 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.073 0.463 . . . . 0.0 110.862 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -114.11 74.37 2.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.733 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.54 -11.76 18.69 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.138 2.559 . . . . 0.0 112.846 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.7 155.38 50.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.8 OUTLIER -60.4 122.79 15.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.115 0.483 . . . . 0.0 111.827 -178.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.5 m120 -61.68 -26.68 68.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.928 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.33 -56.39 2.16 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.683 -0.77 . . . . 0.0 114.221 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.3 p -104.63 -3.6 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.23 10.73 69.96 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.725 178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -71.74 143.51 49.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.416 0.608 . . . . 0.0 110.251 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.39 137.5 21.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.796 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 93.9 m-85 -83.29 134.43 34.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.162 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.414 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 28.8 p -126.38 172.58 10.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.268 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.2 p -50.54 -40.84 52.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.003 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.9 p -75.85 -26.34 57.05 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.796 -0.361 . . . . 0.0 111.254 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HB ' ' H ' ' A' ' 32' ' ' THR . 54.4 t -93.56 113.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.376 0.608 . . . . 0.0 111.392 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -73.63 143.73 46.2 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.106 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.518 ' HD2' ' OD1' ' A' ' 18' ' ' ASP . 23.7 ttm105 -86.29 142.14 28.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.629 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -144.01 169.19 18.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.964 0.412 . . . . 0.0 111.607 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.551 ' CE1' HG22 ' A' ' 46' ' ' VAL . 93.8 m-70 -128.83 146.82 50.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.537 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.3 t -90.44 137.99 31.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -72.76 -6.88 47.69 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.936 ' OD1' HD13 ' A' ' 58' ' ' ILE . 73.4 m-20 -100.69 -70.27 0.74 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.502 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.4 p -76.44 -23.78 53.94 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 72.91 21.98 79.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.39 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.502 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 21.2 m-85 -98.07 160.81 14.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.85 0.357 . . . . 0.0 110.236 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.827 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.4 t -75.96 128.97 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.166 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.891 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.2 mm? -133.43 138.58 46.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.79 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.45 176.32 8.98 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.756 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.08 -52.8 41.1 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.805 -1.188 . . . . 0.0 112.225 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 95.0 m-20 -55.83 -35.84 66.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.891 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.32 -1.7 58.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.462 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.4 p -131.99 28.65 4.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 73.3 mtm180 -84.71 -16.39 41.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.227 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -81.31 164.7 22.0 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.5 136.18 32.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.527 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.96 154.34 25.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.793 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.9 154.0 20.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.936 HD13 ' OD1' ' A' ' 42' ' ' ASN . 2.3 mt -130.3 79.77 71.91 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.054 0.454 . . . . 0.0 110.939 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.06 -8.96 19.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 123.179 2.586 . . . . 0.0 114.19 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.9 mtp -89.08 -37.83 14.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.529 0.681 . . . . 0.0 109.193 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.553 ' HG2' HG22 ' A' ' 58' ' ' ILE . 14.2 mmm180 -83.03 1.04 42.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.454 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.13 6.94 61.3 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.477 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.924 HD12 HD12 ' A' ' 58' ' ' ILE . 75.6 mt -96.2 102.35 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.896 0.379 . . . . 0.0 110.214 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.9 p -88.08 -18.54 28.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.473 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 56.0 mm-40 -103.06 142.53 24.75 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -56.43 124.0 15.21 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.674 1.583 . . . . 0.0 111.819 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.7 mm-40 -124.74 166.81 15.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -70.56 136.71 49.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.618 0.723 . . . . 0.0 111.639 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.607 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.3 m -145.24 -179.27 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.976 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.437 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.56 -168.35 1.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -76.26 -43.71 40.63 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.22 72.68 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 52.8 m -63.84 -40.57 96.91 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.743 0.306 . . . . 0.0 110.41 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.518 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 76.6 t80 -56.79 -39.6 74.4 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 18.1 mt -72.9 -52.49 14.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.536 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.02 -48.27 52.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.385 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.7 mt -65.27 -40.8 94.38 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 62.9 ttt180 -57.04 -19.7 20.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.627 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.7 p -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.359 . . . . 0.0 110.996 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.7 m -62.69 154.73 28.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -91.37 136.36 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.767 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 72.5 mtm -81.57 129.87 34.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.975 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.88 145.18 56.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.192 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.359 -1.245 . . . . 0.0 112.507 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.332 -0.307 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.27 149.78 21.54 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.869 2.379 . . . . 0.0 112.608 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.1 mt -88.34 138.35 31.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.455 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.79 -33.17 42.11 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.538 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.1 m -119.98 147.39 44.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.776 0.322 . . . . 0.0 110.826 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 65.5 mtt -123.68 154.01 40.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.002 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -148.35 45.21 0.73 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.392 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.68 -11.09 52.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.617 0.246 . . . . 0.0 111.421 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -61.93 -6.91 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -67.7 148.86 50.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.864 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.2 p -103.66 149.99 24.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.894 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -96.24 146.93 24.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.922 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.97 57.67 4.74 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.906 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.501 ' O ' ' O ' ' A' ' 44' ' ' GLY . 81.7 t80 -76.38 122.74 24.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.751 0.31 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -91.91 118.67 30.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.419 ' O ' ' NH1' ' A' ' 37' ' ' ARG . 62.8 tt0 -84.24 131.35 34.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.124 0.488 . . . . 0.0 109.685 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.27 154.18 28.47 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' A' ' 37' ' ' ARG . 6.2 m-20 -55.3 -43.55 74.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.984 178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -66.7 -42.49 86.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.373 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -70.25 -30.39 67.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.275 0.56 . . . . 0.0 110.729 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.37 71.11 0.83 Allowed Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.607 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.47 -15.4 24.83 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.9 2.4 . . . . 0.0 112.357 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.33 156.88 48.02 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.483 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 29' ' ' CYS . 8.1 t -63.99 124.98 22.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.241 0.543 . . . . 0.0 111.707 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.1 m-80 -60.28 -26.56 66.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.969 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.45 -55.92 2.37 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.444 -0.884 . . . . 0.0 114.341 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.1 p -105.23 -0.29 26.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.83 9.07 58.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.562 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 24' ' ' CYS . 6.0 p -69.52 143.52 53.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.226 0.513 . . . . 0.0 110.211 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.99 138.98 18.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 92.2 m-85 -84.18 136.04 34.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.375 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.9 p -127.74 171.61 11.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.105 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -47.47 -41.1 19.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.808 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.1 p -73.54 -24.84 60.18 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.641 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -97.89 113.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.738 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -75.72 150.25 37.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.533 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' HD3' ' OD2' ' A' ' 18' ' ' ASP . 14.7 ttp180 -80.18 141.54 35.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.012 0.434 . . . . 0.0 110.598 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -139.96 160.95 38.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.665 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' CE1' HG22 ' A' ' 46' ' ' VAL . 89.9 m-70 -128.49 146.05 50.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.523 -179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.9 t -91.33 136.2 33.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.527 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 11.9 tpt180 -72.33 -4.63 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.91 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.1 m-20 -101.65 -71.54 0.71 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -76.51 -24.04 53.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.23 21.77 78.55 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.79 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.1 m-85 -99.01 160.91 13.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.825 0.345 . . . . 0.0 110.412 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.868 ' C ' HD22 ' A' ' 47' ' ' LEU . 77.5 t -78.36 128.75 38.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.868 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.4 mm? -131.45 140.83 49.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.354 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.4 p -78.85 178.37 8.0 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.608 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -55.59 -52.15 50.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.43 -1.367 . . . . 0.0 112.047 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -54.67 -34.88 62.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.794 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -91.81 -2.23 57.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.832 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.3 p -132.3 28.93 4.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 12.9 mmt85 -84.68 -17.88 37.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.324 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -79.53 165.62 22.8 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.226 0.536 . . . . 0.0 111.475 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 71.0 mtt85 -141.37 134.71 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.273 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.01 153.41 26.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.658 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -86.48 158.0 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.91 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.4 mt -134.15 78.37 58.93 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.919 0.39 . . . . 0.0 110.555 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.82 -12.14 32.74 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.265 2.644 . . . . 0.0 114.066 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.9 mmm -85.31 -38.29 18.99 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.554 ' HG2' HG22 ' A' ' 58' ' ' ILE . 13.9 mmm180 -83.86 1.76 41.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.673 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 9.22 60.39 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.686 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.792 HD12 HD12 ' A' ' 58' ' ' ILE . 61.8 mt -100.58 99.17 7.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.849 0.356 . . . . 0.0 110.356 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.4 p -85.04 -16.99 38.88 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.785 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.6 mt-10 -102.81 145.06 29.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 14.7 Cg_endo -58.67 124.11 15.05 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 121.416 1.411 . . . . 0.0 111.657 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' CG ' HG21 ' A' ' 63' ' ' ILE . 76.4 mm-40 -124.85 167.78 14.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.747 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -72.06 137.2 46.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.652 0.739 . . . . 0.0 111.916 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.646 HG11 ' ND2' ' A' ' 42' ' ' ASN . 35.1 m -146.83 -178.06 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.126 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.475 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -96.4 -162.88 0.99 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -82.62 -42.67 17.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.51 -45.67 75.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.75 0.31 . . . . 0.0 111.691 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 37.0 m -63.19 -40.38 97.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.533 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 72.4 t80 -57.32 -38.97 74.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -71.66 -51.67 21.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.349 -0.841 . . . . 0.0 112.506 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.76 -45.7 78.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.165 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.437 HD11 ' ND2' ' A' ' 42' ' ' ASN . 88.6 mt -67.01 -41.04 87.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.503 0.668 . . . . 0.0 109.346 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -17.93 34.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.811 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.6 m -61.31 -38.77 88.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.944 0.402 . . . . 0.0 110.925 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.9 m -68.96 155.62 40.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -99.4 129.0 45.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.358 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 65.9 mtm -83.46 134.51 34.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.5 148.75 40.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.286 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.399 -1.223 . . . . 0.0 112.433 -179.824 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.451 -0.26 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.22 145.23 55.78 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.725 2.283 . . . . 0.0 112.33 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.6 mt -81.96 144.2 31.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.66 34.15 36.02 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.265 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.6 m -115.23 149.61 37.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 72.1 mtm -57.81 -33.74 68.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.6 135.21 45.84 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.437 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -88.96 7.37 34.98 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -72.53 -3.05 22.18 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.54 145.31 54.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.098 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 95.2 p -114.37 153.24 30.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.455 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 59.2 mttp -56.98 -38.81 73.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -147.81 169.66 28.59 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.384 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . 67.3 t80 -80.33 122.94 27.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.463 ' CZ3' ' HG2' ' A' ' 17' ' ' GLU . 45.9 p-90 -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -84.8 128.37 34.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.187 0.518 . . . . 0.0 109.846 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HG2' ' CZ3' ' A' ' 15' ' ' TRP . 96.4 mt-10 -59.72 152.91 21.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.231 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -56.68 -44.03 81.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.024 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -65.63 -42.33 91.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.053 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -72.11 -30.2 64.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.236 0.541 . . . . 0.0 110.289 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.39 68.18 1.29 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.699 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -72.07 -12.29 27.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 123.07 2.514 . . . . 0.0 112.68 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -136.13 156.39 48.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.3 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 18.4 t -64.54 125.29 24.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.174 0.511 . . . . 0.0 111.437 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.475 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 70.0 m-80 -59.5 -26.44 65.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.031 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.72 -55.46 2.15 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.569 -0.824 . . . . 0.0 114.165 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.8 p -102.92 -4.7 24.38 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.37 10.98 71.08 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.41 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 12.8 p -71.65 142.67 49.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.317 0.559 . . . . 0.0 110.278 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.78 137.75 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.097 0.475 . . . . 0.0 111.534 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.86 134.53 34.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.276 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -127.26 169.61 13.33 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.954 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.6 m -46.84 -42.16 16.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.96 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.1 m -68.54 -36.09 78.34 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.316 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.6 t -90.65 113.67 26.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.338 0.59 . . . . 0.0 111.463 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.33 148.72 39.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.008 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 48.1 ttp85 -78.97 139.54 38.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.551 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.0 m-70 -141.94 162.74 34.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.251 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.518 ' CE1' HG22 ' A' ' 46' ' ' VAL . 89.5 m-70 -129.54 146.57 51.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.642 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 t -91.6 137.91 31.99 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -73.42 -5.47 40.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.943 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.0 m-20 -100.9 -72.06 0.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.613 0.244 . . . . 0.0 111.624 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.495 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.4 p -75.81 -24.89 55.93 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.24 21.63 78.72 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.746 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 26.1 m-85 -98.85 161.85 13.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.935 0.398 . . . . 0.0 110.459 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.85 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.2 t -78.44 128.93 38.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.076 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.85 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.2 mm? -131.41 139.07 49.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.44 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 p -75.64 177.09 7.06 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.73 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.48 -53.07 40.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.241 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD1' ' NH2' ' A' ' 53' ' ' ARG . 86.3 m-20 -55.53 -35.65 65.9 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.713 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.67 -2.03 58.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.317 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.1 p -132.55 27.62 4.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt180 -82.85 -17.85 42.42 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.139 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -79.47 165.06 23.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.113 0.482 . . . . 0.0 111.281 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 -140.82 136.0 31.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.424 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.39 154.48 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.739 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -92.25 150.8 20.67 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.943 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.0 mt -127.3 81.31 70.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 111.058 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.63 -9.98 22.77 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.206 2.604 . . . . 0.0 113.828 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.3 mtt -89.75 -36.89 14.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 109.263 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.525 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 5.3 mmm180 -86.79 15.57 5.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.677 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.02 10.34 85.1 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.854 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.928 HD12 HD12 ' A' ' 58' ' ' ILE . 74.8 mt -101.44 102.65 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.6 p -88.3 -19.11 27.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.588 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mt-10 -103.17 146.61 32.77 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.4 Cg_endo -59.14 123.47 13.52 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.62 1.546 . . . . 0.0 111.71 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.3 mm-40 -124.53 166.73 15.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -71.47 137.29 48.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.624 0.726 . . . . 0.0 112.0 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.621 HG11 ' ND2' ' A' ' 42' ' ' ASN . 30.0 m -145.5 -178.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.872 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.508 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -96.47 -166.45 1.42 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.404 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 55.6 t0 -78.89 -45.16 21.2 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 -46.14 80.99 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.4 m -63.82 -41.25 97.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.388 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.522 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 75.7 t80 -56.38 -40.07 73.98 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD23 ' HD3' ' A' ' 78' ' ' ARG . 15.6 mt -71.7 -52.3 18.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.11 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.15 -48.67 53.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.496 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD21 HG23 ' A' ' 58' ' ' ILE . 58.9 mt -65.88 -41.92 90.98 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 72.2 ttt-85 -56.06 -21.87 24.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 38.1 m -59.21 -36.4 75.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 0.0 110.778 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.6 m -59.1 -34.27 71.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -79.64 139.97 37.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.3 mtp -89.37 133.63 34.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.183 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.68 -49.86 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.963 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.458 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.89 145.84 71.08 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.745 2.296 . . . . 0.0 112.265 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.1 mt -83.9 141.63 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.27 -33.87 62.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.246 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -60.91 -27.98 68.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.951 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.4 mmm -95.28 138.52 32.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.18 2.91 68.05 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.598 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 83.2 tt0 -87.85 12.71 12.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.615 0.245 . . . . 0.0 111.455 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -59.0 -17.96 29.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -61.01 144.3 53.66 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.049 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 76.6 p -144.78 161.43 39.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 13' ' ' GLY . 27.8 mttm -80.53 166.07 21.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.706 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 12' ' ' LYS . . . -29.97 108.75 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 113.113 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -80.63 121.64 26.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.884 0.373 . . . . 0.0 111.072 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.1 p-90 -89.87 119.9 30.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.574 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.863 ' OE1' ' HB2' ' A' ' 21' ' ' ALA . 50.4 tt0 -84.19 128.86 34.83 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.304 0.573 . . . . 0.0 110.295 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -60.44 153.04 24.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.168 -0.923 . . . . 0.0 113.245 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . 41.2 t0 -54.94 -47.28 74.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.084 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -64.74 -41.51 95.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.168 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -70.53 -30.16 66.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.262 0.553 . . . . 0.0 110.225 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.863 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . . . -111.47 70.58 0.82 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.842 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.61 -14.94 30.57 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.942 2.428 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.93 156.95 47.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.459 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -63.11 124.79 22.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.144 0.497 . . . . 0.0 111.439 -179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 66.1 m-80 -60.15 -26.21 66.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.289 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.82 2.25 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.389 -0.91 . . . . 0.0 114.343 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.4 p -104.42 -3.05 24.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.86 10.48 67.98 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.527 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.1 p -71.9 143.99 49.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.269 0.534 . . . . 0.0 110.168 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.93 138.77 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.084 0.469 . . . . 0.0 112.163 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.559 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.7 m-85 -84.46 135.56 34.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 p -127.98 168.0 15.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 34.2 m -46.12 -43.78 15.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.312 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.3 m -66.13 -36.96 84.52 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.981 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.0 t -88.6 113.89 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 CA-C-O 121.406 0.622 . . . . 0.0 111.516 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -73.78 146.07 44.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.362 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 18' ' ' ASP . 21.8 ttp-105 -80.33 140.11 36.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.441 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -142.11 164.64 29.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.6 ' CE1' HG22 ' A' ' 46' ' ' VAL . 93.2 m-70 -130.79 147.44 52.45 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.568 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.7 t -90.23 137.0 32.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.445 ' HD3' ' HB3' ' A' ' 67' ' ' GLU . 53.2 mtp85 -71.43 -6.36 39.74 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.875 ' ND2' HD13 ' A' ' 58' ' ' ILE . 15.6 m-80 -102.88 -70.0 0.77 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.4 p -74.44 -24.81 59.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.783 0.325 . . . . 0.0 111.579 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.37 20.33 79.63 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.686 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.545 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 27.8 m-85 -97.0 164.37 12.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.962 0.411 . . . . 0.0 110.682 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.86 ' C ' HD22 ' A' ' 47' ' ' LEU . 62.2 t -80.83 128.4 38.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.059 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.86 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.5 mm? -132.12 137.62 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.5 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.1 p -77.32 173.33 12.04 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.771 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.11 -54.33 19.54 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.23 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 75.9 m-20 -54.92 -35.85 64.61 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.788 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.37 -1.82 58.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.22 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.1 p -131.16 25.22 4.9 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.771 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 57.9 mtm180 -80.36 -18.65 48.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.805 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.2 m80 -79.42 164.79 23.71 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.006 0.431 . . . . 0.0 111.157 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -143.1 138.15 29.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.451 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -161.5 155.56 22.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.912 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.476 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -82.45 159.48 22.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.875 HD13 ' ND2' ' A' ' 42' ' ' ASN . 1.3 mt -134.49 75.41 63.84 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.48 -12.93 35.73 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.42 2.747 . . . . 0.0 114.34 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 63.8 mtt -87.05 -36.84 17.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.682 ' HG2' HG22 ' A' ' 58' ' ' ILE . 29.0 mmm180 -83.74 5.73 23.71 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.906 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.73 10.66 64.8 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.501 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.784 HD12 HD12 ' A' ' 58' ' ' ILE . 70.2 mt -102.21 102.54 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 0.0 110.363 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.9 p -87.83 -16.63 33.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.601 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.5 mt-10 -104.56 142.79 25.37 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 11.4 Cg_endo -55.13 122.57 11.94 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 121.879 1.719 . . . . 0.0 112.034 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.9 mm-40 -125.15 167.31 14.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.432 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -72.46 140.11 48.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.567 0.699 . . . . 0.0 111.898 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.7 m -147.3 -179.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.085 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.512 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.9 p -93.48 -162.36 0.93 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -83.71 -41.74 17.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.97 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.586 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.14 -41.61 97.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.774 0.321 . . . . 0.0 110.202 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.583 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 87.6 t80 -55.88 -40.61 73.21 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.1 mt -70.51 -49.49 47.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.586 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.45 79.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.855 HD11 HD21 ' A' ' 42' ' ' ASN . 77.4 mt -64.03 -38.17 90.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.024 0.44 . . . . 0.0 110.816 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 8.0 mtp-105 -64.37 -7.54 10.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.212 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.2 m -58.73 152.42 18.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.8 m -120.85 146.51 46.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.623 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -93.08 135.35 34.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.9 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 63.9 mtt -83.24 131.31 35.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.682 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 145.93 50.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.061 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.138 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.6 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 N-CA-C 112.584 -0.206 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.2 147.31 93.97 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.742 2.295 . . . . 0.0 112.079 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.5 mt -81.73 136.93 35.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.583 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.84 124.02 5.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.516 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.5 m -122.67 145.63 48.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 86.5 mtp -133.62 163.86 28.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.4 40.02 20.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.558 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 58.2 mp0 -82.16 7.48 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.66 0.267 . . . . 0.0 111.262 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -58.73 -17.01 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -53.46 143.93 18.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.894 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.8 m -60.91 156.75 16.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.92 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 44.2 mtmt -56.33 -32.04 64.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.41 94.47 0.1 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.777 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.428 ' O ' ' O ' ' A' ' 44' ' ' GLY . 67.5 t80 -78.8 123.13 26.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -91.99 117.8 30.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.942 ' OE1' ' HB2' ' A' ' 21' ' ' ALA . 47.7 tt0 -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.177 0.513 . . . . 0.0 109.866 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -58.29 154.47 13.35 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.483 ' CB ' ' NE ' ' A' ' 37' ' ' ARG . 39.0 p-10 -57.37 -43.94 83.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.541 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 97.3 mt-10 -65.73 -41.73 91.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.826 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -67.65 -32.68 73.54 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.125 0.488 . . . . 0.0 110.857 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.942 ' HB2' ' OE1' ' A' ' 16' ' ' GLN . . . -111.41 72.12 0.91 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.787 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.07 -15.23 32.24 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.1 2.533 . . . . 0.0 112.651 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 157.68 46.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.401 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 10.2 t -62.3 122.48 15.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.224 0.535 . . . . 0.0 111.761 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.5 m120 -61.12 -25.9 67.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.32 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.18 -55.76 2.3 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.554 -0.831 . . . . 0.0 114.51 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.4 p -104.24 -2.65 25.37 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.13 7.97 64.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.253 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -69.6 143.0 53.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.099 0.449 . . . . 0.0 110.162 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.71 137.4 21.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.714 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 92.5 m-85 -82.08 133.12 35.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.386 0.612 . . . . 0.0 109.886 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.416 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 17.2 p -124.7 173.03 8.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.174 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.1 p -50.4 -38.94 45.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.98 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 p -79.18 -22.91 44.29 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.651 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HB ' ' H ' ' A' ' 32' ' ' THR . 41.8 t -96.03 113.12 29.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.42 0.629 . . . . 0.0 111.488 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -73.32 143.64 46.85 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.204 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' NE ' ' CB ' ' A' ' 18' ' ' ASP . 56.9 ttm-85 -84.71 141.14 30.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.428 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.3 m-70 -143.48 167.93 21.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.444 ' NE2' HG22 ' A' ' 46' ' ' VAL . 78.9 m80 -130.71 147.97 52.44 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.596 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.8 t -89.57 137.27 32.47 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 67' ' ' GLU . 92.6 mtt-85 -72.74 -6.34 43.9 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.932 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.2 m-20 -100.71 -70.26 0.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.571 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.99 -24.57 55.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.68 21.92 78.88 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.722 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.8 162.4 13.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.801 0.334 . . . . 0.0 110.512 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.849 ' C ' HD22 ' A' ' 47' ' ' LEU . 87.0 t -78.35 128.23 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.226 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.849 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.0 mm? -132.64 139.52 47.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.8 p -77.54 175.04 10.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.703 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.76 -52.87 35.95 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 119.673 -1.251 . . . . 0.0 112.358 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 93.2 m-20 -55.67 -35.84 66.45 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.802 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.16 -2.34 58.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.24 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -131.78 27.3 4.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.703 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 74.9 mtt180 -82.19 -20.13 38.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.369 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -76.99 163.06 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 111.212 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -139.59 136.55 34.52 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.222 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -160.15 153.97 22.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.79 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -87.3 153.14 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 63' ' ' ILE . 3.1 mt -129.25 77.6 77.33 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.996 0.427 . . . . 0.0 110.808 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.8 -8.49 15.78 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 123.138 2.559 . . . . 0.0 113.894 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 94.6 mmm -89.7 -37.87 14.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.0 109.36 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 2.8 mmm180 -84.31 2.71 38.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.441 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.25 7.68 61.98 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.535 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.957 HD12 HD12 ' A' ' 58' ' ' ILE . 72.7 mt -97.86 102.06 12.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.193 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.3 p -87.59 -17.43 31.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 4.6 mt-10 -103.11 142.01 23.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 32.2 Cg_exo -56.16 124.38 16.12 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.725 1.616 . . . . 0.0 112.061 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.4 mm-40 -126.41 166.85 16.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -69.25 136.44 51.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.473 0.654 . . . . 0.0 111.707 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.582 HG11 ' ND2' ' A' ' 42' ' ' ASN . 28.4 m -148.92 161.1 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.844 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.48 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -75.44 -168.41 0.81 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 55.3 p30 -81.15 -40.3 24.19 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.93 -44.41 73.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.886 0.374 . . . . 0.0 111.37 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 64.3 m -63.91 -40.92 97.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.656 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 38.0 t80 -57.22 -41.09 78.8 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.9 mt -69.2 -49.05 60.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.748 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.91 83.15 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.439 HD11 ' ND2' ' A' ' 42' ' ' ASN . 93.4 mt -65.72 -36.67 84.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.956 0.408 . . . . 0.0 110.55 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.656 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 68.4 mtp180 -67.17 -8.47 31.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.966 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.0 m -61.07 -32.01 71.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.259 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.4 t -43.84 134.44 4.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -90.11 133.32 34.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.944 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.1 mtm -78.26 134.18 37.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.041 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.45 146.75 52.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.231 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.465 -1.186 . . . . 0.0 112.497 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.91 145.18 89.9 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.573 2.182 . . . . 0.0 112.199 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 3' ' ' LEU . 6.0 mp -78.93 -4.97 52.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.339 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.38 -178.98 52.42 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.959 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.0 p -66.99 -20.38 65.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.693 0.282 . . . . 0.0 111.381 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 62.7 mtt -77.82 137.17 38.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.034 0.445 . . . . 0.0 111.288 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.84 -13.8 62.06 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.409 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.0 mp0 -98.05 15.86 22.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.642 0.258 . . . . 0.0 111.153 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -71.71 -4.82 29.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -62.51 140.55 58.62 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.467 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.5 p -135.87 160.1 39.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 111.095 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -102.27 145.84 28.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.69 83.14 0.13 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.283 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -77.94 121.1 23.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 111.298 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -94.97 120.06 34.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.417 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -85.19 128.0 34.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.352 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -55.38 154.13 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.865 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -56.68 -42.67 79.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.002 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -67.15 -42.6 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.044 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -66.92 -32.25 73.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.96 74.44 0.97 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.991 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.36 -15.69 25.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.913 2.409 . . . . 0.0 112.215 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -133.93 155.9 49.09 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.919 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.41 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.6 t -61.73 124.26 20.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.344 0.592 . . . . 0.0 111.904 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 53.5 m-80 -61.41 -27.69 68.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.134 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 -56.05 2.5 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.619 -0.801 . . . . 0.0 114.716 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.6 p -105.56 -0.69 25.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.17 9.15 63.21 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.217 -0.992 . . . . 0.0 113.718 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 14.0 p -71.44 144.91 49.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.409 0.605 . . . . 0.0 109.837 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.96 140.33 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 81.2 m-85 -84.81 135.63 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.344 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.0 p -126.89 167.06 16.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.9 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -45.36 -41.67 9.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.9 m -70.5 -34.81 72.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.32 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.64 114.18 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.503 0.668 . . . . 0.0 111.554 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -78.72 150.19 32.56 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.669 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -90.34 142.53 27.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.137 0.494 . . . . 0.0 110.454 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.9 m-70 -139.7 168.14 20.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.129 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.72 143.93 49.98 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.757 0.313 . . . . 0.0 111.309 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.4 t -90.72 137.87 32.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -72.97 -5.22 37.23 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.946 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.7 -72.21 0.69 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.785 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.0 p -77.09 -24.44 51.8 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.77 77.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.86 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.94 164.02 12.36 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.865 0.364 . . . . 0.0 110.405 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.814 ' C ' HD22 ' A' ' 47' ' ' LEU . 60.9 t -80.8 128.84 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.814 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.0 OUTLIER -130.7 137.64 49.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.348 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.27 174.29 8.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.756 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.08 -53.01 32.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.421 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 70.5 m-20 -56.26 -36.09 68.17 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.731 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -86.91 -3.33 59.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.135 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 65.2 p -131.66 26.03 4.71 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.756 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 70.8 mtp85 -82.21 -16.97 47.76 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.972 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -80.38 166.14 21.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.156 0.503 . . . . 0.0 111.379 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -142.53 135.2 28.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.245 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.28 153.23 25.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.697 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.44 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -89.06 154.61 20.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.946 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.7 mt -131.35 81.11 66.24 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 120.997 0.427 . . . . 0.0 110.733 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.16 -8.12 19.29 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.981 2.454 . . . . 0.0 113.907 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 87.4 mtp -89.37 -37.12 15.09 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.531 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 13.7 mmm180 -84.83 4.0 35.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.584 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.19 4.42 66.64 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.533 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.863 HD12 HD12 ' A' ' 58' ' ' ILE . 74.2 mt -94.65 97.82 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.849 0.356 . . . . 0.0 110.157 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -84.66 -18.51 35.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.428 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 63' ' ' ILE . 2.5 mt-10 -103.84 146.4 32.45 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.9 Cg_endo -57.89 123.84 14.62 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.029 1.819 . . . . 0.0 111.973 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 80.5 mm-40 -126.42 167.52 15.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.833 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -71.76 137.49 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.732 0.777 . . . . 0.0 112.202 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.684 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.2 m -146.66 179.32 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.051 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.498 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.8 p -92.71 -162.25 0.91 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -83.51 -44.04 15.12 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.92 80.66 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.806 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.7 m -64.03 -40.99 97.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.405 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 77.5 t80 -55.8 -40.78 73.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.512 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 13.3 mt -71.35 -53.99 12.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.34 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.9 -48.61 42.31 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.374 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.463 HD21 HG23 ' A' ' 58' ' ' ILE . 72.3 mt -65.28 -42.33 93.27 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 52.8 ttt-85 -54.01 -20.84 6.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.393 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 82.9 p -59.22 -31.69 69.29 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.688 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.4 t -62.32 -34.39 76.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.549 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -94.35 121.21 35.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.255 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 70.9 mtm -87.57 133.84 33.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.683 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 143.39 57.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.714 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.341 -1.255 . . . . 0.0 112.853 -179.662 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.135 0 N-CA-C 112.599 -0.201 . . . . 0.0 112.599 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -60.53 149.63 85.73 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.824 2.349 . . . . 0.0 112.001 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.7 mt -81.69 140.29 34.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.94 -177.09 51.86 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.1 p -70.19 157.9 36.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.0 mmm -60.63 -37.66 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.34 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.35 175.23 40.83 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.543 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 80.5 tt0 -91.23 16.6 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 110.885 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -71.43 -2.15 15.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.203 0.525 . . . . 0.0 109.62 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' O ' ' CB ' ' A' ' 11' ' ' SER . 40.7 tt0 -67.37 109.52 3.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.136 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 9.9 t 159.46 39.8 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.535 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HG3' ' NH2' ' A' ' 61' ' ' ARG . 15.6 tttp -95.06 122.06 37.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.81 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.28 50.65 49.35 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.615 -0.803 . . . . 0.0 112.575 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -75.81 120.87 21.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 110.757 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 40.9 p90 -86.39 118.32 25.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -84.76 126.01 33.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.263 0.554 . . . . 0.0 109.655 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -58.92 153.68 16.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.056 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 19' ' ' GLU . 35.1 p-10 -58.0 -43.28 86.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.245 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 98.9 mt-10 -66.01 -41.5 90.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.865 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -71.78 -30.09 65.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.263 0.554 . . . . 0.0 110.258 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.49 72.62 5.31 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.595 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.87 -10.09 21.27 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.137 2.558 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -135.99 158.01 45.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.366 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 6.8 t -63.18 125.06 22.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.244 0.545 . . . . 0.0 111.643 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 31.8 m120 -63.51 -25.49 68.28 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.364 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.28 -56.66 2.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.684 -0.77 . . . . 0.0 114.679 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 p -105.09 -1.85 25.07 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.22 2.05 65.77 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.138 -1.029 . . . . 0.0 113.423 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.4 p -67.09 143.89 56.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.257 0.528 . . . . 0.0 109.639 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.7 OUTLIER -84.25 143.44 11.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -178.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.649 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 94.5 m-85 -84.28 134.82 34.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.646 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.7 p -126.45 168.75 13.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.061 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.04 -44.7 31.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.356 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 m -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.562 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.7 t -87.96 113.04 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.364 0.602 . . . . 0.0 111.54 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -73.85 149.28 41.68 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.126 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.476 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 20.2 ttp180 -81.74 140.9 34.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.792 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.2 m-70 -142.23 165.89 26.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.144 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.558 ' CE1' HG22 ' A' ' 46' ' ' VAL . 96.7 m-70 -131.35 147.63 52.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.546 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.2 t -90.77 136.7 32.9 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.449 ' NE ' ' OE1' ' A' ' 67' ' ' GLU . 68.6 mtp85 -72.45 -5.45 36.75 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.91 ' ND2' HD13 ' A' ' 58' ' ' ILE . 14.7 m-80 -101.67 -70.33 0.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.9 p -75.0 -24.84 58.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.4 77.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.637 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.501 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.9 m-85 -98.92 163.19 12.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.887 0.375 . . . . 0.0 110.529 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.877 ' C ' HD22 ' A' ' 47' ' ' LEU . 88.6 t -79.72 128.86 38.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.901 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.877 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.3 mm? -132.98 140.64 47.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.89 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.4 p -82.55 175.13 10.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.643 ' O ' ' HG2' ' A' ' 53' ' ' ARG . . . -52.13 -52.65 34.7 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.515 -1.326 . . . . 0.0 112.127 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -53.85 -36.3 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.866 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -92.32 -1.26 57.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.703 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.0 p -132.47 25.91 4.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.942 0.401 . . . . 0.0 110.089 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 49' ' ' GLY . 19.6 mmt180 -79.23 -22.99 44.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -76.33 165.06 25.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.446 0.641 . . . . 0.0 111.854 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -139.7 134.05 31.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.017 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.616 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.38 155.16 26.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.54 159.44 20.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.91 HD13 ' ND2' ' A' ' 42' ' ' ASN . 1.1 mt -133.12 74.96 72.33 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 121.092 0.473 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.95 -14.15 39.44 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.423 2.749 . . . . 0.0 114.491 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 69.3 mtm -86.54 -37.35 18.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.674 ' HG2' HG22 ' A' ' 58' ' ' ILE . 18.3 mmm180 -83.01 3.68 29.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.857 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.07 61.84 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.408 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.699 HD12 HD12 ' A' ' 58' ' ' ILE . 63.7 mt -101.24 101.25 11.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.91 0.386 . . . . 0.0 110.24 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.8 p -87.73 -16.01 35.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.434 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 63' ' ' ILE . 3.7 mp0 -103.19 145.2 30.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.0 Cg_endo -58.57 121.87 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.615 1.544 . . . . 0.0 112.005 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.637 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.7 mt-10 -125.49 168.74 13.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.702 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.489 ' NH1' ' HB3' ' A' ' 68' ' ' ARG . 5.1 ptp180 -72.37 137.28 46.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.741 0.782 . . . . 0.0 112.333 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.403 ' CG1' HD22 ' A' ' 42' ' ' ASN . 21.5 m -145.41 -177.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.897 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.53 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -97.29 -162.14 0.93 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -82.81 -43.91 16.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -45.09 78.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 111.53 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 62.4 m -64.15 -40.53 96.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.289 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.616 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 79.8 t80 -57.25 -41.29 79.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 8.5 mt -70.64 -50.94 31.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.872 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.21 -48.33 54.34 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.824 HD11 HD21 ' A' ' 42' ' ' ASN . 44.8 mt -64.37 -42.3 96.24 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 75' ' ' LEU . 61.0 ttt-85 -55.68 -19.42 10.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.593 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.8 p -59.6 -29.13 67.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.046 0.45 . . . . 0.0 110.313 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -121.06 140.24 52.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.655 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -91.31 141.31 28.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.012 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.3 mtp -82.62 135.29 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.47 143.73 57.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.873 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.091 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.502 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.96 147.28 64.05 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.338 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.2 mt -59.9 -35.16 74.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.794 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.28 176.12 27.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.438 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.8 p -61.66 -27.58 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 110.938 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 94.7 mmm -59.58 -36.03 75.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.038 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.66 31.07 55.23 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.201 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -82.26 7.59 13.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.555 0.217 . . . . 0.0 111.55 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -58.79 -18.15 29.63 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -57.54 142.26 45.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.001 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.2 p -120.89 151.57 39.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.824 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -103.72 134.98 46.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.29 152.61 40.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' GLY . 81.6 t80 -78.04 121.94 24.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 111.008 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -93.32 119.2 32.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -84.15 131.4 34.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.312 0.577 . . . . 0.0 110.347 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.7 153.73 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.255 -0.884 . . . . 0.0 113.044 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.463 ' HB3' ' NE ' ' A' ' 37' ' ' ARG . 35.6 p-10 -57.59 -44.11 85.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.349 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' OD1' ' A' ' 18' ' ' ASP . 97.2 mt-10 -66.36 -42.06 88.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.122 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -66.96 -34.03 76.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.122 0.487 . . . . 0.0 110.658 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.92 74.53 1.76 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.801 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -73.3 -12.3 25.24 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 123.056 2.504 . . . . 0.0 112.549 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.57 48.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.166 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 15.5 t -62.57 123.44 18.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.225 0.536 . . . . 0.0 111.683 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.9 m120 -60.36 -26.79 66.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.181 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.86 -55.88 2.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.588 -0.815 . . . . 0.0 114.429 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.3 p -103.98 -3.15 25.04 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.41 8.96 67.52 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.437 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 12.4 p -70.01 142.69 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 117.208 0.504 . . . . 0.0 110.186 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.95 137.9 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.954 -178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 84.6 m-85 -83.73 134.64 34.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.488 0.661 . . . . 0.0 110.535 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.5 p -127.48 171.2 11.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.001 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.5 m -46.9 -39.63 12.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.398 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.8 p -75.74 -25.45 56.55 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.828 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.9 t -96.74 112.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.36 0.6 . . . . 0.0 111.271 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -75.45 147.74 39.64 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.644 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 22.6 ttp85 -81.93 140.34 34.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.768 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.6 m-70 -141.96 163.9 31.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.232 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -129.26 146.57 51.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.698 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.5 t -91.19 138.03 31.91 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -73.03 -5.43 38.82 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.94 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.2 m-20 -101.46 -71.71 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.1 p -76.94 -24.41 52.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.12 22.09 78.24 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.367 -0.921 . . . . 0.0 112.547 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.51 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.8 m-85 -98.17 161.2 13.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.896 0.379 . . . . 0.0 110.454 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.881 ' C ' HD22 ' A' ' 47' ' ' LEU . 95.5 t -77.62 128.86 37.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.881 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.7 mm? -132.2 139.15 48.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.6 p -78.88 175.94 10.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.754 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -52.51 -53.95 29.7 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 119.764 -1.207 . . . . 0.0 112.333 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -54.83 -35.53 64.05 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.761 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -90.33 -1.94 57.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.441 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 p -131.3 26.25 4.83 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.754 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 94.6 mtt-85 -80.96 -19.39 44.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.117 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -80.58 163.41 23.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.19 0.519 . . . . 0.0 111.438 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 mtm105 -139.36 136.99 35.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.274 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.49 154.62 27.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.95 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.97 151.77 20.95 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.94 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.3 mt -128.39 79.32 74.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.038 0.447 . . . . 0.0 111.026 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.89 -9.97 20.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.217 2.611 . . . . 0.0 114.044 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 71.8 mtm -88.33 -37.87 15.61 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.5 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 30.8 mmm180 -83.17 1.01 42.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.441 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.18 7.42 60.88 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.904 HD12 HD12 ' A' ' 58' ' ' ILE . 74.1 mt -96.64 101.98 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.937 0.398 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.3 p -88.25 -18.94 27.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.384 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 3.5 mm-40 -103.69 138.53 19.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.4 Cg_exo -52.99 124.3 15.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.692 1.595 . . . . 0.0 112.044 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.618 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.6 mt-10 -125.64 167.43 15.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -69.94 136.25 50.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.582 0.706 . . . . 0.0 111.966 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.594 HG11 ' ND2' ' A' ' 42' ' ' ASN . 29.0 m -145.27 179.48 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.982 178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.482 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.89 -166.73 1.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 56.3 p30 -79.36 -42.68 25.06 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -67.9 -45.95 72.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.67 0.271 . . . . 0.0 111.7 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 39.2 m -63.63 -41.43 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.302 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.538 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 68.9 t80 -56.32 -40.36 74.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 78' ' ' ARG . 7.6 mt -72.55 -50.65 24.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.245 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.55 -48.95 62.89 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 116.7 -0.227 . . . . 0.0 110.667 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.6 mt -65.68 -42.03 91.73 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.548 ' HD3' HD23 ' A' ' 75' ' ' LEU . 71.2 ttt180 -58.4 -20.42 44.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.771 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.2 m -51.5 -36.54 45.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.134 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.6 t -135.06 121.5 20.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.913 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -62.69 -37.44 86.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.822 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.9 mtm -90.64 134.69 34.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.069 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.32 145.92 55.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.592 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.78 -4.14 14.93 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.652 2.234 . . . . 0.0 112.177 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 63.7 mt -60.32 -33.49 72.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.48 12.57 61.01 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.645 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.6 t -115.46 145.66 42.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 51.8 ttm -80.47 125.7 30.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.03 0.443 . . . . 0.0 110.899 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.26 -170.87 45.18 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.738 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -81.58 7.29 12.52 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.519 0.199 . . . . 0.0 111.533 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -59.77 -13.78 11.76 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -46.25 -34.29 4.31 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.159 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.5 p -109.17 149.35 29.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.624 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -127.13 151.43 48.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.45 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.74 -4.76 57.99 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.996 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -80.09 122.27 26.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.885 0.374 . . . . 0.0 110.91 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 48.0 p90 -91.91 119.47 31.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.886 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.599 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 63.7 tt0 -82.42 127.81 33.64 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.31 0.576 . . . . 0.0 109.91 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.47 153.46 15.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.818 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' OD1' ' HD2' ' A' ' 37' ' ' ARG . 6.3 m-20 -54.42 -46.49 73.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.295 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.9 -41.46 87.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.46 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -66.44 -33.14 75.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.159 0.504 . . . . 0.0 110.693 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.599 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -112.89 78.07 2.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.713 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.67 -13.28 18.11 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.101 2.534 . . . . 0.0 112.644 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.64 155.82 49.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.438 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.7 t -59.62 123.93 18.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.199 0.523 . . . . 0.0 111.552 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 29.5 m120 -60.83 -28.08 68.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.086 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.15 -54.77 2.36 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.636 -0.792 . . . . 0.0 114.329 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 p -103.68 -4.03 24.3 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.08 7.75 63.37 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.628 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p -69.88 144.16 52.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.264 0.532 . . . . 0.0 110.301 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.78 137.66 20.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.978 0.418 . . . . 0.0 112.066 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.652 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 95.2 m-85 -83.41 134.59 34.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.213 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -128.04 170.78 12.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.836 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -49.3 -43.85 43.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.35 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.5 m -66.53 -35.82 81.18 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.65 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.6 t -89.59 112.66 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.288 0.566 . . . . 0.0 111.364 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -73.08 145.76 46.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.846 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' HD2' ' OD1' ' A' ' 18' ' ' ASP . 58.5 ttm-85 -83.81 141.34 31.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.656 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 99.8 m-70 -143.66 166.25 25.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.383 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.616 ' NE2' HG22 ' A' ' 46' ' ' VAL . 76.3 m80 -130.86 148.85 52.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.0 t -90.02 137.52 32.27 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.459 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 29.2 tpt180 -71.73 -7.18 46.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.861 ' OD1' HD13 ' A' ' 58' ' ' ILE . 68.6 m-20 -100.7 -69.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.508 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.3 p -76.98 -23.08 52.31 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 15' ' ' TRP . . . 73.61 21.5 79.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.504 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.6 m-85 -98.68 161.41 13.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.794 0.33 . . . . 0.0 110.252 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.84 ' C ' HD22 ' A' ' 47' ' ' LEU . 85.2 t -79.21 129.3 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.24 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.878 HD12 ' HB3' ' A' ' 51' ' ' CYS . 2.4 mm? -132.41 141.01 48.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.743 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.2 p -79.45 177.81 8.58 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.88 -52.78 44.03 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 119.459 -1.353 . . . . 0.0 112.242 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -55.59 -35.58 65.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.878 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.15 -1.81 58.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.8 p -132.02 25.8 4.6 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 84.3 mtt-85 -79.88 -19.18 48.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.039 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -80.06 164.21 23.58 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.263 0.554 . . . . 0.0 111.771 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -140.76 135.91 31.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.284 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.6 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.82 155.1 27.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.976 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.473 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.46 154.45 20.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.861 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.6 mt -129.97 80.37 71.29 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.43 . . . . 0.0 110.58 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.99 -12.02 33.56 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.242 2.628 . . . . 0.0 114.189 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 88.3 mtp -86.4 -37.3 18.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.533 ' HG2' HG22 ' A' ' 58' ' ' ILE . 31.9 mmm180 -83.69 2.78 36.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.747 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.97 8.45 63.32 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.193 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.857 HD12 HD12 ' A' ' 58' ' ' ILE . 65.9 mt -97.87 100.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.79 -17.31 33.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.693 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 1.3 mm-40 -103.26 143.92 27.59 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 13.0 Cg_endo -57.13 123.29 13.49 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 121.618 1.545 . . . . 0.0 111.698 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -123.72 167.76 13.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.837 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -71.38 135.79 47.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.695 0.759 . . . . 0.0 111.824 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.623 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -146.0 -177.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.103 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.504 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 2.0 p -98.09 -162.7 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 53.9 p30 -82.97 -41.58 18.6 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.62 -46.23 69.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 111.541 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 65.3 m -64.01 -40.34 96.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.225 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.6 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 73.2 t80 -57.1 -40.42 76.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.573 HD23 ' HD3' ' A' ' 78' ' ' ARG . 9.1 mt -72.67 -52.92 13.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.46 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.64 -48.22 49.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 ' ND2' ' A' ' 42' ' ' ASN . 83.3 mt -66.32 -41.64 89.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.573 ' HD3' HD23 ' A' ' 75' ' ' LEU . 53.0 ttt85 -56.08 -19.77 14.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.307 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.3 t -96.09 81.68 3.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.388 . . . . 0.0 110.605 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -123.1 147.61 46.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -56.73 -36.56 69.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 96.2 mmm -87.59 131.51 34.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.37 142.48 54.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.394 179.882 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.708 -0.157 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.73 146.68 84.29 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 123.013 2.475 . . . . 0.0 112.315 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 mt -62.17 -35.2 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.318 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.39 10.52 62.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.7 t -66.59 155.67 37.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.348 . . . . 0.0 111.013 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 92.6 mmm -56.63 -31.3 64.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.544 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.11 157.8 12.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.623 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 14' ' ' TYR . 94.5 mt-10 -94.88 16.29 16.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.63 0.252 . . . . 0.0 111.309 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -58.17 -18.84 28.56 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 12' ' ' LYS . 31.9 tt0 -61.97 127.47 31.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.819 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.4 p -64.81 -33.84 76.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.946 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.441 ' HB3' ' NE2' ' A' ' 10' ' ' GLN . 19.9 tttt -60.66 -37.36 81.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.153 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.5 145.42 11.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.152 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.482 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 73.2 t80 -79.39 123.3 27.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.481 ' HB2' ' CE1' ' A' ' 39' ' ' HIS . 40.0 p90 -88.46 117.77 27.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.995 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.455 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 63.9 tt0 -84.95 127.24 34.09 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -58.8 153.63 16.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -53.91 -46.11 71.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.7 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.8 -41.11 88.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.159 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.67 -34.15 75.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.199 0.523 . . . . 0.0 110.604 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -111.39 77.54 1.68 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.619 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.64 -13.97 14.43 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.159 2.573 . . . . 0.0 113.181 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.15 156.58 48.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -59.65 125.82 25.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 112.051 -178.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 36.2 m-80 -62.66 -27.76 69.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.593 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.37 -54.42 2.26 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.101 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.6 p -103.46 -3.77 24.93 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.83 11.64 66.51 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.611 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 5.3 p -72.55 143.86 48.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.492 0.646 . . . . 0.0 110.485 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.68 137.14 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.912 -179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.613 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 98.1 m-85 -82.56 135.06 35.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.863 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -125.45 169.44 12.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.28 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 33.5 m -47.19 -43.22 21.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.151 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.9 m -67.78 -37.91 82.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.025 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 48' ' ' CYS . 62.4 t -87.2 113.06 24.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.353 0.597 . . . . 0.0 111.311 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.1 mmt-85 -74.08 149.79 40.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.763 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG3' HG13 ' A' ' 46' ' ' VAL . 64.8 ttp85 -80.95 138.77 36.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.802 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 89.1 m-70 -142.76 165.12 28.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.129 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 15' ' ' TRP . 64.3 m170 -128.18 146.58 50.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.725 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.0 t -90.3 137.47 32.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -72.57 -7.37 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.932 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.7 m-20 -101.21 -71.38 0.71 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.2 p -75.08 -24.04 58.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.695 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.66 20.86 79.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.734 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -99.07 163.24 12.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.953 0.406 . . . . 0.0 110.609 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.813 ' C ' HD22 ' A' ' 47' ' ' LEU . 89.6 t -76.74 128.72 37.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.406 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.878 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.1 mm? -133.06 139.45 47.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.654 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.406 ' HB2' HG11 ' A' ' 35' ' ' VAL . 14.1 p -79.69 175.54 10.52 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.73 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.46 -53.59 34.48 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.307 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.37 -36.14 63.55 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.878 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.65 -1.89 58.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.1 p -132.39 26.78 4.46 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 90.6 mtt-85 -80.22 -19.24 47.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -79.59 164.61 23.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.153 0.501 . . . . 0.0 111.628 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.45 ' NH1' ' HB3' ' A' ' 55' ' ' ARG . 15.9 mtp-105 -140.85 137.93 33.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.84 154.3 23.93 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.863 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.75 147.82 22.71 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.004 HD12 HD12 ' A' ' 63' ' ' ILE . 2.8 mt -126.97 77.69 74.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 121.205 0.526 . . . . 0.0 110.821 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.74 -8.18 12.83 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 123.393 2.729 . . . . 0.0 113.8 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.3 mtp -96.0 -34.99 11.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.766 0.793 . . . . 0.0 109.099 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 40.5 mtp85 -90.01 29.47 1.21 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.289 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.14 23.02 71.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.075 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.004 HD12 HD12 ' A' ' 58' ' ' ILE . 71.5 mt -119.44 101.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.748 0.309 . . . . 0.0 110.394 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.91 -22.86 24.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.817 0.341 . . . . 0.0 111.488 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.6 mm-40 -99.74 138.49 20.4 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 53.1 Cg_exo -52.72 123.04 12.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.4 1.4 . . . . 0.0 111.693 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.667 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.4 mt-10 -124.64 165.69 17.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.562 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -69.56 139.12 53.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.645 0.736 . . . . 0.0 112.186 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.63 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -145.14 -179.12 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.91 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.496 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -96.26 -164.98 1.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -80.19 -43.8 20.91 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.53 -43.84 79.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.734 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.8 m -65.23 -40.1 93.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.377 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 68.2 t80 -57.17 -41.83 79.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 78' ' ' ARG . 6.7 mt -70.43 -50.56 37.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.272 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.62 -51.18 61.17 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.399 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.528 HD11 ' OD1' ' A' ' 42' ' ' ASN . 33.9 mt -65.4 -42.18 92.86 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.522 ' HB3' ' HA ' ' A' ' 75' ' ' LEU . 67.6 ttt180 -58.8 -20.5 50.6 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.725 -1.579 . . . . 0.0 111.725 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.8 t -105.2 148.47 26.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.078 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.5 t -117.1 144.71 44.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.725 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -89.63 130.46 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.74 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.0 mtp -59.77 -35.51 74.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.77 147.43 49.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.049 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.411 -1.216 . . . . 0.0 112.619 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.31 -4.94 16.21 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.594 2.196 . . . . 0.0 112.528 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 mt -85.27 144.43 28.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.028 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.54 144.66 40.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.603 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.5 p -63.56 -23.58 67.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 111.066 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 84.8 mtp -109.51 143.31 39.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.56 111.24 0.41 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.466 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 80.3 tt0 -89.55 13.49 13.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 110.978 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -69.73 -4.18 18.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.281 0.563 . . . . 0.0 109.553 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -72.65 135.07 45.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.888 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.6 t -122.67 141.31 51.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.697 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -126.58 143.93 51.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.011 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.96 -171.86 48.29 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.231 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' GLY . 72.7 t80 -76.92 122.05 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 47.4 p-90 -92.84 118.36 31.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.59 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.536 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 63.5 tt0 -82.37 131.24 35.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.307 0.575 . . . . 0.0 110.314 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -60.27 153.11 23.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.76 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . 31.3 p-10 -56.66 -45.08 81.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.494 178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -64.97 -42.2 94.77 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.012 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -72.01 -29.24 64.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.263 0.554 . . . . 0.0 110.588 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -116.49 72.76 5.36 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.498 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.21 -11.08 17.72 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.245 2.63 . . . . 0.0 112.952 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 156.41 48.92 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.461 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 1.8 t -59.58 123.76 17.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.147 0.499 . . . . 0.0 111.872 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.54 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 63.4 m-80 -61.81 -27.69 68.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.969 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.86 -54.73 2.41 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.749 -0.739 . . . . 0.0 114.104 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.9 p -104.09 -3.19 24.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 69.14 9.08 59.73 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.466 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 6.7 p -70.59 144.79 51.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.156 0.478 . . . . 0.0 110.164 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -81.95 136.62 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.144 -178.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.676 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 99.0 m-85 -82.41 134.9 35.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.959 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 p -126.55 168.24 14.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.775 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.8 m -47.41 -43.58 23.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.204 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.9 m -66.51 -38.06 86.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.6 t -86.71 113.11 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 0.0 111.174 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.85 145.6 46.82 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.049 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 18' ' ' ASP . 22.5 ttm105 -83.24 140.76 32.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.572 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -143.06 167.25 22.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.441 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.452 ' CE1' HG22 ' A' ' 46' ' ' VAL . 96.7 m-70 -128.63 146.66 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.367 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.0 t -89.9 137.45 32.33 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.509 ' O ' ' NH1' ' A' ' 61' ' ' ARG . 14.2 mmt180 -71.83 -7.67 49.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.948 ' OD1' HD13 ' A' ' 58' ' ' ILE . 75.0 m-20 -101.74 -70.33 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.538 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 28.7 p -75.83 -24.2 55.81 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.27 21.11 79.96 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.712 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.54 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 22.0 m-85 -98.72 161.49 13.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.732 0.301 . . . . 0.0 110.349 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.787 ' C ' HD22 ' A' ' 47' ' ' LEU . 73.0 t -75.4 128.96 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.934 HD12 ' HB3' ' A' ' 51' ' ' CYS . 3.7 mm? -132.54 139.42 47.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 p -80.04 174.33 11.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.753 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.66 -53.97 26.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 119.601 -1.285 . . . . 0.0 112.437 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -55.08 -35.32 64.45 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.934 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.62 -2.51 58.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.426 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 p -132.55 26.47 4.41 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.753 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 92.3 mtt-85 -80.49 -20.39 43.77 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.168 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -78.55 163.69 25.32 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 111.289 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -138.26 135.89 35.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.957 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.557 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -156.39 153.94 29.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.973 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.434 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -93.65 149.29 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.994 HD12 HD12 ' A' ' 63' ' ' ILE . 2.1 mt -128.96 76.75 78.85 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.075 0.464 . . . . 0.0 110.918 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.12 -8.43 12.12 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 123.329 2.686 . . . . 0.0 113.693 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.1 mtp -94.87 -35.66 11.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.708 0.766 . . . . 0.0 108.949 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.535 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 7.6 mtp-105 -90.28 29.06 1.31 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.002 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 24.45 72.85 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.11 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.994 HD12 HD12 ' A' ' 58' ' ' ILE . 88.8 mt -123.52 97.93 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.44 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -86.84 -17.58 33.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.712 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.4 mt-10 -102.17 141.13 21.91 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.434 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 40.3 Cg_exo -55.39 122.52 11.88 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 121.492 1.461 . . . . 0.0 111.694 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.718 ' OE1' HD13 ' A' ' 63' ' ' ILE . 94.3 mt-10 -125.52 166.64 16.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -69.36 137.09 52.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.598 0.713 . . . . 0.0 111.984 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.594 HG11 ' ND2' ' A' ' 42' ' ' ASN . 26.9 m -145.89 -179.36 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.027 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 1.9 p -96.89 -166.83 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -78.08 -42.31 32.55 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.76 -45.72 70.66 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 38.4 m -64.38 -41.54 96.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.443 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 73.4 t80 -56.17 -39.59 72.6 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 22.0 mt -72.89 -54.56 8.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.454 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.54 -48.11 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 120.743 0.306 . . . . 0.0 110.364 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.416 HD11 ' OD1' ' A' ' 42' ' ' ASN . 82.6 mt -66.31 -40.94 90.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 66.1 ttt180 -56.63 -19.42 16.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.247 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.7 t -58.22 -38.22 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.872 0.368 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.8 p -78.23 158.79 28.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.734 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -95.89 123.42 39.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.016 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 89.2 mtp -83.82 127.77 34.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.805 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.24 55.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.156 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.277 -1.291 . . . . 0.0 112.435 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.91 146.66 66.92 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.671 2.247 . . . . 0.0 112.311 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 65.8 mt -59.87 -37.06 78.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.708 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.19 -167.17 53.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.472 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.6 m -64.92 151.62 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.72 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.2 ttp -60.62 -35.27 75.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.197 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.63 -172.71 35.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.7 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -83.55 8.63 13.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.636 0.255 . . . . 0.0 111.294 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -58.84 -17.66 25.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -52.08 -38.05 55.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.226 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.1 m -121.36 146.41 46.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.123 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' O ' ' NH2' ' A' ' 61' ' ' ARG . 56.8 mttt -59.22 -37.11 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.626 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -138.25 142.02 12.7 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.241 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.407 ' O ' ' O ' ' A' ' 44' ' ' GLY . 85.5 t80 -79.25 122.01 25.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.965 0.412 . . . . 0.0 111.307 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -89.08 118.79 29.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.839 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.465 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 63.4 tt0 -85.14 127.05 34.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.177 0.513 . . . . 0.0 109.747 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.31 153.35 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.969 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HB3' ' NE ' ' A' ' 37' ' ' ARG . 28.9 p-10 -57.2 -43.63 82.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.868 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.37 -41.99 88.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.987 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -67.83 -33.85 75.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.197 0.522 . . . . 0.0 110.605 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -112.56 75.71 1.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.747 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.99 -11.85 21.5 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 123.039 2.493 . . . . 0.0 112.592 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.75 156.01 49.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.218 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 8.6 t -62.83 123.93 19.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.174 0.511 . . . . 0.0 111.488 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 33.7 m120 -59.15 -27.01 65.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.084 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.11 -55.51 2.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.619 -0.8 . . . . 0.0 114.327 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.3 p -103.84 -2.61 26.02 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.74 8.91 61.36 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.3 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 10.8 p -69.51 143.09 53.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.22 0.51 . . . . 0.0 110.009 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -80.08 137.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.905 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.53 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 87.0 m-85 -84.33 134.93 34.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.7 p -127.74 171.51 11.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.308 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.1 m -48.25 -41.16 26.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.0 p -72.35 -28.05 62.8 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.269 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.8 t -94.9 113.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.432 0.634 . . . . 0.0 111.435 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -74.81 148.17 40.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.369 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 17.9 ttp180 -82.33 140.61 33.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.611 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 98.0 m-70 -142.23 164.99 28.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.014 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 64.2 m80 -130.43 147.09 52.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.514 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.6 t -89.37 138.38 31.49 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.424 ' HG2' ' CD1' ' A' ' 63' ' ' ILE . 24.6 tpt180 -72.55 -7.05 48.1 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.934 ' OD1' HD13 ' A' ' 58' ' ' ILE . 71.2 m-20 -100.66 -70.04 0.75 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.516 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 29.3 p -77.51 -23.86 50.15 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.28 22.13 79.07 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.283 -0.961 . . . . 0.0 112.397 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.516 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.4 m-85 -98.48 163.14 12.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.828 0.347 . . . . 0.0 110.314 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.871 ' C ' HD22 ' A' ' 47' ' ' LEU . 79.9 t -79.73 127.72 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.234 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.871 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.5 mm? -132.32 139.58 48.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.53 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.2 p -79.24 178.01 8.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.731 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -54.04 -53.8 35.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.481 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.42 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 82.8 m-20 -55.28 -35.77 65.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.739 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.48 -2.34 58.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.361 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 82.9 p -131.8 26.15 4.66 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.731 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 93.3 mtt-85 -79.54 -21.4 45.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.305 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -80.16 165.07 22.8 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.279 0.561 . . . . 0.0 111.613 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -140.59 138.09 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.388 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.584 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.37 154.16 26.55 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.834 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.89 154.99 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.934 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.2 mt -130.21 79.53 72.52 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.009 0.433 . . . . 0.0 111.013 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.09 -11.17 26.21 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 123.174 2.583 . . . . 0.0 113.91 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 89.7 mtp -86.91 -37.79 17.31 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG2' HG22 ' A' ' 58' ' ' ILE . 14.9 mmm180 -84.74 4.24 33.7 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.584 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.78 8.82 63.27 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.734 -0.667 . . . . 0.0 112.476 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.859 HD12 HD12 ' A' ' 58' ' ' ILE . 67.0 mt -99.09 100.83 11.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.241 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.0 p -87.09 -16.79 34.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.54 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 34.3 mt-10 -103.81 145.0 29.8 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 17.0 Cg_endo -58.18 123.34 13.42 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 121.688 1.592 . . . . 0.0 111.723 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -124.84 167.71 14.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.754 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 -71.01 136.46 48.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.603 0.716 . . . . 0.0 111.658 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.63 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.0 m -147.08 -178.54 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.159 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.512 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -97.34 -164.96 1.2 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -79.88 -43.97 21.29 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.83 -46.58 74.68 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 54.0 m -63.39 -41.32 98.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.338 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.584 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 75.7 t80 -56.34 -39.05 72.2 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 42.0 mt -73.0 -54.93 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.672 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.05 -47.87 44.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.294 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.406 HD11 ' OD1' ' A' ' 42' ' ' ASN . 91.8 mt -65.55 -41.43 93.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 17.1 ttp180 -57.24 -18.64 17.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.555 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.3 m -64.3 156.59 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.008 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.8 p -117.46 155.93 28.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.709 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -55.39 137.26 48.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 88.0 mtp -85.37 144.27 28.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.044 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.76 -26.13 67.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.448 -1.196 . . . . 0.0 112.522 -179.929 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.12 -3.19 12.81 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.879 2.386 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 mt -81.87 141.93 32.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.17 117.87 0.8 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.425 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.5 p -134.89 157.16 47.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.883 0.373 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 86.2 mtp -120.03 148.44 43.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.66 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.3 -95.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.844 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 10' ' ' GLN . 96.0 mt-10 -65.19 -11.65 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -62.57 -5.81 2.93 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 8' ' ' GLU . 58.8 tt0 -66.26 139.78 58.1 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.048 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -64.23 153.57 37.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.572 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -122.12 134.39 54.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 111.081 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.62 55.59 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.668 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.409 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 76.7 t80 -79.06 121.96 25.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.969 0.414 . . . . 0.0 111.031 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 27.0 p90 -92.49 118.99 31.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.69 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 64.1 tt0 -83.93 130.67 34.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.558 . . . . 0.0 110.243 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -60.03 154.31 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.935 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' OD1' ' HG2' ' A' ' 37' ' ' ARG . 31.6 m-20 -55.95 -44.34 78.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.166 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.37 -42.16 83.86 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -65.98 -33.88 76.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.205 0.526 . . . . 0.0 110.644 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 46' ' ' VAL . . . -112.43 72.61 1.29 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.538 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.64 -13.39 29.84 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.069 2.513 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.94 156.14 49.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.18 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 10.3 t -62.41 123.01 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.181 0.515 . . . . 0.0 111.648 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 68.1 m-80 -60.45 -25.66 66.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.282 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.89 -55.87 2.06 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.189 -178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.5 p -103.09 -4.45 24.51 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.98 10.06 72.28 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.469 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 8.5 p -71.1 142.61 50.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 117.355 0.577 . . . . 0.0 110.353 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.21 138.84 18.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.784 -178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.741 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.4 m-85 -83.85 134.17 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.473 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.4 p -127.89 171.67 11.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.999 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.2 m -48.26 -40.98 26.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.647 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.7 p -73.01 -27.68 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.391 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.1 t -94.61 112.66 27.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.419 0.628 . . . . 0.0 111.345 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -73.85 145.67 44.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.397 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.503 ' CD ' HG11 ' A' ' 46' ' ' VAL . 7.8 tpp180 -77.72 139.38 39.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 98.6 m-70 -142.72 161.9 36.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.221 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -129.96 147.19 51.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -89.9 137.85 31.99 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -72.3 -6.89 46.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.978 ' OD1' HD13 ' A' ' 58' ' ' ILE . 81.4 m-20 -101.54 -71.37 0.71 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.054 0.391 . . . . 0.0 112.054 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 28.3 p -75.73 -24.07 56.11 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . 72.97 22.14 79.34 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.371 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.522 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 23.2 m-85 -99.02 162.57 12.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.826 ' C ' HD22 ' A' ' 47' ' ' LEU . 89.6 t -78.47 128.14 38.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.873 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.826 HD22 ' C ' ' A' ' 46' ' ' VAL . 2.2 mm? -132.31 137.86 47.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.3 p -77.2 176.8 8.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.711 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.58 -54.36 30.71 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 119.811 -1.185 . . . . 0.0 112.29 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -54.85 -35.28 63.83 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.783 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.55 -2.35 58.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.38 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.7 p -132.33 26.18 4.48 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.0 mtt-85 -78.7 -21.39 48.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.217 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -78.39 162.07 26.7 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.118 0.485 . . . . 0.0 111.289 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -138.1 138.22 38.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.01 153.55 24.32 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.5 147.97 22.63 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.07 HD12 HD12 ' A' ' 63' ' ' ILE . 2.3 mt -126.93 76.97 75.39 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.104 0.478 . . . . 0.0 110.95 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.87 -6.97 10.26 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.253 2.636 . . . . 0.0 113.735 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 70.8 mtm -95.75 -36.11 11.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.723 0.773 . . . . 0.0 109.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 45.1 mtp85 -90.03 29.49 1.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.81 22.67 72.12 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.278 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.07 HD12 HD12 ' A' ' 58' ' ' ILE . 76.3 mt -118.54 102.5 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 117.033 0.417 . . . . 0.0 110.544 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.7 p -87.52 -21.68 25.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.397 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.441 ' O ' HG22 ' A' ' 63' ' ' ILE . 4.2 mt-10 -100.36 145.79 30.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.7 Cg_endo -59.49 123.25 12.96 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 121.738 1.625 . . . . 0.0 111.45 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.749 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.5 mt-10 -125.78 165.7 18.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.924 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -68.58 137.2 54.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 0.0 112.067 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.575 HG11 HD21 ' A' ' 42' ' ' ASN . 32.3 m -145.06 177.69 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.976 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.488 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.43 -168.78 1.84 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.25 -42.82 35.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.01 73.87 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 42' ' ' ASN . 54.5 m -64.13 -41.06 97.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.397 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.536 ' CE2' ' HD2' ' A' ' 78' ' ' ARG . 74.5 t80 -56.5 -39.79 73.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 mt -70.28 -49.94 44.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.621 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.13 86.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.492 HD11 ' OD1' ' A' ' 42' ' ' ASN . 93.6 mt -66.66 -36.57 82.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 0.0 110.832 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.536 ' HD2' ' CE2' ' A' ' 74' ' ' TYR . 12.9 mtt180 -68.45 -6.51 25.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.963 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 74.4 m -60.54 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 m -130.68 144.15 51.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.191 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.3 -34.0 73.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.509 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 95.6 mmm -88.14 137.85 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.671 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.63 145.68 48.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.068 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.473 179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.35 138.9 87.2 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.832 2.355 . . . . 0.0 112.293 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.2 mt -90.8 138.51 31.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.506 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.38 -178.17 24.14 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.574 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.5 p -138.45 158.46 44.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.805 0.336 . . . . 0.0 110.909 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 96.4 mmm -58.9 -36.05 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -174.92 51.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -91.41 8.73 34.86 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -67.44 -7.91 29.1 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.88 142.09 58.42 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.778 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -63.4 152.58 37.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.669 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -107.08 146.15 31.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.856 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.47 72.57 0.49 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.642 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.414 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 77.0 t80 -78.9 122.66 26.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.806 0.336 . . . . 0.0 110.799 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -91.79 117.19 29.54 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.376 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 21' ' ' ALA . 62.7 tt0 -84.02 132.53 34.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.304 0.573 . . . . 0.0 110.26 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.0 151.45 18.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.688 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -56.86 -42.72 80.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.83 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.9 -41.19 87.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.465 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 89.0 m-20 -62.53 -36.2 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.813 0.34 . . . . 0.0 111.282 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' NH1' ' A' ' 37' ' ' ARG . . . -114.54 77.66 4.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.505 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 17.1 Cg_exo -67.39 -11.82 33.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.146 2.564 . . . . 0.0 112.819 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.56 158.28 44.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.529 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -60.46 124.73 21.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 111.872 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -61.65 -25.92 67.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.79 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.38 -56.32 2.17 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 p -105.42 -2.3 23.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.47 9.58 68.97 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.191 -1.005 . . . . 0.0 113.737 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.7 p -71.25 143.78 50.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.412 0.606 . . . . 0.0 110.143 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.42 136.95 22.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.97 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 93.8 m-85 -83.03 134.93 35.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.095 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 p -125.75 168.08 14.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.729 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.0 m -47.08 -43.71 20.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.207 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.3 m -66.68 -36.92 83.68 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.025 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 48' ' ' CYS . 64.3 t -88.74 113.85 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.402 0.62 . . . . 0.0 111.468 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -76.75 150.93 36.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.548 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' NH1' ' CD2' ' A' ' 31' ' ' PHE . 68.7 mtt-85 -88.24 141.51 28.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.079 0.466 . . . . 0.0 110.68 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.602 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.2 m-70 -140.01 166.21 25.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.698 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -123.52 144.47 49.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.834 0.35 . . . . 0.0 111.517 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.88 137.34 32.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -71.98 -6.22 40.57 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.939 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.7 m-20 -101.28 -71.82 0.7 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.688 0.28 . . . . 0.0 111.673 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.4 p -75.85 -25.67 56.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.357 . . . . 0.0 111.87 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . 74.13 23.47 75.95 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.821 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 23.7 m-85 -100.45 163.24 12.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.808 0.337 . . . . 0.0 110.63 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.824 ' C ' HD22 ' A' ' 47' ' ' LEU . 68.4 t -78.27 128.67 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.0 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.824 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.8 mm? -131.63 138.3 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.294 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 12.2 p -76.92 174.25 10.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.74 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.8 -52.95 31.89 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.637 -1.268 . . . . 0.0 112.363 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 86.0 m-20 -55.47 -36.1 66.23 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.766 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.81 -2.49 58.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.337 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.8 p -131.97 26.53 4.6 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 91.1 mtt180 -80.76 -17.94 49.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.919 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -81.39 164.7 21.92 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 111.377 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -140.75 135.51 31.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.105 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -157.19 153.98 28.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.73 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -91.62 148.38 22.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.939 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.3 mt -124.9 82.47 60.89 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.28 -10.88 29.07 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.015 2.477 . . . . 0.0 114.048 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.3 mtt -86.95 -37.44 17.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.495 0.664 . . . . 0.0 109.267 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG2' HG22 ' A' ' 58' ' ' ILE . 34.4 mmm-85 -84.44 2.71 39.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.655 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.69 8.14 62.44 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.608 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.878 HD12 HD12 ' A' ' 58' ' ' ILE . 81.6 mt -97.89 101.39 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.347 . . . . 0.0 110.252 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.6 p -87.25 -19.25 28.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.59 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.0 mp0 -102.02 145.9 31.32 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 38.1 Cg_exo -58.45 123.04 12.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.413 1.409 . . . . 0.0 111.674 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' HG2' ' CG2' ' A' ' 63' ' ' ILE . 73.2 mm-40 -124.47 166.83 15.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.587 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -71.11 136.94 48.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.657 0.742 . . . . 0.0 111.978 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.622 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.6 m -145.81 179.3 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.035 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.47 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.1 p -94.61 -165.3 1.29 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -80.12 -44.06 20.6 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.33 -45.3 76.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.752 0.31 . . . . 0.0 111.789 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 35.3 m -63.81 -41.54 97.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.086 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.497 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 79.4 t80 -56.31 -40.7 74.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.68 HD23 ' HD3' ' A' ' 78' ' ' ARG . 11.7 mt -72.13 -51.41 21.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.352 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.13 -48.1 61.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.513 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.469 HD11 ' OD1' ' A' ' 42' ' ' ASN . 59.6 mt -66.67 -42.22 86.93 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.68 ' HD3' HD23 ' A' ' 75' ' ' LEU . 60.4 ttt180 -55.23 -21.39 13.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.389 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.1 p -101.58 141.62 34.17 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.61 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.5 p -89.46 -5.54 57.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.632 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -56.4 -33.44 65.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.731 0.3 . . . . 0.0 111.019 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 92.4 mmm -59.74 -34.55 73.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.185 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.45 142.52 55.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.406 -1.219 . . . . 0.0 112.518 -179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.97 144.64 99.12 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.833 2.355 . . . . 0.0 112.311 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt -60.34 -34.29 73.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.983 0.421 . . . . 0.0 110.574 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.57 -174.19 39.67 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.254 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.4 p -61.29 -28.34 69.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.895 0.379 . . . . 0.0 110.582 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 88.3 mtp -60.57 -35.37 75.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.9 99.89 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.52 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 6' ' ' MET . 95.3 mt-10 -91.94 13.03 19.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.597 0.237 . . . . 0.0 111.226 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -71.32 -0.95 11.24 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -80.7 124.86 29.37 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.985 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.2 p -136.65 142.61 43.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.955 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -121.22 20.06 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.111 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' N ' ' NH2' ' A' ' 61' ' ' ARG . . . -59.46 93.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.172 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 44' ' ' GLY . 79.2 t80 -80.47 123.58 28.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.427 ' O ' ' CD1' ' A' ' 15' ' ' TRP . 44.2 p90 -91.85 118.74 31.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.128 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 61.5 tt0 -81.89 132.7 35.28 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.142 0.496 . . . . 0.0 109.994 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.87 153.96 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.433 ' OD1' ' NH2' ' A' ' 37' ' ' ARG . 14.1 t0 -53.93 -54.35 40.05 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.585 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.45 -40.41 94.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.815 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -69.86 -31.72 69.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.274 0.559 . . . . 0.0 110.295 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -115.48 73.57 4.06 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.675 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.64 -11.34 20.35 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 123.101 2.534 . . . . 0.0 112.849 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.29 156.97 48.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.44 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 11.2 t -63.08 123.95 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.121 0.486 . . . . 0.0 111.613 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -60.46 -26.43 66.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.269 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.06 -56.21 2.36 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.568 -0.825 . . . . 0.0 114.312 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.9 p -105.32 -1.72 24.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.78 11.08 68.81 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.647 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.6 p -72.27 143.45 48.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.261 0.53 . . . . 0.0 110.425 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.06 136.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.727 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.707 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.4 m-85 -82.6 133.79 35.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.08 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.7 p -126.23 169.88 12.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.113 -0.948 . . . . 0.0 111.075 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.3 m -48.12 -43.99 31.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.371 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.6 m -67.46 -36.25 80.79 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.079 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.4 t -87.49 113.27 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.407 0.622 . . . . 0.0 111.541 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -73.62 145.22 45.55 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.194 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.607 ' NH1' HG11 ' A' ' 46' ' ' VAL . 63.3 ttm-85 -83.56 140.21 32.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.95 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -143.74 167.21 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.395 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.635 ' CE1' HG22 ' A' ' 46' ' ' VAL . 96.7 m-70 -130.59 147.62 52.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.357 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.3 t -91.06 137.98 31.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.43 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 60.0 mtp180 -73.18 -5.1 37.04 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.949 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.1 m-20 -101.72 -72.31 0.69 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.624 0.25 . . . . 0.0 111.645 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . 30.8 p -74.59 -24.44 58.89 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.64 19.5 79.71 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.026 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' A' ' 43' ' ' CYS . 36.0 m-85 -97.5 165.66 11.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.598 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.865 ' C ' HD22 ' A' ' 47' ' ' LEU . 92.9 t -81.27 128.28 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.3 mm? -131.67 138.17 48.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.554 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.1 p -76.82 177.03 7.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.737 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.15 -54.03 31.31 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.336 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 84.0 m-20 -55.26 -34.99 64.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.748 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.2 -2.61 58.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.29 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 84.1 p -132.43 25.55 4.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.737 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 71.8 mtp180 -78.32 -21.94 48.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.976 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -77.62 162.91 26.69 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.182 0.515 . . . . 0.0 111.723 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -138.67 137.09 36.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.06 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.599 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.04 154.05 25.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.876 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.37 150.96 21.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.949 HD13 ' OD1' ' A' ' 42' ' ' ASN . 2.9 mt -127.64 82.31 68.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.22 -10.54 27.75 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.109 2.54 . . . . 0.0 113.99 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 73.4 mtm -87.16 -37.17 17.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 13.6 mmm180 -83.94 2.08 40.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.8 7.39 62.9 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.4 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.871 HD12 HD12 ' A' ' 58' ' ' ILE . 77.2 mt -96.5 100.61 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 110.232 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.8 p -86.09 -19.03 30.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.448 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.2 mt-10 -102.84 146.43 32.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 18.9 Cg_endo -58.85 123.5 13.66 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 121.688 1.592 . . . . 0.0 111.954 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.6 mm-40 -125.32 166.84 15.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.697 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -70.15 137.01 50.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 0.0 112.095 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.6 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.8 m -146.43 179.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.904 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.516 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.3 p -95.67 -163.63 1.07 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 72' ' ' ALA . 48.7 p-10 -82.6 -42.45 18.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' N ' ' OD1' ' A' ' 71' ' ' ASP . . . -68.12 -45.18 74.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.748 0.308 . . . . 0.0 111.645 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.431 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 34.3 m -63.51 -41.38 98.52 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.256 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 80.7 t80 -56.55 -39.71 73.9 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 78' ' ' ARG . 7.2 mt -72.72 -51.15 20.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.324 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.11 -47.52 65.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.391 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD11 ' ND2' ' A' ' 42' ' ' ASN . 71.6 mt -65.19 -41.16 94.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 51.3 ttt85 -58.28 -17.68 21.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.6 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.2 m -58.28 -31.43 67.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.5 m -51.63 -32.96 31.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.923 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -84.57 117.73 23.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.565 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.3 mtm -89.79 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.12 144.8 56.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.045 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.355 -1.247 . . . . 0.0 112.521 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.443 ' HA3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' HD2' ' HA3' ' A' ' 1' ' ' GLY . 17.5 Cg_endo -57.71 150.05 64.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.8 2.333 . . . . 0.0 112.375 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.2 mt -84.46 141.53 30.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.744 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.68 -137.26 28.57 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.48 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 98.2 p -126.91 154.77 44.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.852 0.358 . . . . 0.0 110.948 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 51.5 ttm -111.39 132.38 54.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.62 124.58 6.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.407 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -71.55 -9.08 57.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.484 0.183 . . . . 0.0 111.318 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -59.38 -11.38 4.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -64.82 124.97 23.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.025 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.1 m -129.87 147.51 51.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.852 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -59.93 -32.86 71.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.11 0.481 . . . . 0.0 110.104 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.7 145.08 8.51 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.951 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 44' ' ' GLY . 71.5 t80 -78.44 122.42 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.798 0.333 . . . . 0.0 111.126 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 46.0 p-90 -95.1 119.92 34.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.944 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -85.27 131.0 34.48 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.35 154.01 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.826 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -55.78 -45.5 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.06 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -65.89 -42.37 90.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.516 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.05 -34.66 78.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 0.0 110.397 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.68 73.79 0.86 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.606 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.19 -14.67 25.78 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.019 2.48 . . . . 0.0 112.648 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.02 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.267 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.427 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 4.1 t -60.59 125.23 22.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.315 0.579 . . . . 0.0 111.704 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 64.8 m-80 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.886 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.59 -56.17 2.05 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.234 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 29' ' ' CYS . 21.5 p -103.08 -4.14 24.96 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.75 73.33 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.53 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 8.0 p -73.67 143.66 46.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.391 0.595 . . . . 0.0 110.324 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -79.78 137.39 21.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.794 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 86.4 m-85 -83.97 135.08 34.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.301 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.1 p -128.66 170.32 13.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.416 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.9 m -47.82 -44.46 28.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.535 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.4 m -65.44 -35.95 82.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.824 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.03 113.78 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.356 0.598 . . . . 0.0 111.625 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.6 mmt85 -75.38 148.89 38.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.402 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.473 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 24.2 ttp-105 -79.22 141.63 36.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 47' ' ' LEU . 96.5 m-70 -141.22 160.75 39.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.012 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -126.8 145.83 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.375 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 24.8 t -91.34 137.18 32.57 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.9 mmt85 -72.1 -6.85 45.43 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.864 ' OD1' HD13 ' A' ' 58' ' ' ILE . 70.2 m-20 -100.66 -71.64 0.7 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 30.6 p -75.81 -24.28 55.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.02 21.05 79.6 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.449 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 24.5 m-85 -98.54 162.12 13.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 110.515 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.863 ' C ' HD22 ' A' ' 47' ' ' LEU . 90.2 t -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.39 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.863 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.9 mm? -132.12 140.06 48.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.498 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.5 p -78.17 -179.86 6.44 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.708 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.22 -53.65 41.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.206 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 95.3 m-20 -55.2 -36.28 65.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.813 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.53 -2.01 58.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.312 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 p -131.9 26.48 4.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.708 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 81.9 mtt-85 -81.35 -16.86 51.04 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -85.24 167.18 15.89 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.145 0.498 . . . . 0.0 111.339 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.9 mtt85 -144.03 140.88 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.488 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -159.15 154.43 25.47 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.606 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -89.39 149.98 22.74 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.877 HD12 HD12 ' A' ' 63' ' ' ILE . 3.6 mt -125.4 81.51 64.02 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 121.094 0.474 . . . . 0.0 110.596 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.64 -12.67 36.82 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.095 2.53 . . . . 0.0 114.318 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 66.2 mtm -85.72 -37.63 19.16 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.562 ' HG2' HG22 ' A' ' 58' ' ' ILE . 27.5 mmm180 -83.21 1.31 41.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.878 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.32 8.8 59.7 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.559 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.877 HD12 HD12 ' A' ' 58' ' ' ILE . 69.4 mt -98.98 101.5 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.095 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.2 p -88.59 -17.56 29.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.754 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.5 mt-10 -103.03 142.31 24.29 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -55.42 122.39 11.63 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 121.533 1.489 . . . . 0.0 111.694 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 75.8 mm-40 -123.33 166.18 15.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.595 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 mtm105 -71.02 139.41 50.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.499 0.666 . . . . 0.0 111.328 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.634 HG11 ' ND2' ' A' ' 42' ' ' ASN . 28.3 m -147.35 -179.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.244 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.522 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.6 p -95.5 -164.47 1.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -81.25 -43.51 19.1 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.07 -46.06 75.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.712 0.291 . . . . 0.0 111.641 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 40.0 m -63.78 -40.16 96.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.211 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.507 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 83.8 t80 -56.92 -39.86 75.26 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.713 HD23 ' HD3' ' A' ' 78' ' ' ARG . 9.6 mt -72.47 -52.19 16.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.47 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.2 -49.63 52.02 Favored 'General case' 0 CA--C 1.521 -0.15 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.559 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.461 HD11 ' OD1' ' A' ' 42' ' ' ASN . 58.8 mt -65.04 -41.56 95.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.713 ' HD3' HD23 ' A' ' 75' ' ' LEU . 52.3 ttt180 -57.26 -21.17 32.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.146 -1.388 . . . . 0.0 112.041 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.4 p -103.89 154.71 19.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 111.443 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 71.5 p -131.77 154.95 48.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -93.02 140.52 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.993 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 64.3 mtm -59.6 -34.17 72.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.698 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.48 68.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.237 -1.313 . . . . 0.0 112.406 179.857 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 112.705 -0.158 . . . . 0.0 112.705 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -60.31 145.54 98.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.872 2.382 . . . . 0.0 112.169 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 38.7 mt -85.43 140.97 30.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.852 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.07 144.53 34.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.658 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.9 p -75.15 -6.5 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 82.8 mtp -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.858 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.86 98.05 0.85 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.394 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -92.71 9.98 32.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.311 . . . . 0.0 111.489 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -58.74 -18.89 35.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -61.05 137.8 58.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.129 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.3 p -76.95 159.56 29.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.776 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -109.51 131.39 55.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.907 0.384 . . . . 0.0 110.981 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.77 169.57 27.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.763 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 44' ' ' GLY . 71.4 t80 -79.93 122.32 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.452 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -86.69 118.02 25.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.609 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 62.1 tt0 -84.31 131.08 34.75 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.157 0.503 . . . . 0.0 109.807 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.407 ' HA ' ' NH1' ' A' ' 37' ' ' ARG . 95.8 mt-10 -64.01 153.94 35.73 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.492 ' OD1' ' HD3' ' A' ' 37' ' ' ARG . 11.5 m-20 -56.15 -43.93 78.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.769 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.53 -42.61 82.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.266 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -69.4 -32.4 71.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.25 0.548 . . . . 0.0 110.377 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.609 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -113.61 74.3 2.28 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.519 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.92 -11.43 18.09 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.958 2.439 . . . . 0.0 112.346 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.06 155.46 50.71 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.204 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.0 t -64.15 126.94 29.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.111 0.482 . . . . 0.0 111.437 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 34.8 m120 -60.9 -26.39 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.974 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.19 -55.85 2.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 114.229 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.4 p -102.88 -4.18 25.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.93 9.01 65.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.466 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.1 p -69.87 143.22 52.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.127 0.464 . . . . 0.0 110.041 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -80.43 138.23 20.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.083 0.468 . . . . 0.0 112.036 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.571 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.3 m-85 -83.92 133.44 34.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.412 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.9 p -126.54 169.57 12.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -46.68 -39.87 12.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.349 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.8 p -73.71 -25.87 60.43 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.427 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.6 t -97.7 113.14 31.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.23 0.538 . . . . 0.0 111.253 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 64.4 mtt85 -76.51 149.1 36.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.896 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' HD3' ' OD1' ' A' ' 18' ' ' ASP . 18.6 ttp180 -79.29 140.77 37.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.668 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -140.39 158.83 43.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.964 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -125.76 145.33 50.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.353 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.0 t -91.14 137.79 32.1 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 mmt85 -72.95 -6.55 46.05 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.925 ' OD1' HD13 ' A' ' 58' ' ' ILE . 78.6 m-20 -101.08 -72.53 0.67 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.696 0.284 . . . . 0.0 111.754 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 31.2 p -74.87 -25.02 58.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.815 0.34 . . . . 0.0 111.581 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.7 22.84 77.88 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.679 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 24.0 m-85 -99.1 162.76 12.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.841 0.353 . . . . 0.0 110.626 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.865 ' C ' HD22 ' A' ' 47' ' ' LEU . 78.5 t -79.28 128.06 38.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.969 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.865 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.3 mm? -131.49 140.43 49.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.494 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.2 p -79.41 174.02 11.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.761 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -50.42 -54.19 21.44 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.649 -1.263 . . . . 0.0 112.545 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -54.66 -36.13 64.25 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.762 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.9 -2.39 58.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.141 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 p -131.91 25.79 4.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.796 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.6 mtt-85 -81.1 -18.05 47.88 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -80.03 163.43 24.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.278 0.561 . . . . 0.0 111.571 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -139.78 136.68 34.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.231 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -158.58 154.71 27.02 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.018 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -90.71 148.9 22.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.925 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.7 mt -126.69 79.64 71.48 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 121.018 0.437 . . . . 0.0 110.915 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -10.02 21.64 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 123.111 2.54 . . . . 0.0 113.817 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 93.9 mmm -87.7 -37.53 16.61 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 16.2 mmm180 -84.14 3.44 34.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.507 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.95 6.61 65.09 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.243 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.893 HD12 HD12 ' A' ' 58' ' ' ILE . 85.0 mt -95.54 100.6 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.777 0.322 . . . . 0.0 110.358 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 75.5 p -87.45 -19.03 28.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 9.0 mt-10 -103.33 138.6 19.59 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 51.2 Cg_exo -52.74 124.33 15.09 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 121.647 1.565 . . . . 0.0 112.17 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.694 ' OE1' HD13 ' A' ' 63' ' ' ILE . 93.8 mt-10 -125.28 166.67 16.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.551 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -70.24 138.61 51.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.675 0.75 . . . . 0.0 112.092 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.648 HG11 ' ND2' ' A' ' 42' ' ' ASN . 31.3 m -147.08 178.97 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.464 -1.243 . . . . 0.0 110.013 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.499 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 1.7 p -93.46 -165.2 1.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -81.24 -42.82 20.15 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.42 -44.9 77.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 27.0 m -63.52 -41.51 98.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.379 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 56' ' ' ALA . 74.7 t80 -56.06 -39.94 72.81 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.57 HD23 ' HD3' ' A' ' 78' ' ' ARG . 8.8 mt -72.38 -51.8 18.87 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.1 -48.49 61.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.306 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.477 HD11 ' ND2' ' A' ' 42' ' ' ASN . 60.0 mt -65.61 -42.05 92.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.57 ' HD3' HD23 ' A' ' 75' ' ' LEU . 64.7 ttt-85 -56.15 -18.94 11.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.182 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.8 m -58.83 151.16 22.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 26.6 m -120.88 148.9 43.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.53 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.56 -34.02 61.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.688 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 91.9 mtp -88.5 137.85 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.62 145.35 52.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.343 -1.254 . . . . 0.0 112.612 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 1' ' ' GLY . 18.0 Cg_endo -59.94 146.47 95.79 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.578 2.185 . . . . 0.0 112.08 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.0 mt -60.62 -27.7 67.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.12 6.73 48.54 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.15 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.5 m -59.24 -32.85 70.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.995 0.398 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 89.7 mtp -90.5 139.63 30.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.24 8.48 71.53 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.514 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 86.5 tt0 -87.64 13.01 11.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.011 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -71.05 -4.9 27.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.246 0.546 . . . . 0.0 109.559 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -57.62 146.61 29.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.773 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 41' ' ' ARG . 31.2 t -113.36 144.78 42.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.069 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -66.27 133.42 50.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.729 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.57 153.21 5.83 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.406 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 44' ' ' GLY . 80.8 t80 -78.73 121.5 24.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.848 0.356 . . . . 0.0 111.156 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.421 ' O ' ' CD1' ' A' ' 15' ' ' TRP . 48.6 p90 -89.78 119.25 30.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.68 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' CD ' ' HB2' ' A' ' 21' ' ' ALA . 64.1 tt0 -84.8 129.23 34.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.562 . . . . 0.0 110.098 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.6 151.98 19.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.732 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' CB ' ' HD3' ' A' ' 37' ' ' ARG . 37.6 t0 -55.87 -44.66 78.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.68 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.85 -41.89 91.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.039 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -67.04 -34.58 78.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.099 0.476 . . . . 0.0 110.576 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.409 ' HB2' ' CD ' ' A' ' 16' ' ' GLN . . . -111.84 74.24 1.29 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.767 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -71.81 -12.74 28.98 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.057 2.505 . . . . 0.0 112.57 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.8 156.68 48.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.356 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 28' ' ' GLY . 8.3 t -62.03 125.14 22.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.157 0.503 . . . . 0.0 111.523 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.481 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 68.7 m-80 -60.33 -26.72 66.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.86 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.43 -55.19 2.1 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.991 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.8 p -103.69 -4.94 23.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 24' ' ' CYS . . . 70.97 11.58 70.13 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.791 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 9.1 p -72.03 143.41 49.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.374 0.587 . . . . 0.0 110.409 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.44 138.08 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 112.022 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 97.2 m-85 -84.99 135.72 33.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.5 p -127.6 169.52 13.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.815 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 51.6 m -46.63 -42.82 16.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.4 m -66.59 -37.22 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.251 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.35 113.38 25.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.318 0.58 . . . . 0.0 111.524 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.3 mtt85 -74.55 148.31 40.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.492 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.465 ' HG3' HG13 ' A' ' 46' ' ' VAL . 13.7 ttp180 -78.63 141.4 38.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.409 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.4 m-70 -142.18 163.01 34.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.189 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.05 147.52 51.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.906 0.384 . . . . 0.0 111.917 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.0 t -90.57 136.72 32.88 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' NE ' ' HB3' ' A' ' 67' ' ' GLU . 91.3 mtt-85 -70.17 -6.94 37.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 1.08 ' OD1' HD13 ' A' ' 58' ' ' ILE . 5.3 m-20 -102.9 -70.26 0.76 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 26.2 p -75.05 -25.83 58.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.054 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 74.82 20.31 79.54 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.391 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.5 m-85 -97.33 161.11 13.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.861 0.362 . . . . 0.0 110.668 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.83 ' C ' HD22 ' A' ' 47' ' ' LEU . 99.4 t -78.43 128.89 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.089 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 51' ' ' CYS . 1.9 mm? -130.81 140.45 50.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.694 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -78.33 172.46 13.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -51.0 -52.51 30.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.248 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.437 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 89.3 m-20 -55.88 -34.96 65.98 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.842 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.77 -1.37 57.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.278 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.4 p -131.74 25.7 4.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.748 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 78.1 mtp180 -80.72 -19.35 45.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.076 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -78.35 164.77 24.55 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.198 0.523 . . . . 0.0 111.623 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -141.03 134.71 30.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.323 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -160.7 154.09 21.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.82 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -84.8 158.04 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.08 HD13 ' OD1' ' A' ' 42' ' ' ASN . 1.6 mt -132.96 76.64 69.98 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-O 121.087 0.47 . . . . 0.0 110.326 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.8 -11.57 29.91 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 123.238 2.625 . . . . 0.0 114.337 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 85.7 mtp -86.36 -37.64 18.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.621 ' HG2' HG22 ' A' ' 58' ' ' ILE . 16.2 mmm180 -83.94 3.76 32.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.673 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.76 7.96 62.5 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.439 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.897 HD12 HD12 ' A' ' 58' ' ' ILE . 65.8 mt -97.01 101.8 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.281 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.5 p -86.73 -18.34 31.4 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.671 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 63' ' ' ILE . 87.6 mt-10 -102.91 146.68 32.87 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.467 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 19.2 Cg_endo -59.05 122.35 11.44 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.553 1.502 . . . . 0.0 111.673 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 76.8 mm-40 -125.83 167.56 15.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.842 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -71.6 138.45 48.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.556 0.693 . . . . 0.0 112.092 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.3 179.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.751 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.531 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 15.3 p -95.59 -172.53 2.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -73.39 -42.94 61.53 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.07 -45.03 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.725 0.297 . . . . 0.0 111.683 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.1 m -64.64 -40.64 95.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.339 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.627 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 18.9 t80 -56.33 -41.52 76.16 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mt -67.36 -48.26 67.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.513 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.51 86.58 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.489 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.62 HD21 HG23 ' A' ' 58' ' ' ILE . 89.1 mt -66.1 -38.73 88.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.068 0.461 . . . . 0.0 110.353 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.627 ' HG3' ' O ' ' A' ' 74' ' ' TYR . 62.7 mtp180 -64.45 -10.38 24.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.029 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.8 p -58.81 -30.2 67.44 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.673 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 84.2 p -63.72 -29.42 70.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.821 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -94.88 122.69 37.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.845 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 71.1 mtm -84.52 133.76 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.028 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.74 145.49 56.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.547 179.921 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.0 150.64 37.45 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.869 2.38 . . . . 0.0 112.761 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.73 147.22 33.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.99 -152.45 8.47 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.565 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.2 p -60.09 -21.67 61.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 110.974 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 13.8 tpp -52.61 -39.97 62.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.059 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.87 126.32 7.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.257 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 86.8 tt0 -76.47 -0.65 23.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.501 0.191 . . . . 0.0 111.321 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -64.03 -8.45 11.79 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 11' ' ' SER . 58.4 tt0 -63.41 142.37 58.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.709 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 10' ' ' GLN . 6.3 t 178.97 66.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.259 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -60.08 -36.22 76.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.045 0.45 . . . . 0.0 110.608 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -150.41 127.68 2.45 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.6 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 81.3 t80 -76.1 119.84 20.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.977 0.418 . . . . 0.0 111.502 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 26.6 p-90 -87.41 118.25 26.73 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.9 tp60 -80.05 125.59 29.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.326 0.584 . . . . 0.0 110.163 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 148.63 29.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.647 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -57.71 -43.62 85.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.025 178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.41 -42.9 82.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.178 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -66.03 -33.66 76.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.204 0.525 . . . . 0.0 110.63 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.91 76.45 0.97 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.952 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.31 -15.02 25.44 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.778 2.318 . . . . 0.0 112.612 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -134.38 155.59 50.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.336 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.7 t -61.51 125.17 22.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.111 0.482 . . . . 0.0 111.414 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 45' ' ' TYR . 27.0 m120 -61.67 -26.13 67.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.224 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 -55.81 2.23 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.645 -0.788 . . . . 0.0 114.715 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.9 p -104.11 -1.58 27.13 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 7.71 61.91 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.163 -1.018 . . . . 0.0 113.278 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 11.0 p -69.92 143.92 52.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.237 0.519 . . . . 0.0 110.168 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -82.98 138.98 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 112.151 -178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.614 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 96.2 m-85 -82.42 133.91 35.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.503 0.668 . . . . 0.0 110.27 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.5 p -126.88 169.06 13.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.74 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 44.3 m -44.73 -38.79 4.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.473 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.7 p -78.44 -26.76 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -96.14 112.87 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.177 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' NH1' ' CE1' ' A' ' 38' ' ' HIS . 18.1 mtp-105 -78.34 150.03 33.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.425 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.4 mtt85 -89.73 143.2 27.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 110.817 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 96.4 m-70 -138.84 164.44 29.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.389 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -120.86 143.34 48.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.758 0.313 . . . . 0.0 111.063 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.8 t -90.53 136.57 32.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -70.44 -6.76 38.17 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.907 ' OD1' HD13 ' A' ' 58' ' ' ILE . 76.8 m-20 -101.82 -70.66 0.74 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.561 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . 30.0 p -77.56 -25.32 49.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 14' ' ' TYR . . . 75.11 24.13 72.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.916 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 43' ' ' CYS . 20.7 m-85 -102.32 162.33 13.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.8 0.333 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.825 ' C ' HD22 ' A' ' 47' ' ' LEU . 60.5 t -77.35 129.19 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.246 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.825 HD22 ' C ' ' A' ' 46' ' ' VAL . 1.6 mm? -131.53 137.65 48.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.118 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.4 p -74.37 175.23 7.87 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.713 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -53.44 -53.01 37.48 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.497 -1.335 . . . . 0.0 112.044 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -54.76 -35.03 63.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.738 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -89.11 -3.63 58.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.444 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.4 p -131.41 27.93 4.71 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.713 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 88.4 mtt-85 -82.16 -19.21 40.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.197 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -78.59 163.52 25.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.273 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -140.0 135.16 32.41 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.263 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' HB2' ' CE1' ' A' ' 74' ' ' TYR . . . -159.05 153.35 23.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.687 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.437 ' CA ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.29 151.31 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.967 HD12 HD12 ' A' ' 63' ' ' ILE . 2.5 mt -127.37 74.97 77.52 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 121.14 0.495 . . . . 0.0 110.411 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.48 -9.02 14.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.127 2.551 . . . . 0.0 113.738 -178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 64.0 mtt -93.22 -36.72 12.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.556 ' HG3' ' CG2' ' A' ' 58' ' ' ILE . 32.5 mtp85 -89.43 26.34 1.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.358 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.63 23.36 76.72 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.276 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.967 HD12 HD12 ' A' ' 58' ' ' ILE . 73.5 mt -117.98 104.56 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.807 0.304 . . . . 0.0 110.326 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 74.1 p -91.31 -21.04 21.24 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 42.4 mt-10 -100.8 139.24 20.39 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HA ' ' CA ' ' A' ' 57' ' ' ALA . 52.3 Cg_exo -52.71 123.02 11.99 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.591 1.527 . . . . 0.0 111.971 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.667 ' OE1' HD13 ' A' ' 63' ' ' ILE . 92.9 mt-10 -125.18 167.34 14.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.126 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -72.74 140.24 47.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.553 0.692 . . . . 0.0 112.267 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.622 HG11 ' ND2' ' A' ' 42' ' ' ASN . 30.2 m -146.83 179.65 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.527 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.2 p -93.38 -163.62 1.07 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -82.09 -42.99 18.43 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.605 -0.438 . . . . 0.0 112.112 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -45.86 71.77 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 58.5 m -63.57 -40.69 97.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.373 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 67.1 t80 -56.7 -39.72 74.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.572 HD23 ' HD3' ' A' ' 78' ' ' ARG . 8.8 mt -73.02 -53.0 12.27 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.775 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.97 -47.41 61.3 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.26 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.518 HD11 ' OD1' ' A' ' 42' ' ' ASN . 82.2 mt -66.1 -41.94 89.92 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.572 ' HD3' HD23 ' A' ' 75' ' ' LEU . 59.7 ttt180 -56.5 -19.67 16.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.338 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.0 m -103.33 150.24 23.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.9 0.381 . . . . 0.0 111.009 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.2 p -134.45 161.19 35.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.511 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -87.83 134.2 33.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.371 . . . . 0.0 111.111 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 90.3 mtp -60.09 -35.07 74.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.823 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.84 145.88 54.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.282 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.38 -1.234 . . . . 0.0 112.511 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.487 2.096 0 N-CA-C 112.186 -0.366 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.442 ' HD2' ' HA3' ' A' ' 1' ' ' GLY . 19.6 Cg_endo -60.06 143.17 99.58 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.482 2.121 . . . . 0.0 112.088 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 76.0 mt -79.86 142.99 34.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 110.801 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.51 12.97 77.15 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.417 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.0 m -59.86 -36.01 75.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.751 0.31 . . . . 0.0 111.006 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 68.3 mtm -127.77 151.83 48.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.025 0.441 . . . . 0.0 111.058 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.78 170.41 45.39 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.723 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.93 14.25 18.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.634 0.254 . . . . 0.0 111.213 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -70.9 -4.66 25.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.239 0.542 . . . . 0.0 109.65 178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -65.03 143.56 57.86 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.134 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.4 m -120.86 149.4 42.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.579 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -113.34 144.95 41.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.38 153.33 17.61 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.453 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' O ' ' A' ' 44' ' ' GLY . 73.3 t80 -78.79 122.21 25.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.465 ' O ' ' CG ' ' A' ' 15' ' ' TRP . 20.0 p90 -94.08 119.01 32.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -83.18 131.89 35.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.172 0.511 . . . . 0.0 110.089 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -59.86 154.29 18.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.387 -0.824 . . . . 0.0 113.15 -178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.498 ' OD1' ' HD2' ' A' ' 37' ' ' ARG . 14.9 m-20 -54.79 -46.31 74.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.317 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.83 -40.76 88.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.52 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 92.8 m-20 -65.6 -32.78 74.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.949 0.404 . . . . 0.0 111.385 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.3 75.63 4.59 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.489 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 13.3 Cg_exo -70.36 -12.88 32.51 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.232 2.621 . . . . 0.0 113.053 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -137.08 159.65 41.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.6 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.417 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 5.2 t -62.93 128.84 37.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.266 0.555 . . . . 0.0 112.059 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 m-80 -69.19 -24.76 64.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.324 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.43 -57.88 2.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.855 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 p -105.78 -0.3 25.48 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.37 4.05 72.92 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.413 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 24' ' ' CYS . 13.5 p -69.37 143.52 53.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 117.356 0.578 . . . . 0.0 109.795 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.16 144.45 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.7 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 89.7 m-85 -83.54 132.96 34.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.32 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.426 ' H ' ' HB ' ' A' ' 35' ' ' VAL . 28.9 p -124.84 168.66 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.925 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 56.9 m -48.24 -44.5 33.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 m -66.96 -36.16 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 32' ' ' THR . 77.3 t -86.3 113.46 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.512 0.672 . . . . 0.0 111.786 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mmt-85 -73.11 144.83 46.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.897 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HG3' ' CG1' ' A' ' 46' ' ' VAL . 21.5 ttm105 -87.09 141.99 28.25 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.952 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 97.2 m-70 -144.64 171.86 13.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.617 ' CE1' HG22 ' A' ' 46' ' ' VAL . 90.5 m-70 -130.45 148.44 52.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.3 t -90.97 136.75 32.86 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -72.84 -5.68 39.84 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.931 ' OD1' HD13 ' A' ' 58' ' ' ILE . 77.9 m-20 -100.81 -71.49 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.62 0.247 . . . . 0.0 111.47 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.5 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . 29.0 p -75.26 -24.72 57.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 111.614 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 14' ' ' TYR . . . 73.46 20.45 79.86 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.675 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 43' ' ' CYS . 22.6 m-85 -97.75 161.55 13.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.85 0.357 . . . . 0.0 110.538 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.808 ' C ' HD22 ' A' ' 47' ' ' LEU . 95.0 t -76.6 128.44 37.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.089 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.817 HD12 ' HB3' ' A' ' 51' ' ' CYS . 2.6 mm? -131.78 141.09 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.493 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.0 p -79.38 -179.78 6.99 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.707 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -56.89 -53.72 42.17 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.674 -1.251 . . . . 0.0 112.225 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD1' ' NE ' ' A' ' 53' ' ' ARG . 92.7 m-20 -55.38 -35.81 65.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.817 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.7 m -88.92 -2.15 58.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.389 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 97.8 p -131.87 26.39 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.707 ' HG3' ' O ' ' A' ' 49' ' ' GLY . 85.4 mtt180 -80.94 -18.3 47.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.828 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -80.08 162.9 24.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.106 0.479 . . . . 0.0 111.285 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.7 mtp85 -139.8 135.62 33.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HB2' ' CD1' ' A' ' 74' ' ' TYR . . . -157.93 153.39 26.14 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.814 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' N ' ' HA ' ' A' ' 66' ' ' PRO . . . -88.97 149.46 23.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.931 HD13 ' OD1' ' A' ' 42' ' ' ASN . 3.4 mt -125.81 82.36 64.26 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.855 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.14 -10.73 29.64 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 123.087 2.524 . . . . 0.0 114.028 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 65.0 mtt -86.85 -37.76 17.43 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 58' ' ' ILE . 30.2 mmm180 -83.07 1.01 42.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.648 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.51 7.2 62.0 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.284 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.901 HD12 HD12 ' A' ' 58' ' ' ILE . 74.3 mt -96.85 100.48 10.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.931 0.396 . . . . 0.0 110.154 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.5 p -86.66 -17.41 33.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.74 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.1 mt-10 -103.02 144.2 28.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.446 ' HA ' ' N ' ' A' ' 57' ' ' ALA . 31.8 Cg_exo -57.11 123.23 13.35 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 121.642 1.561 . . . . 0.0 111.683 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 74.3 mm-40 -125.35 167.15 15.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.849 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -70.89 137.46 49.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.555 0.693 . . . . 0.0 111.94 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.634 HG11 ' ND2' ' A' ' 42' ' ' ASN . 27.1 m -146.84 179.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.078 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 51' ' ' CYS . 1.7 p -94.49 -160.62 0.79 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' N ' ' SG ' ' A' ' 70' ' ' CYS . 20.9 t70 -85.02 -43.26 14.11 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.74 -44.94 80.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 111.82 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 42' ' ' ASN . 33.3 m -63.98 -40.85 97.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.554 ' CE2' ' NE ' ' A' ' 78' ' ' ARG . 75.8 t80 -57.94 -40.52 80.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.3 mt -69.76 -50.51 42.64 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.509 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.49 84.41 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.39 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD21 HG23 ' A' ' 58' ' ' ILE . 88.6 mt -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.836 0.351 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' NE ' ' CE2' ' A' ' 74' ' ' TYR . 16.6 mtt180 -68.12 -5.2 16.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.034 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 83.3 p -58.06 -20.62 40.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.602 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 m -112.17 150.69 30.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.687 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -63.47 151.45 41.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.767 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 62.1 mtt -83.89 143.05 30.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.842 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.51 -9.4 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.052 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.472 -1.182 . . . . 0.0 112.414 179.986 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 119.832 -0.427 . . . . 19.56 112.832 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.98 -48.19 7.06 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.025 1.816 . . . . 18.34 112.097 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mt -178.63 -53.94 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.792 -1.095 . . . . 17.73 108.475 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 41.32 -126.18 3.38 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.871 -1.059 . . . . 15.69 113.285 179.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.44 -34.5 54.52 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.652 -0.499 . . . . 15.14 109.652 179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.429 ' HA ' ' CE ' ' A' ' 6' ' ' MET . 14.8 mmt -50.31 -26.64 5.05 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.045 -0.525 . . . . 15.2 110.943 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.91 -22.25 40.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.068 -0.587 . . . . 12.41 113.208 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -47.64 -18.91 0.17 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.251 0.834 . . . . 11.0 113.251 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.63 -24.44 21.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.694 -1.224 . . . . 13.3 107.694 175.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.0 OUTLIER -70.82 67.07 0.38 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.823 -1.08 . . . . 8.3 108.182 175.552 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -19.07 107.62 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.474 0.71 . . . . 5.58 112.579 -178.435 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -38.32 93.39 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.781 0.801 . . . . 6.35 110.412 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' C ' ' HA3' ' A' ' 44' ' ' GLY . . . 94.13 86.26 1.64 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 107.661 -2.176 . . . . 1.23 107.661 -174.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -44.02 124.09 3.66 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.97 0.414 . . . . 0.49 111.879 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.444 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.4 p90 -78.21 124.33 27.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 3.44 110.79 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.444 ' HB3' HG23 ' A' ' 46' ' ' VAL . 44.8 tt0 -90.7 123.24 34.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.81 109.813 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -50.97 160.84 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 1.45 112.198 -178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -57.87 -56.48 21.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 2.02 111.414 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -61.9 -42.74 99.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 1.45 111.391 -179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -61.23 -27.78 68.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.175 -0.466 . . . . 1.18 111.236 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.08 76.65 41.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.558 -0.292 . . . . 0.27 111.313 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -76.22 -18.41 16.22 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.281 1.988 . . . . 0.36 112.497 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.88 148.95 52.57 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.434 -0.348 . . . . 0.16 110.838 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.6 t -55.16 124.78 18.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.17 111.7 -179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -64.48 -22.09 66.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 1.19 111.82 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.93 -68.11 1.4 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.649 -0.786 . . . . 0.17 113.792 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.9 p -88.56 -27.8 21.16 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.984 0.365 . . . . 0.17 111.984 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.67 22.28 26.6 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.455 -0.879 . . . . 0.15 112.73 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.0 p -83.25 144.56 29.66 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.805 0.336 . . . . 0.16 110.635 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.48 143.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.89 111.09 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CZ ' HG12 ' A' ' 46' ' ' VAL . 88.7 m-85 -89.91 130.48 36.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.914 -0.584 . . . . 0.23 111.099 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 p -120.46 175.32 6.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.19 110.728 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.8 m -54.91 -31.12 59.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.285 -0.416 . . . . 0.78 111.363 -179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.67 -44.91 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 1.2 111.078 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.67 108.41 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.012 0.434 . . . . 0.2 110.895 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -74.87 163.45 27.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.788 -0.642 . . . . 2.74 109.717 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HG2' HG13 ' A' ' 46' ' ' VAL . 15.1 ttm105 -88.64 152.86 21.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.747 0.647 . . . . 3.44 112.747 -178.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -157.52 139.61 14.35 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.342 -0.844 . . . . 0.22 110.369 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 15' ' ' TRP . 5.2 m-70 -106.7 155.41 19.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.975 0.417 . . . . 1.16 111.573 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.0 t -94.11 129.85 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.132 -0.692 . . . . 0.11 109.132 179.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -62.27 -17.76 59.41 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.817 0.673 . . . . 2.39 112.817 -177.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.549 ' ND2' HG11 ' A' ' 69' ' ' VAL . 66.1 m-80 -92.97 -69.32 0.75 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.665 0.269 . . . . 0.57 111.698 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.3 p -79.57 -41.36 27.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.519 -0.31 . . . . 0.11 111.52 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.448 ' HA3' ' C ' ' A' ' 13' ' ' GLY . . . 96.46 -13.02 66.07 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.416 -0.897 . . . . 0.1 113.497 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -58.6 163.55 3.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.761 -0.459 . . . . 0.4 109.761 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.794 ' C ' HD22 ' A' ' 47' ' ' LEU . 67.9 t -82.41 132.68 30.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.487 -0.485 . . . . 0.17 110.47 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.794 HD22 ' C ' ' A' ' 46' ' ' VAL . 3.3 mm? -133.79 142.68 47.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.609 -0.723 . . . . 0.13 110.875 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.1 p -82.45 -173.01 4.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.907 -0.588 . . . . 0.15 110.302 179.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.38 -57.95 16.96 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.604 -0.808 . . . . 0.16 112.925 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -52.66 -51.36 60.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.915 0.388 . . . . 1.15 111.606 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.43 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.6 m -66.98 -24.3 66.03 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.999 -0.546 . . . . 0.14 111.996 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.4 p -115.06 45.48 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.541 . . . . 0.15 110.645 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -97.64 -25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.471 -0.786 . . . . 2.44 110.815 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -73.92 169.79 16.71 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.324 0.583 . . . . 0.62 112.299 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.5 mtt85 -145.76 138.92 26.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.225 -0.898 . . . . 2.76 109.805 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.17 137.57 6.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.09 111.324 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.12 148.99 46.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.19 110.257 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.558 HG23 HD21 ' A' ' 77' ' ' LEU . 3.2 mt -126.59 76.57 74.11 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.595 -0.275 . . . . 0.2 111.234 -179.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.78 -26.53 79.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.403 2.069 . . . . 0.36 112.543 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 67.6 mtp -71.87 -30.85 65.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.425 -0.352 . . . . 1.96 110.759 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' HG2' HG22 ' A' ' 58' ' ' ILE . 15.5 mmm180 -101.3 21.69 13.67 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.346 -0.388 . . . . 1.43 111.671 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.31 25.33 68.65 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.67 -0.776 . . . . 0.52 113.268 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.497 ' CD1' HD12 ' A' ' 58' ' ' ILE . 33.1 mt -122.65 88.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.794 0.33 . . . . 0.17 110.671 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.1 p -76.56 -14.41 60.01 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.202 0.445 . . . . 0.27 112.202 -179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -101.49 147.96 34.54 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 121.22 -0.192 . . . . 2.02 110.908 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.32 120.59 8.56 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.13 1.887 . . . . 0.46 112.085 179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' HG21 ' A' ' 63' ' ' ILE . 69.9 mm-40 -125.78 164.07 21.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.047 0.451 . . . . 1.46 111.048 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -75.08 136.58 41.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.816 -0.629 . . . . 2.42 112.531 -178.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.549 HG11 ' ND2' ' A' ' 42' ' ' ASN . 33.4 m -144.31 -172.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.105 -0.952 . . . . 0.19 109.534 179.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.438 ' CB ' ' HG ' ' A' ' 47' ' ' LEU . 3.9 p -100.02 -157.18 0.59 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.186 -0.302 . . . . 0.16 110.186 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -83.43 -50.36 8.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.852 -0.339 . . . . 1.63 111.025 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.52 -64.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.408 . . . . 0.12 110.959 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 62.5 m -50.55 -39.67 49.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.16 111.813 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -59.76 -34.16 72.62 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.108 -0.701 . . . . 0.27 109.108 177.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 79' ' ' SER . 8.3 mt -80.69 -44.03 19.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.229 -0.896 . . . . 0.26 109.473 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 73' ' ' CYS . . . -51.93 -50.76 60.51 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.634 -0.712 . . . . 0.19 110.727 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.558 HD21 HG23 ' A' ' 58' ' ' ILE . 60.7 mt -64.56 -37.5 87.75 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.806 -0.813 . . . . 0.26 108.806 178.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.94 -30.73 70.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.538 -0.912 . . . . 2.3 108.538 176.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 81' ' ' ASN . 1.9 m -61.34 -15.96 41.19 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.305 -0.861 . . . . 1.46 110.916 179.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 t -67.54 70.21 0.11 Allowed 'General case' 0 C--N 1.345 0.405 0 N-CA-C 108.729 -0.841 . . . . 3.14 108.729 178.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 79' ' ' SER . 0.7 OUTLIER -33.9 143.19 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.642 0.978 . . . . 6.23 113.642 -177.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.0 132.75 54.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.005 -0.998 . . . . 8.68 110.905 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.13 26.85 3.08 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.176 -0.466 . . . . 9.26 111.638 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.426 -1.208 . . . . 11.33 112.314 -179.962 . . . . . . . . 0 0 . 1 stop_ save_